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 This thesis details the use of aromatic ions, especially aminocyclopropenium ions, as 
empowering design elements in the development of new chemical reactions, organic catalysts 
and polymeric materials. A particular focus is placed throughout on understanding the 
relationship between the structure of aromatic ions and their performance in these novel 
applications. Additionally, the benefits that aromatic ions provide in these contexts are 
highlighted. 
 The first chapter briefly summarizes the Lambert Group’s prior efforts toward exploiting 
the unique reactivity profiles of aromatic ions in the context of new reaction design. Also 
provided in the first chapter is a comprehensive literature review of aminocyclopropenium ions, 
upon which the majority of advances described in this thesis are based.  
To set the stage for the first application of aminocyclopropenium ions, Chapter 2 
provides an account of existing highly Brønsted	  basic functional groups, including guanidines, 
proazaphosphatranes and iminophosphoranes. The provided review on the synthesis and use in 
asymmetric catalysis of these bases indicates that there is a high need for conceptually new 
Brønsted	  basic functional groups.  
To address this need, the development of chiral 2,3-bis(dialkylamino)cyclopropenimines 
as a new platform for asymmetric Brønsted	  base catalysis is described in Chapter 3. This new 
class of Brønsted	   base is readily synthesized on scale, operates efficiently under practical 
conditions, and greatly outperforms closely related guanidine-based catalysts. Structure-activity 
relationship studies, mechanistic experiments and computational transition state modeling are all 
discussed in the context of asymmetric glycinate imine Michael reactions in order to arrive at a 
working model for cyclopropenimine chemistry. Cumulatively, this chapter provides a “user’s 
guide” to understanding and developing further applications of 2,3-
bis(dialkylamino)cyclopropenimines.  
The use of our optimal chiral 2,3-bis(dialkylamino)cyclopropenimine catalyst to promote 
asymmetric Mannich reactions of glycinate imines and N-Boc-aldimines is described in Chapter 
4. The products of this transformation are optically enriched α,β-diamino acid derivatives, an 
important motif widely utilized in medicinal and synthetic chemistry. Importantly, unlike 
existing methods, our technology promotes reactions between tert-butyl glycinate and aliphatic 
N-Boc-aldimine substrates. A preparative-scale reaction is demonstrated and derivatization of its 
product to several valuable chiral compounds is shown. 
Chapter 5 describes the use of tris(dialkylamino)cyclopropenium (TDAC) ions as a new 
class of onium-like catalyst. A simple TDAC chloride salt is prepared on a 75-gram scale and its 
use as a phase transfer catalyst for a variety of reactions is demonstrated. This same salt is also 
utilized as an epoxide opening catalyst for a variety of transformations, including the fixation of 
carbon dioxide. 
Chapter 6 briefly highlights several continued applications of the chemistry advanced 
throughout this thesis. First, the work of other members of the Lambert Group toward the 
continued development of cyclopropenimine chemistry is described. Second, a broad initiative 
between the Lambert and Campos Groups at Columbia University focused on the synthesis and 
application of TDAC-based polymers is introduced. Lastly, the identification of a previously 
unknown equilibrium between fulvenes and imines/aldehydes in the context of a new mode of 
catalysis is presented. 
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Chapter 1 
Aromatic Ions and the Lambert Group 
 
Introduction 
Hückel’s rule, introduced in 1931, predicts that cyclic planar compounds with 4n+2 (n = 
integer) π electrons will exhibit aromatic stabilization.1 An important consequence of Hückel’s 
rule is that planar cyclic ionic species can also enjoy the benefits of aromaticity. In this way, 
chemical species bearing net ionic charge and/or ring strain can exhibit high stability if they obey 
Hückel’s rule. Indeed, the many known compounds containing cyclopropenyl cations 2 , 
cyclopentadienyl anions 3  and cycloheptatrienyl cations 4 , are all testaments to aromatic 
stabilization. The dichotomy of being electronically charged yet stable bestows these aromatic 
ions with the unique ability to shuttle between stable aromatic ion-pairs and uncharged covalent 
compounds (Scheme 1). Strategic exploitation of these equilibria provides opportunities for the 
design of conceptually new chemical transformations and reaction processes. In this regard, the 
Lambert group has recently pioneered the use of aromatic ions in reaction and catalyst design. 
 
Scheme 1. Equilibria with aromatic ions. 
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In 2009, the Lambert group initiated a research program aimed at developing aromatic 
ions and aromatic ion-like species as promoters and catalysts for organic chemical 
transformations. This was an especially exciting premise given the wealth of information 
available from the field’s many years of studies on ionic aromatic compounds; however, it was 
surprising to note that almost no examples or general concepts regarding aromatic ions serving as 
catalysts or reagents existed at the time.5 The unique properties exhibited by aromatic ions 
coupled with their modularity and tunability has since provided the Lambert group with an ever-
increasing terrain for chemical exploration.   
 
Aromatic Ions and the Lambert Group 
At the time I joined the Lambert group in 2009, three classes of applications using 
aromatic ions in organic transformations were actively being developed. These included (a) 
cyclopropenium-activation of alcohols; (b) cyclopentadienyl anions as carbon-based leaving 
groups; and (c) tropylium promoted α-substitution of aliphatic amines.  
In 2009, Dr. Brendan Kelly discovered that rapid chlorodehydration of simple alcohols 
occurred in the presence dichlorodiphenylcyclopropene. It was thus shown that alcohols rapidly 
react with cyclopropenes bearing geminal leaving groups to form cyclopropenium ethers. This 
ultimately was conceptualized as a general activation paradigm for alcohols, and the Lambert 
group went on to develop a number of methodologies based on this mode of reactivity (Scheme	  
2). In the seminal report, chloride anion displaced the cyclopropenium-activated alcohol 
intermediate to deliver alkyl chlorides in high yields with quantitative formation of 
cyclopropenone byproduct (Scheme	   2a). 6  By using methanesulfonic anhydride as a 
cyclopropenone-activating agent, mesylate anion displacement of alcohols was also achieved 
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(Scheme	   2b).7 Cyclization of diols to form cyclic ethers was also developed under similar 
reaction conditions (Scheme	  2c).8 Cyclopropenium activation has additionally been extended to 
Beckmann rearrangements, rapidly converting oximes to amides via a dehydrative molecular 
rearrangement (Scheme	   2d).9 Lastly, an analogous process for effecting nucleophilic acyl 
substitutions was reported in 2009 (Scheme	  2e).10 Notably, this methodology is compatible with 
amine bases and is especially effective for peptide couplings.  
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Scheme 2. Cyclopropenium-promoted dehydrative transformations. 
 
In 2011 the group developed conditions that allowed for catalytic quantities of 
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cyclopropenone is initially activated to a cyclopropene bearing geminal leaving groups, which is 
then capable of forming a cyclopropenium-activated alcohol. After nucleophilic attack on this 
key species has occurred, cyclopropenone is reformed and can undergo initiation again. It was 
thus shown that both oxalyl chloride and methane sulfonic anhydride7 were effective activating 
agents for the cyclopropenone-catalyzed alcohol substitution with chloride and mesylate anions, 
respectively. 
The Lambert group has also been interested in studying negatively charged aromatic ions, 
such as the cyclopentadienyl anion. The group’s first disclosure regarding the cyclopentadienyl 
anion described the ability of penta(4-acylphenyl)cyclopentadienyl anion to serve as a competent 
nucleofuge in Tsuji-Trost reactions (Scheme	  3).12 This behavior is attributed to the high stability 
of the substituted-cyclopentadienyl anion, mainly a consequence of aromatic stabilization.  
 
 
Scheme 3. Cyclopentadienyl anion as a nucleofuge. 
 
In a closely related application and project that I was involved in, we demonstrated that 
fulvene formation between imines and cyclopentadienes can be a reversible process (Scheme	  
4).13 As above, cyclopentadienes bearing electron-withdrawing groups were competent leaving 
groups (in fulvene to imine equilibrium direction). Reversible fulvene formation was an 
important discovery for our lab because at the time we had a number of project ideas that relied 
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Scheme 4. Reversible fulvene formation with imines. 
 
Lastly, a method utilizing tropylium cations as promoters for the α-cyanation of aliphatic 
amines has also been developed (Scheme	   5).14 In this process the tropylium ion oxidizes the 
amine via α-hydride abstraction yielding an iminium ion and cycloheptatriene. The resulting 
iminium ion is then trapped by a cyanide ion to yield valuable α-amino nitriles. The use of the 
tropylium aromatic cation for this process is attractive because the oxidant is a simple, shelf-
stable salt that produces a volatile hydrocarbon upon reduction. 
 
 
Scheme 5. Tropylium-promoted amine cyanation. 
 
The above reactions highlight the variety of reaction processes that aromatic ions may 
participate in. Especially promising is the use of carbon-based aromatic cations, such as the 
cyclopropenium ion, as catalysts for selective transformations. Not discussed above are amino-
substituted cyclopropenium ions; these cations represent an extremely stable class of aromatic 
ions that have unparalleled modularity via amino group substitution. Indeed, the bulk of this 
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review describing the synthesis, properties, reactivity and applications of these ions is provided 
below to set the stage for this thesis. 
 
Introduction to Aminocyclopropenium Ions15 
In 1957, Breslow famously reported the first synthesis and characterization of a 
cyclopropenium ion.2 Although cyclopropenium ions had been theorized to be stable aromatic 
species, it was not experimentally verified until Breslow’s disclosure of the 
triphenylcyclopropenium ion. Since then, alkyl- and aryl-substituted cyclopropenium ions have 
been the focus of many theoretical, experimental and application-focused research articles that 
have greatly contributed to chemists’ understanding of aromaticity.16 Aminocyclopropenium ions 
are a particularly intriguing subclass of the cyclopropenium ion that were first reported in the 
1970’s and are beginning to emerge as significant interest across chemical disciplines.17 Indeed, 
the presence of nitrogen atoms adjacent to the cationic cyclopropenium core bestows 
aminocyclopropenium ions with relatively high stability for a carbocation. This stability leads to 
a number of rather remarkable physical properties and reactivity trends that have only recently 
started being exploited for application-based research. The simple synthesis of these compounds 
coupled with their potentially useful properties make them ideally suited for application 
development, and in this regard aminocyclopropenium ions have now found use as ionic liquids, 
metal ligands and organocatalysts. The synthesis, chemical properties and development of these 
applications are detailed throughout this chapter. The information detailed below both inspired 
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Synthesis of Aminocyclopropenium Ions 
Yoshida reported the first synthetic approach to tris(dialkylamino)cyclopropenium 
(TDAC) ions in 1971 in a process that has proved timeless, as it still represents the simplest 
mode of accessing these species.17 Yoshida’s approach involves the simple addition of excess 
dialkylamine to tetrachlorocyclopropene (26),18, 19 followed by the addition of perchloric acid to 
achieve anion exchange (Figure 1). Using this method, Yoshida initially reported triple addition 
of small dialkylamines (dimethylamine, piperdine, morpholine and N-alkyl anilines) to the 
cyclopropenium ring to deliver essentially quantitative yields of salts 27–32. Notably, although 
the original methodology reported involved refluxing these reaction solutions for extended time 
(24+ h), we have since found that these additions typically occur rapidly at room temperature for 
most dialkylamines. Additionally, perchlorate anion exchange is not necessary and the chloride 
salts of these aminocyclopropenium ions can easily be obtained; however, some 
aminocyclopropenium chloride salts are water soluble, which can make laboratory handling and 
purification difficult. Nevertheless, most aminocyclopropenium ions can be prepared in a process 
derived from this original methodology and indeed, the majority of aminocyclopropenium ions 
synthesized in this thesis utilized closely related approaches. 
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Figure 1. TDAC synthesis from tetrachlorocyclopropene. 
 
Yoshida also described in his initial report that sterically hindered dialkylamines, such as 
diisopropylamine, only add twice to the cyclopropenium ion leading to 
chlorobis(dialkylamino)cyclopropenium ions of type 33. Clearly, the cyclopropenium scaffold is 
only able to accommodate two amino groups of this type, as a third addition would result in 
significant steric interactions between the alkyl chains of the amino groups. It turns out, 
however, that this reactivity pattern allows for simple modification of the resulting 
chlorobis(dialkylamino)cyclopropenium ions, a process that is commonly exploited for the 
preparation of aminocyclopropenium ions used in applied chemistry. An example of this is salt 
34, which we utilize throughout this thesis for simple access to many of our useful 
aminocyclopropenium ions.20 
 A slight modification to Yoshida’s method was reported in 1994 by Taylor that utilizes 
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additional equivalent of amine is used to promote HCl elimination from 37 to access 
tetrachlorocyclopropene in situ (Scheme 6). The advantage of this process is that the standard 
procedure for isolating tetrachlorocyclopropene (26) can be a labor intensive and low-yielding 
process from pentachlorocyclopropane (37). Meanwhile, the synthesis and purification of 
pentachlorocyclopropane (37) is straightforward and can be done in multi-hundred gram scale. 
Moreover, pentachlorocyclopropane (37) is prepared from trichloroethylene (35) and sodium 
trichloroacetate (36), both commodity chemicals. Indeed, we prepare our optimal 
aminocyclopropenium catalysts discussed in Chapters 3 and 5 via this method, thus allowing 
truly preparative and economical access to these valuable systems.  
 
 
Scheme 6. TDAC synthesis from pentachlorocyclopropane. 
 
Weiss reported in 1975 a fundamentally different approach to aminocyclopropenium ions 
than Yoshida’s general method. 22  Detailed in Figure 2, the Weiss process utilizes 
trimethylsilylamines as simple reagents that add directly to tetrachlorocyclopropene (26), 
quantitatively yielding aminocyclopropenium chloride salts (39–41) with chlorotrimethylsilane 
as the only byproduct. This method obviates the need for excess base and allows for preparation 
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As previously mentioned, certain aminocyclopropenium chloride salts are water-soluble making 
their purification somewhat difficult; however, Weiss’s trimethylsilylamine method allows for 
easy access to these salts as simple reaction concentration typically delivers pure materials. 
Although we do not use Weiss’s protocol in the work detailed in this thesis, our lab has found it 
quite useful for a number of other aminocyclopropenium applications not detailed herein. 
 
 
Figure 2. Trimethylsilylamine addition to tetrachlorocyclopropene method for TDAC synthesis. 
 
It is worth highlighting that Weiss’s trimethylsilylamine method allows for the 
installation of primary amino groups onto the cyclopropenium ring (Scheme 7). Thus, Weiss 
used this method to prepared tris(anilino)cyclopropenium salt 42, which was deprotonated to 




Scheme 7. TDAC synthesis with primary amines.  
 
Taub modified Yoshida’s procedure in 1976 to access 
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procedure involves the simple addition of diisopropylamine to phenylcyclopropene 44 and it was 
also shown that the products of this reaction can be hydrolyzed to deliver amino/aryl 
cyclopropenones (46). Notably, when smaller amines, such as dimethylamine, were employed, 
this hydrolysis reaction yielded ring-opened decomposition products of type 47.  
 
 
Scheme 8. Synthesis of aminoarylcyclopropenium ions. 
 
This decomposition process exemplifies the well-known tendency of cyclopropenium 
ions and cyclopropenes25 to undergo nucelophilic ring opening. As will be discussed in Chapter 
3, we’ve also observed ring opening in related systems and have worked to reduce the tendency 
of these species to decompose via this pathway. The mechanism of this ring-opening pathway is 
described in Scheme 9. Clearly, the principle driving force for this reaction is the relief of ring 
strain of the cyclopropene system; thus, if nucelophilic attack is not sterically blocked, ring 
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Scheme 9. Cyclopropene fragmentation mechanism. 
 
Using chlorobis(dialkylamino)cyclopropenium salts of type 52, Yoshida developed a 
procedure to access aryl-substituted derivatives of type 53.26 Thus, aryl Grignard addition to 52 
(Scheme 10, top), or better, aryl Grignard addition to methoxy-substituted cyclopropenium ions 
of type 55, delivers bis(dialkylamino)arylcyclopropenium ions 53 in good yields.  
   
 
 
Scheme 10. Grignard additions to chlorocyclopropenium salts.  
 
 In summary, Yoshida’s method for the simple addition of dialkylamines to 
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can be easily adapted for the synthesis of other related aminocyclopropenium ions. These 
methods, having been developed decades ago, remain the ideal routes toward these ions and have 
undoubtedly aided the study of aminocyclopropenium ion properties and the development of 
their applications. 
Properties of Aminocyclopropenium Ions 
The aromatic core, flanked with three nitrogen atoms capable of conjugation, reduces the 
energetic penalty for having an incomplete octet thus making aminocyclopropenium ions some 
of the most stable carbocations known today.27  One measure of the stability of a carbocation is 
its pKR+ value, which is numerically equivalent to the pH of an aqueous solution in which a 
given cation is 50% converted to the corresponding carbinol. Selected values for substituted 
cyclopropenium ions are given in Figure 3. Notably, the tris(dimethylamino)cyclopropenium ion 
was estimated by Yoshida to have a pKR+ value of around 13.28 Indeed, even the presence of just 
a single amino group on a cyclopropenium ion can lead to pKR+ values above 13.29  These high 
pKR+ values indicate that even in strongly basic solution, aminocyclopropenium ions retain their 
cationic charge. This fact leads to a number of other intriguing properties and also has direct 














Ph Ph+ n-Pr n-Pr
+
n-Pr
–6.6–7.4 3.1 7 13 (est)
pKR+ values
	   15 
One such related property to their high stability is the observation that  
tris(dialkylamino)cyclopropenium ions can actually be considered electron-rich, or electron-
surplus, cations in many settings. For example, Weiss reported the one-electron oxidation of 
TDAC ions 38 via treatment with antimony (V) chloride; this reaction led to isolable TDAC 
radical dications (56) that are brick-red microcrystals and are stable in the atmosphere for hours 
(Scheme 11).22 Yoshida has reported on similar work as well.30 
 
 
Scheme 11. One-electron oxidation of TDAC ions. 
 
The electron-rich nature of TDAC ions also led Weiss to predict that certain salts of this 
type might experience a repulsive interaction between the TDAC cation and its counteranion, a 
phenomenon Weiss termed “ion-pair strain.” 31 The rationale for this prediction is shown in 
Figure 4; on the left, the symmetrical orbitals of the TDAC ion indicate that its high-energy 
HOMO is symmetrical around the cyclopropenium ring. This symmetrical nature results in 
mutual electronic repulsion between HOMOs when, for example, a chloride anion is aligned 
with the cationic cyclopropenium core (Figure 4, right). Ultimately, these repulsive orbital 
interactions lead to highly unstablized, or “naked,” counteranions that should have increased 
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Figure 4. Orbital repulsion in TDAC chloride salts. 
 
Weiss demonstrated the “ion-pair strain” phenomenon via the preparation of several 
remarkable H-bonding adducts between a variety of acids and TDAC chloride salts. For 
example, treatment of benzoic acid with TDAC chloride 39 led to complex 57, which was 
characterized by X-ray diffraction analysis (Scheme 12). Interestingly, TDAC salts of this type 
can thus be used to solubilize carboxylic acids in organic solvents by disrupting H-bonded 
carboxylic acid dimer interactions. Weiss also showed similar interactions with a range of 
phenols to access structures of type 58 (Scheme 12). Importantly, other strong chloride donors 
such as tetraethylammonium chloride, hexamethylguanidinium chloride, N[P(NMe2)3]2Cl, or 
P[NP(NMe2)3]4Cl do not participate in such H-bonding complexes. This direct comparison hints 
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Scheme 12. Ion-pair strain complexes of TDAC ions. 
 
In a related observation, Curnow reported the structure of TDAC chloride hydrate salt 59 
in which the chloride anions were associated with the water molecules instead of the cationic 
cyclopropenium ion (Figure 5).32  As shown in Figure 60, the chloride anions form a dichloride 
hexahydrate “cube” wherein the chloride anions are surface ions each bearing three H-bonds. 
 
 
Figure 5. Crystal structure of tris(diisopropylamino)cyclopropenium chloride trihydrate. 
 
The “ion-pair strain” phenomenon is not unique to chloride anions; in 1995 Weiss 
demonstrated that TDAC iodide salts also show remarkable reactivity patterns. 33   Thus, 
tris(dimethylamino)cyclopropenium iodide (61) reacts with iodoalkynes to yield complexes of 
type 62 (Scheme 13). In this reaction, the organic iodide serves as a σ* acceptor for the highly 
nucleophilic iodide anion. Interestingly, when diiodoacetylene was used as an acceptor, a one-
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Scheme 13. TDAC iodide complex with 2-iodo-1-phenylacetylene. 
 
Weiss also demonstrated that certain electron-deficient iodoarenes also serve as 
competent σ-acceptors for this type of adduct-chemistry (Scheme 14).34 Importantly, products of 
these reactions (64) were characterized via X-ray diffraction in order to show that the 
Meisenheimer complexes of type 65 were not being formed. A selection of competent iodoarenes 
is included in Scheme 14. 
 
 
Scheme 14. TDAC iodide additions to iodoarenes. 
 
Reactivity of Aminocyclopropenium Ions 
A major consequence of the electron-rich nature and high stability of TDAC ions is their 
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values, and indeed hydrolysis of TDAC ions requires heating under highly basic solutions. These 
reactions thus lead to cyclopropenones like 66 (Scheme 15); however, if the amino group is 
electron-deficient, such as N-methylanilino, then ring-opening products often compete with the 
hydrolysis pathway to yield acrylamides (67).35 The basic hydrolysis of TDAC ions generally 
provides a reliable route to 2,3-bis(dialkyamino)cyclopropenones, which can be treated with 
oxalyl chloride to deliver chlorobis(dialkylamino)cyclopropenium salts; this process is useful for 
accessing TDAC salts that feature only two relatively small amino groups (i.e. 2,3-
bis(dimethylamino)cyclpropenium salts). We used this protocol to access cyclopropenimines 
derived from 2,3-bis(pyrrolidino)cyclopropenium salts (Chapter 3). 
 
 
Scheme 15. Hydrolysis of TDAC ions. 
 
Breslow took advantage of the well-known susceptibility of cyclopropenones to undergo 
a decarbonylative [2+1] reaction in the context of 2,3-bis(dialkylamino)cyclopropenones 
(Scheme 16).36 Thus, cyclopropenones of type 69, which can be prepared by hydrolysis from 
TDAC salts 68, yield ynediamines (70) when heated under pyrolysis conditions. Importantly, 
these synthetically valuable ynediamines37 are typically prepared using toxic and unstable 
dichloroacetylene38; thus, Breslow’s approach to these compounds represents a scalable and 
reliable approach to ynediamines. This chemistry represents the only known use of TDAC ions 
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Scheme 16. Ynediamine synthesis via cyclopropenone intermediates. 
 
Applications of Aminocyclopropenium Ions I: Ionic Liquids 
Curnow recently discovered that certain TDAC salts have ionic liquid (IL) properties 
(Scheme 17).39  ILs, as their name suggests, are salts that exist as liquids at relatively low 
temperatures; these types of salts have recently emerged as attractive materials with potential 
applications in synthetic, medical and energy-related domains.40 Despite the widespread interest 
in ILs, most reported variants are derived from imidazolium, ammonium, pyrrolidinium and 
phosphonium scaffolds. Therefore, the realization that TDAC ions can also serve as ILs brings 
new design possibilities to this area of research. Specifically, Curnow has shown that readily 
prepared TDACs of type 72 have melting points that range between 7 and 105 °C, and whose 
thermal decomposition onset temperatures are all above 290 °C (the highest being 409 °C). 
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With respect to synthetic utility, ionic liquids have found use as reaction media for a 
range of reaction processes. Their use in this regard can be beneficial due to their low vapor 
pressure, high dielectric constant and recyclability possibilities. Curnow demonstrated the 
employment of the TDAC ionic liquid [C3(NBu2)3]BF4 as a solvent for the alkylation of sodium-
β-naphthoxide (73). It is well established that reaction selectivity of ambident nucleophiles of 
this type depends on the solvent media;41 it was thus shown that TDAC ionic liquids yielded 
product with greater selectivity than other common ionic liquid solvents (Scheme 18).42 To date, 
this is the only application of TDAC ILs although it hints at the advantages this class of ions may 
provide to the IL field. 
 
 
Scheme 18. Application of TDAC ionic liquids in alkylation reactions. 
 
Applications of Aminocyclopropenium Ions II: Metal Complexes 
Almost immediately after their discovery, cyclopropenium ions began being explored for 
their potential to serve as metal ligands. Along these lings, a significant body of literature is 
available regarding the use of alkyl- and aryl-substituted cyclopropenium ions in metal ligand 
chemistry.16 Aminocyclopropenium ions have their own unique binding modes to metals that 
have only recently been utilized within the context of catalysis. The binding modes reported for 
aminocyclopropenium species can be divided into four categories: (a) TDAC π-complexes, (b) 
bis(dialkyamino)cyclopropenium (BDAC) σ-complexes, (c) cyclopropenimine nitrogen(I)-based 
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ligands, and (d) BDAC-phosphorus ligands (Figure 6). This section highlights important 




Figure 6. Binding modes of TDAC-related species with metals. 
 
TDAC π-complexes. A large number of alkyl- and aryl-substituted cyclopropenium ions have 
been used as electron-accepting ligands for metals. TDAC ions, however, are not capable of 
binding in this manner due to their extreme electron richness and orbital repulsion with 
nucleophilic species. Harris and Gray attempted to reverse this bonding scenario and utilize 
TDAC ions as π-donor ligands for palladium and platinum metal centers.43 However, as is shown 
in Scheme 19, only simple anion exchange was observed with metal chlorides when treated with 
TDAC salt 39. No bonding between the cyclopropenium ion and the metal was observed in the 
crystal structure and reactivity experiments further confirmed this arrangement.  
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BDAC σ-complexes.	  Carbene ligands, especially N-heterocyclic carbenes (NHCs), are widely 
used to exquisitely tune and control reactivity of metal centers through electronic and steric 
regulation.44 The ability of these ligands to affect the reactivity of the metal center has proven 
critical for advancing many classes of metal-catalyzed transformations. Central to their success is 
the excellent σ-donor properties of NHC ligands. Identification of new scaffolds with strong σ-
donor properties provides an alternative approach toward catalyst tuning and in this regard 
bis(dialkylamino)cyclopropenylidene compounds represent an exciting new avenue of ligand 
research.  
In a landmark report, Bertrand and coworkers synthesized and characterized the first free 
cyclopropenylidene 78 in 2006 (Scheme 20).45  It was found that only specific combinations of 
anions of salt 77 with certain bases provided the uncomplexed carbene 78.46 The crystal structure 
of 78 revealed a carbene bond angle of just 57.2° and that there was significant π-donation of the 
amino groups to the cyclopropenium ring. These results suggest that cyclopropenylidenes could 
perhaps function as metal ligands with similar efficacy as NHC ligands. Unsurprisingly, 
treatment of 78 with carbon dioxide delivered betaine 79 in near quantitative yield.47 
 
 
Scheme 20. Synthesis of free cyclopropenylidene 78. 
 
The isolation of a free bis(dialkylamino)cyclopropenylidene in 2006 also suggested that 
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that is characteristic of NHC compounds. In 2007, Tamm reported chiral cyclopropenylidene 81 
and its use as a catalyst for the benzoin condensation of benzaldehyde.48  Although few details 
were provided, compound 80 was produced with 18% ee, thus demonstrating the feasibility of 
enantioselective cyclopropenylidene catalysis.  
 
 
Scheme 21. Asymmetric benzoin reaction with a chiral cyclopropenylidene. 
 
In a more recent report, Gravel discovered that simple 
bis(diethylamino)cyclopropenylidine 83 was an effective catalyst for a range of carbene-
catalyzed acyl anion Umpolung reactions. 49  For the Stetter reaction between p-
methoxybenzaldehyde and trans-chalcone, cyclopropenylidene 83 was shown to be significantly 
more active than other widely used catalysts such as thiazolium 84 and triazolium 85 (Scheme	  
22).  
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Returning to their use as metal ligands, the literature regarding 
bis(dialkylamino)cyclopropenylidene compounds as metal ligands can be divided into two 
categories based on how the metal complexes are prepared. Prior to Bertrand’s isolation of free 
cyclopropenylidene 78, metal complexes of these carbenes were accessed via transmetalation of 
lithium adducts. Since then, several reports have accessed metal complexes directly from the free 
cyclopropenylidene. These two categories are only briefly highlighted below, although an in-
depth review on these complexes is available to the more interested reader.50 
BDACs of type 86 can be lithiated with nBuLi to access lithiated-cyclopropenium 87 that 
can be added to a variety of electrophiles and metals in situ to deliver adducts of type 88–91 
(Scheme 23).51,52 Notably, although it had been discussed in the literature for decades, Bertrand 
isolated and characterized adduct 87 for the first time in 2006.47  
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The high nucleophilicity of free cyclopropenylidene 78 has recently allowed access to a 
variety of interesting metal complexes (Scheme 24). For example, the strong σ-donating ability 
of 78 allowed for the substitution of PPh3 in Wilkinson’s catalyst (92) and the displacement of 
bidentate ligands such as TMEDA from Pd (93) and COD from Ni complexes (94).53 More 
recently, 78 was found to stabilize mononuclear iron complexes, such as 95.54 
 
 
Scheme 24. Synthesis of BDAC-metal complexes from free cyclopropenylidene 78. 
 
Although a large number of cyclopropenylidene-metal complexes have been prepared, 
only several uses of these complexes for catalysis have been reported. This is especially 
surprising considering it is now well-known that the σ-donating ability of 
bis(dialkylamino)cyclopropenylidenes can exceed that of NHC ligands. Yoshida reported the 
first use of BDAC-metal complexes in catalysis in 1988 (Scheme 25a).55  It was shown that 
palladium complexes of this type rapidly catalyze the isomerization of quadricyclane (96) to 
norbornadiene (98). Notably, an amino-substituted cyclopropenylidene vastly outperformed an 
alkyl-substituted cyclopropenylidene. Montgomery much more recently utilized BDAC ligands 
in the catalysis of the reductive coupling of aldehydes and alkynes.56  A particularly selective 
reaction is shown in Scheme 25b as an example of this transformation. It’s expected that BDAC 
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Scheme 25. BDAC-metal complexes in catalysis. 
 
Cyclopropenimine ligands.	   Alcarazo developed the first practical application of 
cyclopropenimines in 2010 when they were shown to be an interesting new class of metal 
ligand. 57  A variety of bis(dialkylamino)cyclopropenimines (101) were prepared by amine 
addition to salt 86 followed by deprotonation with strong base (Scheme 26). These 
cyclopropenimines were then complexed to rhodium to access complexes of type 102. Their 
infrared CO stretching revealed that the cyclopropenimine ligand was strongly coordinating; 
notably, however, the substituent identity on the cyclopropenimine imino head group had little 
effect on the donating ability.  
 
 
Scheme 26. Synthesis of cyclopropenimines and their Rh complexes. 
 
Alcarazo hypothesized that these cyclopropenimines could potentially serve as nitrogen 
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unequivocally proven when a biscyclopropenimine complexed to palladium(II) chloride revealed 
that each imino nitrogen was coordinated to two metal centers (103, Figure 7). A gold complex 




Figure 7. Some cyclopropenimine-metal complexes. 
 
BDAC-Phosphorus ligands.  Alcarazo also extended the cyclopropenimine concept to 
cyclopropenylidene-stabilized phosphenium cations of type 105.58 It was expected that much like 
cyclopropenimines, the strong σ-donating ability of the bis(dialkylamino)cyclopropenylidene 
core would provide significant stabilization of the phosphenium center while at the same time 
resist π-back donation. Salts 105 were trivially prepared from 86 in high yields (Scheme 27). 
Rhodium complexes (not shown) of these phosphenium ligands revealed that they possessed 
similar donor properties as simple triarylphosphines. 
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Gold complexes 106 of these phosphenium ligands were also prepared in a simple ligand 
exchange process (Scheme 28). Alcarazo demonstrated that complex 106 possessed high 
catalytic activity for a range of typical gold-catalyzed reactions. For example, high yields were 
achieved for (a) hydroarylation, (b) cyclopropanation, (c) hydroxide abstraction and 
rearrangement, and (d) cycloisomerization of enynes (Scheme 28). An important highlight of 
these catalyst systems is their simple recyclability; for example, the reaction shown in Scheme 
28d was repeated five times with the same recycled catalyst 106 with no loss in yield. 
 
Scheme 28. BDAC-phosphorus gold complexes as catalysts for a range of transformations. 
 
The principle behind cyclopropenylidene-stabilized phosphenium cations was taken to 
the extreme by Alcarazo in 2011 when he reported the preparation of tricationic species of type 
[L3P]+3, where L = cyclopropenylidene (Scheme 29).59 A variety of tricationic phosphenium ions 
(116) were trivially prepared from salt 52 in a reverse electron demand “onio-substituent 
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single bonds. Again, simple complexation was accomplished to palladium and platinum metals 
to access compounds 117 and 118. 
 
 
Scheme 29. Tricationic tris(BDAC)phosphorus ligands. 
 
In the case of these tricationic phosphenium complexes, significant π-back-donation of 
the metal to the phosphorus atom increases the π-acidity of the metal center. Alcarazo exploited 
this effect in the context of hydroarylation catalysis of alkynes.60 Thus, after chloride abstraction 
by treatment with Ag[CB11H6Cl6], 118 efficiently promoted the hydroarylation at 5 mol% 
catalyst loadings of a variety of ortho-alkynylated biaryls (Scheme 30). In this report, 22 
substrates with wide functional group tolerability were included. Notably, catalyst 118 was 
significantly more active than any other ligand system tested, including PPh3, P(OPh)3 and 
P(C6F5)3 complexed with PtCl2. It is likely that catalysts of type 118 could find wide utility as 
catalysts for π-activation of a variety of functional groups. 
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Aminocyclopropenium Ions Summary 
Since their first synthesis in 1971, aminocyclopropenium ions have been revealed to be 
extremely intriguing molecules with a number of fascinating structural and reactivity properties. 
Early work by pioneers such as Yoshida and Weiss gave chemists straightforward access to bulk 
quantities of aminocyclopropenium derivatives. Additionally, their work revealed that these 
highly stable carbocationic species generally resist nucleophilic attack and can even increase the 
nucleophilicity of their counteranions via electronic repulsions. By far, the most common use of 
aminocyclopropenium ions has been their employment as metal ligands; however, the use of 
these ions as ionic liquids and carbene organocatalysts has also been recently demonstrated. 
The reliable availability of aminocyclopropenium ions coupled with their interesting 
properties attracted our attention in 2010. As part of a broader program on aromatic ions as 
design elements in catalysis, we began exploring ways of exploiting aminocyclopropenium ions 
for useful applications. This thesis reports my efforts in this regard. Chapters 3 and 4 detail the 
use of chiral 2,3-bis(dialkylamino)cyclopropenimines as highly effective enantioselective 
Brønsted base catalysts. In Chapter 5, we exploit the high stability and “ion-pair strain” of 
TDAC ions within the context of phase transfer catalysis and nucleophilic catalysis. Last, 
Chapter 6 introduces a collaborative research program focused on the design of new classes of 
polycationic polymers featuring the stable aminocyclopropenium ion.  
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Chapter 2 
Asymmetric Brønsted Base Catalysis with Chiral Superbases 
 
Introduction 
Reaction promotion using Brønsted base reagents and catalysts is a widely utilized 
strategy due to its extreme generality. The generality of this approach originates from the simple 
activation paradigm upon which Brønsted base chemistry functions – proton transfer from an 
acidic substrate to a Brønsted base. The resulting deprotonated substrate is thus generically 
activated to undergo a wide range of transformations. These aspects have made Brønsted bases 
indispensible tools for synthetic chemists across disciplines and an especially useful application 
has been the development of chiral variants employed in asymmetric Brønsted base catalysis.1 
The most obvious limit placed upon Brønsted base chemistry is that acid-base equilibria 
place an inherent boundary to the substrates that may be activated by a specific Brønsted base. 
As substrate acidity decreases, stronger Brønsted bases are required in order to ensure sufficient 
reaction promotion. While chemists have many relatively weak organic Brønsted bases at their 
disposal, such as tertiary amines and pyridines, there is notably less variety available with respect 
to strongly Brønsted basic functional groups. This is especially true in the context of chiral 
Brønsted bases used for asymmetric catalysis.  
Over the past two decades, two approaches have been used to address the need for 
stronger chiral Brønsted base catalysts. The first approach pairs strong hydrogen-bonding 
functional groups with relatively weak Brønsted basic functional groups onto a scaffold that acts 
as a bifunctional catalyst.2 This approach has been broadly effective at achieving high reactivity 
and selectivity with many relatively acidic substrate classes but has limited success with less 
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acidic substrates (pKa >17 in DMSO). Another approach focuses on the identification of new 
chiral scaffolds that are assembled around strongly Brønsted basic functional groups.   
This chapter reviews these efforts with a brief historical account of strongly Brønsted 
basic functional groups and a particular emphasis placed on their employment in asymmetric 
catalysis. Ishikawa has designated “superbases” to be those Brønsted bases whose basicity 
compares to or is greater than the widely used 1,8-diaminonapthlene (Proton Sponge), which has 
a conjugate acid pKa of 18.6 in acetonitrile.1 Thus, guanidine, proazaphosphatrane and 
iminophosphorane bases all fall under this classification and are independently discussed in the 
following sections (Figure	  1).3   
 
 
Figure 1. Basicity range of common organic Brønsted bases. 
 
Guanidines 
Guanidine and guanidinium functional groups are widely found in naturally occurring 
chemicals and in biological systems. 4  The utility of the guanidine functional group is 
underscored by its presence in the essential amino acid arginine. Arginine is located in the active 
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often facilitates enzymatic activity. For example, pectin lyase utilizes arginine in the base-
promoted elimination of saccharide oligomers, thus playing a vital role in energy storage and use 
in plant species.5 Indeed, synthetic organic chemists were inspired by this reactivity many years 





First reports. Barton reported the first systematic study of the Brønsted basicity of sterically 
hindered acyclic guanidines in 1981.6 These bases, termed Barton’s bases, have conjugate acids 
with a pKa around 23-24 in acetonitrile. Furthermore, Barton demonstrated that because of the 
steric congestion at the basic imino nitrogen, these guanidines are poor nucleophiles suggesting 
their high potential for use in base-promoted reactions. A few years later, Schwesinger reported 
the cyclic guanidines TBD and MTBD, with conjugate acid pKas of 26 and 25.5, respectively.7 
In the historical context of Brønsted base chemistry, these developments represented the 
strongest neutral organic Brønsted bases available at the time (Figure	  2).8  
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Synthesis. Because of their rich history in both natural product synthesis and synthetic reagent 
development, a number of complementary synthetic routes to guanidine bases have been 
developed (Scheme	   1).1a The most common route utilizes ureas and thioureas, which can be 
prepared from the combination of dialkylamines with phosgene, triphosgene or thiophosgene. 
Ureas/thioureas are activated, commonly by oxalyl chloride or phosgene, to produce imidoyl 
chloride intermediates (1) in moderate to good yields. A number of other activating agents have 
also been utilized for this step, including methylating agents and Br2/PPh3 combinations. The 
imidoyl chloride intermediate 1 is highly reactive and prone to hydrolysis in the presence of trace 
moisture, therefore highly anhydrous conditions must be maintained. Addition of a primary 
amine to this species yields guanidine hydrochloride salts, which are generally deprotonated by 
hydroxide, methoxide or tert-butoxide anions. This general approach is used for the synthesis of 
the vast majority of chiral guanidines discussed below. Usually, optimization is required to (a) 
select between urea and thiourea routes; (b) identify optimal activating agent; and (c) find proper 
neutralization conditions for guanidine hydrochloride salts. In summary, three to four separate 
reaction steps with moderate to good yields, often after optimization, are required for the 
synthesis of guanidine bases.  
 
 
Scheme 1. Common synthetic route to guanidines. 
 
Asymmetric catalysis. The deprotonation of and complexation with nitroalkanes by bicyclic 
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available to chiral guanidines, led to the earliest efforts toward asymmetric Brønsted base 
catalysis with chiral guanidines. Nájera pioneered these efforts in his seminal report in 1994 
describing chiral acyclic guanidine 3 as a catalyst for an asymmetric Henry reaction (Scheme	  
2).10 Although the observed enantioselectivies were low, this finding nevertheless paved the way 
for further developments in the past twenty years. Both because of guanidine’s history in organic 
chemistry and the straightforward preparation of chiral derivatives, guanidines have been the 
most studied class of chiral organic superbases. Several reviews dedicated solely to this topic are 
available1b,c; this section describes major advances in catalyst development in the context of 
highly selective (>90% ee) asymmetric Brønsted base catalysis.  
 
 
Scheme 2. An early example of chiral guanidine catalysis. 
 
The first highly selective chiral guanidine catalyzed reactions were developed for the 
asymmetric Strecker reaction between hydrogen cyanide and aryl aldimines. In 1996, Lipton 
reported the use of dipeptide guanidine 6 for this reaction with N-benzyl protected aldimines 
(Scheme	  3a).11 Interestingly, replacement of the guanidine functional group with an imidazole 
group resulted in a catalyst with very low reactivity. In 1999, Corey developed the first effective 
C2-symmetric bicyclic chiral guanidine 9 for Strecker reactions with N-diphenylmethane 




















40% yield, 34% ee
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Scheme 3. Highly enantioselective guanidine-catalyzed Strecker reactions. 
 
The previous examples of guanidine-catalyzed reactions involve relatively acidic 
pronucleophiles, HCN and nitroalkanes (pKa 12.9 and 17 in DMSO, respectively). In a major 
step forward, Ishikawa exploited the high basicity of guanidines for the activation of less acidic 
substrates, such as glycinate benzophenone imines. Thus, in 2001, Ishikawa developed chiral 
bifunctional guanidine 12 for highly enantioselective Michael reactions between tert-butyl 
glycinate benzophenone imine 10 (pKa 18.7 DMSO) and electron-deficient alkenes (Scheme	  
4a).13 Catalyst 12 had good reactivity in the absence of solvent, however low turnover numbers 
were observed when the reaction was conducted in solvent. In 2008, Kobayashi used an isomeric 
catalyst, 16, for highly selective Mannich reactions between tert-butyl glycinate fluorenone 
imines (pKa <16 DMSO) and N-Boc aldimines (Scheme	  4b).14 Other derivatives of guanidine 12 
have been prepared and used in related base-promoted reactions, although lower levels of 
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Scheme 4. Bifunctional guanidine-catalyzed asymmetric reactions with amino acid surrogates. 
 
The next major advance in chiral guanidine catalyst development came in 2006, when 
Terada and Tan developed two new C2-symmetric chiral guanidines that have since proven to be 
the most general in inducing high degrees of asymmetry in a range of base-promoted 
transformations. First, Terada reported the binapthyl-derived class of axially chiral guanidines 
for the enantioselective Michael addition of malonates to nitroalkenes and amination of β-
ketoesters (Scheme	  5a).16 Since these initial reports, Terada has reported highly enantioselective 
reactions utilizing a range of pronucleophiles, including phosphites, nitroalkanes, α-cyano 
thioesters, α-keto esters, lactones and azlactones (Scheme	  5c).17 These pronucleophiles can be 
added to electrophiles such as Michael acceptors, diazodicarboxylates, aldehydes and imines. 
Particularly relevant to this thesis is the use of guanidine 21 for the enantioselective [3+2] 
cycloaddition of glycinate benzaldehyde-derived imine 22 (Scheme	  5b).18 Collectively, Terada’s 
axially chiral guanidines have demonstrated success in a range of transformations; however, the 
high molecular weight, lengthy synthesis and lack of simple tunability of these catalysts partially 
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Scheme 5. Reactions with Terada’s binapthyl-based chiral guanidines. 
 
Building off of Corey’s C2-symmetric guanidine 9, Tan introduced benzyl-substituted 
derivative 27 in 2006 for the enantioselective Diels-Alder reaction between anthrones and 
various dieneophiles (Scheme	   6a).19 Notably, the Tan lab developed a unique route for the 
synthesis of these types of guanidines by the coupling of chiral aziridines followed by cyclization 
using standard approaches.20 The tert-butyl-substituted derivative (30) of this catalyst type was 
also reported by Tan in 2007.21 Collectively, these C2-symmetric bicyclic guanidines have shown 
high success in activating diarylphosphites, thiomalonates, malonates, α-fluoro malonates, and β-
γ-unsaturated esters.22 Perhaps more significantly, the Tan group has utilized these guanidines to 
activate a variety of relatively less acidic pronucleophiles for unique transformations. For 
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reported in 2009 (Scheme	   6b). 23  Additionally, β-fluoro-α-tetralone derivatives undergo 
asymmetric addition to imines and diazodicarboxylates in the presence of guanidine 30 (Scheme	  
6c).24 Lastly, guanidine 30 also catalyzes the enantioselective decarboxylative addition reaction 
of malonic acid half thioesters (Scheme	  6d).25  
 
 
Scheme 6. Reactions with Tan’s chiral bicyclic guanidines. 
 
The last major advance discussed herein utilizes intramolecular H-bonding catalyst 
organization to reduce conformational freedom of the catalyst backbone. In 2009, Feng reported 
guanidine 39 for the catalytic addition/cyclization of azlactones with salicylimines (Scheme	  7).26 
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required for high selectivities. More recently, Feng developed C2-variants of this catalyst type 
along with other closely related derivatives.27  
 
 
Scheme 7. Asymmetric cycloaddition of azlactones with Feng’s chiral guanidine. 
 
Higher analogues. The synthetic combination of Brønsted basic functional groups into 
conjugated analogues is one conceptual approach to increasing the basicity of known 
compounds.  In this regard, guanidines have served as units in higher-order Brønsted bases 
(Figure	   3). Conceptually, the most straightforward approach is the combination of multiple 
guanidines; polyguanidines, such as the biguanidine 40, indeed have higher basicity than their 
monomeric counterparts.28 Another approach relies on proton-chelation, such as the guanidine-
analogue of Proton Sponge 41. 29  More recently, Leito and Jahn developed 
bis(imidazolyl)guanidine bases of type 42 as a new class of highly basic hybrid guanidines.30 
These clever approaches offer promise in advancing the utility of guanidine bases, especially in 
the context of activating weakly acidic pronucleophiles. At this time, no chiral derivatives of 
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In 1977, Verkade reported a rather unusual new class of superbasic compounds; known 
as proazaphosphatranes, these bases protonate at the P-atom, unlike all other known organic 
superbases. 31  These serendipitously discovered bases rely on intramolecular coordination 
between the axial nitrogen and the protonated hypervalent phosphorus to stabilize the conjugate 
acid azaphosphatrane species (Scheme	   8). It has been observed that the distance between the 
axial nitrogen and phosphorus atoms shrinks from 3Å to 2Å upon proazaphosphatrane 
protonation.32 This extreme example of trans-annular stabilization leads to approximate pKas of 
32-34 (MeCN) for azaphosphatrane acids.33 Unfortunately, the unique P-protonation of these 
bases restricts the incorporation of chirality proximal to the site of basicity. For example, the 
basic imino nitrogen of guanidines can be attached to a chiral substituent that is not part of the 
guanidinyl basic backbone. This is not the case with proazaphosphatranes; for these bases, 
chirality must be incorporated into the backbone of the cage structure away from the site of 


























•  Verkade 1977
•  32-34 pKBH+
•  trans-annular stabilization






	   47 
and their use in asymmetric synthesis. Nonetheless, proazaphosphatranes represent a creative and 
important addition to the collection of highly Brønsted basic functional groups.  
 
 
Scheme 8. Stabilization of azaphosphatrane acids.  
 
Synthesis. The synthesis of proazaphosphatranes is accomplished by the cyclization of 
tris(ethylamino)amines (46) to form azaphosphatrane salts followed by deprotonation with an 
inorganic base (Scheme	  9).33 The reagent of choice for cyclization is ClP(NMe2)2; attempts to 
directly prepare neutral proazaphosphatranes from tris(ethylamino)amines have routinely 
failed. 34  Trisubstituted (R = alkyl) are the most commonly prepared and utilized 
proazaphosphatranes; however, a small number of nonsymmetric mono- and disubstituted 
proazaphosphatranes have been synthesized in low yields.33 Because proazaphosphatranes rely 
on trans-annular stabilization through a defined cage structure, syntheses must rely on 
tris(ethylamino)amines and thus there is not a great scope for structural diversity. As a 
consequence, only a handful of chiral derivatives have been synthesized because of the difficulty 
associated with chiral tris(ethylamino)amine preparation. In summary, cyclization to form 
trisubstituted proazaphosphatranes is readily accomplished; however, the required 
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Scheme 9. Synthesis of proazaphosphatranes. 
 
Chiral proazaphosphatranes. For reasons previously discussed, only a handful of chiral 
proazaphosphtrane bases have been reported. Chirality can be incorporated into two different 
positions. First, the substituents on the phosphorus-bonded nitrogens can be made chiral such as 
in proazaphosphatrane 48. Using this enantiopure compound as a Lewis base catalyst for the 
cyanation of benzaldehyde, only racemic cyanohydrin 47 was obtained under a variety of 
conditions (Scheme 10a).35 Chirality can also be incorporated into the cage backbone of 
proazaphosphatranes, such as in compounds 49 and 50 (Scheme	  10b).36 This chirality originates 
from enantiopure aziridines of type 51, which are transformed into chiral tris(ethylamino)amines 
before cyclization in a five-step process. While these bases have shown excellent reactivities, 
they have consistently failed to achieve appreciable enantioselectivity in any such process.37 
Further work is required to develop an effective chiral proazaphosphatrane for asymmetric 
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In 1987, Schwesinger introduced a new class of Brønsted bases known as 
phosphazenes.38 Phosphazenes are characterized by a triaminoiminophosphorane skeleton that 
contains a phosphorus(V) atom. This atom’s presence allows for conjugate acid stabilization by 
three amino groups, compared to the carbon-based analogous guanidines that are stabilized by 
two amino groups. Phosphazenes are classified by the number of phosphorus atoms in the 
molecule (Pn) and P1-P4 variants are now widely available. Simple P1 phosphazenes have 
conjugate acid pKas between 25 and 29 (MeCN), while higher order analogues, such as P4 
phosphazenes, have basicities that approach those of organolithium compounds (>40 pKBH+ 
MeCN).39 The wide range of basicity coupled with several effective chiral scaffolds have made 
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Synthesis. Simple P1 phosphazenes are most commonly prepared in a three-step process. First, 
the addition of three equivalents of a dialkylamine to phosphorus pentachloride at low 
temperature yields phosphonium cations of type 52. Substitution of this intermediate with a 
primary amine followed by neutralization with potassium methoxide yields the neutral 
phosphazene (Scheme 11a).1a The preparation of most chiral phosphazenes, including many 
chiral bicyclic phosphazenes, follows a similar route. For higher analogues, addition of three 
equivalents of unsubstituted P1-phosphazenes to trichloroiminophosphoranes followed by 
neutralization with potassium amide in liquid ammonia delivers neutral P4 phosphazenes 
(Scheme 11b). Other higher order phosphazenes, such as P2, P3, P5 and P7 are prepared by a 
combination of these methods. Lastly, simple iminophosphoranes can be synthesized via an 
interrupted Staudinger reduction between triarylphosphines and alkyl azides (Scheme	  11c).  
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Much like guanidine synthesis, these simple routes toward iminophosphorane compounds 
are made somewhat difficult due to the use of reactive intermediates, moisture-sensitive 
reactions, moderate yields, hazardous chemicals and difficult purifications. Thus, while a number 
of straightforward routes are available for phosphazene synthesis, reaction optimization and 
purification can be a tedious process. Nevertheless, a wide variety of phosphazenes, including 
chiral derivatives, have been reported and are becoming increasingly employed for the 
promotion of a range of chemical transformations. 
 
Asymmetric catalysis. Beginning in 2007, the Ooi group has pioneered the development and 
application of chiral cyclic phosphazenes for enantioselective Brønsted base catalysis. Catalyst 
58 was first reported for the highly enantioselective Henry reaction at low temperature (Scheme	  
12a).40 The chiral backbone of 58 is accessed from amino acids, wherein double aryl Grignard 
addition followed by amination yields chiral 1,2-ethylenediamine derivatives.41 This catalyst 
system was extended to 60, which successfully promoted enantioselective C-P bond formation 
via the addition of phosphites to aldehydes (Scheme	   12b).42 Later, these catalysts were also 
shown to add nitroalkanes and phosphites to ynones, thus yielding synthetically valuable chiral 
alcohols.43 An interesting application was reported in 2012 in a collaboration between Ooi and 
Johnson wherein phosphazene 58 promoted the enantioselective aldol/phosphate transfer 
reaction of α-alkyl-α-hydroxy trialkyl phosphonoacetates (Scheme 12c). 44  These types of 
phosphazene catalysts have also been shown to promote high stereoselectivity with azlactone 
pronucleophiles for the synthesis of amino acid derivatives. For example, Scheme	  12d shows the 
enantio- and regioselective 1,6-addition of azlactone 37 to an extended Michael acceptor.45 
Additional examples of selective 1,8-addition were also reported using this methodology. 
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Furthermore, a methodology for the phosphazene-catalyzed addition of azlactones to alkynoates 
to produce either E- or Z-substituted vinyl azlactones was developed in 2013.46 Lastly, this 
catalyst type was used to achieve an enantioselective Payne-type oxidation of N-sulfonyl imines 
to produce optically enriched oxaziridines (Scheme 12e).47  
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In a more recent contribution to chiral iminophosphorane chemistry, Dixon reported the 
use of bifunctional triaryliminophosphorane 71 for the enantioselective aza-Henry reaction of 
ketimines (Scheme 13).48 These thiourea-substituted amino acid-derived catalysts were prepared 
in situ via an interrupted Staundinger reduction of chiral azides with triarylphosphines. The 
conjugate acids of these triaryliminophosphoranes have approximate pKas between 22-23 
(MeCN), making them significantly less basic than closely related phosphazenes.  
 
 
Scheme 13. Asymmetric aza-Henry reaction using Dixon’s bifunctional iminophosphorane 
catalyst. 
 
Higher analogues. The synthesis of strongly basic P4 phosphazenes was previously discussed; 
however, chiral derivatives for use in asymmetric catalysis are still awaiting development. 
Meanwhile, Terada recently reported chiral bis(guanidine)iminophosphorane 74 for the 
enantioselective amination of tetralone-like ketones (Scheme 14). 49  The pKa of acyclic 
bis(guanidine)iminophosphorane conjugate acids are known to be around 27 in THF.50 Although 
the pKa’s of Terada’s bicyclic chiral derivative was not determined, it is likely that this system 
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Scheme 14. Asymmetric amination with Terada’s bis(guanidine)iminophosphorane catalyst. 
 
Summary 
Neutral organic Brønsted bases are integral synthetic tools for chemists as they offer 
many advantages over inorganic Brønsted bases. For example, organic Brønsted bases operate 
under mild reaction conditions, have high solubility in organic solvents, lack a coordinating 
cation and can be made chiral for asymmetric applications. Despite these advantages, their 
widespread use has been hampered by the accessibility of strongly basic (>24 pKa MeCN) 
neutral organic functional groups. Only four known functional groups can reach basicity levels in 
this regime: amidines, guanidines, proazaphosphatranes and iminophosphoranes. This chapter 
has highlighted the use of these functional groups in asymmetric Brønsted base catalysis. While 
significant achievements have been made, there is clearly a need for new functional groups that 
possess high basicity and are both modular and tunable. Detailed in the next chapter, we have 
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Chapter 3 
Asymmetric Brønsted Base Catalysis with Chiral Cyclopropenimines1 
 
Introduction 
Organic Brønsted bases serve an essential role in synthetic chemistry and thus the 
development of new and improved Brønsted bases remains a constant challenge. Especially with 
regard to enantioselective synthesis, there is high demand for new effective chiral Brønsted base 
scaffolds that are able to activate pronucleophiles with ever decreasing levels of acidity. Over the 
past several decades, many research groups have addressed this challenge by designing chiral 
scaffolds around a limited number of Brønsted basic functional groups. Detailed in the previous 
chapter, these functional groups include guanidines, iminophosphoranes and phosphazenes. 
While indeed these efforts have significantly advanced the field of asymmetric Brønsted base 
catalysis, there remains much work to be done. The performance of a particular Brønsted base 
catalyst is inherently limited by the basicity of its core functional group (i.e. guanidine or 
phosphazene center) and this indirectly limits the degree of catalyst synthetic modularity and 
thus performance tunability. Therefore, ideal Brønsted base functional groups should not only 
exhibit high basicity, they must also be modular and tunable in a synthetically simple manner. 
Most current superbasic functional groups do not offer simple modularity. To address these 
shortcomings and challenges, we introduced cyclopropenimines as a new platform for Brønsted 
base chemistry in 2012. This chapter describes the development of chiral cyclopropenimines as 
enantioselctive Brønsted base catalysts in the context of glycinate imine Michael reactions. 
Particular attention is given to understanding cyclopropenimine structure-activity relationships in 
an effort to assemble an overall guide to cyclopropenimine chemistry.  
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Cyclopropenimines Before 2012 
Generally as synthetic intermediates or as reaction byproducts, cyclopropenimines have 
appeared throughout the literature sporadically for the past half-century and representative 
examples are described in Scheme 1.2 Paquette reported their first targeted synthesis in 1967 in 
which treatment of 2,3-diarylcyclopropenones (1) reacted smoothly with isocyanates (2) to 
produce several N-functionalized cyclopropenimines (3, Scheme 1a). 3   Weiss utilized the 
trimethylsilylamine transfer method (see Chapter 1) to prepare tris(anilino)cyclopropenium ion 
8, which was deprotonated with strong base to yield 2,3-bis(anilino)cyclopropenimine 6 (Scheme 
1b).4 Another representantive synthesis of 2,3-bis(dialkylamino)cyclopropenimines was reported 
by Alcarazo in 2010, which involved the simple addition of amines to chlorocyclopropenium 
salts of type 7 followed by deprotonation (Scheme 1c). 5  Alcarazo’s work using these 
cyclopropenimines as metal ligands was discussed in detail in Chapter 1. It was around this time 
(2010) that we became interested in developing this functional group as a new class of Brønsted 
base. Although 2,3-bis(dialkylamino)cyclopropenimines had been predicted to posses strong 
Brønsted basicity,6 no experimental determination of their basicity or their employment as 
Brønsted bases had been reported prior to our work. 
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Scheme 1. Previous syntheses of cyclopropenimines. 
 
Design Rationale and Proof of Principle 
The core design feature of the cyclopropenimine platform is the latent aromatic 
cyclopropenium ion that is revealed upon protonation of the imino nitrogen (Figure 1). The three 
adjacent nitrogen atoms, each bearing an electron-releasing lone pair of electrons, provide 
additional stabilization of the conjugate acid. The tris(amino)cyclopropenium conjugate acid can 
be compared to the more commonly found guanidinium ion; however, the additional stabilization 
provided by the aromatic cation core renders 2,3-bis(dialkylamino)cyclopropenimines much 
stronger bases than their guanidine analogues. The Lambert Group has termed the 
cyclopropenium analogues of common functional groups (such as cyclopropenimines compared 
to imines) as being “cyclopropenylogous,” a term that helps to conceptualize the enhanced 
reactivity and properties observed of these species. As previously mentioned, no experimental 
demonstration of the presumed potent Brønsted basicity of cyclopropenylogous imines had been 
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Figure 1. Design rationale and proof of principle.  
 
As an initial proof of concept, we immediately desired to quantify the Brønsted basicity 
of a simple achiral 2,3-bis(dialkylamino)cyclopropenimine (Figure 1). To do this, we measured 
the acidity of the conjugate acid (pKBH+) of cyclopropenimine 10 in acetonitrile (27.4) and found 
it to be over 4 orders of magnitude more basic than a comparable guanidine, BTMG (23.6). 
Notably, cyclopropenimine 10 is approximately as basic as the phosphazene base P1-tBu (26.98) 
and bicyclic guanidine TBD (26.03). Thus, these findings confirm that 2,3-
bis(dialkylamino)cyclopropenimines are exceptionally strong Brønsted bases (“superbases,” see 
Chapter 2), as predicted. Furthermore, the unique architecture of the cyclopropenium scaffold led 
us to pursue the development of chiral variants for the utilization of this potent Brønsted basicity 
in the context of asymmetric catalysis.  
 
Cyclopropenimine Synthesis 
The assessment of the overall value of any catalytic methodology must consider the 
availability of the catalyst itself; thus, simple syntheses from readily available starting materials 
is of paramount importance for the development of new catalyst systems. With this in mind, we 
modified Yoshida’s7original method for tris(dialkylamino)cyclopropenium synthesis (see Chapter 
1) to obtain straightforward access to 2,3-bis(dialkylamino)cyclopropenimines. For example, 
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pentachlorocyclopropane (11),8  delivers the quantitative formation of chlorocyclopropenium salt 
12, which is an easily isolated and stable solid that can be stored indefinitely (Scheme 2). Using 
this method, we have prepared up to 60-gram batches of this material (12).  
The imino head group can then be attached to chlorocyclopropenium salt 12 by simple 
addition of primary amine; purification requires only acid washing to yield the hydrochloride salt 
of our cyclopropenimine catalysts. Notably, the addition of the imino head group can be 
performed in the same reaction pot as the synthesis of chlorocyclopropenium salt 12, and we 
have used this one-pot protocol to prepare up to 47-gram scale batches of our optimal chiral 
cyclopropenimine hydrochloride salt (14•HCl). All cyclopropenimines described in this chapter 
were prepared in analogous fashion and the full details are provided in the Supporting 
Information section.  
 
 
Scheme 2. Our one-pot synthesis of 2,3-bis(dialkylamino)cyclopropenimines. 
 
As well be discussed in a later section (Catalyst Stability), we keep cyclopropenimine 
catalysts as their hydrochloride salts for long-term storage at room temperature. To generate the 
cyclopropenimine freebase, a dichloromethane solution of the cyclopropenimine hydrochloride 
salt is simply washed with 1M NaOH, and the organic layer is then dried and concentrated. The 
resulting freebase is typically a free-flowing powder with sufficient purity to be used directly in 
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low temperature and more details in this regard are described below. In certain cases, the 
deprotonation of cycopropenimines with sterically less-demanding 2,3-dialkylamino groups may 
necessitate the use of stronger bases, such as NaH or KOtBu.  
 
Chiral Cyclopropenimine Catalysis 
Having verified the high basicity of 2,3-bis(dialkylamino)cyclopropenimines and 
developed efficient syntheses to access their derivatives, we next turned our attention to 
exploiting this functionality for asymmetric catalysis. To do this, we selected the Michael 
reaction between benzophenone glycinate imine 15a and methyl acrylate (16) to develop chiral 
cyclopropenimine catalysis. This reaction was selected for two reasons. First, this Michael 
reaction produces synthetically valuable α-amino acid adducts that can readily be transformed to 
a variety of chiral heterocyclic scaffolds.9 Second, although a mechanistically straightforward 
reaction, the low acidity of glycinate 15a (18.7 in DMSO) renders this reaction difficult for 
typical chiral Brønsted bases to promote. Indeed, the only known (in 2012) chiral Brønsted base 
capable of promoting this reaction with high levels of selectivity was Ishikawa’s bifunctional 
guanidine 18 (Scheme 3).10 This guanidine catalyst requires three days to deliver high yields of 
adduct 17a under neat conditions; however, guanidine 18 loses its reactivity in solvent. Thus, we 
recognized that the Michael reaction shown in Figure 3 likely represents the upper threshold for 
guanidine catalysis and provided an ideal landscape to develop chiral cyclopropenimine 
catalysis.	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Scheme 3. Comparison of cyclopropenimine and guanidine catalysts for glycinate imine Michael 
reactions. 
 
 We identified chiral cyclopropenimine 14 as a highly efficient catalyst for the Michael 
reaction shown in Scheme 3. Under neat conditions, 14 delivers adduct 17a in quantitative yield 
with 91% ee in just 5 minutes. Furthermore, cyclopropenimine 14 performs excellently in 
solvent, such as ethyl acetate, which led to adduct 17a in quantitative yield and 98% ee in 1 h. 
The side-by-side comparison of cyclopropenimine 14 to guanidine 18 highlights the efficacy of 
cyclopropenylogy within the context of Brønsted base catalysis and hints at the broad potential 
of this new class of chiral catalyst. Cyclopropenimine 14 was identified as our optimal catalyst 
after screening a range of other derivatives; this process was rapidly facilitated by the simple 
syntheses of these bases. Rather than describe the work that led to its identification, derivatives 
of 14 will be discussed throughout this chapter in a manner that yields an appreciation of the 
structure-activity relationship of the 2,3-bis(dialkylamino)cyclopropenimine system.   
We sought to demonstrate the scalability of cyclopropenimine-catalyzed reactions with 
the goal of highlighting the true practicality of this methodology. As shown in Scheme 4, over 25 
grams of Michael adduct 17a was produced in 8 h using just 2.5 mol% of cyclopropenimine 
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in this thesis: aminocyclopropenium chemistry lends itself to simple and scalable chemistry that 
is required for widespread use throughout the chemical community. Thus, as has already been 
shown for the synthesis of cyclopropenimine 14 and adduct 17a, the preparation of catalysts and 




Scheme 4. Preparative-scale cyclopropenimine-catalyzed Michael reaction. 
 
At this point, we have gained reliable access to a new class of potent chiral Brønsted base 
that show potential for widespread use in asymmetric Brønsted base catalysis. In order to gain an 
in-depth understanding of the cyclopropenimine system, we describe below mechanistic 
experiments, strategic substrate and catalyst modifications, and computational work to assemble 
an overall “user’s guide” to cyclopropenimne chemistry. This work is done within the context of 
cyclopropenimine-catalyzed Michael reactions and thus the proceeding sections also serve to 
highlight the capabilities of this methodology (such as substrate scope). In a broader sense, the 
work described below also yielded invaluable information regarding the aminocyclopropenium 
scaffold in general; and, as will be shown, this work facilitated the rapid development of other 
applications of these ions detailed in Chapters 5 (onium-catalysis) and 6 (polymeric materials).  
 
Role of H-Bonding in Cyclopropenimine Catalysis 
The first aspect of this methodology we sought to explore concerned the role H-bonding 
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Chapter 2, effective chiral Brønsted bases that have been reported by other groups were 
systematically detailed. One common aspect to these effective chiral bases was the presence of 
an H-bonding functional group in addition to the site of Brønsted basicity. It could be imagined 
that this additional H-bonding group activates the pronucleophile by lowering the energy barrier 
for deprotonation by the Brønsted base. Additionally, once deprotonation has occurred, the 
conjugate acid of the catalyst now possesses two possible H-bonding groups that may serve to 
activate the electrophile via LUMO-lowering general acid catalysis and/or provide two-point 
binding to the nucleophilic anion; both of these possibilities ultimately could lead to a highly 
controlled transition state geometry to deliver optically-enriched reaction products.  
Consistent with the chiral Brønsted bases detailed in Chapter 2, effective chiral 
cyclopropenimines also require an H-bonding group to achieve both high yields and selectivities. 
To demonstrate this need, we prepared three derivatives and compared their performance to 
optimal cyclopropenimine 14 in the glycinate Michael reaction (Scheme 5). First, simple 
removal of the alcohol in catalyst 14 yielded a catalyst (19) that had greatly diminished reactivity 
and zero stereoselectivity. When the phenylalaninol backbone of catalyst 14 was substituted for a 
phenylalanine methyl ester backbone (catalyst 20) all catalytic activity was lost. Last, 
replacement of the methyl ester in catalyst 20 with a primary amide gave a catalyst (21) that had 
little reactivity yet retained an appreciable level of stereoselectivity. Thus, the alcohol in 
cyclopropenimine 14 is required for both substrate activation as well as the 3-dimensional 
transition state assembly. Other members of the Lambert Group have created a small library of 
cyclopropenimine derivatives that possess other H-bonding functionality; however, no derivative 
has been identified that outperforms catalyst 14. Additionally, one must consider compatibility 
issues with the incorporation of Brønsted acidic H-bonding groups into potent Brønsted base 
	   68 
catalysts. Nevertheless, the results detailed in Scheme 5 highlight the importance of having two 
H-bonding groups present in the conjugate acid of our cyclopropenimine catalyst system. 
 
 
Scheme 5. Modification of cyclopropenimine H-bonding group and its effect on catalyst 
performance. 
 
We next explored the impact reaction conditions had on the stereoselectivity observed for 
the glycinate Michael reaction with cyclopropenimine 14. We found that the concentration and 
temperature at which the reaction was conducted had little impact on the reaction yield or 
stereoselectivity (not shown). We were more interested to examine how the catalyst responded to 
changes in solvent dielectric constants as well as the nature of the solvent’s functional groups. 
The results of a solvent screen performed at 23 °C and at 0.20 M concentration are tabulated in 
Table 1. All solvents with a dielectric constant ≤6 yielded product with 98-99% ee. Extending 
pass this dielectric value, we found that the enantioselectivity decreased relatively modestly in 
response to increased dielectric constants, reaching 80% ee in acetone (ε = 21). Notably, in 
triethylamine, the reaction product was isolated with 99% ee; however, in n-butanol, the product 
was obtained with only 55% ee. The relatively minor impact of dielectric constant on reaction 





































	   69 
reasonably strong intermolecular forces, most likely dominated by H-bonding, govern the 
organization of the transition state assembly. Other intermolecular forces, such as van der Waal, 
π-π and electrostatic interactions are typically rather sensitive to subtle changes in the dielectric 
constant of the solvent media.11 
 
Table 1. Solvent effect on cyclopropenimine-catalyzed Michael reaction.a 
 
a Conversion determined by 1H NMR based on Bn2O standard. Enantiomeric excess (ee) was 
determined by chiral HPLC. ε: dielectric constant. 
 
An examination of the electron-withdrawing group on the Michael acceptor was next 
explored in order to understand the limits of this Michael reaction methodology and to gain 
further insight into the role of H-bonding (Table 2). We first noticed that the size of the alkyl 
group on the acrylate (entries 1-4) only affected the reaction rate, with tert-butyl acrylate reacting 
significantly slower than other simple acrylates. Trifluoroethyl acrylate (entry 5), despite its 
greater electrophilicity, added slowly to glycinate 15a to yield adduct with just 57% ee. Methyl 
vinyl ketone, as predicted, engaged rapidly with glycinate 15a to deliver product with high ee 
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(entry 6). Acrylonitrile (entry 7) and phenyl vinyl sulfone (entry 8), both with significantly 
different electron-withdrawing groups compared to those found in entries 1-6, yielded product 
slowly and with low ee. These results indicate that our cyclopropenimine-catalyzed Michael 
reaction works best with unsaturated ketone and ester acceptors; additionally, the steric and 
electronic environments surrounding the carbonyl’s of these electrophiles were found to impact 
their relative reactivity. Thus, the cyclopropenimine conjugate acid is almost certainly engaging 
in general acid activation of the electrophile via H-bonding to the carbonyl oxygen.  
 
Table 2. Unsubstituted Michael acceptor scope for cyclopropenimine-catalyzed Michael 
reactions.a 
 
a Isolated yields. Enantiomeric excess (ee) was determined by chiral HPLC. 
 
Strategic modifications were next made to the pronucleophile component of the glycinate 
Michael reaction catalyzed by cyclopropenimine 14 (Scheme 6). First, both methyl and benzyl 
glycinate imines led to Michael adducts 17b and 17c, respectively, with high ee. These substrates 
required 45 m for reaction completion, slightly less than the 1 h required for tert-butyl glycinate 
imine 15a (Scheme 3). In enantioselective Mannich reactions of these glycinates, a much more 
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dramatic rate difference is observed which allows for some interesting optimization possibilities; 
this is discussed in detail in Chapter 4. Replacing the ester of the glycinate imine with a nitrile 
led to a faster reaction delivering adduct 23 with almost no enantioselectivity. Tellingly, 
reinstatement of the ester and removal of the nitrogen atom of glycinate imine led to a slower 
reaction, yet a significant amount of enantioselectivity returned (adduct 24). The comparison of 
adducts 23 and 24 indicate that H-bonding to the carbonyl of the glycinate ester is more 
important that H-bonding to the nitrogen atom of the glycinate’s imine component. Given that 
the conjugate acid of cyclopropenimine 14 contains two H-bonding groups (N-H and O-H) and 
that the carbonyl’s of both the pronucleophile and electrophile engage in H-bonding, we propose 




Scheme 6. Pronucleophile scope for cyclopropenimine-catalyzed Michael reactions. 
 
2,3-Amino Groups Structure Activity Relationship in Cyclopropenimine Catalysis 
The importance of the 2,3-amino groups in cyclopropenimine chemistry cannot be 
overstated. The many roles they play in governing catalyst reactivity and selectivity are 
discussed in detail in this section with a particular emphasis placed on understanding the origin 
X EWGPh
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of these effects. When we began exploring chiral cyclopropenimine catalysts, we synthesized 
approximately 15-20 variants based on the 2,3-bis(diisopropylamino)cyclopropenimine scaffold 
without identifying a truly effective catalyst system. We then explored alteration of the 2,3-
amino groups, including chiral 2,3-amino groups, only to find generally lower levels of 
selectivity than the 2,3-bis(diisopropylamino)cyclopropenimine catalysts. Somewhat to our 
surprise, we finally realized a highly effective catalyst (14) simply by changing the 
diisopropylamino groups to dicyclohexyl amino groups. Given that isopropyl and cyclohexyl 
groups are often considered iso-steric in many contexts, we were motivated to discover how the 
cyclopropenium scaffold assembled a structure wherein the difference between isopropyl and 
cyclohexyl groups proved to be paramount for catalyst performance. This section thus mainly 
focuses on the number of ways in which the dicyclohexylamino groups enhance 
cyclopropenimine 14’s overall performance.  
Scheme 7 illustrates the importance of the dicyclohexylamino groups by comparing 
catalyst 14 to catalysts with diisopropyl amino (25) and pyrrolidino (26) groups. There is a loss 
in both reaction rate and selectivity in correlation with decreasing the size of the 2,3-amino 
groups. Diisopropylamino catalyst 25 yields product with 87% ee and 26 yields product with just 
65% ee. Importantly, we have found that regardless of the method used for deprotonation of their 
hydrochloride salts, these catalysts delivered the shown ee values consistently. Initial rate 
comparisons between dicyclohexylamino catalyst 14 and diiospropylamino catalyst 25 revealed 
an approximate five-fold rate enhancement offered by the dicyclohexylamino substituents. This 
indicates that any difference in catalyst stability under the reaction conditions (see Catalyst 
Stability) is not the sole factor for the decreased levels of reaction conversion observed with the 
diisopropylamino catalyst 25. 
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Scheme 7. Modification of cyclopropenimine 2,3-amino groups and its effect on catalyst 
performance. 
 
In order to begin our study on the 2,3-amino groups, we obtained single-crystal X-ray 
structures (Parkin group, Columbia University) of 14•HCl (Figure 2a and b) and 25•HCl (Figure 
2c and d). There are several differences between these two structures that can be attributed to the 
size difference between the dicyclohexylamino and diisopropyl amino groups. First, the views 
provided in Figure 2a-d show that the dicyclohexylamino groups are torqued 18° out of planarity 
with respect to the cyclopropenium ring (Figure 2a); meanwhile, no such torqueing in the 
diisopropylamino catalyst 25•HCl exists (Figure 2c). This torqueing phenomenon has previously 
been observed for sterically encumbered tris(dialklyamino)cyclopropenium ions.12 An important 
inference is that the degree of torqueing modulates the amount of electronic stabilization that the 
2,3-amino groups can provide to the cyclopropenium cation. Thus, the bulky dicyclohexylamino 
groups in 14 are expected to yield a system with lower electronic stabilization compared to the 
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Figure 2. Molecular structure of (a) 14•HCl side view; (b) 14•HCl top view; (c) 25•HCl side 
view; (d) 25•HCl top view (e) depiction of amino group torquing phenomenon of 14•HCl; and 
(f) depiction of cyclohexyl gearing effect and key CH---O interaction of 14•HCl.  For (a) and (b) 
a co-crystallized molecule of H2O has been omitted for clarity.  For (c) and (d) the 
hydroxymethyl group was disordered and only one of the crystal forms is shown for clarity.  
 
We desired to quantify this torqueing phenomenon by determining the basicity of 
analogous dicyclohexylamino and diisopropylamino cyclopropenimines. We were unable to 
determine the relative basicities of 14 and 25, which we attribute to the alcohol functional group 
that may have interfered with NMR chemical shifts and titrations. We were, however, able to 
determine the pKBH+ values of N-Me cyclopropenimines 27 and 28 in acetonitrile. This was 
accomplished by determining their equilibrium values with a P1-tBu phosphazene base – 
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the diisopropylamino cyclopropenimine 27 is approximately 1.5 pKa units more basic than the 
dicyclohexylamino analog 28 (Figure 3). We were unable to determine the pKBH+ of N-tBu 
cyclopropenimine 29, as decomposition was observed whenever deprotonation of its 
hydrochloride salt was attempted. It is interesting to note, however, that N-Me cyclopropenimine 
27 is more basic than N-tBu cyclopropenimine 10, suggesting that the large t-butyl head group 
on 10 might induce torqueing of the diisopropylamino groups akin to that observed for catalyst 
14. Our lab is currently working to assemble pKBH+ values for a number of other achiral 
cyclopropenimines in order to understand these effects further and also to have access to 
cyclopropenimine bases with a range of basicity levels.  
 
 
Figure 3. Basicities of achiral cyclopropenimines. The pKBH+ values were determined by 1H 
NMR in d3-MeCN in reference to the P1-tBu phosphazene base (see Supporting Information). 
 
The fact that diisopropylamino cyclopropenimines are more basic than 
dicyclohexylamino cyclopropenimines raises an important question as to why the 
dicyclohexylamino cyclopropenimine 14 greatly outperforms diisopropylamino 
cyclopropenimine 25 in catalytic reactions. We have shown (vide infra) that the carbon-carbon 
bond-forming step of the Michael reaction is the rate-determining step of the Michael reaction. 
At this stage of the catalytic cycle, the catalyst is in its protonated state, and thus its ability to 
function as a H-bond donor may be critical for the promotion of fast reactions and catalyst 
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thus better H-bond donors, than diisopropylamino analogues, this may help to explain why 14 
has faster turnovers than 25. However, as discussed below, a number of other key differences 
may actually be more important for governing reaction rates using these catalysts.  
The second difference attributed to the size of the cyclohexyl groups of catalyst 14 can be 
readily seen in the top view structure of Figure 2b. The extended reach of the bulkier cyclohexyl 
groups relative to that of the isopropyl groups in 25 (see Figure 2d) result in more steric 
congestion along the chiral backbone of the cyclopropenimine head group in 14. This could 
impact the geometry of the reaction components as they bind to the catalyst in the transition 
state; additionally, this increased steric influence could help to rigidify the acyclic chiral 
backbone of the imino head group on catalyst 14. While we have no evidence supporting the 
former hypothesis, we have observed an intricate relationship between the size of the 2,3-amino 
groups and the size of the chiral substituent on the imino head group. As shown in Scheme 8, 
when the benzyl substituent (14) is replaced with a methyl group (30), enantioselectivity is 
unaffected for bis(dicyclohexylamino)cyclopropenimines (98 vs 97% ee) but is significantly 
affected for bis(diisopropylamino)cyclopropenimines (89 vs 65% ee). A possible explanation for 
this observed trend is that the size of the 2,3-amino groups work with the chiral center’s 
substituent to enforce a rigid bond conformation about the N–C bond of the imino nitrogen to the 
chiral center. This effect likely works in conjunction with the third difference between the 
cyclohexyl and isopropyl catalysts to help assemble a rigid and defined catalyst structure.  
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Scheme 8. Relationship between 2,3-amino groups and substituent on the chiral amino alcohol 
backbone of cyclopropenimines and its effect on catalyst performance. 
 
The third important difference between the cyclohexyl and isopropyl groups can again be 
seen by comparing the top views of their cyclopropenimine acid structures in Figures 2b and 2d. 
The cyclohexyl groups in catalyst 14 all adopt chair conformations that are geared across the 
cyclopropenium scaffold, ultimately resulting in the predisposition of an α-C–H bond to engage 
in a CH···O interaction with the hydroxyl of the phenylalaninol substituent (see the farthest right 
cyclohexyl group in Figure 2b). No such gearing is observed for catalyst 25 in Figure 2d and its 
amino groups’ α-C–H bonds are actually pointed away from the hydroxyl group of the 
phenylalaninol substituent. This CH···O interaction was first suggested by computational 
analysis, at which time we reexamined the crystal structure shown in Figure 2b to observe it in 
the ground state structure of the catalyst’s hydrochloride salt. Importantly, the distance between 
the oxygen atom and the cyclohexyl α-hydrogen is 2.51 Å in this structure, significantly less than 
the van der Waal radii of the two atoms (~2.70 Å). Additionally, the angle between the CHO 
atoms is 170°, which suggests that these three atoms are indeed aligning themselves in a linear 
arrangement typical of most other identified CH···O interactions. In the catalytic reaction, it’s 
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compresses to just 2.2 Å and that calculated transition states lacking this interaction were found 
to be much higher in energy (>10 kcal/mol). The details of this computational work are described 
below (Computational Transition State Modeling).  
 Over the past several decades, CH···O hydrogen bonds have gone from hypothetical (and 
at times controversial) interactions to being recognized as important design elements and 
structural factors in enzymes, 13  other biomolecules, 14  and supramolecular complexes. 15  
Furthermore, examples exploiting polarized C–H bonds for CH···O interactions in order to 
control asymmetric reactions are being increasingly reported.16  These CH···O interactions 
typically are quite weak (~0.5-1.0 kcal/mol) and generally have been reported between catalyst 
and substrate; CH···O interactions within a catalyst’s own architecture is notably less common.17 
In an effort to experimentally observe this CH…O interaction, we synthesized a tetra-
deuterated catalyst ((S)-d4-14) and tested for any observable kinetic isotope effects (KIEs). First, 
employing (S)-d4-14 in a range of cyclopropenimine-catalyzed reactions consistently yielded 
nearly identical levels (<2% ee difference) of enantioselectivity as non-deuterated 
cyclopropenimine 14. Second, initial rate comparisons of the two catalysts showed less than a 
5% rate difference. In a final attempt to measure a KIE, we prepared a catalyst mixture 
containing 50% (S)-d4-14 and 50% (R)-14 and employed this system for the Michael reaction 
between glycinate imine 15a and methyl acrylate (Scheme 9). A non-zero measurement of ee 
would result from a faster reaction of one of the isotopic catalysts; however, ee values were 
consistently measure to be <3% ee.  
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Scheme 9. KIE competition experiment between (R)-14 and d4-14 in glycinate imine Michael 
reaction. 
 
The results described in the above paragraph and shown in Scheme 9 were not entirely 
unexpected. Indeed, calculations performed by Professor Vetticatt led to an expected KIE of 
around 1.01 – a value too small for us to experimentally measure. The calculated value of 1.01 
resulted from a significant normal secondary KIE attributable to the CH…O interaction mitigated 
by a predicted inverse secondary KIE for the three α-CH bonds not engaged in the CH…O 
interaction. Additionally, because the calculated lowest energy pathways to both the major and 
minor enantiomer benefit from this CH…O interaction, little difference in enantioselectivity was 
expected between the isotopic catalysts. Therefore, the lack of an observed KIE does not 
necessarily undermine the importance of the CH…O interaction in the reaction’s transition state. 
In summary, the dicyclohexylamino groups bestow cyclopropenimine 14 with many 
favorable properties compared to diisopropylamino cyclopropenimine catalysts and other 
variants. We had assumed that there would be minimal difference between these two classes of 
cyclopropenimines during our initial development of cyclopropenimine chemistry; however, we 
have uncovered a number of important differences between these two catalyst systems. In this 
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bis(dicyclohexylamino)cyclopropenimines and described their origin. Ultimately, the 
dicyclohexylamino groups lead to a highly rigidified and active catalyst architecture, 
accomplished by steric, electronic and non-classical H-bonding interactions that have all been 
described and quantified in this section.  
 
Role of Chiral Centers in Cyclopropenimine Catalysis 
The final structural aspect we addressed was the role that the chiral center on the imino 
head group played in dictating selectivity. As was discussed in the above section (2,3-Amino 
Groups), the size of the chiral substituent on 2,3-bis(dicyclohexylamino)cyclopropenimines of 
type 14 had little effect on catalyst selectivity. For example, alaninol derived catalyst 30 and 
valinol derived catalyst 32 both delivered Michael adducts with high ee (Table 3). When the 
substituent was switched to a phenyl group (33), the catalyst had low reactivity and diminished 
stereoselectivity. In this case, we attribute the lower performance of 33 to electronic effects of 
the phenyl substituent. We additionally reason that the large 2,3-dicyclohexylamino groups 
restrict bond rotation about the N–C bond of the imino nitrogen to the chiral center; thus, the size 
of the chiral substituent is relatively unimportant because of the extended reach and steric 
influence of the 2,3-dicyclohexylamino groups.    
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Table 3. Screen of chiral substituent in the cyclopropenimine-catalyzed enantioselective Michael 
reaction.a 
 
a Conversion determined by 1H NMR based on Bn2O standard. Enantiomeric excess (ee) was 
determined by chiral HPLC. 
 
We next explored the incorporation of chirality adjacent to the hydroxyl group (Table 3). 
First, we prepared catalyst 34 and 35 with vicinal phenyl-substituted stereocenters. We indeed 
observed a matched (34, entry 5, 77% ee) and a mismatched (35, entry 6, 22% ee) effect in these 
types of arrangement. Notably, neither of the two catalysts with vicinal stereocenters 
outperformed catalyst 33 (entry 4, 86% ee), with a single phenyl-substituted stereocenter 
adjacent to the imino nitrogen. Moving the single chiral substituent over one carbon and now 
adjacent to the hydroxyl group, as the in the case of catalysts 36 and 37, resulted in catalysts with 
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lower reactivity and moderate enantioselectivities (entry 7). Catalysts 33–37 were selected for 
this comparison study because their chiral amino alcohol components are commercially 
available. These results indicate a single chiral center adjacent the imino nitrogen is the optimal 
chiral backbone for cyclopropenimines of type 14. The observations made in Table 3 are 
understandable considering the dicyclohexylamino group’s conformational locking effect and the 
CH···O interaction, which both contribute to a pseudo-ring (40, Figure 4) that biases the catalyst 
toward one major conformation. 
 
 
Figure 4. Proposed catalyst pseudo-ring conformation with a CH---O interaction. 
 
We finished our exploration of the chiral center by examining catalysts derived from the 
1-amino-2-indanol scaffold. These cyclopropenimines were studied as part of an attempt to 
design cyclopropenimine catalysts with long-term stability, the details of which are described in 
the Catalyst Stability section below. We found that the trans-aminoindanol derived 
cyclopropenimine 38 had activity that rivaled our optimal catalyst 14, delivering quantitative 
product in 2 h with 98% ee (entry 8). As expected from our work with other vicinal-substituted 
stereocenters, the cis-aminoindanol catalyst 39 resulted in a mismatched scenario and had poor 
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13C NMR Reaction Mechanism Study 
The preceding sections discussed in detail the structure activity-relationship for our 
optimal cyclopropenimine catalyst 14 and we attempted to rationalize the observed trends. While 
these studies yielded much useful information, a detailed picture of the transition state and exact 
origin of enantioselectivity for glycinate imine Michael reactions remained unclear. To address 
this, we teamed with computational chemistry Professor Matt Vetticatt of State-University of 
New York at Binghamtom and his student Greg Sauer and initiated a series of collaborative 
experiments in 2012.  
First, we undertook a mechanistic study of the glycinate imine Michael reaction using 
experimental 13C kinetic isotope effects (KIEs). 13C KIEs are uniquely sensitive probes of the 
rate-limiting transition state geometry of a reaction and have been successfully used to probe the 
mechanism of several fundamental organic reactions.18 In order for this approach to work, the 
reaction to be studied must be scalable (>1 gram) and the reaction products must be easily 
isolable and cannot be prone to decomposition. Our methodology is indeed the perfect candidate 
for this type of study given our demonstrated scalability and experimental practicality.  
We chose the reaction between glycinate imine 15a and benzyl acrylate (41) catalyzed by 
14 for the measurement of 13C KIEs using NMR methodology at natural abundance (Scheme 
10).19 Complementary approaches were used for the determination of 13C KIEs for the two 
reaction components 15a and 41. The KIEs for 15a were determined by analysis of product 
samples. 20  Thus, the isotopic composition of 42 was measured from two independent 
experiments taken to 21±2% and 22±2% conversion in 15a and compared to samples of 42 
isolated from reactions taken to 100% conversion. The KIEs for 41 were determined by analysis 
of recovered starting material: 21  samples of 41 were re-isolated from two independent 
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experiments taken to 76±2% and 77±2% conversion (with respect to 41) and were compared to 
samples of unreacted 41. The experimental KIEs calculated from the change in 13C isotopic 
composition and the fractional conversion are shown in Scheme 10. I performed the described 
reactions and isolated the desired materials, at which point the samples were sent to Professor 
Vetticatt for KIE determination.  
 
 
Scheme 10. Experimental 13C KIEs for reaction of 15a and 41 catalyzed by 14. The two sets of 
KIEs for each carbon represent two independent experiments and the numbers in parentheses 
represent the standard deviation in the last digit as determined from six measurements. KIEs for 
the bond-forming carbon atoms are shown in red. 
 
The experimental 13C KIEs yield qualitative information regarding the rate-limiting step 
in the cyclopropenimine catalytic cycle. As will be detailed below (Overall Mechanistic 
Understanding), the Michael reaction initiates by deprotonation of the glycinate 15a by base 14. 
Subsequent addition of the glycinate enolate of 15a to acrylate occurs, followed by a final proton 
transfer from the conjugate acid of 14 to deliver product and regenerate catalyst 14. The values 
shown in Scheme 10 indicate a substantial KIE on the two carbons involved in the C–C bond 
forming step (shown in red, Scheme 10); thus, the conjugate addition of the glycinate enolate to 
N CO2tBuPh
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the Michael acceptor represents the rate-determing (and enantiodetermining) step of this catalytic 
cycle.  
 
Computational Transition State Modeling of Cyclopropenimine Catalysis 
The second goal of our collaboration with Professor Vetticatt and Greg Sauer was to gain 
detailed insight into the organization of the enantio-determining carbon-carbon bond-forming 
transition state through theoretical studies. This work was entirely performed by Professor 
Vetticatt and Greg Sauer and the results of these computational experiments are summarized in 
this section.  
Our results reported in the structure activity-relationship studies provided useful 
information to help begin the computation analysis of the Michael reaction’s transition state. 
However, comprehensive theoretical study of this reaction is complicated by a number of factors, 
including: (1) the size of the system – the cyclopropenimine-catalyzed reaction of 15a and 
methyl acrylate involves 150 atoms, (2) the possibility of several conformations for the catalyst, 
(3) the possibility of either E or Z geometry of the glycinate enolate and of s-cis or s-trans 
geometry of the methyl acrylate, and (4) several competing H-bonding scenarios in the assembly 
of the transition state. Because of the size of the system and all the different possibilities of 
substrate conformations, Vetticatt used the hybrid ONIOM22 (B3LYP/6-31+G**:AM1) method 
as implemented in Gaussian '0923 to initially study the coordination of the glycinate enolate of 
15a to the conjugate acid of cyclopropenimine 14. This computational method divides the 
components of the reaction into two sets. The first set, including the key bond-forming and H-
bonding portions of the reactants, was studied using high-level DFT methods (B3LYP/6-
31+G**). The second set, including the steric bulk of the reaction components, was studied using 
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the semi-empirical method (AM1). The exact division of these layers is shown in Figure 5. 
Importantly, this ONIUM method allowed for the rapid exploration of many different H-bonding 
scenarios and reactant conformations for enolate-catalyst binding that are discussed in Figure 6 
below. Once these binding possibilities were identified by the ONIUM method, full DFT 
calculations were performed for transition state assembly predictions discussed after. 
 
 
Figure 5. Division of layers for the ONIOM method used for initial exploration of transition 
structures. 
 
To begin, Professor Vetticatt determined the calculated lowest energy conformation of 
protonated cyclopropenimine 14, which could then be used for transition state analysis. A 
detailed investigation of the catalyst geometry revealed a preference for a conformation wherein 
the cyclohexyl rings are geared in the same direction and the hydrogen atom at the chiral center 
is oriented anti to the NH proton (the H-C-N-H dihedral angle is -146°; B3LYP/6-31+G**).24  
Next, possible docking modes of the glycinate imine enolate to the protonated 
cyclopropenimine catalyst were explored (denoted complex 43). Based on our structure activity 
study, and especially the results discussed in the H-bonding section above, it was known that the 
catalyst provided single point H-bonding to the glycinate imine enolate and also single point H-
bonding to the Michael acceptor. Thus, only docking modes involving H-bonding of the 
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discussed here. Two-point binding between the glycinate enolate and cyclopropenimine was also 
examined but is not discussed in this thesis.  
The exploratory ONIOM study led to the identification of a subset of viable transition 
structures arising from two distinct binding modes (43a–b, Figure 6) of the catalyst–enolate 
complex 43. A simple template that can be used to describe these ‘most likely’ transition state 
assemblies is shown in Figure 6. After initial deprotonation of glycinate imine 15a by 14, the 
resulting catalyst–bound enolate 43 can adopt either the E or Z geometry. In binding mode 43a, 
the enolate is held by a single H-bonding interaction between the hydroxyl group on the catalyst 
and the enolate oxygen. The NH moiety of protonated 14 presumably directs conjugate attack by 
H-bonding to the carbonyl oxygen atom of methyl acrylate at the transition state. Four possible 
orientations of binding mode 43a that allow for this combination of H-bonding interactions are 
shown in Figure 6a. They are labeled 43aRE, 43aRZ, 43aSE, and 43aSZ based on the binding 
mode (43a), the enantiomer of product formed (R or S), and the glycinate enolate geometry (E or 
Z).  A similar (and complementary) situation arises when the enolate oxygen is H-bonded to the 
NH moiety of catalyst 14 – binding mode 43b. In this binding mode, the enolate can once again 
adopt either an E or Z conformation and the hydroxyl group directs conjugate attack via H-
bonding to the methyl acrylate carbonyl oxygen atom. Four additional conformations – 43bRE, 
43bRZ, 43bSE, and 43bSZ – can be envisioned from binding mode 43b. 
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(b) mono-coordinated binding mode 43b - enolate NH bound
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The next step in the study was the identification of carbon-carbon bond forming 
transition structures leading to the major and minor enantiomers of product 17a and the 
theoretical prediction of enantioselectivity. Transition structures based on the distinct binding 
modes of 43 were re-calculated using the B3LYP/6-31G* method.25  
 
 
Figure 7. Transition structures leading to major (S) enantiomer of product 17a that utilize mono-
coordinated binding modes 43a and 43b. Most hydrogen atoms have been removed for clarity. 
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All transition structures are oriented with the acrylate in the foreground and the enolate in the 
background. 
 
Figure 8. Transition structures leading to minor (R) enantiomer of product 17a that utilize mono-
coordinated binding modes 43a and 43b. Most hydrogen atoms have been removed for clarity. 
All transition structures are oriented with the acrylate in the foreground and the enolate in the 
background. 
 
Shown in Figure 7 (S transition structures) and Figure 8 (R transition structures) are the 
eight transition structures corresponding to the eight geometries shown in Figure 6 for binding 
modes 43a and 43b. Two features are common to all eight transition structures: (1) strong H-
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bonding interactions between both reactants (15a and 16) and the two H-bond donors in 
protonated 14, and (2) an s-cis conformation of methyl acrylate (16). The lowest energy 
transition structures leading to each enantiomer – TS43bSE (Erel= 0.0 kcal/mol, Figure 7) and 
TS43aRZ (Erel= 1.7 kcal/mol, Figure 8) – are highlighted using green and red boxes, 
respectively. This energy difference (1.7 kcal/mol) corresponds to a predicted 89% ee. However, 
a contributing second transition structure leading to the major enantiomer was also identified 
(TS43aSE, Erel = 0.9 kcal/mol; which is still lower in energy than TS43aRZ by 0.8 kcal/mol) 
that results in an altered prediction of 92% ee. Considering the size of the reaction system, this is 
in good agreement with the experimental 98% ee. 
As the eight transition state structures shown in Figures 7 and 8 originated directly from 
the optimized glycinate-catalyst complexes in Figure 6, it was somewhat surprising that all but 
two transition state assemblies were within 5 kcal/mol of the lowest energy transition state. The 
key outliers were TS43bSZ (Erel=11.5 kcal/mol) and TS43bRE (Erel=10.4 kcal/mol). This was 
especially intriguing because these two structures closely resembled each other (they differ in 
geometry of the glycinate enolate). Vetticatt examined these structures in more detail and 
realized that these were the only two transition states in which the aforementioned CH…O 
interaction is absent (3.4–3.5 Å distances for these structures). Indeed, this was the first 
realization that a CH…O interaction may guide cyclopropenimine 14’s architecture. All other 
transition state structures involved CH…O interactions in the range of 2.1–2.3 Å, which suggests 
quite a strong and important interaction. 
Using the two lowest energy transition states that lead to the major observed enantiomer 
(TS43bSE and TS43aSE), theoretical 13C KIE values predicted by these transition states were 
calculated. 26, 27, 28 The theoretical (red) and experimental (black) 13C KIE values are shown in 
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Figure 9. The excellent agreement between experiment and theory both supports the accuracy of 
the predicated transition state assemblies and validates that the C–C bond forming step is rate-
determining for the overall reaction.  
 
 
Figure 9. Comparison of experimental (black) and predicted (red) 13C KIEs. 
 
Calculations summary. The two main features that distinguish TS43bSE from the other two 
low energy structures are shorter C-C bond distance (1.99 Å) and a stronger interaction between 
the acrylate oxygen atom and the H-bond donor atom (1.69 Å and ∠OHO = 173.2°). Since C-C 
bond formation is more advanced in TS43bSE, there is a greater build-up of negative charge at 
the acrylate carbonyl oxygen atom resulting in stronger H-bonding interaction. Favorable CH-π 
interactions were also identified in both TS43bSE and TS43aSE that were absent in TS43aRZ.  
A complete description of the factors specifically responsible for enantioselection in 
these cyclopropenimine-catalyzed reactions is at this time still unclear. While the above 
calculations have arranged the most likely transition state assemblies, a full understanding of the 
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system remains complicated. It appears that the transition states are primarily organized by H-
bonding and that secondary interactions may also be critical for enantioselection. However, 
unlike most asymmetric reactions, this system controls selectivity through a dynamic network of 
H-bonding in which two very distinct low energy transition states lead to the major enantiomer. 
Although perhaps fortuitous, it is remarkable that the catalyst finds a low energy pathway to 
deliver the major enantiomer regardless of the H-bonding partners engaged with the reacting 
partners. For example, the glycinate enolate can be NH-bound (TS43bSE) or OH-bound 
(TS43aSE) to the catalyst, yet a low energy pathway for the major enantiomer results in both 
scenarios. Unfortunately, this dynamic control of stereoselectivity suggests that predicting other 
reactions catalyzed by 14 may require their own considerations as each reactant likely engages in 
H-bonding with 14 in a unique manner. Nonetheless, the calculations performed by Vetticatt 
give us a nice template for glycinate-catalyst binding (Figure 6) that may be used for other 
reactions involving glycinate imine pronucleophiles. We are currently adopting this template for 
the optimization of reactions that are in the early stages of development (discussed in Chapter 6). 
  
Overall Mechanistic Understanding 
This section attempts to describe an overall mechanistic assessment of cyclopropenimine-
catalyzed glycinate imine Michael reactions that is consistent with the results that have been 
described in this chapter. The proposed catalytic cycle is shown in Figure 10. The initial 
deprotonation is a reversible step, with an equilibrium value Keq < 0.01, as has been shown by 
NMR titration. Because this acid-base equilibrium lies heavily in favor of neutral 15a and 14, we 
have been unable to spectroscopically interrogate initial glycinate enolate-cyclopropenimine 
complexes. Notably, the glycinate enolate in this complex can adopt both E and Z geometrical 
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configurations. The glycinate enolate-cyclopropenimine complex then engages with the 
electrophilic acrylate (16) via H-bonding to the cyclopropenimine catalyst (43). This likely 
occurs through one of three options: (1) glycinate E-enolate bound to cyclopropenimine N–H 
and s-cis acrylate O–H bound to hydroxyl of cyclopropenimine; (2) glycinate E-enolate bound to 
hydroxyl of cyclopropenimine and s-cis acrylate O–H bound to cyclopropenimine N–H; or (3) 
glycinate Z-enolate bound to hydroxyl of cyclopropenimine and s-cis acrylate O–H bound to 
cyclopropenimine N–H. Scenarios (1) and (2) lead to the major (S) enantiomeric product while 
scenario (3) leads to the minor (R) enantiomeric product. We currently suspect that secondary 
orbital overlap between the benzophenone imine (of 15a) and the developing enolate of methyl 
acrylate (16) occurs in scenarios (1) and (2) but not in (3). 13C KIE studies confirm that this 
enantiodermining conjugate addition is also the rate-determining step of the catalytic cycle. A 
final proton transfer in intermediate 44 delivers optically enriched Michael adduct 17a and 
regenerates cyclopropenimine 14.	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Over the first couple months developing cyclopropenimines, we discovered that neutral 
cyclopropenimines lost their catalytic activity over time while in storage. It was then realized 
that cyclopropenimines bearing hydroxyl functionality are prone to decomposition through the 
rearrangement shown in Scheme 11. This was not entirely surprising, as nucleophilic ring 
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believe that the basic imino group assists cyclopropenimine decomposition via general base 
activation of the hydroxyl group. We now store cyclopropenimines as their hydrochloride salts at 
room temperature and neutralize them as needed; neutral cyclopropenimine 14 can be stored in a 
freezer for approximately one month without noticeable loss of activity. While this protocol 




Scheme 11. Cyclopropenimine decomposition pathway. 
 
We’ve measured the stability of a variety of cyclopropenimines under various conditions 
in order to understand their decomposition process better (Table 5). Catalyst 14, while stored as a 
solid at room temperature, has an approximate half-life of 15 d (entry 1a); however, its half-life 
increases to 8 months upon storage in a -20 °C freezer (entry 1b). As previously mentioned, no 
decomposition has been observed over a 3-year period for the hydrochloride salt of this catalyst 
(entry 1c). Under conditions related to reaction employment, such as a 0.035 M solution in 
toluene, 14 decomposes rather quickly with a half-life of just 7 h (entry 1d). Notably, the rate of 
decomposition is unaffected by the presence of glycinate imine 15a. Entries 2 and 3 show that as 
the size of the substituent at the chiral center is decreased, catalyst stability increases with the 
methyl-substituted catalyst 30 having a half-life of up to 5 months at room temperature. Perhaps 
the most important finding in Table 5 is that aminoindanol-derived catalyst 38, which functions 
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month period resulting in a calculated half-life greater than 5 years at room temperature (entry 
4a). In solution, cyclopropenimine 38 decomposes slower than 14, but does still does so at an 
appreciable rate (entry 4b). Entry 5 highlights another important effect of the 2,3-amino groups; 
2,3-bisdiisopropylamino catalyst 25 rapidly decomposes, thus underscoring another benfit 
provided by the dicyclohexylamino groups in catalyst 14.29 
 
Table 4. Catalyst stability screen.a 
 
a Decomposition monitored by 1H NMR; see supporting information for method used for each 
cyclopropenimine. 
 
A side-by-side catalyst activity test for cyclopropenimines 14 and 38 demonstrated the 
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after one month of storage as freebases at room temperature, cyclopropenimine 14 retained less 
than 5% of its original activity while there was no observable decrease in performance of 
cyclopropenimine 38. We are currently testing the performance of this aminoindanol-derived 
catalyst in a variety of asymmetric transformations. It should be noted that the aminoindanol 
chiral backbone is a more expensive source of chirality than phenylalaninol, and this price 
comparison must be balanced with the benefits of increased stability when making an 
overarching evaluation of cyclopropenimine catalysts.  
 
 
Scheme 12. Catalytic activity comparison of month-old cyclopropenimine catalysts. 
 
Additional Michael Acceptor Substrate Scope 
We assembled an increased Michael acceptor substrate scope as a final exploration of 
cyclopropenimine-catalyzed glycinate Michael reaction technology (Table 6). We specifically 
were interested in exploring substitution effects and geometrical constraints that may limit 
cyclopropenimine catalysis but might also give us insight into the predicted transition state 
structures. We first found that 2-cyclopentenone had low but appreciable reactivity and were 
surprised to find almost no enantioselectivity for the major diastereomeric product (entry 1). 
Meanwhile, 2-cyclohexenone had almost no reactivity over a 48 h period. A telling result came 
2 h, 95% con, 98% ee
2 h, 99% yield, 97% ee
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when 2-methylenecyclopentanone was employed as a Michael acceptor, rapidly delivering a 1:1 
diastereomeric product mixture with each diastereomer having 95% ee. The diastereomeric 
mixture results from nonselective protonation of the intermediate ketone enolate or perhaps from 
racemization of this position (entry 3). The results of entries 1–3 provide strong support that, as 
predicted, s-cis conformations of Michael acceptors are present in the reaction’s optimal 
transition state. Entries 4 and 5 show that dimethyl fumarate participated well in this chemistry 
(entry 4), while dimethyl maleate had poor reactivity; again, we attribute this to the ability of 
these substrates to access s-cis conformations. Certain unsaturated ketones were found to be 
viable substrates for this chemistry, including 4-phenylbut-3-en-2-one (entry 6) and chalcone 
(entry 7). Aiming to exploit the highly controlled delivery of Michael acceptors by the 
cyclopropenimine catalyst to the nucleophile, we tested a bis-unsaturated acceptor (entry 7). 
Thus, (2E,4E)-1,5-diphenylpenta-2,4-dien-1-one underwent selective 1,4-addition to deliver 
adduct with excellent diastereo- and enantioselectivity. It should be noted that this 1,4-selectivity 
contrasts with the 1,6- and 1,8-regioselectivites observed by Ooi in related reactions with 
azlactone pronucleophiles.30 A list of Michael acceptors that were unreactive under our standard 
reaction conditions is included in the supporting information of this chapter.  
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Table 5. Additional Substrate Scope for Cyclopropenimine-Catalyzed Michael Reaction.a 
 
a Yield based on isolated and purified product. Diastereomeric ratio (dr) and enantiomeric excess 





























































































	   101 
Conclusion 
This chapter has detailed the development 2,3-bis(dialkylamino)cyclopropenimines as a 
new and promising class of chiral Brønsted base catalyst. We’ve shown these compounds to 
poses potent basicity while maintaining a wide range of tunability and modularity. Importantly, 
these adjustments can be made in a synthetically simple manner through robust chemistry; this 
allowed for the preparation of a large-scale batch of our optimal chiral cyclopropenimine 14. 
This chiral cyclopropenimine is especially effective at promoting enantioselective Michael 
additions of glycinate imines, outperforming guanidine-based catalysts by orders of magnitude. 
Importantly, this methodology is amenable to preparative scale productions of these valuable 
amino acid adducts and tolerates a range of substrate classes. 
We undertook a detailed study examining the structure-activity relationship of chiral 
cyclopropenimines of type 14. H-bonding was shown to be the principle intermolecular force 
responsible for transition state organization, as depicted in computationally calculated structures. 
Furthermore, it was found that the 2,3-amino groups of these cyclopropenimines regulate the 
electronic and steric environment of the catalyst system while also providing a critical non-
classical H-bond that rigidifies the overall catalyst architecture. The information gained through 
this in-depth study has greatly aided the development of other cyclopropenimine and 
aminocyclopropenium chemistry; these efforts are discussed in the following chapters.  
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Experimental Information 
General information. All reactions were performed open to the atmosphere, unless otherwise 
noted. Methylene chloride, diethyl ether, tetrahydrofuran and toluene were dried using a J.C. 
Meyer solvent purification system. All other solvents and commercial reagents were used as 
provided, unless otherwise noted. Flash column chromatography was performed employing 40-
63 µm silica gel (SiliaFlash P60 from Silicycle). Thin-layer chromatography (TLC) was 
performed on silica gel 60 F254 plates (EMD). Organic solutions were concentrated using a Buchi 
rotary evaporator. 
 1H and 13C NMR spectra were recorded in CDCl3 (except where noted) on Bruker DRX-
300, DRX-400 or DRX-500 spectrometers as noted. Data for 1H NMR are reported as follows: 
chemical shift (δ ppm), multiplicity (s = singlet, br s = broad singlet, d = doublet, t = triplet, q = 
quartet, dd = doublet of doublets, td = triplet of doublets, m = multiplet), coupling constant (Hz), 
integration, and assignment. Data for 13C and 19F NMR are reported in terms of chemical shift. 
Infrared spectra were recorded on a Nicolet Avatar 370DTGS FT-IR. Optical rotations were 
measured using a Jasco DIP-1000 digital polarimeter. High-resolution mass spectra were 
obtained from the Columbia University Mass Spectrometry Facility on a JOEL JMSHX110 HF 
mass spectrometer using FAB+ ionization mode. Low-resolution mass spectrometry (LRMS) 
was performed on a JEOL JMS-LCmate liquid chromatography spectrometer system using 
APCl+ ionization technique. HPLC analysis was performed on an Agilent Technologies 1200 




Cyclcopropenimine 14 catalyst: This is an optimized large-scale procedure for synthesis of the 
standard cyclopropenimine catalyst 14. For synthesizing cyclopropenimine derivatives, 
chloro[bis(dicyclohexylamino)]cyclopropenium chloride was prepared and used as a common 




hydrochloride (14•HCl). Dicyclohexylamine (108 mL, 541 mmol, 6.0 equiv) 
was slowly added to a solution of pentachlorocyclopropane1 (19.3 g, 90.2 mmol, 1.0 equiv) in 
CH2Cl2 (900 mL) in a 3L round bottom flask. A white precipitate formed as the reaction mixture 
was stirred for a further 48 hr at room temperature. Next, (S)-2-amino-3-phenylpropan-1-ol2 
(15.0 g, 99.2 mmol, 1.1 equiv) was added in one portion and the reaction mixture was stirred for 
an additional 12 hr. The crude reaction mixture was filtered through a celite plug, then washed 
with 1.0 M HCl (3 x 500 mL), dried with anhydrous sodium sulfate and concentrated in vacuo to 
yield crude cyclopropenimine hydrochloride salt as an off-white solid. Recrystallization from hot 
ethyl acetate/hexanes (approximately 1/2) yielded pure cyclopropenimine hydrochloride salt as a 
white solid (38.5 g, 73% yield). 1H NMR (400 MHz, CDCl3) δ 7.35 (d, 9.2 Hz, 1H, NH), 7.0-
7.15 (m, 5H, ArH), 5.17 (t, 5.6 Hz, 1H, -OH), 3.60-3.85 (m, 3H, NCHBnCH2OH), 3.10 (m, 4H, 
NCyH), 2.80-3.00 (m, 2H, -CH2Ph), 1.00-1.70 (m, 40H, CyH). 13C NMR (100 MHz, CDCl3) δ 
137.8, 129.2, 128.0, 126.2, 116.5, 114.5, 63.7, 61.3, 59.1, 38.4, 32.1, 31.9, 25.4, 24.4. IR (thin 
                                                
1 Tobey, S. W.; West, R. J. Am. Chem. Soc. 1966, 88, 2478.  
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film, cm-1) 3175, 2929, 2855, 1498, 1450, 1372, 1317, 1181, 894, 727, 697. [α]20D = -38.9 (1.0 c, 
CHCl3). LRMS (APCI+) m/z = 546.43 calcd for C36H56N3O [M+]+, found 546.98.  
 
(S)-2-(2,3-Bis(dicyclohexylamino)cyclopropenimine)-3-phenylpropan-1-ol 
(14). Cyclopropenimine freebase was prepared and stored in a freezer on a 
weekly basis. Pure cyclopropenimine freebase was quantitatively obtained by 
dissolving the corresponding hydrochloride salt in CH2Cl2 and washing the solution with 1.0 M 
NaOH (3 x), drying with anhydrous sodium sulfate and concentrating in vacuo. The 
cyclopropenimine is obtained as an off-white solid. 1H NMR (400 MHz, CDCl3) δ 7.10-7.25 (m, 
5H, ArH), 3.79 (m, 1H, NCHBnCH2OH), 3.40-3.50 (m, 2H, NCHBnCH2OH), 3.00-3.10 (m, 4H, 
NCyH), 2.70-2.85 (m, 2H, -CH2Ph), 1.00-1.90 (m, 40H, CyH). 13C NMR (100 MHz, CDCl3) δ 
140.5, 129.7, 129.4, 127.8, 125.5, 65.1, 61.7, 58.3, 41.7, 34.4, 33.1, 32.8, 32.6, 26.3, 26.1, 25.3, 
25.2. 
 




Chloro[bis(dicyclohexylamino)]cyclopropenium chloride (12). 
Dicyclohexylamine (186 mL, 936 mmol, 6.0 equiv) was slowly added to a 
solution of pentachlorocyclpropane (33.4 g, 156 mmol, 1.0 equiv) in dichloromethane (1.6 L, 0.1 
M). The resulting solution was stirred at room temperature for a further 48 hours (hr) during 























CH2Cl2, rt, 12 h
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1 M NaOH(aq)




precipitate excess dicyclohexylamine. The reaction mixture was filtered and the filtrate was 
washed with 1.0 M HCl (3 x 500 mL and 3 x 250 mL), dried with Na2SO4 and concentrated in 
vacuo. The resulting crude solid was washed with hot ethyl acetate (3 x 200 mL) to yield the 
pure title compound as a white powder (60.0 g, 128 mmol, 82% yield). 1H NMR (400 MHz, 
CDCl3) δ 3.62 (m, 2H, NCyH), 3.44 (m, 2H, NCyH), 2.11-1.30 (m, 40H, CyH). 13C NMR (100 
MHz, CDCl3) 132.2, 93.5, 65.8, 56.9, 32.7, 30.8, 25.4, 25.2, 24.5, 24.4. IR (thin film, cm-1) 2933, 
2851, 1583, 1419, 1324, 1123, 990, 891. LRMS (APCI+) m/z = 413.37; calcd for C37H45N2O 
[M]+ 413.35; note: this mass corresponds to hydrolyzed cyclopropenium depicted below: 
 
 
General procedure for cyclopropenimine hydrochloride salt synthesis: 
Chiral amine (1.10 equiv) was added to a solution of 
chloro[bis(dicyclohexylamino)]cyclopropenium chloride (1.00 equiv) and N,N-
diisopropylethylamine (2.00-3.00 equiv) in dichloromethane (0.1 M). The reaction solution was 
stirred for 12 hr before being washed with 1.0 M HCl (3 x reaction volume), dried with Na2SO4 
and concentrated in vacuo. The crude solid material was recrystallized from a hot mixture of 
specified solvents to yield the pure title compound as a white solid. All cyclopropenimines were 
fully characterized as their hydrochloride salt.  
 
 General procedure for cyclopropenimine hydrochloride deprotonation: The 












dichloromethane (approximately 0.2 M) and washed with an equal volume of 1.0 M NaOH(aq) (3 
x). The dichloromethane solution was dried with Na2SO4 and concentrated in vacuo. Notes: (a) 
the temperature of the rotovap was kept at or below 20 °C; (b) the resulting solid was further 
dried on a vacuum pump for two hr before use; (c) the catalyst was stored in a freezer while not 
in use; (d) this process was repeated on a weekly basis as needed. 1H and 13C NMR of the 
obtained freebase are included below. In certain cases characterization of neutral 
cyclopropenimines was complicated by: cyclopropene carbons were not always observed in the 
13C NMR, cyclohexane carbons appeared broad in the 13C NMR, and cyclopropenimine 
decomposition occurred quickly; thus all cyclopropenimines were fully characterized as their 
hydrochloride salts prior to deprotonation.  
 
 (R)-2-(2,3-Bis(dicyclohexylamino)cyclopropenimine)-3-phenylpropan-1-ol 
hydrochloride (R-14•HCl). (R)-2-amino-3-phenylpropan-1-ol (500 mg, 3.31 
mmol, 1.10 equiv) was added to a solution of 
chloro[bis(dicyclohexylamino)]cyclopropenium chloride (1.40 g, 3.00 mmol, 1.00 equiv) and 
N,N-diisopropylethylamine (0.90 mL, 6.00 mmol, 2.0 equiv) in dichloromethane (30 mL, 0.1 M). 
The reaction solution was stirred for 12 h before being washed with 1.0 M HCl (3 x 30 mL), 
dried with Na2SO4 and concentrated in vacuo. The crude solid material was recrystallized from a 
hot mixture of ethyl acetate and hexanes (approximately 2:1) to yield the pure title compound as 
a white solid (1.63 g, 2.80 mmol, 93% yield). 1H NMR (400 MHz, CDCl3) δ 7.82 (d, J = 9.5 Hz, 
1H, NH), 7.23 (m, 5H, ArH), 5.22 (s, 1H, OH), 4.0-3.80 (m, 3H, NCHBnCH2OH), 3.26 (m, 4H, 
NCyH), 3.09 (dd, J = 8.3 and 13.7 Hz, 1H, CHPh), 3.02 (dd, J = 5.6 and 13.7 Hz, 1H, CHPh), 






114.8, 64.0, 61.8, 59.4, 38.7, 32.4, 32.2, 25.7, 25.7, 24.7. IR (thin film, cm-1) 3128, 2926, 2854, 
1498, 1447, 1371, 1346, 1251, 1179, 894. [α]20D = +32.9 (1.0 c, CHCl3). LRMS (APCI+) m/z = 
546.98 calcd for C36H56N3O [M+]+, found 545.28.  
 
(R)-2-(2,3-Bis(dicyclohexylamino)cyclopropenimine)-3-phenylpropan-1-ol 
(R-14•HCl).  Pure cyclopropenimine freebase was quantitatively obtained by 
dissolving the corresponding hydrochloride salt in CH2Cl2 and washing the 
solution with 1.0 M NaOH (3 x), drying with anhydrous sodium sulfate and concentrating in 
vacuo. The cyclopropenimine is obtained as an off-white solid. 1H NMR (400 MHz, CDCl3) δ 
7.10-7.25 (m, 5H, ArH), 3.79 (m, 1H, NCHBnCH2OH), 3.40-3.50 (m, 2H, NCHBnCH2OH), 
3.00-3.10 (m, 4H, NCyH), 2.85 (dd, J = 6.4 and 13.2 Hz, 1H, -CHPh), 2.78 (dd, J = 7.4 and 13.2 
Hz, 1H, CHPh), 1.00-1.90 (m, 40H, CyH). 13C NMR (100 MHz, CDCl3) δ 140.7, 129.8, 127.9, 
125.6, 65.3, 62.1, 58.4, 41.7, 32.9, 32.7, 26.2, 25.3. 
 
(S)-N1,N1,N2,N2-tetracyclohexyl-3-(1-phenylethylimino)cycloprop-1-ene-1,2-
diamine hydrochloride salt (19•HCl): Dicyclohexylamine (1.27 mL, 6.42 
mmol, 6.0 equiv) was slowly added to a solution of tetrachlorocyclopropene 
(0.13 mL, 1.07 mmol, 1.0 equiv) in CH2Cl2 (20 mL) at room temperature. A white precipitate 
formed as the reaction mixture was stirred for a further four h. Next, (S)-1-phenylethanamine 
(0.28 mL, 2.14 mmol, 2.0 equiv) was added in one portion and the reaction mixture was stirred 
overnight. The crude reaction mixture was filtered through a celite plug, then washed with 1.0 M 
HCl (3 x 20 mL), dried with anhydrous sodium sulfate and concentrated in vacuo to yield pure 
cyclopropenimine hydrochloride salt as a white solid (567 mg, 96% yield). The 









NMR (400 MHz, CDCl3) δ 8.85 (d, 8.0 Hz, 1H, NH), 7.45 (d, 7.6 Hz, 2H, ArH), 7.35 (t, 7.6 Hz, 
2H, ArH), 7.20 (t, 7.2 Hz, 2H, ArH), 4.90 (qt, 7.2 Hz, 1H, NCHMePh), 3.25-3.35 (m, 4H, 
NCyH), 1.20-1.90 (m, 43H, CyH, CH3); 13C NMR (100 MHz, CDCl3) δ 143.6, 128.7, 127.0, 
125.8, 116.3, 115.7, 59.4, 57.0, 32.2, 32.0, 25.5, 25.5, 24.5, 24.1. 
 
(S)-N1,N1,N2,N2-tetracyclohexyl-3-(1-phenylethylimino)cycloprop-1-ene-1,2-
diamine (19): Pure cyclopropenimine was quantitatively obtained by dissolving 
the corresponding hydrochloride salt in CH2Cl2 and washing the solution with 
1.0 M NaOH (3 x), drying with anhydrous sodium sulfate and concentrating in vacuo. The 
cyclopropenimine is obtained as an off-white solid. 1H NMR (400 MHz, CDCl3) δ 7.52 (d, 7.2 
Hz, 2H, ArH), 7.25 (t, 7.6 Hz, 2H, ArH), 7.10 (t, 7.2 Hz, 1H, ArH), 4.80 (q, 6.4 Hz, 1H, 
NCHMePh), 3.10 (br s, 4H, NCyH), 1.10-1.90 (m, 40H, CyH), 1.45 (d, 6.4 Hz, 3H, CH3); 13C 
NMR (100 MHz, CDCl3) δ 127.8, 126.7, 125.3, 59.6, 58.4, 33.2, 32.9, 28.7, 26.4, 25.4; [α]20D = -
8.1 (1.0 c, CHCl3);  LRMS (APCI+) m/z = 516.43 calcd for C35H53N3 [M+1]+, found 517.07. 
 
(S)-Methyl 2-(2,3-bis(dicyclohexylamino)cyclopropenimine)-3-
phenylpropanoate hydrochloride (20•HCl). The general procedure was 
followed using L-phenylalanine methyl ester hydrochloride (500 mg, 2.32 
mmol), chloro[bis(dicyclohexylamino)]cyclopropenium chloride (985 mg, 2.11 mmol) and N,N-
diisopropylethylamine (0.90 mL, 6.33 mmol) in dichloromethane (21 mL). Recrystallization 
from hot ethyl acetate yielded the title product as a white solid (1.25 g, 2.05 mmol, 97% yield). 
1H NMR (400 MHz, CDCl3) δ 8.83 (d, J = 9.0 Hz, 1H, NH), 7.45 (d, J = 7.1 Hz, 2H, ArH), 7.26 











9.4 and 14.0 Hz, 1H, CHPh), 3.81 (s, 3H, CO2CH3), 3.42 (dd, J = 3.9 and 14.0 Hz, 1H, CHPh), 
3.28 (m, 4H, NCyH), 1.90-1.25 (m, 40H, CyH). 13C NMR (100 MHz, CDCl3) δ 171.2, 137.1, 
129.6, 128.3, 126.7, 115.9, 115.5, 61.2, 59.5, 52.7, 37.0, 32.6, 32.0, 26.0, 25.5, 25.5, 24.9, 24.5. 
IR (thin film, cm-1) 3223, 2926, 2858, 1740, 1498, 1453, 1372, 1256, 1181, 891. [α]20D = -34.3 
(1.0 c, CHCl3). LRMS (APCI+) m/z = 574.58; calcd for C37H56N3O2 [M]+ 574.43. 
 
(S)-Methyl 2-(2,3-bis(dicyclohexylamino)cyclopropenimine)-3-
phenylpropanoate (20). 1H NMR (400 MHz, CDCl3) δ 7.30 (t, J = 7.1 Hz, 
2H, ArH), 7.16 (t, J = 7.1 Hz, 2H, ArH), 7.11 (t, J = 7.3 Hz, 1H, ArH), 4.33 
(dd, J = 5.2 and 8.2 Hz, 1H, Cp=NCH), 3.63 (s, 3H, CO2CH3), 3.116 (dd, J = 5.3 and 13.1 Hz, 
1H, CHPh), 3.12 (m, 4H, NCyH), 2.95 (dd, J = 8.4 and 13.0 Hz, 1H, CHPh), 1.80-1.00 (m, 40H, 
CyH). 13C NMR (100 MHz, CDCl3) δ 176.0, 140.4, 130.0, 127.6, 125.6, 117.6, 67.0, 58.5, 51.4, 
42.1, 33.2, 32.7, 26.4, 26.3, 26.2, 25.3. 
 
(S)-2-(2,3-Bis(dicyclohexylamino)cyclopropenimine)-3-
phenylpropanamide hydrochloride (21•HCl). The general procedure was 
followed using L-phenylalaninamide hydrochloride (500 mg, 3.05 mmol), 
chloro[bis(dicyclohexylamino)]cyclopropenium chloride (1.30 g, 2.77 mmol) and N,N-
diisopropylethylamine (0.80 mL, 6.33 mmol) in dichloromethane (28 mL). Recrystallization 
from ethyl acetate/hexanes/dichloromethane yielded the title product as a white solid (1.40 g, 
2.51 mmol, 90% yield). 1H NMR (400 MHz, CDCl3) δ 9.5 (s, 1H, NH), 8.62 (d, J = 9.8 Hz, 1H, 
CpNH), 7.41 (d, J = 7.2 Hz, 2H, ArH), 7.30-7.18 (m, 3H, ArH), 5.53 (s, 1H, NH), 4.16 (m, 1 H, 












1.89-1.30 (m, 40H, CyH). 13C NMR (100 MHz, CDCl3) δ 174.0, 137.3, 129.3, 128.0, 126.4, 
115.0, 114.6, 64.8, 59.2, 38.4, 31.9, 31.8, 25.3, 25.3, 24.3. IR (thin film, cm-1) 3159, 2928, 2845, 
1687, 1537, 1500, 1447, 1373, 1322, 1251, 1180, 895, 577. [α]20D = 2.3 (1.0 c, CHCl3). LRMS 
(APCI+) m/z = 559.35; calcd for C36H55N4O [M]+ 559.43. 
 
(S)-2-(2,3-Bis(dicyclohexylamino)cyclopropenimine)-3-
phenylpropanamide (21). 1H NMR (400 MHz, CDCl3) δ 7.28 (m, 2H, ArH), 
7.16-7.10 (m, 3H, ArH), 4.26 (dd, J = 4.4 and 6.1 Hz, 1H, Cp=NCH), 3.15-
2.95 (m, 6H, NCyH and CH2Ph), 1.85-1.05 (m, 40H, CyH). 13C NMR (100 MHz, CDCl3) δ 
179.4, 139.5, 130.4, 127.2, 126.6, 125.5, 114.7, 111.4, 66.2, 58.8, 57.7, 42.5, 33.3, 33.1, 32.4, 
32.1, 26.3, 26.2, 26.1, 25.3. 
 
(S)-2-(2,3-Bis(dicyclohexylamino)cyclopropenimine)propan-1-ol 
hydrochloride (30•HCl). The general procedure was followed using (S)-2-
amino-1-propanol (1.0 mL, 12.8 mmol), 
chloro[bis(dicyclohexylamino)]cyclopropenium chloride (5.45 g, 11.7 mmol) and N,N-
diisopropylethylamine (3.3 mL, 23.3 mmol) in dichloromethane (117 mL). Recrystallization 
from ethyl acetate/hexanes yielded the title product as a white solid (4.50 g, 9.58 mmol, 82% 
yield). 1H NMR (400 MHz, CDCl3) δ 7.78 (d, J = 6.8 Hz, 1H, CpNH), 5.44 (s, 1H, OH), 3.85 
(m, 3H, NCHCH2OH), 3.35 (m, 4H, NCyH), 1.95-1.20 (m, 40H, CyH), 1.26 (d, J = 6.2 Hz, 3H, 
CH3). 13C NMR (100 MHz, CDCl3) δ 116.6, 115.2, 64.5, 59.7, 55.5, 32.4, 25.8, 25.7, 24.7, 19.1. 












= -0.5 (1.0 c, CHCl3). LRMS (APCI+) m/z = 310.36; calcd for C18H35N3O [M]+ 310.28. LRMS 
(APCI+) m/z = 470.29; calcd for C30H52N3O [M]+ 470.40. 
 
(S)-2-(2,3-Bis(dicyclohexylamino)cyclopropenimine)propan-1-ol (30). 1H 
NMR (400 MHz, CDCl3) δ 3.62-3.55 (m, 2H, CHOH and Cp=NCH), 3.30 (dd, 
J = 6.4 and 9.2 Hz, 1H, CHOH), 3.17 (m, 4H, NCyH), 1.90-1.10 (m, 40H, 
CyH), 1.10 (d, J = 6.2 Hz, 3H, CH3). 13C NMR (100 MHz, CDCl3) δ 113.7, 67.6, 58.4, 55.8, 
32.9, 32.8, 26.3, 26.2, 25.3, 21.0. 
 
(S)-2-(2,3-Bis(dicyclohexylamino)cyclopropenimine)-3-methylbutan-1-ol 
hydrochloride (32•HCl). The general procedure was followed using (S)-2-
amino-3-methyl-1-butanol (1.00 g, 9.69 mmol), 
chloro[bis(dicyclohexylamino)]cyclopropenium chloride (4.12 g, 8.81 mmol) and N,N-
diisopropylethylamine (2.5 mL, 17.6 mmol) in dichloromethane (88 mL). Recrystallization from 
ethyl acetate/hexanes yielded the title product as a white solid (3.50 g, 7.03 mmol, 80% yield).  
1H NMR (400 MHz, CDCl3) δ 7.55 (d, J = 9.0 Hz, 1H, CpNH), 5.21 (s, 1H, OH), 4.02 (m, 1H, 
NCHCH2OH), 3.81 (m, 1H, CHOH), 3.45 (m, 1H, CHOH) 3.45 (m, 4H, NCyH), 2.09 (quintet, J 
= 6.9 Hz, 1H, CHMe2), 1.94-1.20 (m, 40H, CyH), 0.98 (d, J = 6.7 Hz, 6H, CH3). 13C NMR (100 
MHz, CDCl3) δ 117.3, 115.0, 65.1, 61.3, 59.4, 32.3, 32.2, 30.6, 25.6, 24.6, 19.5, 18.7. IR (thin 
film, cm-1) 3226, 2930, 2855, 1501, 1450, 1378, 1177, 894, 731. [α]20D = -30.7 (1.0 c, CHCl3). 













(32). 1H NMR (400 MHz, CDCl3) δ 3.52 (m, 2H, CH2OH), 3.30 (q, J = 5.8 Hz, 
1H, Cp=NCH), 3.13 (m, 4H, NCyH), 1.85-1.10 (m, 41H, CyH and CHMe2), 
0.91 (d, J = 6.4 Hz, 6H, 2 x CH3). 13C NMR (100 MHz, CDCl3) δ 65.8, 63.0, 58.4, 32.9, 32.8, 
32.7, 26.2, 25.3, 19.9, 18.8. 
 
(S)-2-(2,3-Bis(dicyclohexylamino)cyclopropenimine)-2-phenylethanol 
hydrochloride (33•HCl). The general procedure was followed using (S)-2-
phenylglycinol (500 mg, 3.64 mmol), 
chloro[bis(dicyclohexylamino)]cyclopropenium chloride (1.55 g, 3.31 mmol) and N,N-
diisopropylethylamine (1. 0 mL, 6.62 mmol) in dichloromethane (33 mL). Recrystallization from 
ethyl acetate/hexanes/dichloromethane yielded the title product as a white solid (1.89 g, 3.08 
mmol, 93% yield). 1H NMR (400 MHz, CDCl3) δ 8.04 (d, J = 5.8 Hz, 1H, CpNH), 7.36-7.25 (m, 
5H, ArH), 5.95 (t, J = 7.4 Hz, 1H, OH), 4.97 (m, 1H, CHPh), 4.05 (m, 1H, CHOH), 3.93 (m, 1H, 
CHOH), 3.30 (m, 4H, NCyH), 1.95-1.20 (m, 40H, CyH). 13C NMR (100 MHz, CDCl3) δ 139.4, 
128.8, 127.7, 126.1, 116.5, 116.0, 65.8, 63.7, 59.6, 32.2, 32.2, 25.7, 25.6, 24.6. IR (thin film, cm-
1) 3168, 2928, 2858, 1500, 1447, 1375, 1068, 898, 726, 703. [α]20D = 6.3 (1.0 c, CHCl3). LRMS 
(APCI+) m/z = 532.33; calcd for C35H54N3O [M]+ 532.42. 
 
(S)-2-(2,3-Bis(dicyclohexylamino)cyclopropenimine)-2-phenylethanol (33). 
1H NMR (400 MHz, CDCl3) δ 7.35 (d, J = 7.4 Hz, 2H, ArH), 7.25 (m, 2H, 
ArH), 7.13 (t, J = 7.3 Hz, 1H, ArH), 4.69 (dd, J = 4.7 and 7.5 Hz, 1H, NCHPh), 















NCyH), 1.90-0.95 (m, 40H, CyH). 13C NMR (100 MHz, CDCl3) δ 145.7, 128.0, 127.0, 126.0, 
68.7, 64.4, 58.1, 33.1, 32.7, 26.4, 26.2, 26.1, 25.3. 
 
(1S,2S)-2-(2,3-Bis(dicyclohexylamino)cyclopropenimine)-1,2-
diphenylethanol hydrochloride (34•HCl). The general procedure was 
followed using (S,S)-2-amino-1,2-diphenylethanol (500 mg, 2.34 mmol), 
chloro[bis(dicyclohexylamino)]cyclopropenium chloride (996 mg, 2.13 mmol) and N,N-
diisopropylethylamine (0.60 mL, 4.26 mmol) in dichloromethane (21 mL). Recrystallization 
from ethyl acetate/hexanes yielded the title product as a white solid (1.33 g, 2.06 mmol, 97% 
yield). 1H NMR (400 MHz, CDCl3) δ 8.61 (d, J = 8.3 Hz, 1H, CpNH), 7.21-7.10 (m, 10H, ArH), 
6.26 (m, 1H, CHPh), 5.31 (s, 1H, OH), 4.76 (t, J = 8.0 Hz, 1H, CHPh), 3.31 (m, 4H, NCyH), 
1.90-1.20 (m, 40H, CyH). 13C NMR (100 MHz, CDCl3) δ 141.2, 139.7, 128.2, 127.7, 127.6, 
127.5, 127.2, 127.1, 116.3, 115.6, 68.6, 59.5, 32.2, 62.1, 25.6, 25.5, 24.6. IR (thin film, cm-1) 
3152, 2927, 2855, 1499, 1447, 1372, 1179, 1056, 700. [α]20D = -19.9 (1.0 c, CHCl3). LRMS 
(APCI+) m/z = 608.62; calcd for C41H58N3O [M]+ 608.45. 
 
(1S,2S)-2-(2,3-Bis(dicyclohexylamino)cyclopropenimine)-1,2-
diphenylethanol (34). 1H NMR (400 MHz, CDCl3) δ 7.30-7.12 (m, 10H, ArH), 
4.60 (d, J = 4.6 Hz, 1H, CHPh), 4.50 (d, J = 4.4 Hz, 1H, CHAr), 3.04 (br s, 4H, 
NCyH), 1.79-1.00 (m, 40H, CyH). 13C NMR (100 MHz, CDCl3) δ 146.2, 144.8, 127.7, 127.6, 















diphenylethanol hydrochloride (35•HCl). The general procedure was 
followed using (1R,2S)-2-amino-1,2-diphenylethanol (500 mg, 2.34 mmol), 
chloro[bis(dicyclohexylamino)]cyclopropenium chloride (996 mg, 2.13 mmol) and N,N-
diisopropylethylamine (0.60 mL, 4.26 mmol) in dichloromethane (21 mL). Recrystallization 
from ethyl acetate/hexanes yielded the title product as a white solid (1.23 g, 2.02 mmol, 95% 
yield). 1H NMR (400 MHz, CDCl3) δ 7.33 (d, J = 7.2 Hz, 1H, CpNH), 7.21-7.00 (m, 10H, ArH), 
6.69 (m, 1H, CHPh), 5.68 (s, 1H, OH), 5.28 (dd, J = 2.8 and 7.4 Hz, 1H, CHPh), 3.31 (m, 4H, 
NCyH), 1.90-1.20 (m, 40H, CyH). 13C NMR (100 MHz, CDCl3) δ 139.9, 137.6, 127.9, 127.8, 
127.6, 127.5, 127.2, 126.7, 115.5, 115.4, 74.5, 66.4, 59.4, 32.3, 25.6, 25.5, 24.7. IR (thin film, 
cm-1) 3199, 2933, 2855, 1501, 1453, 1375, 1181, 890.1, 740.9. [α]20D = -38.2 (1.0 c, CHCl3). 
LRMS (APCI+) m/z = 608.61; calcd for C41H58N3O [M]+ 608.45. 
 
(1R,2S)-2-(2,3-Bis(dicyclohexylamino)cyclopropenimine)-1,2-
diphenylethanol (35). 1H NMR (400 MHz, CDCl3) δ 7.10-6.95 (m, 10H, ArH), 
4.94 (m, 2H, 2 x CHPh), 3.21 (br s, 2H, NCyH), 2.99 (br s, 2H, NCyH), 1.95-
1.10 (m, 40H, CyH). 13C NMR (100 MHz, CDCl3) δ 142.9, 142.0, 128.4, 127.1, 127.0, 126.9, 
126.2, 126.0, 125.7, 78.1, 69.0, 58.2, 33.1, 32.7, 26.2, 26.1, 25.3. 
 
(R)-2-(2,3-Bis(dicyclohexylamino)cyclopropenimine)-1-phenylethanol 
hydrochloride (36•HCl). The general procedure was followed using (R)-2-
amino-1-phenylethanol (301 mg, 2.20 mmol), chloro[bis(dicyclohexylamino)]cyclopropenium 

















dichloromethane (20 mL). Recrystallization from ethyl acetate/hexanes yielded the title product 
as a white solid (957 mg, 1.80 mmol, 90% yield). 1H NMR (400 MHz, CDCl3) δ 8.17 (t, J = 5.4 
Hz, 1H, CpNH), 7.44 (d, J = 7.4 Hz, 2H, ArH), 7.29 (t, J = 7.3 Hz, 2H, ArH), 7.22 (t, J = 7.2 Hz, 
1H, ArH), 5.88 (s, 1H, OH), 5.15 (d, J = 7.3 Hz, 1H, CHPh), 3.84-3.73 (m, 2H, NCH2), 3.30 (m, 
4H, NCyH), 1.90-1.20 (m, 40H, CyH). 13C NMR (100 MHz, CDCl3) δ 142.1, 128.2, 127.4, 
126.1, 116.6, 114.5, 72.1, 59.6, 54.3, 32.3, 25.7, 24.5. IR (thin film, cm-1) 3141, 2930, 2855, 
1528, 1491, 1447, 1372, 1099, 891. [α]20D = -9.7 (1.0 c, CHCl3). LRMS (APCI+) m/z = 532.55; 
calcd for C35H54N3O [M]+ 532.42. 
 
(R)-2-(2,3-Bis(dicyclohexylamino)cyclopropenimine)-1-phenylethanol (36). 
1H NMR (400 MHz, CDCl3) δ 7.42 (d, J = 7.3 Hz, 2H, ArH), 7.30 (t, J = 7.4 
Hz, 2H, ArH), 7.20 (t, J = 7.3 Hz, 1H, ArH), 4.70 (dd, J = 4.0 and 8.8 Hz, 1H, CHPhOH), 3.85 
(dd, J = 4.2 and 11.6 Hz, 1H, Cp=NCH), 3.35 (dd, J = 9.1 and 11.6 Hz, 1H, Cp=NCH), 3.12 (m, 
4H, NCyH), 1.95-1.00 (m, 40H, CyH). 13C NMR (100 MHz, CDCl3) δ 144.0, 128.0, 126.7, 
126.0, 73.6, 59.6, 58.4, 32.7, 26.3, 25.3. 
 
(R)-1-(2,3-Bis(dicyclohexylamino)cyclopropenimine)propan-2-ol 
hydrochloride (37•HCl). The general procedure was followed using (R)-1-
amino-2-propanol (165 mg, 2.20 mmol), chloro[bis(dicyclohexylamino)]cyclopropenium 
chloride (935 mg, 2.00 mmol) and N,N-diisopropylethylamine (0.68 mL, 4.00 mmol) in 
dichloromethane (20 mL). Recrystallization from ethyl acetate/hexanes yielded the title product 
as a white solid (780 mg, 1.66 mmol, 83% yield). 1H NMR (400 MHz, CDCl3) δ 7.94 (s, 1H, 










1.90-1.20 (m, 40H, CyH), 1.23 (d, J = 4.6 Hz, 3H, CH3). 13C NMR (100 MHz, CDCl3) δ 116.9, 
114.5, 65.6, 59.6, 54.3, 32.4, 32.3, 25.8, 24.7, 20.8. IR (thin film, cm-1) 3226, 2933, 2858, 1494, 
1453, 1375, 1321, 1249, 1181, 894. [α]20D = -9.9 (1.0 c, CHCl3). LRMS (APCI+) m/z = 470.30; 
calcd for C30H52N3O [M]+ 470.40. 
 
(R)-1-(2,3-Bis(dicyclohexylamino)cyclopropenimine)propan-2-ol (37). 1H 
NMR (400 MHz, CDCl3) δ 3.79 (m, 1H, CHOH), 3.59 (dd, J = 3.7 and 11.4 
Hz, 1H, Cp=NCH), 3.13 (m, 5H, NCyH and Cp=NCH), 1.90-1.20 (m, 40H, CyH), 1.17 (d, J = 
6.1 Hz, 3H, CH3). 13C NMR (100 MHz, CDCl3) δ 67.4, 58.8, 58.4, 32.8, 26.3, 25.4, 20.2. 
 
(1S,2S)-1-(2,3-Bis(dicyclohexylamino)cyclopropenimine)-2,3-dihydro-1H-
inden-2-ol hydrochloride (38•HCl). The general procedure was followed 
using (1S,2S)-trans-1-amino-2-indanol (300 mg, 2.01 mmol), 
chloro[bis(dicyclohexylamino)]cyclopropenium chloride (855 mg, 1.83 mmol) and N,N-
diisopropylethylamine (0.55 mL, 3.84 mmol) in dichloromethane (18 mL). Recrystallization 
from ethyl acetate/hexanes yielded the title product as a white solid (1.00 g, 1.72 mmol, 94% 
yield). 1H NMR (400 MHz, CDCl3) δ 7.72 (d, J = 5.9 Hz, 1H, CpNH), 7.21-7.10 (m, 3H, ArH), 
6.97 (d, J = 7.4 Hz, 1H, ArH), 6.1 (s, 1H, OH), 5.00 (q, J = 9.1 Hz, 1H, CHOH), 4.91 (t, J = 6.2 
Hz, 1H, CHNH), 3.37 (m, 4H, NCyH), 3.20 (dd, J = 7.3 and 15.2 Hz, 1H, CHAr), 2.96 (dd, J = 
9.9 and 15.0 Hz, 1H, CHAr), 1.90-1.20 (m, 40H, CyH). 13C NMR (125 MHz, CDCl3) δ 140.6, 
139.2, 128.3, 126.8, 125.3, 122.4, 116.6, 115.1, 77.9, 68.5, 59.5, 37.1, 32.4, 32.2, 25.6, 25.5, 
24.6. IR (thin film, cm-1) 3209, 2926, 2855, 1498, 1447, 1375, 1177, 894, 744. [α]20D = 79.0 (1.0 












inden-2-ol (38). 1H NMR (400 MHz, CDCl3) δ 7.13 (m, 4H, ArH), 4.74 (d, J 
= 7.9 Hz, 1H, NCHAr), 4.40 (broad q, J = 7.5 Hz, 1H, CHOH), 3.20 (m, 4H, 
NCyH), 3.11 (dd, J = 7.4 Hz, 1H, CHAr), 2.85 (dd, J = 9.7 and 14.7 Hz, 1H, CHAr), 1.90-1.00 
(m, 40H, CyH). 13C NMR (100 MHz, CDCl3) δ 138.9, 126.8, 126.5, 124.4, 124.0, 82.0, 73.1, 
58.5, 37.3, 32.9, 26.3, 26.1, 25.2. 
 
(1S,2R)-1-(2,3-Bis(dicyclohexylamino)cyclopropenimine)-2,3-dihydro-1H-
inden-2-ol hydrochloride (39•HCl). The general procedure was followed 
using (1S,2R)-cis-1-amino-2-indanol (300 mg, 2.01 mmol), 
chloro[bis(dicyclohexylamino)]cyclopropenium chloride (855 mg, 1.83 mmol) and N,N-
diisopropylethylamine (0.55 mL, 3.84 mmol) in dichloromethane (18 mL). Recrystallization 
from ethyl acetate/hexanes yielded the title product as a white solid (1.04 g, 1.79 mmol, 98% 
yield). 1H NMR (400 MHz, CDCl3) δ 7.28-7.15 (m, 4H, ArH), 6.80 (br s, 1H, OH), 6.55 (d, J = 
8.4 Hz, 1H, CpNH), 5.05 (m, 2H, CHOH and CHNH), 3.35 (m, 4H, NCyH), 3.20-3.14 (m, 2H, 
CH2Ar), 1.90-1.20 (m, 40H, CyH). 13C NMR (100 MHz, CDCl3) δ 141.4, 140.4, 128.6, 126.7, 
125.9, 123.6, 115.8, 114.6, 71.7, 63.6, 59.4, 40.0, 32.6, 32.5, 26.1, 25.7, 25.6, 24.8. IR (thin film, 
cm-1) 3155, 2930, 2858, 1501, 1450, 1372, 1181, 894, 734. [α]20D = 85.0 (1.0 c, CHCl3). LRMS 
(APCI+) m/z = 544.56; calcd for C36H54N3O [M]+ 544.42. 
 
(1S,2R)-1-(2,3-Bis(dicyclohexylamino)cyclopropenimine)-2,3-dihydro-1H-












= 5.0 Hz, 1H, NCHAr), 4.40 (broad t, J = 3.6 Hz, 1H, CHOH), 3.20 (m, 4H, NCyH), 3.03 (m, 
2H, CH2Ar), 1.90-1.00 (m, 40H, CyH). 13C NMR (100 MHz, CDCl3) δ 147.0, 141.3, 126.7, 
126.2, 125.0, 73.6, 67.9, 58.5, 39.5, 33.2, 32.9, 26.4, 26.3, 26.2, 25.3. 
 
N-Methyl-(2,3-bis(dicyclohexylamino)cyclopropenimine hydrochloride 
(27•HCl). The general procedure was followed using methylamine (1.1 mL 
2.0M in THF, 2.14 mmol), chloro[bis(dicyclohexylamino)]cyclopropenium chloride (1.00 g, 
2.14 mmol) and N,N-diisopropylethylamine (1.12 mL, 6.42 mmol) in dichloromethane (21 mL). 
Recrystallization from ethyl acetate/hexanes yielded the title product as a white solid (892 mg, 
1.93 mmol, 90% yield). 1H NMR (400 MHz, CD3CN) δ 7.11 (s, 1H, NH), 3.36 (tt, J = 3.9 and 
12.1 Hz, 4H, NCyH), 3.12 (d, J = 4.8 Hz, 3H, NCH3), 1.95-1.20 (m, 40H, CyH). 13C NMR (125 
MHz, CD3CN) δ 117.7, 115.6, 60.1, 33.1, 32.7, 26.5, 25.3. IR (thin film, cm-1) 2925, 2854, 1500, 
1447, 1371, 1251, 1182, 1078, 894. LRMS (APCI+) m/z = 426.41; calcd for C28H48N3 [M]+ 
426.38. 
 
Synthesis of tetradeutero cyclopropenimine (S)-d4-14. 
 
 
 Bis(cyclohexyl-1-d)amine. Benzyl amine (5.22 mL, 47.8 mmol, 1.0 equiv) and 
cyclohexanone (4.95 mL, 47.8 mmol, 1.0 equiv) were added to a dichloromethane 








































was stirred at room temperature overnight then concentrated in vacuo and redissolved in dry 
methanol (48 mL, 1.0 M). The solution was cooled to 0 °C and sodium borodeuteride (2.00 g, 
47.8 mmol, 1.0 equiv) was slowly added. The reaction mixture was stirred for one hour before 
directly concentrating to a crude solid. Extraction of the crude solid with diethyl ether followed 
by concentration yielded a crude yellow oil. This material was passed through a short silica gel 
plug (10% MeOH/DCM eluent) before carrying forward. A crude 1H NMR spectrum is provided 
below. 
Crude N-benzylcyclohexan-1-d-1-amine obtained above was hydrogenated under 1 atm 
of hydrogen in the presence of Pd/C (500 mg) and Pd(OH)2 (500 mg) in dry methanol (200 mL, 
0.25 M) for 72 h. Upon completion, determined by 1H NMR, the reaction mixture was filtered 
through wetted celite and the filtrate was concentrated in vacuo to yield crude cyclohexan-1-d-1-
amine. A crude 1H NMR spectrum is provided below. 
Crude cyclohexan-1-d-1-amine (47.8 mmol assumed, 1.0 equiv) was added to a solution 
of cyclohexanone (5.22 mL, 47.8 mmol, 1.0 equiv) in dichloromethane (48 mL, 1.0 M) 
containing freshly activated molecular sieves (4Å, 10 g). The mixture was stirred at room 
temperature overnight then concentrated in vacuo and redissolved in dry methanol (48 mL, 1.0 
M). The solution was cooled to 0 °C and sodium borodeuteride (2.00 g, 47.8 mmol, 1.0 equiv) 
was slowly added. The reaction mixture was stirred for one hour before directly concentrating to 
a crude solid. Extraction of the crude solid with diethyl ether followed by addition of HCl (25 
mL of a 4.0 M dioxane solution) resulted in the precipitation of bis(cyclohexyl-1-d)amine 
hydrochloride salt. The solid was collected by filtration then dissolved in dichlormethane and 
washed with 1 M NaOH to yield pure bis(cyclohexyl-1-d)amine as a clear oil (2.13 g, 11.6 mmol, 
24% overall yield). 1H NMR (400 MHz, CDCl3) δ 1.95-1.55 (m, 10H, -CH2- x 5), 1.40-1.00 (m, 
 123 
10H, -CH2- x 5), 0.67 (br s, 1H, NH). 2H NMR (400 MHz, CHCl3) δ 2.52 (br s, 2D, NCD x 2). 
13C NMR (100 MHz, CDCl3) δ 52.6 (t), 34.3, 26.3, 25.4. 
 
(S)-2-(2,3-Bis(bis(cyclohexyl-1-d)amino))cyclopropenimine)-3-
phenylpropan-1-ol hydrochloride (d4-14•HCl). A dichloromethane 
solution of bis(cyclohexyl-1-d)amine (1.60 g, 8.73 mmol, 2.5 equiv in 10 
mL DCM) was slowly added to a solution of tetrachlorocyclopropene (0.43 
mL, 3.49 mmol, 1.0 equiv) and N,N-diisopropylethylamine (2.40 mL, 14.0 mmol, 4.0 equiv) in 
dichloromethane (25 mL, 0.1 M overall concentration). The reaction mixture was stirred at room 
temperature overnight and then (S)-2-amino-3-phenylpropan-1-ol (792 mg, 5.24 mmol, 1.5 
equiv) was added in one portion. After a further 12 h, the reaction mixture was filtered and 
washed with 1 M HCl (5 x 30 mL), dried with sodium sulfate and concentrated in vacuo to a 
crude solid. The crude solid could be recrystallized by two methods: a) from a hot ethyl 
acetate/hexanes solution (approximately 2:1 EtOAc/hexanes); b) layering hexanes onto a 
solution of crude solid in benzene. From these methods approximately 1.8 g of pure title product 
was isolated as a white crystalline solid (1.8 g, 3.07 mmol, 88% yield). 1H NMR (400 MHz, 
CDCl3) δ 7.89 (d, J = 9.4 Hz, 1H, NH), 7.24 (m, 5H, ArH), 5.21 (br s, 1H, OH), 3.94 (m, 3H, 
NCHCH2OH), 3.14 (dd, J = 8.6 and 13.9 Hz, 1H, CHPh), 3.02 (dd, J = 5.6 and 13.9 Hz, 1H, 
CHPh), 1.95-1.20 (m, 40H, CyH). 2H NMR (400 MHz, CHCl3) δ 3.26 (br s, 4D, NCyD). 13C 
NMR (100 MHz, CDCl3) δ 137.7, 129.1, 127.9, 126.1, 116.4, 114.4, 63.6, 61.2, 58.5 (t), 38.2, 
31.8, 31.7, 25.2, 24.2. IR (thin film, cm-1) 3129, 2926, 2856, 1527, 1498, 1454, 1341, 1262, 












phenylpropan-1-ol (d4-14). Pure cyclopropenimine freebase was 
quantitatively obtained by dissolving the corresponding hydrochloride salt 
in dichloromethane and washing the solution with 1.0 M NaOH (3 x), 
drying with anhydrous sodium sulfate and concentrating in vacuo. The cyclopropenimine was 
obtained as an off-white solid and used immediately. 1H NMR (400 MHz, CDCl3) δ 7.20 (m, 5H, 
ArH), 3.80 (m, 1H, NCHBn), 3.45 (m, 2H, CH2OH), 2.78 (m, 2H, CH2Ph), 1.90-1.10 (m, 40H, 
CyH). 2H NMR (400 MHz, CHCl3) δ 3.12 (br s, 4D, NCyD). 13C NMR (100 MHz, CDCl3) δ 
140.4, 129.7, 127.9, 125.6, 113.7, 65.0, 61.8, 58.1 (t), 41.5, 32.7, 32.5, 26.1, 25.2. 
 




hydrochloride (25•HCl). Diisopropylamine (3.93 mL, 27.9 mmol, 6.0 equiv) 
was slowly added to a solution of pentachlorocyclopropane3 (0.57 mL, 4.65 
mmol, 1.0 equiv) in CH2Cl2 (46 mL, 0.1 M) in a 250 mL round bottom flask. The reaction 
mixture was stirred for a further 24 hr at room temperature. Next, N,N-diisopropylethylamine 
(2.40 mL, 14.1 mmol, 3.0 equiv) and (S)-2-amino-3-phenylpropan-1-ol4 (854 mg, 5.65 mmol, 
                                                
3 Tobey, S. W.; West, R. J. Am. Chem. Soc. 1966, 88, 2478.  
4 Shi, L.; Chen, L.; Chen, R.; Chen, L. J. Label Compd. Radiopharm. 2010, 53, 147-151. 
HNiPr2 (excess)
































1.2 equiv) was added in one portion and the reaction mixture was stirred for an additional 24 hr. 
The crude reaction mixture was then washed with 1.0 M HCl (3 x 100 mL), dried with 
anhydrous sodium sulfate and concentrated in vacuo to yield crude cyclopropenimine 
hydrochloride salt as an off-white solid. Recrystallization from ethyl acetate/hexanes 
(approximately 2/1) yielded pure cyclopropenimine hydrochloride salt as a white solid (1.73 g, 
4.10 mmol, 88% yield). 1H NMR (400 MHz, CDCl3) δ 7.10-7.25 (m, 5H, ArH), 6.30 (d, 9.6 Hz, 
NH), 3.60-4.0 (m, 8H, NCHBnCH2OH, NCH(CH3)2), 1.20 (m, 24H, NCH(CH3)2); 13C NMR 
(100 MHz, CDCl3) δ 137.9, 129.5, 128.5, 126.6, 116.3, 113.7, 64.6, 62.4, 50.5, 38.1, 22.1, 22.0. 
IR (thin film, cm-1) 3257, 3124, 2971, 2930, 1501, 1457, 1344, 1211, 1136, 1034, 700. [α]20D = -




(25). Pure cyclopropenimine freebase was quantitatively obtained by 
dissolving the corresponding hydrochloride salt in CH2Cl2 and washing the solution with 1.0 M 
NaOH (3 x), drying with anhydrous sodium sulfate and concentrating in vacuo. The 
cyclopropenimine is obtained as an off-white solid. The isolated cyclopropenimine was used 
immediately after deprotonation. Note: identical spectra were obtained when deprotonated with 
sodium hydride in acetonitrile. 1H NMR (400 MHz, CD3CN) δ 7.10-7.30 (m, 5H, ArH), 3.60-
3.75 (m, 5H, NCH(CH3)2, NCHBnCH2OH), 3.20-3.40 (m, 2H, NCHBnCH2OH), 2.60-2.80 (m, 
2H, NCHCH2Ph), 1.20 (d, 6.8 Hz, 24H, NCH(CH3)2); 13C NMR (100 MHz, CD3CN) δ 141.5, 








N-Methyl-(2,3-Bis(diisopropylamino)cyclopropenimine) (28•HCl). This 
cyclopropenimine was prepared in an analogous fashion as directly above 
using pentachlorocyclopropane (347 mg, 1.62 mmol, 1.0 equiv), N,N-diisopropylamine (1.36 
mL, 9.72 mmol, 6.0 equiv) and methylamine (2.44 mL of 2.0M THF solution, 4.88 mmol, 3.00 
equiv). Silica gel column chromotragaphy (20:1 DCM:MeOH) followed by recrystallization 
from ethyl acetate/hexanes yielded the titled product as an off-white solid (180 mg, 0.596 mmol, 
37% yield). 1H NMR (400 MHz, CD3CN) δ 8.37 (s, 1H, NH), 3.83 (quintet, J = 6.8 Hz, 4H, 
NCHMe2), 3.06 (d, J = 4.8 Hz, 3H, NCH3), 1.28 (d, J = 6.8 Hz, 24H, NCH(CH3)2). 13C NMR 
(100 MHz, CD3CN) δ 118.1, 114.9, 51.3, 32.7, 22.1. IR (thin film, cm-1) 2929, 2858, 1504, 1451, 






hydrochloride (31•HCl). The general procedure was followed using (S)-2-
amino-1-propanol (0.15 mL, 1.94 mmol), 
chloro[bis(diisopropylamino)]cyclopropenium chloride mix (1.11 g, 1.62 mmol) and N,N-
diisopropylethylamine (0.90 mL, 6.33 mmol) in dichloromethane (16 mL). Silica gel 
chromotagraphy (5% MeOH/DCM) yielded the title product as a tan solid (145 mg, 0.469 mmol, 
29% yield). 1H NMR (400 MHz, CDCl3) δ 8.40 (s, 1H, CpNH), 5.28 (t, J = 7.1 Hz, 1H, OH), 
Cl Cl
HNiPr2 (excess)

































4.0-3.80 (m, 3H, NCHCH2OH), 3.85 (qt, J = 6.8 Hz, 4H, NCHMe2), 1.38 (two d, J = 7.8 Hz, 
24H, NCH(CH3)2), 1.26 (d, J = 6.5 Hz, NCHCH3). 13C NMR (100 MHz, CDCl3) δ 116.3, 113.6, 
64.4, 55.7, 50.4, 22.0, 22.0, 18.6. IR (thin film, cm-1) 3189, 2930, 2855, 1532, 1498, 1450, 1375, 
1344, 724. [α]20D = 14.9 (1.0 c, CHCl3). LRMS (APCI+) m/z = 310.41; calcd for C18H36N3O [M]+ 
310.28. 
 
(S)-2-(2,3-Bis(diisopropylamino)cyclopropenimine)propan-1-ol (31). The 
corresponding hydrochloride salt was dissolved in acetonitrile (0.1 M) and 
stirred with sodium hydride (1.1 equiv, prewashed with hexanes) for 15 minutes. Filtration 
through a short celite plug and concentration yielded pure cyclopropenimine. 1H NMR (400 
MHz, CDCl3) δ 3.87 (septet, J = 6.8 Hz, 4H, NCHMe2), 3.70 (m, 1H, Cp=NCH), 3.58 (dd, J = 
3.8 and 11.3 Hz, 1H, CHOH), 3.47 (dd, J = 6.8 and 11.3 Hz, 1H, CHOH), 1.28 (d, J = 4.4 Hz, 
12H, 4 x CH3), 1.26 (d, J = 4.4 Hz, 12H, 4 x CH3), 1.16 (d, J = 6.5 Hz, 3H, CH3). 13C NMR (100 






N-tert-Butyl-(2,3-Bis(diisopropylamino)cyclopropenimine) (10•HCl): tert-Butylamine (1.4 
mL, 13.25 mmol, 3.0 equiv) was added to a solution of chlorocyclopropenium salt5 (1.640 g, 
4.42 mmol, 1.0 equiv) in CH2Cl2 (50 mL). A white precipitate was observed as the reaction 
mixture was stirred for 48 h at room temperature. The crude reaction mixture was washed with 
                                                
















1.0 M HCl (3 x 30 mL), dried with anhydrous sodium sulfate and concentrated in vacuo to yield 
pure cyclopropenimine hydrochloride salt as a white solid (1.490 g, 97% yield). The 
cyclopropenimine salt can be stored at room temperature without noticeable decomposition. 1H 
NMR (400 MHz, CD3CN) δ 5.40 (s, 1H, NH), 4.00 (m, 6.8 Hz, 4H, NCH(CH3)2), 1.39 (s, 9H, 
NC(CH3)3), 1.27 (d, 8 Hz, 24H, NCH(CH3)2); 13C NMR (100 MHz, CD3CN) δ 117.1, 114.4, 
54.0, 51.1, 30.5, 22.3; LRMS (APCI+) m/z = 308.31 calcd for C19H37N3 [M+1]+, found 308.47. 
Neutral cyclopropenimine was prepared in situ in CD3CN to be used for pKBH+ estimation. 1H 
NMR data was recorded after addition of excess sodium hydride or potassium tert-butoxide to 
the corresponding cyclopropenimine hydrochloride salt in CD3CN. 1H NMR (300 MHz, CD3CN) 
δ 3.60 (m, 4H, NCH(CH3)2), 1.10-1.40 (m, 33H, NC(CH3)3, NCH(CH3)2). 
 




hydrochloride (26•HCl). Pyrrolidine (13.4 mL, 163.3 mmol, 7.0 equiv) was 
slowly added to a 0 °C solution of pentachlorocyclopropane (5 g, 23.3 mmol, 
1.0 equiv) in dichloromethane (230 mL, 0.1 M). After addition the reaction solution was allowed 
to warm to room temperature and was stirred overnight before direct concentration by rotary 
evaporator to yield a crude mixture of tris(pyrrolidino)cyclopropenium chloride and pyrrolidine 
hydrochloride salts.  
ii)
i) pyrrolidine (7 equiv)






MeOH, 60 °C, 8 h
NN
O (COCl)2
CH2Cl2, rt, 1 h
ii)




















The crude solid from above was subjected to hydrolysis by dissolution in methanol (90 
mL) and mixing with 15% KOH (13.5 g KOH in 90 mL H2O). The reaction mixture was stirred 
at 60 °C for 8 h before extraction with dichloromethane (3 x 100 mL). The extracted organics 
were dried with sodium sulfate and concentrated in vacuo to yield 2,3-di(pyrrolidin-1-
yl)cycloprop-2-en-1-one. A crude 1H NMR of this material is provided below. This material was 
not further purified. 
Oxallyl chloride (0.27 mL, 3.12 mmol, 1.5 equiv) was added dropwise to a solution of 
2,3-di(pyrrolidin-1-yl)cycloprop-2-en-1-one (400 mg, 2.08 mmol, 1.0 equiv) in dichloromethane 
(21 mL, 1.0 M). After stirring for 1 hr at room temperature the reaction solution was 
concentrated in vacuo and further dried on a vacuum pump for an addition 2 hr. The obtained 
crude solid was then redissolved in dichloromethane (21 mL, 1.0 M) and (S)-2-amino-3-
phenylpropan-1-ol (786 mg, 5.20 mmol, 2.5 equiv) was added in one portion. After stirring at 
room temperature overnight the reaction solution was washed with 1 M HCl (3 x 10 mL), dried 
with sodium sulfate and concentrated in vacuo to a crude solid. Purification by silica gel 
chromotagraphy (5-10% MeOH/DCM eluent) yielded the title hydrochloride salt as a tan solid 
(254 mg, 0.702 mmol, 34% yield from cyclopropenone). 1H NMR (500 MHz, CDCl3) δ 8.90 (d, 
J = 8.5 Hz, 1H, CpNH), 7.35 (m, 4H, ArH), 7.19 (t, J = 7.1 Hz, 1H, ArH), 4.86 (s, 1H, OH), 3.72 
(dd, J = 3.2 and 11.6 Hz, 1H, CHOH), 3.56 (m, 1H, CHOH), 3.49 (m, 1H, CpNCHBn), 3.45 (br 
s, 8H, CpNCH2 x 4), 2.93 (dd, J = 5.6 and 13.6 Hz, 1H, CHPh), 2.87 (dd, J = 8.7 and 13.6 Hz, 
1H, CHPh), 1.91 (quintet, J = 3.5 Hz, -CH2- x 4). 13C NMR (125 MHz, CD3CN) δ 139.8, 130.6, 
129.3, 127.2, 115.7, 114.0, 64.8, 63.4, 51.3, 38.6, 26.3. IR (thin film, cm-1) 3134, 2926, 2871, 
1505, 1478, 1453, 1345, 1178, 1047, 744, 702. [α]20D = -28.3 (1.0 c, CHCl3). LRMS (APCI+) 




Neutral cyclopropenimine was obtained by dissolving the corresponding 
hydrochloride salt in CH2Cl2 and washing the solution with 3.0 M NaOH (3 x), 
drying with anhydrous sodium sulfate and concentrating in vacuo. The cyclopropenimine is 
obtained as a brown solid. Note: treatment with sodium hydride or potassium tert-butoxide in 
acetonitrile did not appear to achieve deprotonation (the material obtained from these 
deprotonation attempts did not have any catalytic activity for the glycinate imine Michael 
reaction). 1H NMR (300 MHz, CDCl3) δ 7.40-7.10 (m, 5H, ArH), 3.50-3.40 (m, 2H, CH2OH), 
3.28 (br s, 9H, 4 x NCH2 and NCHBn), 2.68 (m, 2H, CH2Ph), 1.85 (m, 8H, 4 x –CH2-). 13C 
NMR (100 MHz, CD3CN) δ 141.1, 130.5, 129.0, 126.7, 113.3, 65.8, 65.4, 51.1, 40.0, 26.3. 
 
General procedure for catalyst structure-activity relationship study (Scheme 5, Scheme 6 
and Table 3). 
Freshly deprotonated cyclopropenimine (0.0169 mmol, 0.1 equiv) and tert-butyl 
glycinate benzophenone Schiff base (50 mg, 0.169 mmol, 1.0 equiv) were dissolved in ethyl 
acetate (0.48 mL, 0.35 M). Methyl acrylate (46.0 µL, 0.508 mmol, 3.0 equiv) was then added to 
the vial and the reaction solution was stirred at room temperature. The reaction was monitored by 
1H NMR spectroscopy and conversion was determined by comparing tert-butyl integrals of the 
starting material and product. Upon 95% conversion, or after 24 hr if not complete, the reaction 
solution was concentrated and the crude material subjected to silica gel column chromatography 





Chiralpak AD-H (Hex/IPA = 97/3, 1.0 mL/min, 254 nm, 23°C), 6.1 min (minor), 6.7 min 
(major). 
The initial reaction profiles of the above Michael reactions catalyzed by 




Note: Our previous method for determining cyclopropenimine hydrochloride salt pKa relied on 
knowing the chemical shifts for both the cyclopropenimine hydrochloride and cyclopropenimine 
freebase. We recently found that depending on the base used to deprotonate cyclopropenimine 
hydrochloride salts (e.g. NaH, KOtBu, KH or NaOH) that the observed chemical shifts were 
rarely consistent. Thus, there was uncertainty associated with the identifying a chemical shift that 
accurately corresponded to the cyclopropenimine freebase. We therefore base our calculations 























General procedure. Cyclopropenimine hydrochloride salts were recrystallized before use. 
Phosphazene base P1-t-Bu-tris(tetramethylene) (tBu-P1(pyrr)) was used from a freshly opened 
commercial source (Sigma Aldrich Co.). Reference chemical shifts for both the freebase and 
hydrochloride salts of tBu-P1(pyrr) were recorded in triplicate; the average chemical shifts are 
shown above. Stock solutions of cyclopropenimine hydrochloride salts and tBu-P1(pyrr) in 
CD3CN were prepared to insure accurate stoichiometric ratios. 
A CD3CN (0.6 mL) solution containing cyclopropenimine hydrochloride (0.03 mmol, 
0.05 M, 1.0 equiv) and tBu-P1(pyrr) (0.03 mmol, 0.05 M, 1.0 equiv) was prepared and allowed to 
mix for 15 minutes before obtaining an 1H NMR spectrum (this spectrum did not change over the 
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chemical shifts (ppm) for 
tBu-P1(pyrr):
3.196, 1.2713 3.1488, 1.8002 3.1763, 1.8528, 1.2635
Calculated 
equilibrium constant 































P1(pyrr) to tBu-P1(pyrr)HCl, and thus the ratio of CpImHCl to CpIm, could be determined. 
Representative observed chemical shifts of tBu-P1(pyrr) for these experiments are listed above. 
Using the equations shown above, with the known pKBH+ of tBu-P1(pyrr) (28.41 in MeCN),6 an 
estimated pKa for the cyclopropenimine hydrochloride salt was determined. Each experiment 
was ran in triplicate and the calculated K and pKa values are shown above. Example 1H NMR 
spectra are provided below. 
 
Solvent effect on Glycinate-Michael Additions (Table 1). 
Cyclopropenimine 14 (9.2 mg, 0.0169 mmol, 0.1 equiv) and tert-butyl glycinate 
benzophenone Schiff base (50 mg, 0.169 mmol, 1.0 equiv) were dissolved in solvent (0.85 mL, 
0.20 M). Methyl acrylate (46 µL, 0.508 mmol, 3.0 equiv) was then added to the vial and the 
reaction solution was stirred at room temperature. The reaction was monitored by 1H NMR 
spectroscopy and conversion was determined by comparing tert-butyl integrals of the starting 
material and product. Upon 95% conversion, or after 24 hr if not complete, the reaction solution 
was concentrated and the crude material subjected to silica gel column chromatography (1/5 
Et2O/Hexanes) to yield pure product. Enantioselectivities were determined via chiral HPLC: 
Chiralpak AD-H (Hex/IPA = 97/3, 1.0 mL/min, 254 nm, 23°C), 6.1 min (minor), 6.7 min 
(major). 
 
General Procedure for Glycinate-Michael Additions with Unsubstituted Acceptors (Table 
2). 
 
                                                
6 Kaljurand, I.; Kütt, A.; Sooväli, L.; Rodima, T.; Mäemets, V.; Leito, I.; Koppel, I. A. J. 
Org.Chem. 2005, 70, 1019. 
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Cyclopropenimine 14 (3.6 mg, 0.00677 mmol, 0.1 equiv) and tert-butyl glycinate benzophenone 
Schiff base (20 mg, 0.0677 mmol, 1.0 equiv) were dissolved in ethyl acetate (0.2 mL). Michael-
acceptor (0.203 mmol, 3.0 equiv) was then added to the vial and the reaction solution was stirred 
at room temperature. Upon complete consumption of starting material, monitored by 1H NMR 
spectroscopy, the reaction solution was concentrated and the crude material subjected to silica 
gel column chromatography (1/4 Et2O/Hexanes eluent).  
 
(S)-1-tert-Butyl-5-methyl 2-(diphenylmethyleneamino)pentanedioate 
(17a).7 Isolated as a colorless oil (26 mg, 100% yield). 1H NMR (400 MHz, 
CDCl3) δ 7.64 (d, 7.2 Hz, 2H, ArH), 7.14-7.45 (m, 8H, ArH), 3.97 (t, 6.4 Hz, HCCO2tBu), 3.59 
(s, 3H, CO2CH3), 2.35-2.45 (m, 2H, -CH2-), 2.15-2.25 (m, 2H, -CH2-), 1.44 (s, 9H, C(CH3)3); 
13C NMR (100 MHz, CDCl3) δ 173.7, 170.9, 170.8, 139.6, 136.6, 130.4, 128.9, 128.7, 128.6, 
128.1, 127.9, 81.3, 64.9, 51.6, 30.6, 28.8, 28.2. HPLC analysis: Chiralpak AD-H (Hex/IPA = 
97/3, 1.0 mL/min, 254 nm, 23°C), 6.1 min (minor), 6.7 min (major), 98% ee.  
Large-scale (Scheme 4): The general procedure was followed using cyclopropenimine 14 
(0.924 g, 1.693 mmol, 0.025 equiv), tert-butyl glycinate benzophenone Schiff base (20.0 g, 67.7 
mmol, 1.0 equiv) and methyl acrylate (18.4 mL, 203.1 mmol, 3.0 equiv) dissolved in ethyl 
acetate (200 mL). The product was isolated as a colorless oil (25.03 g, 97% yield). HPLC 
                                                
7 Ma, T.; Fu, X.; Kee, W. K.; Zong, L.; Pan, Y.; Huang, K.W.; Tan, C.H. J. Am. Chem. Soc. 





















analysis: Chiralpak AD-H (Hex/IPA = 97/3, 1.0 mL/min, 254 nm, 23°C), 6.1 min (minor), 6.7 
min (major), 99% ee. 
 
 (S)-1-tert-Butyl 5-ethyl 2-(diphenylmethyleneamino)pentanedioate (Table 
2, entry 1).7 Reaction performed on a 0.169 mmol scale of tert-butyl glycinate 
benzophenone Schiff base. The title product was isolated as a colorless oil (64 mg, 0.162 mmol, 
96% yield). 1H NMR (400 MHz, CDCl3) δ 7.64 (d, J = 7.1 Hz, 2H, ArH), 7.48-7.30 (m, 6H, 
ArH), 7.19 (dd, J = 3.0 and 4.3 Hz, 2H, ArH), 4.05 (t, J = 7.1 Hz, 2H, CO2CH2CH3), 3.96 (t, J = 
6.0 Hz, 1H, HCCO2tBu), 2.35 (m, 2H, CH2), 2.22 (m, 2H, CH2), 1.44 (s, 9H, C(CH3)3), 1.19 (t, J 
= 7.1 Hz, 3H, CO2CH2CH3). 13C NMR (100 MHz, CDCl3) δ 173.3, 170.9, 170.7, 139.6, 136.6, 
130.4, 128.9, 128.7, 128.6, 128.1, 127.9, 81.3, 65.0, 60.4, 30.9, 28.8, 28.2, 14.3. HPLC analysis: 
Chiralpak AD-H (Hex/IPA = 97/3, 1.0 mL/min, 254 nm, 23°C), 5.2 min (minor), 5.6 min 
(major), 99% ee. 
 
(S)-1-tert-Butyl-5-butyl 2-(diphenylmethyleneamino)pentanedioate8 (Table 
2, entry 2): Isolated as a colorless oil (29 mg, 100% yield). 1H NMR (400 
MHz, CDCl3) δ 7.64 (m, 2H, ArH), 7.30-7.45 (m, 6H, ArH), 7.15-7.20 (m, 2H, ArH), 3.90-4.00 
(m, 3H, HCCO2tBu, CO2CH2), 2.35 (m, 2H, -CH2-),  2.20 (m, 2H, -CH2-), 1.55 (m, 2H, -CH2-), 
1.44 (s, 9H, C(CH3)3, 1.35 (m, 2H, -CH2-), 0.90 (t, 7.2 Hz, -CH3); 13C NMR (100 MHz, CDCl3) 
δ 173.4, 170.9, 170.8, 139.7, 136.7, 130.4, 128.9, 128.7, 128.6, 128.1, 127.9, 81.3, 65.0, 64.4, 
30.9, 30.8, 28.9, 28.2, 19.2, 13.8. HPLC analysis: Chiralpak AD-H (Hex/IPA = 98/2, 1.0 
mL/min, 254 nm, 23°C), 6.7 min (minor), 7.4 min (major), 98% ee. 
                                                












(Table 2, entry 3): Isolated as a colorless oil (30 mg, 97% yield). 1H NMR 
(400 MHz, CDCl3) δ 7.63 (m, 2H, ArH), 7.30-7.45 (m, 11H, ArH), 7.15 (m, 2H, ArH), 5.03 (s, 
2H, CO2CH2Ph), 3.97 (dd, 7.2 Hz and 5.2 Hz, 1H, HCCO2tBu), 2.44 (m, 2H, -CH2-), 2.35 (m, 
2H, -CH2-), 1.43 (s, 9H, C(CH3)3); 13C NMR (100 MHz, CDCl3) δ 173.1, 170.9, 170.8, 139.6, 
136.6, 136.1, 130.5, 129.0, 128.7, 128.6, 128.6, 128.3, 128.1, 127.9, 81.3, 66.3, 65.0, 30.9, 28.8, 
28.2. HPLC analysis: Chiralpak AD-H (Hex/IPA = 98/2, 1.0 mL/min, 254 nm, 23°C), 11.1 min 
(minor), 12.8 min (major), 98% ee. 
 
(S)-di-tert-Butyl 2-(diphenylmethyleneamino)pentanedioate11 (Table 2, 
entry 4): Isolated as a colorless oil (28 mg, 98% yield). 1H NMR (400 MHz, 
CDCl3) δ 7.65 (d, 7.2 Hz, ArH), 7.30-7.50 (m, 6H, ArH), 7.20 (m, 2H, ArH), 3.95 (t, 5.6Hz, 1H, 
HCCO2tBu), 2.15-2.30 (m, 4H, -CH2CH2-), 1.44 (s, 9H, C(CH3)3), 1.39 (s, 9H, C(CH3)3); 13C 
NMR (100 MHz, CDCl3) δ 172.6, 171.0, 170.7, 139.7 136.7, 130.4, 128.9, 128.7, 128.6, 128.1, 
128.0, 81.2, 80.3, 65.1, 32.1, 29.0, 28.2. HPLC analysis: Chiralpak AD-H (Hex/IPA = 98/2, 0.6 
mL/min, 254 nm, 23°C), 9.0 min (minor), 9.6 min (major), 99% ee.  
 
(S)-1-tert-Butyl 5-(2,2,2-trifluoroethyl) 2-
(diphenylmethyleneamino)pentanedioate (Table 2, entry 5). Reaction 
performed on a 0.169 mmol scale of tert-butyl glycinate benzophenone Schiff base. The title 
product was isolated as a colorless oil (68 mg, 0.151 mmol, 90% yield). 1H NMR (400 MHz, 














2H, CO2CH2CF3), 3.99 (dd, J = 5.0 and 7.3 Hz, 1H, CHCO2R), 2.49 (m, 2H, -CH2-), 2.24 (m, 
2H, -CH2-), 1.44 (s, 9H, C(CH3)3). 13C NMR (125 MHz, CDCl3) δ 171.7, 171.0, 170.6, 139.5, 
136.5, 130.6, 128.9, 128.8, 128.2, 127.9, 81.5, 64.7, 60.4 (q), 30.2, 28.5, 28.2. 19F NMR (470 
MHz, CDCl3) δ 72.8 ppm (s, 3F). IR (thin film, cm-1) 2977, 2936, 1757, 1733, 1627, 1368, 1280, 
1143, 973, 693. [α]20D = -40.0 (1.0 c, CHCl3). LRMS (APCI+) m/z = 450.11; calcd for 
C24H26F3NO4 [M+1]+ 450.18. HPLC analysis: Chiralpak OD-H (Hex/IPA = 98.5/1.5, 1.0 mL/min, 
254 nm, 23°C), 5.9 min (major), 7.2 min (minor), 58% ee. 
 
(S)-tert-Butyl 2-(diphenylmethyleneamino)-5-oxohexanoate6 (Table 2, entry 
6): Isolated as a colorless oil (24 mg, 97% yield). 1H NMR (400 MHz, CDCl3) 
δ 7.63 (m, 2H, ArH), 7.30-7.50 (m, 6H, ArH), 7.15 (m, 2H, ArH), 3.96 (t, 6.4 Hz, 1H, 
HCCO2tBu), 2.45-2.60 (m, 2H, -CH2-), 2.15 (m, 2H, -CH2-), 2.12 (s, 3H, -COCH3), 1.43 (s, 9H, 
C(CH3)3); 13C NMR (100 MHz, CDCl3) δ 208.4, 171.1, 170.6, 139.6, 136.6, 130.4, 128.9, 128.7, 
128.6, 128.2, 127.9, 81.3, 64.8, 40.0, 30.0, 28.2, 27.9. HPLC analysis: Chiralpak AD-H 
(Hex/IPA = 97/3, 1.0 mL/min, 254 nm, 23°C), 7.2 min (minor), 8.1 min (major), 95% ee. 
 
(S)-tert-Butyl 4-cyano-2-(diphenylmethyleneamino)butanoate 9  (Table 2, 
entry 7): Obtained as a pale yellow oil (23 mg, 98% yield). 1H NMR (400 
MHz, CDCl3) δ 7.66 (m, 2H, ArH), 7.30-7.50 (m, 6H, ArH), 7.20 (m, 2H, ArH), 4.05 (m, 1H, 
HCCO2tBu), 2.20-2.50 (m, 4H, -CH2CH2-), 1.44 (s, 9H, C(CH3)3); 13C NMR (100 MHz, CDCl3) 
δ 172.1, 170.0, 139.2, 136.1, 130.7, 129.0, 128.9, 128.7, 128.2, 127.5, 119.5, 81.9, 63.8, 29.5, 
28.1, 13.9. HPLC analysis: Chiralpak AD-H (Hex/IPA = 98/2, 1.0 mL/min, 254 nm, 23°C), 9.3 
                                                










min (minor), 11.7 min (major), 77% ee. 
 
(S)-tert-Butyl 2-(diphenylmethyleneamino)-4-(phenylsulfonyl)butanoate 10 
(Table 2, entry 8): Isolated with phenyl vinyl sulfone starting material (88% 
yield based on benzyl ether standard). 1H NMR (400 MHz, CDCl3) δ 7.90 (m, 2H, ArH), 7.50-
7.70 (m, 5H, ArH), 7.30-7.45 (m, 6H, ArH), 7.10 (m, 2H, ArH), 4.00 (m, 1H, HCCO2tBu), 3.10-
3.35 (m, 2H, CH2SO2Ph), 2.10-2.30 (m, 2H, CH2CH2SO2Ph), 1.37 (s, 9H, C(CH3)3); 13C NMR 
(100 MHz, CDCl3) δ 171.5, 169.9, 139.1, 139.0, 136.1, 130.7, 129.4, 128.9, 128.9, 128.7, 128.2, 
128.1, 127.7, 81.8, 63.6, 52.9, 28.0, 27.1. HPLC analysis: Chiralpak AD-H (Hex/IPA = 95/5, 1.0 
mL/min, 254 nm, 23°C), 12.9 min (minor), 16.8 min (major), 41% ee. 
 
Enolates other than tert-butyl glycinate benzophenone imine (Scheme 6). 
 
(S)-Dimethyl 2-(diphenylmethyleneamino)pentanedioate (17b). 11 
Cyclopropenimine 14 (11.0 mg, 0.0197 mmol, 0.1 equiv) and methyl glycinate 
benzophenone imine (50 mg, 0.197 mmol, 1.0 equiv) were dissolved in ethyl 
acetate (0.56 mL, 0.35 M). Methyl acrylate (54.0 µL, 0.592 mmol, 3.0 equiv) was then added to 
the vial and the reaction solution was stirred at room temperature. After 45 min the reaction 
mixture was purified by silica gel column chromatography (1/4 Et2O/Hexanes) to yield the title 
product as a colorless oil (67 mg, 0.197 mmol, 100% yield). 1H NMR (400 MHz, CDCl3) δ 7.63 
(d, J = 7.1 Hz, 2H, ArH), 7.46-7.32 (m, 6H, ArH), 7.18 (m, 2H, ArH), 4.13 (t, J = 6.3 Hz, 1H, 
                                                
10 Tsubogo, T.; Saito, S.; Seki, K.; Yamashita, Y.; Kobayashi, S. J. Am. Chem. Soc. 2008, 130, 
13321-13332.  









NCHCO2Me), 3.71 (s, 3H, CO2CH3), 3.58 (s, 3H, CO2CH3), 2.38-2.35 (m, 2H, -CH2-), 2.26-
2.22 (m, 2H, -CH2-). 13C NMR (100 MHz, CDCl3) δ 173.4, 172.2, 171.3, 139.4, 136.2, 130.6, 
129.0, 128.9, 128.7, 128.2, 127.9, 64.2, 52.3, 51.6, 30.5, 28.7. HPLC analysis: Chiralpak OD-H 
(Hex/IPA = 97/3, 1.0 mL/min, 254 nm, 23°C), 9.6 min (minor), 11.1 min (major), 96% ee.  
 
 (S)-1-Benzyl 5-methyl 2-(diphenylmethyleneamino)pentanedioate (17c).12 
Cyclopropenimine 14 (8.3 mg, 0.0152 mmol, 0.1 equiv) and benzyl glycinate 
benzophenone imine (50 mg, 0.152 mmol, 1.0 equiv) were dissolved in ethyl 
acetate (0.43 mL, 0.35 M). Methyl acrylate (41.0 µL, 0.455 mmol, 3.0 equiv) was then added to 
the vial and the reaction solution was stirred at room temperature. After 45 min the reaction 
mixture was purified by silica gel column chromatography (1/3 Et2O/Hexanes) to yield the title 
product as a colorless oil (62 mg, 0.149 mmol, 98% yield). 1H NMR (400 MHz, CDCl3) δ 7.65 
(d, J = 7.2 Hz, 2H, ArH), 7.40-7.31 (m, 11H, ArH), 7.11 (m, 2H, ArH), 5.15 (two d, J = 12.4 Hz, 
2H, CH2Ph), 4.16 (t, J = 6.3 Hz, 1H, NCHCO2Bn), 3.58 (s, 3H, CO2CH3), 2.38-2.35 (m, 2H, -
CH2-), 2.30-2.25 (m, 2H, -CH2-). 13C NMR (100 MHz, CDCl3) δ 173.5, 171.5, 139.4, 136.2, 
135.9, 130.6, 129.0, 128.8, 128.6, 128.3, 128.2, 128.2, 127.9, 66.7, 64.3, 51.6, 30.5, 28.6. IR 
(thin film, cm-1) 3028, 2947, 1736, 1624, 1443, 1256, 1160, 1256, 1078, 700. LRMS (APCI+) 
m/z = 417.26; calcd for C26H25NO4 [M+1]+ 416.18. HPLC analysis: Chiralpak OD-H (Hex/IPA = 
97/3, 1.0 mL/min, 254 nm, 23°C), 11.7 min (minor), 12.4 min (major), 97% ee.  
 
 (S)-Methyl 4-cyano-4-(diphenylmethyleneamino)butanoate (23). 
                                                
12 Shibuguchi, T.; Mihara, H.; Kuramochi, A.; Sakuraba, S.; Ohshima, T.; Shibasaki, M. Angew. 








Cyclopropenimine 14 (24.8 mg, 0.0454 mmol, 0.1 equiv) and 2-
(diphenylmethyleneamino)ethanenitrile (100 mg, 0.454 mmol, 1.0 equiv) were dissolved in ethyl 
acetate (1.30 mL, 0.35 M). Methyl acrylate (123 µL, 1.36 mmol, 3.0 equiv) was then added to 
the vial and the reaction solution was stirred at room temperature. After 15 min the reaction 
mixture was purified by silica gel column chromatography (1/4 Et2O/Hexanes) to yield the title 
product as a colorless oil (135 mg, 0.441 mmol, 97% yield). 1H NMR (400 MHz, CDCl3) δ 7.65 
(m, 2H, ArH), 7.52-7.42 (m, 4H, ArH), 7.35 (t, J = 7.8 Hz, 2H, ArH), 7.20 (dd, J = 2.7 and 7.7 
Hz, 2H, ArH), 4.35 (t, J = 6.4 Hz, 1H, CHCN), 3.61 (s, 3H, CO2CH3), 2.60-2.51 (m, 2H, -CH2-), 
2.24-2.22 (m, 2H, -CH2-). 13C NMR (100 MHz, CDCl3) δ 173.8, 172.6, 138.3, 135.1, 131.4, 
129.5, 129.1, 128.3, 127.4, 119.1, 51.9, 51.8, 30.0, 29.9. IR (thin film, cm-1) 3066, 2953, 1726, 
1624, 1443, 1215, 1153, 731, 697. [α]20D = -28.4 (1.0 c, CHCl3). LRMS (APCI+) m/z = 307.22; 
calcd for C19H18N2O2 [M+1]+ 307.14. HPLC analysis: Chiralpak OD-H (Hex/IPA = 98.5/1.5, 0.7 
mL/min, 254 nm, 23°C), 19.3 min (minor), 20.2 min (major), 10% ee.  
 
(R)-Dimethyl 2-(2,2-diphenylvinyl)pentanedioate (24). Cyclopropenimine 14 
(54 mg, 0.099 mmol, 0.1 equiv) and methyl 4,4-diphenylbut-3-enoate (250 mg, 
0.99 mmol, 1.0 equiv) were dissolved in ethyl acetate (2.8 mL, 0.35 M). Methyl 
acrylate (270 µL, 2.97 mmol, 3.0 equiv) was then added to the vial and the reaction solution was 
stirred at room temperature. After 48 hr the reaction mixture was purified by silica gel column 
chromatography (1/9 Et2O/Hexanes) to yield the title product as a colorless oil (37 mg, 0.109 
mmol, 11% yield). Unreacted starting material methyl 4,4-diphenylbut-3-enoate was also 
isolated (195 mg, 0.77 mmol, 78% recovery). 1H NMR (500 MHz, CDCl3) δ 7.48-7.19 (m, 10H, 





1H, C=CHCHCO2Me), 2.28 (m, 2H, CH2CO2Me), 2.07 and 1.94 (m, 2H, -CH2-). 13C NMR (125 
MHz, CDCl3) δ 117.2, 173.3, 145.2, 141.7, 139.2, 129.9, 128.5, 128.3, 127.7, 127.6, 127.5, 
125.5, 52.1, 51.7, 31.5, 27.9. IR (thin film, cm-1) 2950, 1733, 1494, 1440, 1205, 1157, 765, 700. 
[α]20D = -141.4 (0.5 c, CHCl3). LRMS (APCI+) m/z = 339.25; calcd for C21H21O4 [M+1]+ 338.14. 
HPLC analysis: Chiralpak OD-H (Hex/IPA = 98/2, 0.8 mL/min, 254 nm, 23°C), 10.5 min 
(minor), 11.1 min (major), 71% ee.  
 
 
General Procedure for Glycinate-Michael Additions with Substituted Acceptors (Table 6). 
 
Cyclopropenimine 14 (9.2 mg, 0.0169 mmol, 0.1 equiv) and tert-butyl glycinate benzophenone 
Schiff base (50 mg, 0.169 mmol, 1.0 equiv) were dissolved in ethyl acetate (0.48 mL, 0.35 M). 
Michael-acceptor (0.508 mmol, 3.0 equiv) was then added to the vial and the reaction solution 
was stirred at room temperature. Upon complete consumption of starting material, monitored by 
1H NMR spectroscopy, the reaction solution was concentrated and the crude material subjected 
to silica gel column chromatography (Et2O/Hexanes eluent as noted). Selectivities were 
determined via chiral HPLC as noted. Directly below the characterization of these substrates is a 
list of Michael acceptors that failed to give appreciable yield. 
 
tert-Butyl 2-(diphenylmethyleneamino)-2-(3-oxocyclopentyl)ethanoate 















cyclopentenone (43 µL, 0.508 mmol, 3.0 equiv) as the Michael acceptor. After 48 hr the reaction 
mixture was purified by silica gel column chromatography (1/6 à 1/4 Et2O/Hexanes) to yield 
the title product as a white solid as a mixture of diastereomers (56 mg, 0.148 mmol, 88% yield). 
1H NMR (500 MHz, CDCl3) δ 7.62 (m, 2H, ArH), 7.45-7.31 (m, 6H, ArH), 7.15 (m, 2H, ArH), 
4.00 (d, J = 5.0 Hz, 1H, minor NCHCO2tBu), 3.92 (d, J = 6.5 Hz, 1H, major NCHCO2tBu), 2.92 
(m, 1H, β-CH), 2.31 (m, 2H, -CH2-), 2.17 (m, 2H, -CH2-), 1.93 (m, 2H, -CH2-) 1.45 (s, 9H, 
major C(CH3)3), 1.44 (s, 9H, minor C(CH3)3). 13C NMR (125 MHz, CDCl3) δ 171.4, 171.0*, 
170.4, 170.3*, 139.4, 136.6, 130.6, 130.6*, 128.9, 128.8, 128.7, 128.2, 127.9, 81.6, 81.5*, 77.4, 
69.1, 68.5*, 42.2, 41.0*, 40.3*, 40.1, 38.3, 28.2, 26.4*, 25.5 (* denotes minor diastereomer 
where observable). IR (thin film, cm-1) 2964, 1743, 1723, 1627, 1283, 1222, 1143, 697. [α]20D = -
7.5 (1.0 c, CHCl3).  LRMS (APCI+) m/z = 378.29; calcd for C24H27NO3 [M+1]+ 378.20. HPLC 
analysis: Chiralpak AD-H (Hex/EtOH = 98/2, 1.0 mL/min, 254 nm, 23°C), 7.3 min (minor 
diastereomer), 7.8 min (major diastereomer), 8.3 (major diastereomer), 9.5 (minor diastereomer), 
78:22 dr, 4% ee major diastereomer, 30% ee minor diastereomer.  
 
(2S)-tert-Butyl 2-(diphenylmethyleneamino)-3-(2-
oxocyclopentyl)propanoate (Table 6, entry 3). The general procedure was 
followed using tert-butyl glycinate benzophenone Schiff base (25 mg, 0.0846 
mmol, 1.0 equiv) and 2-methylenecyclopentanone (24.4 mg, 0.254 mmol, 3.0 equiv) as the 
Michael acceptor. After 45 min the reaction mixture was purified by silica gel column 
chromatography (1/4 Et2O/Hexanes) to yield the title product as a clear oil as a 1:1 mixture of 
diastereomers (33.0 mg, 0.0843 mmol, 100% yield). 1H NMR (400 MHz, CDCl3) δ 7.64 (m, 2H, 






NCHCO2tBu), *3.97 (dd, J = 4.4 and 8.8 Hz, 1H, NCHCO2tBu), 2.50 (m, 1H, CHC=O), *2.40 
(m, 1H, CHC=O), 2.30-1.60 (m, 8H, 4 x –CH2-), 1.44 (s, 9H, C(CH3)3), *1.43 (s, 9H, major 
C(CH3)3); *denotes diastereomer where observable. 13C NMR (100 MHz, CDCl3) δ 171.4, 
171.3, 170.5, 170.4, 139.7, 139.6, 136.7, 136.6, 130.4, 130.4, 128.9, 128.9, 128.8, 128.7, 128.5, 
128.1, 127.9, 127.8, 81.2, 81.2, 64.6, 64.1, 46.6, 37.9, 37.8, 34.0, 33.9, 30.6, 29.8, 28.1, 20.9, 
20.8. (IR (thin film, cm-1) 2970, 1733, 1661, 1600, 1276, 1153, 697, 638. [α]20D = -86.0 (0.5 c, 
CHCl3).  LRMS (APCI+) m/z = 392.33; calcd for C25H29NO3 [M+1]+ 392.21. HPLC analysis: 
Chiralpak AD-H (Hex/IPA = 96/4, 1.0 mL/min, 254 nm, 23°C), 7.1 min (minor), 8.1 min 
(minor), 8.9 min (major), 9.9 min (major), 94 and 95% ee for the two diastereomers. 
 
(1S,2S)-1-tert-Butyl 2,3-dimethyl 1-(diphenylmethyleneamino)propane-
1,2,3-tricarboxylate (Table 6, entry 4). The general procedure was 
followed using dimethyl fumarate (73 mg, 0.508 mmol, 3.0 equiv) as the Michael acceptor. After 
2.5 hr the reaction mixture was purified by silica gel column chromatography (1/10 à 1/4 
Et2O/Hexanes) to yield the title product as a clear oil (69 mg, 0.157 mmol, 93% yield). 1H NMR 
(500 MHz, CDCl3) δ 7.60 (m, 2H, ArH), 7.45-7.31 (m, 6H, ArH), 7.15 (m, 2H, ArH), 4.42 (d, J 
= 5.0 Hz, 1H, NCHCO2tBu), 3.65 (s, 3H, CO2CH3), 3.63 (m, 1H, CHCO2Me), 3.60 (s, 3H, 
CO2CH3) 3.10 (dd, J = 9.6 and 17.0 Hz, 1H, CHCO2Me), 2.68 (dd, J = 3.9 and 17.0 Hz, 1H, 
CHCO2Me), 1.44 (s, 9H, C(CH3)3); 13C NMR (125 MHz, CDCl3) δ 172.9, 172.7, 172.2, 169.3, 
139.4, 136.1, 130.6, 129.1, 128.9, 128.4, 128.1, 128.0, 82.1, 66.2, 52.1, 51.9, 44.7, 32.4, 28.1. IR 
(thin film, cm-1) 2977, 2950, 1733, 1624, 1443, 1222, 1150, 697. [α]20D = -96.5 (1.0 c, CHCl3). 
LRMS (APCI+) m/z = 440.18; calcd for C25H29NO6 [M+1]+ 440.20. HPLC analysis: Chiralpak 








(Table 6, entry 6).7 The general procedure was followed using 
benzylideneacetone (73 mg, 0.508 mmol, 3.0 equiv) as the Michael acceptor. After 7 hr the 
reaction mixture was purified by silica gel column chromatography (1/20 à 1/4 Et2O/Hexanes) 
to yield the title product as a white solid (69 mg, 0.156 mmol, 92% yield). 1H NMR (400 MHz, 
CDCl3) δ 7.66 (m, 2H, ArH), 7.35-7.10 (m, 11H, ArH), 6.70 (d, J = 7.0 Hz, 2H, ArH), 4.05 (d, J 
= 7.0 Hz, 1H,  NCHCO2tBu), 3.98 (m, 1H, PhCH), 3.15-3.01 (m, 1H, CH2COMe), 2.07 (s, 3H, 
CH3), 1.31 (s, 9H, C(CH3)3); 13C NMR (125 MHz, CDCl3) δ 207.5, 171.2, 170.0, 141.3, 139.4, 
136.3, 130.5, 128.9, 128.7, 128.5, 128.3, 128.3, 128.1, 127.6, 126.8, 81.4, 70.9, 45.4, 44.7, 30.4, 
28.0. IR (thin film, cm-1) 2981, 1719, 1621, 1361, 1147, 697. LRMS (APCI+) m/z = 442.20; 
calcd for C29H31NO3 [M+1]+ 442.23. HPLC analysis: Chiralpak AD-H (Hex/IPA = 95/5, 1.0 
mL/min, 254 nm, 23°C), 6.3 min (minor), 7.8 min (major), 94.5% ee. 
 
 (2S,3R)-tert-Butyl 2-(diphenylmethyleneamino)-5-oxo-3,5-
diphenylpentanoate (Table 6, entry 7).7 The general procedure was followed 
on a slightly smaller scale using cyclopropenimine (3.6 mg, 0.00677 mmol, 0.1 equiv), tert-butyl 
glycinate benzophenone Schiff base (20 mg, 0.0677 mmol, 1.0 equiv) and trans-chalcone (42, 
0.203 mmol, 3.0 equiv) in ethyl acetate (0.20 mL, 0.35 M). After 1.5 hr the reaction mixture was 
purified by silica gel column chromatography (1/9 à 1/4 Et2O/Hexanes) to yield the title 
product as a white solid (33 mg, 0.0657 mmol, 97% yield). A 6:1 diastereomeric ratio was 
determined by 1H NMR of the crude reaction mixture. 1H NMR (400 MHz, CDCl3) δ 8.00 (d, 7.2 










(m, 2H, ArH), 4.20 (m, 2H, NCHCO2tBu, CHPh), 3.60-3.80 (m, 2H, CH2COPh), 1.33 (s, 9H, 
C(CH3)3); 13C NMR (125 MHz, CDCl3) δ 198.8, 171.2, 170.1, 141.5, 139.5, 137.3, 136.4, 132.9, 
130.4, 129.0, 128.7, 128.6, 128.5, 128.3, 128.3, 128.2, 128.1, 127.6, 126.7, 81.4, 44.9, 40.1, 28.0. 
HPLC analysis: Chiralpak AD-H (Hex/IPA = 95/5, 1.0 mL/min, 254 nm, 23°C), 8.8 min (minor), 




phenylethyl)-5-phenylpent-4-enoate (Table 6, entry 8). The general 
procedure was followed using (2E,4E)-1,5-diphenylpenta-2,4-dien-1-one 13  (119 mg, 0.508 
mmol, 3.0 equiv) as the Michael acceptor. After 8 hr the reaction mixture was purified by silica 
gel column chromatography (1/9 Et2O/Hexanes) to yield the title product as a white solid (56 
mg, 0.106 mmol, 63% yield). 1H NMR (500 MHz, CDCl3) δ 7.98 (d, J = 7.4 Hz, 2H, ArH), 7.70 
(d, J = 7.3 Hz, 2H, ArH), 7.40 (t, J = 7.5 Hz, 1H, ArH), 7.50-7.32 (m, 8H, ArH), 7.21 (d, J = 4.3 
Hz, 2H, ArH), 7.15 (m, 3H, ArH), 6.35 (d, J = 15.9 Hz, 1H, C=CHPh), 6.03 (dd, J = 8.6 and 
15.9 Hz, 1H, HC=CHPh), 4.12 (d, J = 5.7 Hz, 1H, NCHCO2tBu), 3.71 (m, 1H, HCC=C), 3.42-
3.33 (m, 2H, -CH2-), 1.38 (s, 9H, C(CH3)3). 13C NMR (125 MHz, CDCl3) δ 199.1, 171.4, 170.3, 
139.6, 137.4, 137.3, 136.6, 133.0, 132.0, 130.6, 129.8, 129.0, 128.7, 128.7, 128.5, 128.4, 128.2, 
128.0, 127.3, 126.3, 81.5, 69.9, 43.2, 40.4, 28.2. IR (thin film, cm-1) 2977, 1726, 1685, 1447, 
1283, 1147, 969, 751, 693. [α]20D = -28.8 (1.0 c, CHCl3). LRMS (APCI+) m/z = 530.47; calcd for 
C36H35NO3 [M+1]+ 530.26. HPLC analysis: Chiralpak OD-H (Hex/EtOH = 97/3, 1.0 mL/min, 
                                                
13 Batovska, D.; Parushev, S.; Stamboliyska, B.; Tsvetkova, I.; Ninova, M.; Najdenski, H. Eur. J. 




254 nm, 23°C), 4.9 min (minor), 6.1 min (major), 92% ee. Note: other diastereomer and 
regioisomer are visible in HPLC trace and account for <5% of the material.  
 




Cyclopropenimine decomposition study (Table 5). 
 
Rearranged product 46 was purified by passing crude rearranged material through a silica gel 
plug treated with triethylamine in a 1% triethylamine/ethyl acetate mixture and was obtained as a 
white solid. 1H NMR (300 MHz, CDCl3) δ 7.10-7.30 (m, 5H, ArH), 6.95 (s, 1H, C=CH), 5.50 
(br s, 1H), 4.25 (m, 1H), 3.85 (d, 6.9 Hz, -CH2O), 2.70-3.20 (m, 4H), 3.50 (m, 1H), 1.00-2.00 
(m, 40H, CyH); 13C NMR (75 MHz, CDCl3) δ 168.3, 139.2, 139.1, 129.4, 128.3, 126.0, 100.3, 
69.3, 67.6, 57.5, 57.0, 54.4, 42.1, 34.5, 33.5, 33.2, 31.1, 26.8, 26.2, 25.7;  [α]20D = 77.4 (1.0 c, 
CHCl3);  LRMS (APCI+) m/z = 546.44 calcd for C36H55N3O [M+1]+, found 547.28. 
Decomposition as a solid at room temperature rate study: Freshly obtained cyclopropenimine 
was placed in a vial (250 mg per vial) and stored at room temperature At each time point, a small 
































cyclopropenimine to the rearranged product. The time required for 50% of the 
cyclopropepenimine to rearrange is noted as the half-life. For iminoindanol catalyst 38, no 
decomposition was noted over a three-month period.  
Decomposition in solution rate study: Freshly obtained cyclopropenimine (0.028 mmol) was 
dissolved in d8-toluene (0.8 mL, 0.035 M) containing benzyl ether standard (0.007 mmol). This 
concentration is identical to that of cyclopropenimine in cyclopropenimine-catalyzed Michael 
reactions. At each time point, 1H NMR was used to measure the ratio of cyclopropenimine to 
benzyl ether standard. The time required for 50% of the cyclopropepenimine to decompose is 
noted as the half-life.  
The rates of decomposition were found to be identical when tert-butyl glycinate 
benzophenone Schiff base (82.7 mg, 0.280 mmol, 10 equiv relative to cyclopropenimine) was 
included in the d8-toluene solution. 
Comparison of one-month-old catalysts. After storing deprotonated cyclopropenimine 
catalysts 14 and 38 as solids (200 mg each) at 23 °C for one month in a desiccator their activity 
was reassessed as follows. Cyclopropenimine decomposition solid (9.2 mg, originally 0.0169 
mmol, 0.1 equiv; note: mmol and equiv correspond to value of cyclopropenimine prior to 
decomposition) and tert-butyl glycinate benzophenone Schiff base (50 mg, 0.169 mmol, 1.0 
equiv) were dissolved in ethyl acetate (0.48 mL, 0.35 M). Methyl acrylate (54 µL, 0.508 mmol, 
3.0 equiv) was then added to the vial and the reaction solution was stirred at room temperature. 
The reaction was monitored by 1H NMR spectroscopy and conversion was determined by 
comparing tert-butyl integrals of the starting material and product. Upon 95% conversion, or 
after 24 hr if not complete, the reaction solution was concentrated and the crude material 
subjected to silica gel column chromatography (1/5 Et2O/Hexanes) to yield pure product. 
 148 
Enantiomeric excesses were determined via chiral HPLC: Chiralpak AD-H (Hex/IPA = 97/3, 1.0 
mL/min, 254 nm, 23°C), 6.1 min (minor), 6.7 min (major).  
 
Product racemization test. 
 
Michael adduct (50 mg, 0.131 mmol, 1.0 equiv) and cyclopropenimine 14 (7.2 mg, 0.0131 
mmol, 0.1 equiv) were dissolved in ethyl acetate (0.37 mL, 0.35 M). The reaction solution was 
stirred for 48 hr at room temperature after which time the Michael adduct was reisolated via 
silica gel column chromotagraphy (1/5 Et2O/Hexanes eluent). Enantiomeric excesses were 
determined via chiral HPLC: Chiralpak AD-H (Hex/IPA = 97/3, 1.0 mL/min, 254 nm, 23°C), 6.1 
min (minor), 6.7 min (major). Original sample: 96% ee; reisolated sample: 95% ee. 
 
KIE test with deuterated cyclopropenimine (Scheme 9). 
A catalyst mixture containing 50% (S)-2-(2,3-bis(bis(cyclohexyl-1-
d)amino))cyclopropenimine)-3-phenylpropan-1-ol and 50% (R)-2-(2,3-
bis(dicyclohexylamino)cyclopropenimine)-3-phenylpropan-1-ol (0.0169 mmol total, 0.1 equiv.) 
and tert-butyl glycinate benzophenone Schiff base (50 mg, 0.169 mmol, 1.0 equiv) were 
dissolved in toluene (0.48 mL, 0.35 M). Methyl acrylate (54 µL, 0.508 mmol, 3.0 equiv) was 
then added and the reaction solution was stirred at room temperature for 3 h. Upon complete 
consumption of glycinate imine, monitored by 1H NMR spectroscopy, the reaction solution was 












96% ee 95% ee
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concentrated and the crude material subjected to silica gel column chromatography (1/4 
Et2O/Hexanes eluent). The title product was isolated as a colorless oil. 1H NMR (400 MHz, 
CDCl3) δ 7.64 (d, 7.2 Hz, 2H, ArH), 7.14-7.45 (m, 8H, ArH), 3.97 (t, J = 6.4 Hz, HCCO2tBu), 
3.59 (s, 3H, CO2CH3), 2.35-2.45 (m, 2H, -CH2-), 2.15-2.25 (m, 2H, -CH2-), 1.44 (s, 9H, 
C(CH3)3); 13C NMR (100 MHz, CDCl3) δ 173.7, 170.9, 170.8, 139.6, 136.6, 130.4, 128.9, 128.7, 
128.6, 128.1, 127.9, 81.3, 64.9, 51.6, 30.6, 28.8, 28.2. HPLC analysis: Chiralpak AD-H 
(Hex/IPA = 97/3, 1.0 mL/min, 254 nm, 23°C), 6.1 min (R), 6.7 min (S).  
This procedure was repeated three times and the HPLC-determined enantiomeric 
excesses are shown above. For a control experiment, a 1:1 mixture of (R)- and (S)-2-(2,3-
bis(dicyclohexylamino)cyclopropenimine)-3-phenylpropan-1-ol was also tested in triplicate and 
found to give < 3% ee as well. The catalyst mixtures were prepared independently for each 
experiment on ~100-150 mg scale in order to reduce error associated with weighing catalyst 
quantities.  
 
13C KIE experiments (Scheme 10). 
 
Cyclopropenimine catalyst 14 (218 mg, 0.400 mmol, 0.2 equiv) and tert-butyl glycinate 
benzophenone Schiff base (591 mg, 2.00 mmol, 1.0 equiv) were dissolved in ethyl acetate (5.7 
mL, 0.35 M). Benzyl acrylate (0.45 mL, 3.00 mmol, 1.5 equiv) was then added and the reaction 










CO2Bn1.0 eq 1.5 eq
99% isolated yield
 150 
material, monitored by 1H NMR spectroscopy, the reaction solution was concentrated and the 
crude material subjected to silica gel column chromatography (1/4 Et2O/Hexanes eluent).  
 
(S)-5-benzyl-1-tert-butyl 2-(diphenylmethyleneamino)pentanedioate:  
Isolated as a white solid (906 mg, 1.98 mmol, 99% yield). 1H NMR (400 MHz, 
CDCl3) δ 7.63 (m, 2H, ArH), 7.30-7.45 (m, 11H, ArH), 7.15 (m, 2H, ArH), 5.03 (s, 2H, 
CO2CH2Ph), 3.97 (dd, J = 7.2 and 5.2 Hz, 1H, HCCO2tBu), 2.44 (m, 2H, -CH2-), 2.35 (m, 2H, -
CH2-), 1.43 (s, 9H, C(CH3)3); 13C NMR (100 MHz, CDCl3) δ 173.1, 170.9, 170.8, 139.6, 136.6, 
136.1, 130.5, 129.0, 128.7, 128.6, 128.6, 128.3, 128.1, 127.9, 81.3, 66.3, 65.0, 30.9, 28.8, 28.2. 
HPLC analysis: Chiralpak AD-H (Hex/IPA = 98/2, 1.0 mL/min, 254 nm, 23°C), 11.1 min 
(minor), 12.8 min (major), 98% ee. 
 
Cyclopropenimine catalyst 14 (109 mg, 0.200 mmol, 0.1 equiv) and tert-butyl glycinate 
benzophenone Schiff base (2.95 g, 10.0 mmol, 5.0 equiv) were dissolved in ethyl acetate (28.6 
mL, 0.35 M). Benzyl acrylate (0.30 mL, 2.00 mmol, 1.0 equiv) was then added and the reaction 
solution was stirred at room temperature for 3 h. Upon complete consumption of benzyl acrylate, 
monitored by 1H NMR spectroscopy (21.5% conversion of glycinate imine), the reaction solution 
was concentrated and the crude material subjected to silica gel column chromatography (1/9 
Et2O/Hexanes eluent). (S)-5-benzyl-1-tert-butyl 2-(diphenylmethyleneamino)pentanedioate was 



















Cyclopropenimine 14 (109 mg, 0.200 mmol, 0.025 equiv) and tert-butyl glycinate 
benzophenone Schiff base (2.36 g, 8.00 mmol, 1.0 equiv) were dissolved in ethyl acetate (22.8 
mL, 0.35 M). Benzyl acrylate (1.50 mL, 10.0 mmol, 1.25 equiv) was then added and the reaction 
solution was stirred at room temperature for 36 h. Upon complete consumption of glycinate 
imine, monitored by 1H NMR spectroscopy (76% conversion of benzyl acrylate), the reaction 
solution was concentrated and the crude material subjected to silica gel column chromatography 
(1/20 Et2O/Hexanes eluent). Unreacted benzyl acrylate was reisolated as a colorless liquid (341 

















Chiral HPLC Traces 
 
Note: For each entry, the top HPLC trace is a racemic sample that was prepared using standard 
conditions and a cyclopropenimine catalyst lacking a chiral substituent.  
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Chapter 4 




The α,β-diamino acid scaffold represents a privileged chiral motif in biological, 
medicinal and synthetic chemistry.2 Indeed, this stereoarray is widely found in bioactive natural 
products and medicines; even its simplest derivative, 2,3-diaminopropionic acid, has found 
widespread use across chemical disciplines.3  Due to their high value, the challenge of producing 
optically enriched α,β-diamino acid compounds has attracted the attention of synthetic chemists 
for decades.4 Although a number of routes toward assembly of this stereoarray have been 
developed, direct catalytic enantioselective Mannich reactions between α-amino acid surrogates 
and imines represent the most ideal approach. Unfortunately, current methods leave much to be 
desired in terms of substrate compatibility and protecting group employment. To address these 
shortcomings, we detail herein chiral cyclopropenimines as highly active and selective catalysts 
for the benzophenone glycinat imine Mannich reaction with N-Boc-aldimines. The described 
methodology represents the state-of-the-art route to many α,β-diaminoacid derivatives due to its 
high selectivities, good chemical yields, functional group tolerance, low catalyst loading, 
scalability and ease of operation. 
 
α,β-Diamino Acids in Natural Products and Medicine 
The tremendous value of α,β-diamino acid compounds is indicated by their presence in 
naturally occurring chemicals as well as carefully designed synthetic therapeutic agents. A short 
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overview of the history, biology and applications of α,β-diamino acids is discussed below. A full 
tabulation of the fascinating biology and chemistry of this privileged architecture is beyond the 
scope of this thesis and several references are provided for the interested reader.2 
The presence of the simplest free α,β-diamino acid compounds, such as 2,3-
diaminopropionic acid (Dap) and 2,3-diaminobutanoic acid (Dab), has been identified in 
multiple living organisms (Figure	  1).5 In certain cases, such as in various species of Mimosa and 
Acacia tree species, Dap is even a component of the general amino acid pool used in protein 
synthesis. 6  Even more fascinating is that Dab was detected in the Murchison meteorite, 
indicating its possible presence in primitive Earth conditions and thus suggesting diamino acids 
may have played a role in early peptide-nucleic acid synthesis.7 
 
 
Figure 1. Simple free α,β-diamino acid compounds. 
 
The vast majority of naturally occuring α,β-diamino acid compounds however represent 
secondary metabolites and generally pertain to several main classes, including β-substituted 
alanines, peptidic antibiotics and marine-derived natural products. Selected examples of β-
substituted alanines8 are shown in Figure	   2; notably, heterocyclic derivatives such as L-
quisqualic acid9 and L-willardine10 have high affinities for kainate neurotransmitter receptors. 
Meanwhile, L-mimosine acts as a specific blocker of the cell cycle and iron(III) chelators with 
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β-methylaminoalanine (BMAA)12 and 3-(N-oxalyl)-L-2,3-diaminopropionic acid (β-ODAP)13 
serve as defensive neurotoxins for several plant species.  
 
 
Figure 2. Selected examples of β-substitued alanines. 
 
A selected sample of several naturally occurring peptidic antibiotics containing α,β-
diamino acid units are shown in Figure	   3.  The value of these antibiotics is underscored by 
bleomycin A2, which is on the World Health Organization’s List of Essential Medicines that are 
needed for a basic health system.14 Bleomycin A2, along with its derivatives, are a group of 
antitumor antibiotics used for the treatment of Hodgkin’s lymphoma, testicular tumors, and skin 
carcinomas. Sch37137 is a structurally interesting diamino acid peptide isolated from 
Micromonospora sp. that selectively inhibits glucose-6-phosphate synthase from Candida 
albicans, a common source of oral and genital infections in humans.15  Additionally, the 
polyketide-peptide hybrid zwittermicin A has both antibacterial and insecticidal activity.16 One 
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Figure 3. α,β-Diamino acids in antibiotic peptides. 
 
Medicinal and biological chemists have sought to utilize α,β-diamino acid derivatives to 
both understand and treat a variety of cellular processes and diseases. The diamino acid scaffold 
is often examined because of its ability to modulate the degree of hydrogen-bonding, anion-
binding, polar interactions, electronic charge, and secondary structure (i.e. helicity) properties. In 
this way, derivatives have aided the study of substrate-protein binding, pharmaceutical structure-
activity relationships, ion transport through cellular membranes, biomimetic enzyme design and 
radiopharmaceutical labeling (PET imaging).18 With an eye toward direct therapeutic value, 
roxifiban (Figure	   4) serves as the ester prodrug of XV459, a selective oral antagonist of the 
platelet glycoprotein IIb/IIIa receptor with potential use for the treatment of intravascular 
thrombosis and angina pectoris.19 Furthermore, imidapril (Figure	   4) is used clinically for the 
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Figure 4. Medicinally relevant α,β-diamino acid derivatives. 
 
Synthetic Value of α,β-Diamino Acids 
Simple α,β-diamino acid compounds have tremendous potential as synthetic precursors to 
more complex molecules. To be sure, the bottom-up synthesis of derivatives of the previously 
discussed natural products in a function-oriented manner is widely performed. However, further 
elaboration of α,β-diamino acids to structurally distinct compounds is also useful. For example, a 
classic route to the famous β-lactam antibiotics21 involves intramolecular coupling of α,β-
diamino acids to form the 3-amino-β-lactam skeleton (Figure	  5a). In fact, the now widely used 
coupling reagent N,N’-dicyclohexylcarbodiimide (DCC) was specifically designed by Sheehan 
for this purpose in the 1950’s.22 This is an especially attractive route for monobactams, which are 
useful antibiotics void of a second fused ring to the β-lactam ring; an example of this is the 
commercially available aztreonam.23 Further synthetic uses of the α,β-diamino scaffold include 
the preparation oligopeptides and heterocyclic scaffolds such as piperazine and imidazolidine 
derivatives (Figure	   5b).  Chiral vicinal diamines also represent a privileged backbone in the 
design of enantioselective organic and inorganic catalysts.24 While α,β-diamino acids have 
seldomly been used for this purpose, they hold high potential for future study as components of 
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Figure 5. Synthetic value of α,β-diamino acid derivatives. 
 
Literature Synthetic Routes to α,β-Diamino Acids 
A number of methods to assemble the α,β-diamino acid scaffold in a catalytic asymmetric 
manner have been developed and can generally be divided into four main categories (Figure	  6).4 
These are (A) diamination of α,β-unsaturated acid derivatives; (B) asymmetric hydrogenation of 
α,β-bis-(amido)-acrylates; (C) aza-Henry reactions between imines and nitro compounds; and 
(D) Mannich reactions between imines and glycinate ester Schiff bases. Routes (A) and (B) have 
the disadvantage of requiring preassembly of the carbon backbone. In addition, few effective and 
practical routes have been developed for the asymmetric diamination of simple α,β-unsaturated 
acid derivatives. 25  Furthermore, hydrogenation route (B) cannot be applied toward the 
preparation of tetrasubstituted carbon stereocenters.26 For these reasons, direct enantioselective 
Mannich reactions between prochiral nitrogen-substituted pronucleophiles and imines (routes C 











































piperazines imidazolidines cyclohexanediamines ethylenediamines
(a) β-lactam antiobiotics
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Figure 6. Synthetic routes to α,β-diamino acid compounds. 
 
A wide variety of catalyst systems and substrate classes have proven to be viable in the 
aza-Henry route (C), including Brønsted base-, Brønsted acid-, phase-transfer-, and metal-
catalyzed methodologies.4 Notably, routes for the production of both anti and syn α,β-diamino 
acid diastereomers are known through this approach. The main drawback of this general strategy 
is the required reduction of the nitro functional group to access α-amino adducts; this is avoided 
in route (D) by having the amino-group protected in its desired oxidation state.  
With the above considerations in mind, glycinate imine Mannich reactions represent the 
most direct route toward α,β-diamino acid production. Importantly, this approach can leave the 
adducts with orthogonally protected functional groups; i.e. both amino groups and the carboxylic 
acid can all be selectively deprotected. This feature is required for selective and simple further 
synthetic derivatization of the obtained α,β-diamino acid products. Therefore, when assessing the 
value of reported methodologies, particular attention should be paid to the choice of protecting 
groups used. This includes the protecting group on the imine Mannich-acceptor and the amino 
group and ester of the pronucleophile glycine derivative. Ideally, the protecting groups should be 
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There are indeed numerous reported catalyst systems for the glycine imine Mannich 
reaction; however, a careful survey of these methods reveals there is still much to be desired in 
terms of substrate scope and practicality. These methods include Maruoka’s use of chiral N-spiro 
quaternary ammonium phase transfer-catalyst 4 for tert-butyl glycinate benzophenone imine (2a) 
and N-PMP α-imino ester (1) Mannich reactions (Scheme	  1a).27 Additionally, Ooi has reported 
the use of tetraamino-phosphonium catalyst 8 for Mannich reactions between azlactones and N-
(2,5-xylyl)sulfonyl imines of type 5 (Scheme	  1b).28 Metal-catalyzed systems, generally based on 
copper-chiral ligand complexes, have also been developed (Scheme	   1c).29 These reactions 
require N-tosyl or other sulfonyl-protected imine Mannich acceptors, which cannot be 
deprotected under mild conditions. Notably, these metal-based approaches can access both syn 
and anti diastereomeric adducts, a feature not currently reported by any organocatalytic method.  
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Scheme 1. Asymmetric Mannich additions using non-N-Boc protected aldimines. 
 
Noticeably absent from the above highlighted methods are N-Boc or other N-carbamoyl 
protected imine Mannich acceptors. These are undoubtedly the most desired protecting group 
due to the numerous mild methods known for their deprotection. To be sure, a number of 
methods have been reported employing N-Boc imine substrates. All reported catalytic methods 
for glycinate imine Mannich reactions with N-carbamoyl protected imines are individually 
discussed in this section. In 2005, Shibasaki and coworkers reported a tartrate-derived 
diammonium phase-transfer catalyst 17 for reactions between tert-butyl glycinate benzophenone 
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temperatures between -20 and -40 °C and products with good diastereoselectivities (>20:1) and 
moderate enantioselectivities (60-80% ee) were obtained. In 2007, the same group reported 
another tartrate derived diammonium salt 18 that was again used for phase transfer-catalyzed 
Mannich reactions of tert-butyl glycinate benzophenone imines and N-Boc aldimines under 
similar reaction conditions (Scheme	   2).31 With this system, N-Boc-benzaldimine resulted in 
adduct with 90% ee; however, most substrates still were obtained with moderate enantiomeric 
excess (70-85% ee). In this report, Shibasaki utilized alkyl N-Boc aldimines for the first time in 
glycinate imine Mannich reactions; these adducts were obtained in 70-75% ee.  
 
 
Scheme 2. Phase transfer catalyzed Mannich reactions with N-Boc aldimines. 
 
Kobayashi reported a further development in 2008 with the introduction of fluorenone 
glycine esters.32 These substrates have increased α-acidity compared to benzophenone glycine 
esters due to the increased aromaticity of the fluorenyl anion. It was thus shown that Ishikawa’s 
pseudo-C2 symmetric chiral guanidine 21 was an effective Brønsted base catalyst for Mannich 
reactions with N-Boc-aldimines at low temperatures (Scheme	  3a).  Unfortunately, the difficulty 
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forward by this development. A complementary approach of using stronger Brønsted base 
catalysts could allow for the use of the less acidic but readily available benzophenone glycine 
esters. Indeed, this approach was shown successful in 2011 when Barbas and coworkers utilized 
Cinchona alkaloid derived thiourea catalyst 22 for Mannich reactions between methyl glycinate 
benzophenone imine and aryl N-Boc-aldimines (Scheme	  3b).33 This represented the first highly 
selective (dr and ee) Mannich reactions between simple glycinate imines and N-Boc-aldimines. 
Notably, the N-Boc-aldimines were prepared in situ, however long reaction times were required 
for good conversion. Unfortunately, this catalyst system entirely failed when tert-butyl glycinate 
benzophenone imine was used as the pronucleophile. Because tert-butyl esters can be hydrolyzed 
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In summary, a number of general methods have been developed for the catalytic 
asymmetric assembly of α,β-diamino acid stereoarrays. The methodologies available for the 
direct Mannich reaction of glycinate imines can be assessed by their compatibility with simple 
and easily transformed protecting groups. In this regard, no method is available for highly 
selective reactions between tert-butyl glycinate benzophenone imines and N-Boc-aldimines. 
There is especially an absence of reports detailing high enantioselectivity with alkyl N-Boc-
aldimines. This chapter describes the employment of chiral cyclopropenimine catalysis for 
highly selective Mannich reactions that addresses these unmet challenges. 
 
Reaction Discovery and Optimization 
Given the success of chiral cyclopropenimines in glycinate imine Michael additions 
detailed in Chapter 3, we reasoned that similarly successful Mannich reactions could be 
achieved.34 Because our reported Michael methodology operates under mild reaction conditions, 
we were especially hopeful that sensitive yet desirable N-Boc-aldimines could be employed as 
Mannich acceptors. Enantioselective Michael reactions with cyclopropenimine 24 were 
successful in many solvents (98% ee in solvents with dielectric constants <7.0) and at various 
concentrations, thus suggesting we had significant space in tailoring reaction condition 
parameters to achieve effective Mannich reactions. A portion of these optimizations is shown in 
Table	  1. 
 
	   293 
Table 1. Optimization of enantioselective cyclopropenimine-catalyzed Mannich reaction.a 
 
a Reactions taken to 95% conversion of glycine imine. b Ground mol sieves were used.  c 1.5 eq 
of 23 was used.  
 
We selected the reaction between tert-butyl glycinate benzophenone imine 2a and N-
Boc-benzaldimine (23) to optimize our cyclopropenimine-catalyzed methodology. For 
practicality, we performed all reactions open to the atmosphere. First, identical reaction 
conditions to the ones used for enantioselective glycinate imine Michael reactions were 
employed with encouraging yield and selectivities (entry 1). A solvent screen revealed the use 
aromatic solvents led to products with the highest level of selectivities. Diluting the reaction 
concentration led to a slight increase in observed enantioselectivity (entries 5-9), while 
decreasing the reaction temperature had minimal impact on enantioselectivity (not shown). Last, 
we found that finely ground molecular sieves led to slightly improved results over the use of 
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hydrolysis of the N-Boc imine and possibly prevent water from disrupting any transition state H-
bonding arrangements.  
 
Methodology Comparison 
A side-by-side comparison of our developed methodology with Barbas’ thiourea33 is 
provided in this section. These two catalyst systems are currently the only known methods for 
highly enantioselective (>90% ee) Mannich reactions between glycinate benzophenone imines 
and N-Boc-aldimines. When comparing methyl glycinate benzophenone imine substrates (2b), 
both catalysts performed well, although cyclopropenimine 24 required only 15 minutes to 
achieve similar yields and selectivities as Cinchona alkaloid thiourea 22 over 24-36 hours. More 
importantly, the desirable tert-butyl glycinate benzophonone imine substrate 2b was a competent 
pronucleophile under cyclopropenimine catalysis conditions. Meanwhile, thiourea 22 was wholly 
incapable of activating this substrate. It is also worth noting that cyclopropenimine 24 operates 
most efficiently in toluene, as compared to the more expensive and less green α, α, α-
trifluorotoluene. Furthermore, the cost advantage of cyclopropenimine 24 (Sigma Aldrich 
L511188, $30/gram) over thiourea 22 (Sigma Aldrich 690384, $350/0.25 gram) is of significant 
factor. 35  These results clearly demonstrate the advantage of cyclopropenimine-catalyzed 
Mannich reactions over currently known technologies, both in terms of reaction performance and 
economy. 
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Scheme 4. Comparison of cyclopropenimine and thiourea methodology. 
 
Glycinate Imine Mannich Reaction Substrate Scope 
We explored the substrate scope of the cyclopropenimine-catalyzed Mannich reaction 
methodology using the above optimized reaction conditions (Table 2). We performed each 
substrate entry on a one-gram scale of glycinate imine in order to demonstrate the robustness and 
scalability of this chemistry. All reaction products were purified by silica gel column 
chromatography, although, as shown below, no column chromatography is required if the 
diamine reaction product is deprotected via acid hydrolysis. To begin, we found that methyl, 
benzyl and tert-butyl glycinate esters were all suitable pronucleophiles; notably, methyl and 
benzyl glycinate reactions proceeded in a matter of minutes. Because the tert-butyl glycinate is 
generally the more desired pronucleophile (due to its amenability to mild deprotection) and its 
lack of reactivity with other catalyst systems, we used this substrate to examine the scope of the 
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Table 2. Gram-scale substrate scope of Mannich reaction.a 
 
a Yields based on purified products. Diastereomeric ratio (dr) and enantiomeric excess (ee) was 
determined by HPLC. b Yield determined by 1H NMR versus Bn2O as a standard; product 
characterized after hydrolysis of the benzophenone imine. c Reaction performed at a 
concentration of 0.07 M.  d 20 mol% catalyst was used; 0.9 mmol scale. 
 
Entries 2 and 3 show that o- and p-toulidene derived imines functioned well, with high 



















R = tBu, 20 h, 97% yield 
99:1 dr, 94% ee
36 h, 84% yield
99:1 dr, 97% ee
24 h, 86% yield
97:3 dr, 94% ee
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96 h, 87% yield






48 h, 63% yield
91:9 dr, 95% ee
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R = Me, 15 m, 81% yieldb 
94:6 dr, 95% ee
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reacting imine, entry 2 yielded diamine with slightly lower diastereoselectivity (91:9 dr). As 
expected, incorporation of the strong electron-donating methoxy group in entry 4a led to slower 
reaction rate, although high yields and selectivities were still observed. Notably, reaction time 
was greatly decreased using the more reactive methyl glycinate pronucleophile (entry 4b). Para-
halogentated N-Boc-benzaldimines were excellent substrates (entries 5 and 6); however, strong 
electron-withdrawing groups, such as –CF3, slowly yielded product with poor enantioselectivity 
(entry 10). Interestingly, while use of tert-butyl glycinate 2a in conjunction with 3-pyridinyl 
imines resulted in adduct with just 51% ee (entry 7a), the more reactive methyl glycinate 2b 
rapidly led to product with 94% ee (entry 7b). With other heterocycles, such as furanyl and 
thiophenyl imines, tert-butyl glycinate substrate restored typical high levels of selectivities 
(entries 8 and 9). Last, an alanine-derived pronuclophile produced an adduct containing a 
quaternary stereocenter, albeit with low selectivity (entry 11). We are currently exploring ways 
to increase the selectivity in reactions that produce quaternary stereocenters. In summary, tert-
butyl glycinate imine 2a engages with an array of aryl N-Boc-aldimines under this methodology; 
with certain substrates, methyl glycinate imine 2b can be used to mitigate shortcomings 
associated with use of the tert-butyl glycinate 2a.  
We were particularly interested in employing aliphatic N-Boc-aldimines in this mild and 
selective methodology. We initially observed good performance of an isopropyl-substituted N-
Boc-aldimine (37) with tert-butyl glycinate 2a on gram scale (Scheme 5). As other catalyst 
systems fail to deliver such high selectivities with aliphatic N-Boc-aldimines, this represents the 
first use of aliphatic N-Boc-aldimines for a highly enantioselective direct Mannich reaction with 
glycine imines.  
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Scheme 5. Initial demonstration of aliphatic N-Boc aldimine compatability. 
 
With a catalyst system in hand that allowed for excellent reactivity with aliphatic N-Boc-
aldimines, we sought to develop this as a general methodology for this substrate class. In order to 
achieve high performance with these challenging substrates, a number of changes to our aryl N-
Boc-aldimine reaction conditions were made. First, we demonstrated the scope of these reactions 
using the more reactive methyl glycinate imine 2b. Second, additional equivalents of N-Boc-
aldimine were often added and the reactions were conducted at lower temperatures (where 
noted). These efforts were made primarily to avoid base-promoted enamine formation of the 
aliphatic imine, which leads to an array of undesired side reactions and decomposition of the 
Mannich acceptor. Ultimately, we were able to effect methyl glycinate imine additions to an 





72 h, 90% yield
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Table 3. Aliphatic substrate scope of Mannich reaction.a 
 
a Yields based on purified products. Diastereomeric ratios (dr) and enantiomeric excesses (ee) 
were determined by HPLC. b One gram scale of glycine imine. c 4 equiv of N-Boc-Imine used. d 
0 °C. e N-Boc-Imine made in situ with Cs2CO3; 20 mol% catalyst used. f -25 °C.  
 
 
First, the size of the alkyl substituent was varied to assess what role the size of these 
groups played in reaction selectivity. Substrates bearing isopropyl and ethyl groups resulted in 
high diastereo- and enantioselectivities (entries 1 and 2).  Entry 3 shows the production of 
protected 2,3-diaminobutanoic acid 41, an α,β-diaminoacid widely found as a key motif in a 
number of naturally occurring peptides (discussed above).2 For this substrate, the N-Boc-
aldimine was formed in situ due to its instability and difficulty of isolation.  At 0 °C, the reaction 
proceeded with good conversion, albeit with only 44% ee. The selectivity could be increased to 
83% ee upon cooling to –78 °C, however at this temperature the reaction did not reach 
completion.36  Nonetheless, this substrate demonstrated the possibility of forming the N-Boc-
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silyl protected alcohol (entry 4) and N-Boc protected amine (entry 5) functional groups to be 
well accommodated. Additionally, a substrate bearing a terminal olefin worked well with high 
selectivities (entry 6). The presence of a diverse set of functional groups in these adducts should 
allow for further derivatization of these diamines into synthetically useful compounds. The 
manipulation of some of these adducts is discussed in the next section. 
 
Reaction Scalability and Synthetic Application of α,β-Diamino Acid Derivatives 
A major highlight of our cyclopropenimine-catalyzed Michael reaction methodology is 
its amenability to preparative-scale reactions using low catalyst loadings. In an effort to continue 
this goal, we investigated the performance of just 1 mol% of catalyst 24 for the production of 
preparative amounts of chiral diamino acid derivatives (Scheme 1, eq 3). Thus, 26.7 g of the 
diamino ester 45 was prepared (73% yield, 96:4 dr, 93% ee) in 8 h following imine hydrolysis 
with citric acid. No chromatography was required for this preparative-scale procedure, as simple 
acid-base washing was sufficient for purification.  
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Scheme 6. Preparative scale synthesis and derivatization of diamine 45. (a) TFA, CH2Cl2, rt; (b) 
dimethyloxylate, MeOH, reflux; (c) CBzCl, Na2CO3 (aq), PhMe, rt; (d) TMSCl, CH2Cl2, 0 °C 
then tBuMgCl; (e) 4-bromobenzaldehyde, TEA, CH2Cl2, rt then NBS, 0 °C; (f) Z-Ala-OH, EDC, 
HOBt, TEA, CH2Cl2, 0 °C to rt; (g) Boc-Phe-OH, EDC, HOBt, TEA, CH2Cl2, 0 °C to rt. 
 
Adduct 45 was subsequently converted to several useful derivatives, including 
diketopiperazine 46, β-lactam 47, amidine 48, and tripeptide 49, three in multigram quantities in 
three or less operations (Scheme 6).  2,3-Diketopiperazines, isomers of the more commonly found 
2,5-diketopiperazines, are being increasingly studied for their potential medicinal properties.37 
Furthermore, β-lactam 47 represents a simple derivative of the medically valuable 3-amino-β-
lactam class of antibiotics.21  
Amidine 48 is a derivative of imidazolines that are effective chiral metal ligands and 
catalysts for a variety of asymmetric reactions.38 Currently, diphenylethylenediamine and other 
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ester derivatives such as 48 allow for the introduction of increased functionality that may have 
superior or altered performance than current catalyst systems. 
Lastly, tripeptide 49 was synthesized using standard amino acid coupling protocols. The 
ability to selectively deprotect each amino group allowed for selective coupling. In this way, the 
simple adducts obtained under our methodology could allow for the bottom-up synthesis of 
many α,β-diamino acid derived peptidic antibiotics. 
 
Conclusion 
Using our newly discovered chiral cyclopropenimine 24, we have addressed several 
major shortcomings associated with previous technologies for the production of chiral α,β-
diamino acid compounds. With an eye toward mildly and selectively removable protecting 
groups on the diamino acid scaffold, the cyclopropenimine achieved high reaction efficiency and 
selectivity for tert-butyl glycinate imine additions to N-Boc-aldimines. Furthermore, the mild 
reaction conditions allowed for the employment of aliphatic N-Boc aldimines to produce highly 
functionalized α,β-diamino acids. Lastly, scalability and low catalyst loadings were demonstrated 
throughout in order to highlight the robust nature of cyclopropenimine-based methodologies. 
Ultimately, this readily available technology has been shown to be, for many classes of 
substrates, the most attractive approach toward the production of α,β-diamino acid adducts and 
their synthetic derivatives.  
  
	   303 
References 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1. Bandar, J. S.; Lambert, T. H. J. Am. Chem. Soc. 2013, 135, 11799. 
  
2. (a) Viso, A.; de la Pradilla, R. F.; García, A.; Flores, A. Chem. Rev. 2005, 105, 3167. (b) Viso, 
A.; de la Pradilla, R. F.; Tortosa, M.; García, A.; Flores, A. Chem. Rev. 2011, 111, PR1. (c) 
Lucet, D.; Le Galle, T.; Mioskowski, C. Angew. Chem., Int. Ed. 1998, 37, 2580. 
 
3. (a) Yegani, R.; Hirozawa, H.; Teramoto, M.; Himei, H.; Okada, O.; Takigawa, T.; Ohmura, 
N.; Matsumiya, N.; Matsuyama, H. J. Membr. Sci. 2007, 291, 157. (b) Liu, H.-L.; Yoshikawa, Y. 
J. Coord. Chem. 2006, 59, 613. (c) Arslan, O.; Dogan, S. J. Sci. Food Agric. 2005, 85, 1499. (d) 
Rizzi, G. P. J. Agric. Food Chem. 2008, 56, 7160. 
 
4. For a review, see: Go ́mez Arraya ́s, R.; Carretero, J. C. Chem. Soc. Rev. 2009, 38, 1940. 
 
5. Corrigan, J. J.; Srinivasan, N. G. Biochemistry 1966, 5, 1185. 
 
6. Evans, C. S.; Qureshi, M. Y.; Bell, E. A. Phytochemistry 1977, 16, 565. 
 
7. (a) Meierhenrich, U. J.; Mun˜oz Caro, G. M.; Bredehöft, J. H.; Jessberger, E. K.; Thiemann, 
W. H.-P. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 9182. (b) Bredehöft, J. H.; Breme, K.; 
Meierhenrich, U. J.; Hoffmann, S. V.; Thiemann, W. H.-P. Chirality 2007, 19, 570. 
 
8. (a) Ref  6 (b) Ikegami, F.; Murakoshi, I. Phytochemistry 1994, 35, 1089. 
 
9. (a) Subasinghe, N.; Schulte, M.; Roon, R. J.; Koerner, J. F.; Johnson, R. L. J. Med. Chem. 
1992, 35, 4602. (b) Hermit, M. B.; Greenwood, J. R.; Bräuner-Osborne, H. J. Biol. Chem. 2004, 
279, 34811.  
 
10. (a) Martínez, A. P.; Lee, W. W. J. Org. Chem. 1965, 30, 317. (b) Jane, D. E.; Hoo, K.; 
Kamboj, R.; Deverill, M.; Bleakman, D.; Mandelzys, A. J. Med. Chem. 1997, 40, 3645. (c) 
Nollet, A. J. H.; Pandit, U. K. Tetrahedron 1969, 25, 5983. 
 
11. (a) Chang, H.-C.; Lee, T.-H.; Chuang, L.-Y.; Yen, M.-H.; Hung, W.-C. Cancer Lett. 1999, 
145, 1. (b) Dobbin, P. S.; Hider, R. C.; Hall, A. D.; Taylor, P. D.; Sarpong, P.; Porter, J. B.; Xiao, 
G.; van der Helm, D. J. Med. Chem. 1993, 36, 2448. 
 
12. (a) Copani, A.; Canonico, P. L.; Catania, M. V.; Aronica, E.; Bruno, V.; Ratti, E.; van 
Amsterdan, F. T. M.; Gaviraghi, G.; Nicoletti, F. Brain Res. 1991, 558, 79. (b) Vega, A.; Bell, E. 
A. Phytochemistry 1967, 6, 759. (c) Davis, A. J.; Hawkes, G. E.; O’Brien, P.; Wang, G.; Nunn, 
P. B. J. Chem. Res. (S) 1991, 84. 
 
13. (a) Ross, S. M.; Roy, D. N.; Spencer, P. S. J. Neurochem. 1989, 53, 710. (b) Sabri, M. I.; 
Lystrup, B.; Roy, D. N.; Spencer, P. S. J. Neurochem. 1995, 65, 1842. (c) Abraham, M.; Abay, 
S. M. Pharmacology 2009, 381. (d) Yan, Z.-Y.; Spencer, P. S.; Li, Z.-X.; Liang, Y.-M.; Wang, 
Y.-F.; Wang, C.-Y.; Li, F.-M. Phytochemistry 2006, 67, 107. (e) Chase, L. A.; Peterson, N. L.; 
	   304 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Koerner, J. F. Toxicol. Appl. Pharmacol. 2007, 219, 1. 
 
14. (a) Umezawa, H.; Maeda, K.; Takeuchi, T.; Okami, Y. J. Antibiotics, Ser. A 1966, 19, 200. 
(b) Umezawa, H.; Muraoka, Y.; Fujii, A.; Naganawa, H.; Takita, T. J. Antibiot. 1980, 33, 1079. 
(c) Galm, U.; Hager, M. H.; Van Lanen, S. G. V.; Ju, J.; Thorson, J. S.; Shen, B. Chem. Rev. 
2005, 105, 739. (d) Galm, U.; Wendt-Pienkowski, E.; Wang, L.; George, N. P.; Oh, T.-J.; Yi, F.; 
Tao, M.; Coughlin, J. M.; Shen, B. Mol. BioSyst. 2009, 5, 77. 
 
15. (a) Rane, D. F.; Girijavallabhan, V. M.; Ganguly, A. K.; Pike, R. E.; Saksena, A. K.; 
McPhail, A. T. Tetrahedron Lett. 1993, 34, 3201. (b) Andruszkiewicz, R. J. Antibiot. 1994, 47, 
380. (c) Andruszkiewicz, R.; Zieniawa, T.; Ciimara, H.; Kasprzak, L.; Borowski, E. J. Antibiot. 
1994, 47, 715. (d) Cooper, R.; Horan, A. C.; Gentile, F.; Gullo, V.; Loebenberg, D.; Marquez, J.; 
Patel, M.; Pua Truumess, I. J. Antibiot. 1988, 41, 13. 
 
16. (a) Zhao, C.; Song, C.; Luo, Y.; Yu, Z.; Sun, M. FEBS Lett. 2008, 582, 3125. (b) Rogers, E. 
W.; Molinski, T. F. J. Org. Chem. 2009, 74, 7660. 
 
17. Sakai, R.; Oiwa, C.; Takaishi, K.; Kamiya, H.; Tagawa, M. Tetrahedron Lett. 1999, 40, 6941. 
 
18. For examples, discussion and further references see ref 2. 
 
19. (a) Pesti, J. A.; Yin, J.; Zhang, L.-H.; Anzalone, L.; Waltermire, R. E.; Ma, P.; Gorko, E.; 
Confalone, P. N.; Fortunak, J.; Silverman, C.; Blackwell, J.; Chung, J. C.; Hrytsak, M. D.; 
Cooke, M.; Powell, L.; Ray, C. Org. Process Res. Dev. 2004, 8, 22. (b) Serebruany, V. L.; 
Malinin, A. I.; O’Connor, C. M.; Gurbel, P. A. Am. Heart J. 2003, 146, 91. 
 
20. (a) Hosoya, K.; Ishimitsu, T. CardioVasc. Drug Rev. 2002, 20, 93. (b) Wang, J.-M.; Wang, 
Y.; Zhu, Z.-S.; Zhang, M.-C.; Zou, Y.; Li, J.-J.; Li, M.-J.; Jiang, X.-J.; Li, X.-Y. Life Sci. 2004, 
75, 407. 
 
21. (a) Synthesis of β-lactams see: Pitts, C. R.; Lectka, T. Chem. Rev. Articles ASAP. For the 
biology of β-lactams see: (b) Crowfoot, D.; Bunn, C. W.; Rogers-Low, B. W.; Turner-Jones, A. 
In Chemistry of Penicillin; Clarke, H. T., Johnson, J. R., Robinson, R., Eds.; Princeton 
University Press: Princeton, NJ, 1949. (c) Singh, G. S. Mini-Rev. Med. Chem. 2004, 4, 69. (d) 
Singh, G. S. Mini-Rev. Med. Chem. 2004, 4, 93. 
 
22. Sheehan, J. C.; Hess, G. P. J. Am. Chem. Soc. 1955, 77, 1067. 
 
23. For a review see: Galletti, P.; Giacomini, D. Curr. Med. Chem. 2011, 18, 4265. 
 
24. For examples, discussion and applications see ref 2c. 
 
25. (a) Muñiz, K.; Nieger, M. Chem. Commun. 2005, 2729. (b) Almodovar, I.; Hövelmann, C. 
H.; Streuff, J.; Nieger, M.; Muñiz, K. Eur. J. Org. Chem., 2006, 704. 
 
	   305 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
26. (a) Kuwano, R.; Okuda, S.; Ito, Y. Tetrahedron: Asymmetry 1998, 9, 2773. (b) Robinson, A. 
J.; Stanislawski, P.; Mulholland, D. J. Org. Chem. 2001, 66, 4148. 
 
27. Ooi, T.; Kameda, M.; Fujii, J.; Maruoka, K. Org. Lett. 2004, 6, 2397. 
 
28. Uragachi, D.; Ueki, Y.; Ooi, T. J. Am. Chem. Soc. 2008, 130, 14088. 
 
29. (a) Bernardi, L.; Gothelf, A. S.; Hazell, R. G.; Jørgensen, K. A. J. Org. Chem. 2003, 68, 
2583. (b) Salter, M. M.; Kobayashi, J.; Shimizu, Y.; Kobayashi, S. Org. Lett. 2006, 8, 3533. (c) 
Yan, X. X.; Peng, Q.; Li, Q.; Zhang, K.; Yao, J.; Hou, X. L.; Wu, Y. D. J. Am. Chem. Soc. 2008, 
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Experimental Information 
General information. All reactions were performed open to the atmosphere, unless otherwise 
noted. Organic solutions were concentrated using a Buchi rotary evaporator. Methylene chloride 
and toluene were dried using a J.C. Meyer solvent purification system. All other solvents and 
commercial reagents were used as provided. Flash column chromatography was performed 
employing 40-63 µm silica gel (SiliaFlash P60 from Silicycle). Thin-layer chromatography 
(TLC) was performed on silica gel 60 F254 plates (EMD).  
 1H and 13C NMR spectra were recorded in CDCl3 (except where noted) on Bruker DRX-
300, DRX-400 or DRX-500 spectrometers as noted. Data for 1H NMR are reported as follows: 
chemical shift (δ ppm), multiplicity (s = singlet, br s = broad singlet, d = doublet, t = triplet, dd = 
doublet of doublets, td = triplet of doublets, m = multiplet), coupling constant (Hz), integration, 
and assignment. Data for 13C and 19F NMR are reported in terms of chemical shift. Infrared 
spectra were recorded on a Nicolet Avatar 370DTGS FT-IR. Optical rotations were measured 
using a Jasco DIP-1000 digital polarimeter. High-resolution mass spectra were obtained from the 
Columbia University Mass Spectrometry Facility on a JOEL JMSHX110 HF mass spectrometer 
using FAB+ ionization mode. Low-resolution mass spectrometry (LRMS) was performed on a 
JEOL JMS-LCmate liquid chromatography spectrometer system using APCl+ ionization 
technique. HPLC analysis was performed on an Agilent Technologies 1200 series instrument 
with a Daicel Chiralpak AD-H or OD-H chiral column (25 cm) using the given conditions. 
Preparation of Starting Materials 
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Glycinate imines: Methyl, benzyl and tert-butyl glycinate benzophenone imines were prepared 
according to established procedures.1  
N-Boc-aldimines: Most N-Boc-aldimines were prepared according to established procedures 
that are noted for each substrate entry below. Three new aliphatic N-Boc-aldimines were used 
and their preparation is described here. 
 
 
 tert-Butyl 1-(phenylsulfonyl)ethylcarbamate: The following chemicals were 
mixed and stirred at room temperature for three days: acetaldehyde (1.4 mL, 25.5 
mmol, 2.0 equiv), tert-butyl carbamate (1.50 g, 12.8 mmol, 1.0 equiv), benzenesulfinic acid 
sodium salt (5.20 g, 32.0 mmol, 2.5 equiv), formic acid (1.3 mL), methanol (16 mL) and water 
(32 mL). A white precipitate formed during the course of the reaction. The reaction mixture was 
extracted with dichloromethane (3 x 30 mL), the combined dichloromethane was then dried with 
anhydrous sodium sulfate and concentrated in vacuo to a white solid. This solid was triturated 
with hot hexanes to yield the title product as a white solid (1.91 g, 6.66 mmol, 52% yield). 1H 
NMR (400 MHz, CDCl3) δ 7.93 (d, J = 7.5 Hz, 2H, ArH), 7.62 (t, J = 7.3 Hz, 1H, ArH), 7.54 (t, 
J = 7.5 Hz, 2H, ArH), 5.13 (d, J = 10.2 Hz, 1H, NHBoc), 5.00 (m, 1H, CHNHBoc), 1.62 (d, J = 
6.9 Hz, 3H, CH3), 1.21 (s, 9H, CO2C(CH3)3). 13C NMR (100 MHz, CDCl3) δ 154.3, 136.8, 
134.0, 129.5, 129.2, 80.9, 66.9, 28.1, 13.1. IR (thin film, cm-1) 3337, 2974, 1691, 1517, 1447, 
1312, 1241, 1144, 850, 727, 690, 580. The mass spectrum of this compound showed only a peak 
corresponding to the tert-butyl ethylidenecarbamate elimination product; LRMS (APCI+) m/z = 
144.07 calcd for C7H13NO2 [M+1]+ 144.09. 
                                                
1 (a) O'Donnell, M. J.; Polt, R. L. J. Org. Chem., 1982, 47, 2663. (b) Danner, P.; Bauer, M.; Phukan, P.; 















piperidine-1-carboxylate: The following chemicals were mixed and stirred 
at room temperature for three days: 1-Boc-piperidine-4-carboxaldehyde (500 mg, 2.34 mmol, 1.0 
equiv), tert-butyl carbamate (275 mg, 2.34 mmol, 1.0 equiv), benzenesulfinic acid sodium salt 
(1.00 g, 5.86 mmol, 2.5 equiv), formic acid (0.2 mL), methanol (3.0 mL) and water (6.0 mL). A 
white precipitate formed during the course of the reaction. The reaction mixture was extracted 
with dichloromethane (3 x 10 mL), the combined dichloromethane was then dried with 
anhydrous sodium sulfate and concentrated in vacuo to a white solid. This solid was triturated 
with hot hexanes to yield the title product as a white solid (580 mg, 1.28 mmol, 55% yield). 1H 
NMR (400 MHz, CDCl3) δ 7.90 (d, J = 7.8 Hz, 2H, ArH), 7.63 (t, J = 7.2 Hz, 1H, ArH), 7.53 (t, 
J = 7.8 Hz, 2H, ArH), 5.10 (d, J = 11.2 Hz, 1H, NHBoc), 4.77 (dd, J = 3.4 and 11.2 Hz, 1H, 
CHNHBoc), 4.18 (br s, 2H, CyH), 2.77 (m, 2H, CyH), 2.61 (m, 1H, CyH), 2.09 (d, J = 12.4 Hz, 
1H, CyH), 1.75 (d, J = 12.6 Hz, 1H, CyH), 1.46 (s, 9H, CO2C(CH3)3), 1.35 (m, 2H, CyH), 1.21 
(s, 9H, CO2C(CH3)3). 13C NMR (100 MHz, CDCl3) δ 154.6, 153.9, 137.6, 133.9, 129.1, 129.0, 
80.9, 79.6, 73.3, 43.2 (broad), 34.8, 28.4, 27.9. IR (thin film, cm-1) 3364, 2977, 1713, 1684, 
1510, 1428, 1311, 1160, 1134, 867, 591. The mass spectrum of this compound showed only a 
peak corresponding to the N-Boc-aldimine elimination product; see directly below for details. 
 
 tert-Butyl 4-((tert-butoxycarbonylimino)methyl)piperidine-1-carboxylate: A 
25 mL round bottom flask, charged with cesium carbonate (1.80 g, 5.50 mmol, 
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argon, and a solution of the title product from the previous reaction (250 mg, 0.55 mmol, 1.0 
equiv) in dichloromethane (6 mL) was added and the reaction mixture was stirred at room 
temperature. After four hours (hr), the reaction mixture was diluted with hexanes (10 mL), 
filtered through celite and the filtrate was concentrated in vacuo to yield the title product as a 
clear oil (160 mg, 0.51 mmol, 93% yield). Note: the temperature of the rotovap was kept at 20 
°C or cooler. 1H NMR (400 MHz, CDCl3) δ 8.11 (s, 1H, NH), 4.05 (br s, 2H, CyH), 2.77 (t, J = 
11.6 Hz, 2H, CyH), 2.41 (m, 1H, CyH), 2.20 (m, 2H, CyH), 1.47 (s, 9H, CO2C(CH3)3), 1.40 (s, 
9H, CO2C(CH3)3), 1.47-1.40 (m, 2H, CyH). 13C NMR (100 MHz, CDCl3) δ 176.0, 162.1, 154.7, 
82.4, 79.6, 43.1 (broad), 41.8, 28.5, 27.9, 27.7. LRMS (APCI+) m/z = 312.91 calcd for 
C16H28N2O4 [M+1]+ 313.20. 
 
 
 tert-Butyl 1-(phenylsulfonyl)pent-4-enylcarbamate: The following 
chemicals were mixed and stirred at room temperature for three days: pent-4-
enal2 (1.18 g, 14.0 mmol, 1.0 equiv), tert-butyl carbamate (1.60 g, 14.0 mmol, 1.0 equiv), 
benzenesulfinic acid sodium salt (5.70 g, 35.0 mmol, 2.5 equiv), formic acid (1.0 mL), methanol 
(8 mL) and water (16 mL). A white precipitate formed during the course of the reaction. The 
reaction mixture was extracted with dichloromethane (3 x 25 mL), the combined 
dichloromethane was then dried with anhydrous sodium sulfate and concentrated in vacuo to a 
white solid. This solid was triturated with hot hexanes to yield the title product as a white solid 
(606 mg, 1.86 mmol, 13% yield). 1H NMR (400 MHz, CDCl3) δ 7.91 (d, J = 7.3 Hz, 2H, ArH), 
7.61 (t, J = 7.4 Hz, 1H, ArH), 7.52 (t, J = 7.8 Hz, 2H, ArH), 5.80 (m, 1H, H2C=CHR), 5.18 (d, J 
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= 10.6 Hz, 1H, NHBoc), 5.05 (m, 2H, H2C=CHR), 4.89 (td, J = 2.8 and 10.6 Hz, 1H, 
CHNHBoc), 2.33 (m, 2H, -CH2-), 2.18 (m, 1H, -CH2-), 1.86 (m, 1H, -CH2-), 1.21 (s, 9H, 
CO2C(CH3)3). 13C NMR (100 MHz, CDCl3) δ 153.8, 137.0, 136.0, 133.9, 129.4, 129.1, 116.7, 
80.8, 70.3, 29.4, 28.0, 25.7. IR (thin film, cm-1) 3281, 2977, 1691, 1527, 1309, 1251, 1141, 683, 
589. The mass spectrum of this compound showed only a peak corresponding to the N-Boc-
aldimine elimination product; see directly below for details. 
 
tert-Butyl pent-4-enylidenecarbamate: A 25 mL round bottom flask, charged 
with cesium carbonate (1.50 g, 4.60 mmol, 10 equiv), was flame-dried for five minutes. The 
flask was then put under an atmosphere of argon, and a solution of the title product from the 
previous reaction (150 mg, 0.46 mmol, 1.0 equiv) in dichloromethane (5 mL) was added and the 
reaction mixture was stirred at room temperature. After four hr, the reaction mixture was diluted 
with hexanes (10 mL), filtered through celite and the filtrate was concentrated in vacuo to yield 
the title product as a clear oil (75 mg, 0.41 mmol, 89% yield). Note: the temperature of the 
rotovap was kept at 20 °C or cooler.  1H NMR (400 MHz, CDCl3) δ 8.30 (s, 1H, NH), 5.85 (m, 
1H, H2C=CHR), 5.05 (td, J = 1.6 and 12.4 Hz, 2H, H2C=CHR), 2.50 (br s, 2H, -CH2-), 2.39 (t, J 
= 6.3 Hz, 2H, -CH2-), 1.53 (s, 9H, CO2C(CH3)3). 13C NMR (100 MHz, CDCl3) δ 174.5, 162.1, 






Cyclcopropenimine catalyst: An improved synthesis of chiral cyclopropenimine 1 is described 
below.3 Our previously reported preparation uses tetrachlorocyclopropene as a starting material, 





hydrochloride: Dicyclohexylamine (108 mL, 541 mmol, 6.0 equiv) was 
slowly added to a solution of pentachlorocyclopropane4 (19.3 g, 90.2 mmol, 1.0 equiv) in 
CH2Cl2 (900 mL) in a 3L round bottom flask. A white precipitate formed as the reaction mixture 
was stirred for a further 48 hr at room temperature. Next, (S)-2-amino-3-phenylpropan-1-ol5 
(15.0 g, 99.2 mmol, 1.1 equiv) was added in one portion and the reaction mixture was stirred for 
an additional 12 hr. The crude reaction mixture was filtered through a celite plug, then washed 
with 1.0 M HCl (3 x 500 mL), dried with anhydrous sodium sulfate and concentrated in vacuo to 
yield crude cyclopropenimine hydrochloride salt as an off-white solid. Recrystallization from 
ethyl acetate/hexanes (approximately 1/2) yielded pure cyclopropenimine hydrochloride salt as a 
white solid (38.5 g, 73% yield). 1H NMR (400 MHz, CDCl3) δ 7.35 (d, 9.2 Hz, 1H, NH), 7.0-
7.15 (m, 5H, ArH), 5.17 (t, 5.6 Hz, 1H, -OH), 3.60-3.85 (m, 3H, NCHBnCH2OH), 3.10 (m, 4H, 
                                                
3 For full characterization of this cyclopropenimine: Bandar, J. S.; Lambert, T. H. J. Am. Chem. Soc. 2012, 
134, 5552. 
4 Tobey, S. W.; West, R. J. Am. Chem. Soc. 1966, 88, 2478.  
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NCyH), 2.80-3.00 (m, 2H, -CH2Ph), 1.00-1.70 (m, 40H, CyH). 13C NMR (100 MHz, CDCl3) δ 
137.8, 129.2, 128.0, 126.2, 116.5, 114.5, 63.7, 61.3, 59.1, 38.4, 32.1, 31.9, 25.4, 24.4. 
 
(S)-2-(2,3-Bis(dicyclohexylamino)cyclopropenimine)-3-phenylpropan-1-ol: 
Cyclopropenimine freebase was prepared and stored in a freezer on a weekly 
basis. Pure cyclopropenimine freebase was quantitatively obtained by 
dissolving the corresponding hydrochloride salt in CH2Cl2 and washing the solution with 1.0 M 
NaOH (3 x), drying with anhydrous sodium sulfate and concentrating in vacuo. The 
cyclopropenimine is obtained as an off-white solid. 1H NMR (400 MHz, CDCl3) δ 7.10-7.25 (m, 
5H, ArH), 3.79 (m, 1H, NCHBnCH2OH), 3.40-3.50 (m, 2H, NCHBnCH2OH), 3.00-3.10 (m, 4H, 
NCyH), 2.70-2.85 (m, 2H, -CH2Ph), 1.00-1.90 (m, 40H, CyH). 13C NMR (100 MHz, CDCl3) δ 
140.5, 129.7, 129.4, 127.8, 125.5, 65.1, 61.7, 58.3, 41.7, 34.4, 33.1, 32.8, 32.6, 26.3, 26.1, 25.3, 
25.2. 
General Procedure for Glycinate Mannich Reactions  
 
Cyclopropenimine (0.1 equiv), glycinate benzophenone Schiff base (1.0 g, 1.0 equiv) and 
activated ground 4Å molecular sieves (500 mg) were mixed in toluene (0.25 M). N-Boc-
aldimine (2.0 equiv) was then added and the reaction solution was stirred at room temperature. 
Upon complete consumption of starting material, monitored by 1H NMR, the reaction solution 
was concentrated and the crude material subjected to silica gel column chromatography 
























(diphenylmethyleneamino)-3-phenylpropanoate (25b):6  General procedure 
was followed using cyclopropenimine (215 mg, 0.395 mmol, 0.1 equiv), methyl 
glycinate benzophenone imine (1.00 g, 3.95 mmol, 1.0 equiv) and tert-butyl 
benzylidenecarbamate7 (1.62 g, 7.9 mmol, 2.0 equiv). The reaction was complete after 15 min. 
Benzyl ether (188 µl, 0.987 mmol, 0.25 equiv) was added to the reaction solution to use as an 
internal standard (80% 1H NMR yield was determined, see spectrum below). HPLC analysis: 
Chiralpak AD-H (Hex/IPA = 96/4, 1.0 mL/min, 254 nm, 23 °C), 13.9 min (major), 15.1 min 
(minor), 16.0 min (anti), 17.1 (anti), 94:6 dr (syn:anti), 95% ee (syn). This product was 
characterized after hydrolysis of the benzophenone imine (see below). 
 
 (2S,3R)-Methyl 2-amino-3-(tert-butoxycarbonylamino)-3-
phenylpropanoate: The reaction mixture from entry 1 (R = Me) of Table 2 
was concentrated in vacuo, dissolved in THF (112 mL) and added to a 0.5 M citric acid aqueous 
solution (8.80 g citric acid in 80 mL H2O). The reaction mixture was stirred for 1 hr, then 
washed with Et2O (3 x 100 mL), basified with sat. Na2CO3(aq), and extracted with ethyl acetate 
(3 x 100 mL). The collected ethyl acetate solution was concentrated in vacuo to a crude solid that 
was recrystallized from hexanes to yield the pure title product as white crystals (0.940 g, 3.19 
mmol, 80% two-step yield). 1H NMR (400 MHz, CDCl3) δ 7.35-7.25 (m, 5H, ArH), 5.85 (d, 9.0 
Hz, 1H, PhCHNHBoc), 5.20 (s, 1H, CHNH2CO2Me), 3.89 (s, 1H, NHBoc), 3.75 (s, 3H, 
CO2CH3), 1.42 (s, 9H, CO2C(CH3)3). 13C NMR (100 MHz, CDCl3) δ 173.0, 155.3, 139.9, 128.6, 
                                                
6 Zhang, H.; Syed, S.; Barbas, III, C. F. Org. Lett. 2010, 12, 708. 









127.5, 126.4, 79.5, 58.6, 56.4, 52.4, 28.3. IR (thin film, cm-1) 3400, 3371, 2973, 1732, 1684, 
1512, 1364, 1244, 1156, 882, 765, 706, 553. [α]20D = +21.1 (1.0 c, CHCl3). LRMS (FAB+) m/z = 
295.16 calcd for C15H22N2O4 [M+1]+ 295.16. 
 
 (2S,3R)-tert-Butyl 3-(tert-butoxycarbonylamino)-2-
(diphenylmethyleneamino)-3-phenylpropanoate (25a):8 General procedure 
was followed using cyclopropenimine (185 mg, 0.339 mmol, 0.1 equiv), tert-
butyl glycinate benzophenone imine (1.00 g, 3.39 mmol, 1.0 equiv) and tert-butyl 
benzylidenecarbamate (1.39 g, 6.78 mmol, 2.0 equiv). After 24 hr, the reaction mixture was 
purified by silica gel column chromatography (1/4 Et2O/Hexanes) to yield the title product as a 
white solid (1.65 g, 3.29 mmol, 97% yield). 1H NMR (400 MHz, CDCl3) δ 7.49 (d, 7.2 Hz, 2H, 
ArH), 7.30-7.08 (m, 11H, ArH), 6.43 (d, 6.4 Hz, 2H, ArH), 6.30 (d, 8.8 Hz, 1H, ArCHNHBoc), 
5.37 (d, 8.4 Hz, 1H, CHCO2tBu), 4.07 (s, 1H, NHBoc), 1.41 (s, 9H, CO2C(CH3)3), 1.39 (s, 9H, 
CO2C(CH3)3). 13C NMR (100 MHz, CDCl3) δ 172.2, 169.2, 155.2, 140.8, 139.0, 136.2, 130.5, 
128.9, 128.5, 128.3, 128.2, 128.0, 127.2, 127.0, 126.7, 81.9, 79.3, 70.3, 56.8, 28.5, 28.0. IR (thin 
film, cm-1) 3435, 2977, 2932, 1715, 1629, 1486, 1449, 1366, 1277, 1151, 847, 696. [α]20D = -96.1 
(1.0 c, CHCl3). LRMS (FAB+) m/z = 501.18 calcd for C31H36N2O4 [M+1]+  501.27. HPLC 
analysis: Chiralpak AD-H (Hex/IPA = 97.5/2.5, 1.0 mL/min, 254 nm, 23 °C), 9.9 min (minor), 
11.2 min (anti), 13.8 min (anti), 19.9 (major), 99:1 dr (syn:anti), 94% ee (syn). 
 
                                                
8 Okada, A.; Shibuguchi, T.; Ohshima, T.; Masu, H.; Yamaguchi, K.; Shibasaki, M. Angew. Chem. Int. 







(diphenylmethyleneamino)-3-phenylpropanoate (25c): General procedure 
was followed using cyclopropenimine (166 mg, 0.304 mmol, 0.1 equiv), benzyl 
glycinate benzophenone imine (1.00 g, 3.04 mmol, 1.0 equiv) and tert-butyl 
benzylidenecarbamate (1.25 g, 6.08 mmol, 2.0 equiv). After 10 min, the reaction mixture was 
purified by silica gel column chromatography (1/4 Et2O/Hexanes) to yield the title product as a 
white solid (1.60 g, 3.00 mmol, 99% yield). 1H NMR (400 MHz, CDCl3) δ 7.60 (d, 7.3 Hz, 2H, 
ArH), 7.41-7.16 (m, 16H, ArH), 6.40 (m, 3H, ArH + ArCHNHBoc), 5.5 (d, 8.8 Hz, 2H, 
CHCO2Bn), 5.22 (s, 2H, -OCH2Ph), 4.31 (s, 1H, NHBoc), 1.48 (s, 9H, CO2C(CH3)3). 13C NMR 
(125 MHz, CDCl3) δ 172.8, 169.9, 155.3, 140.5, 138.9, 135.8, 135.8, 130.8, 129.0, 128.6, 128.3, 
128.1, 127.2, 126.7, 79.6, 69.8, 67.1, 56.8, 28.5. IR (thin film, cm-1) 3431, 3061, 2976, 1713, 
1627, 1484, 1453, 1365, 1162, 1084, 746, 695, 563. [α]20D = -100.9 (1.0 c, CHCl3). LRMS 
(FAB+) m/z = 535.16 calcd for C34H34N2O4  [M+1]+ 535.25. HPLC analysis: Chiralpak OD-H 
(Hex/IPA = 98/2, 1.0 mL/min, 254 nm, 23 °C), 7.0 min (minor), 8.6 min (anti), 9.2 min (major), 
10.6 (anti), 95:5 dr (syn:anti), 96% ee (syn). 
 
(2S,3R)-tert-Butyl 3-(tert-butoxycarbonylamino)-2-
(diphenylmethyleneamino)-3-o-tolylpropanoate (27):7 General procedure 
was followed using cyclopropenimine (185 mg, 0.339 mmol, 0.1 equiv), tert-
butyl glycinate benzophenone imine (1.00 g, 3.39 mmol, 1.0 equiv) and tert-butyl 2-
methylbenzylidenecarbamate8 (1.48 g, 6.78 mmol, 2.0 equiv). After 48 hr, the reaction mixture 
was purified by silica gel column chromatography (1/4 Et2O/Hexanes) to yield the title product 











2H, ArH), 7.40-7.05 (m, 10H, ArH), 6.43 (d, 8.6 Hz, 1H, ArCHNHBoc), 6.33 (m, 2H, ArH), 
5.66 (d, 8.6 Hz, 1H, CHCO2tBu), 4.05 (s, 1H, NHBoc), 2.11 (s, 3H, ArCH3), 1.50 (s, 9H, 
CO2C(CH3)3), 1.46 (s, 9H, CO2C(CH3)3). 13C NMR (100 MHz, CDCl3) δ 172.3, 169.4, 155.2, 
138.8, 136.1, 134.8, 130.6, 130.3, 128.9, 128.5, 128.2, 128.1, 127.1, 127.0, 126.6, 125.7, 81.8, 
79.3, 67.8, 53.8, 28.6, 28.3, 18.5. IR (thin film, cm-1) 2976, 1714, 1624, 1484, 1366, 1222, 1150, 
1048, 1026, 749, 696. [α]20D = -107.9 (1.0 c, CHCl3). LRMS (FAB+) m/z = 515.19 calcd for 
C32H38N2O4 [M+1]+ 515.28. HPLC analysis: Chiralpak AD-H (Hex/IPA = 97.5/2.5, 1.0 mL/min, 
254 nm, 23 °C), 5.0 min (minor), 7.0 min (anti), 7.7 min (anti), 13.3 (major), 91:9 dr (syn:anti), 
94% ee (syn). 
 
 (2S,3R)-tert-Butyl 3-(tert-butoxycarbonylamino)-2-
(diphenylmethyleneamino)-3-p-tolylpropanoate (28):7 General 
procedure was followed using cyclopropenimine (185 mg, 0.339 mmol, 0.1 
equiv), tert-butyl glycinate benzophenone imine (1.00 g, 3.39 mmol, 1.0 equiv) and tert-butyl 4-
methylbenzylidenecarbamate9 (1.48 g, 6.78 mmol, 2.0 equiv). After 36 hr, the reaction mixture 
was purified by silica gel column chromatography (1/4 Et2O/Hexanes) to yield the title product 
as a white solid (1.47 g, 2.86 mmol, 84% yield). 1H NMR (400 MHz, CDCl3) δ 7.61 (d, 7.2 Hz, 
2H, ArH), 7.41-7.30 (m, 6H, ArH), 7.08 (m, 4H, ArH), 6.58 (d, 6.4 Hz, 2H, ArH), 6.37 (d, 8.8 
Hz, 1H, ArCHNHBoc), 5.43 (d, 8.8 Hz, 1H, CHCO2tBu), 4.17 (s, 1H, NHBoc), 2.32 (s, 3H, 
ArCH3), 1.51 (s, 9H, CO2C(CH3)3), 1.49 (s, 9H, CO2C(CH3)3). 13C NMR (100 MHz, CDCl3) δ 
172.0, 169.3, 155.2, 139.1, 137.9, 136.5, 136.3, 130.5, 128.9, 128.8, 128.5, 128.3, 128.1, 127.8, 
127.3, 126.7, 81.9, 79.3, 70.3, 56.6, 28.6, 28.2, 21.1. IR (thin film, cm-1) 3436, 3342, 2976, 2930, 
                                                







1716, 1629, 1485, 1315, 1277, 1149, 1050, 779, 696, 558. [α]20D = -78.6 (1.0 c, CHCl3). LRMS 
(FAB+) m/z = 515.20 calcd for C32H38N2O4 [M+1]+ 515.28. HPLC analysis:  Chiralpak AD-H 
(Hex/IPA = 97.5/2.5, 1.0 mL/min, 254 nm, 23 °C), 10.7 min (minor), 11.7 min (anti), 12.9 min 




General procedure was followed using cyclopropenimine (185 mg, 0.339 
mmol, 0.1 equiv), tert-butyl glycinate benzophenone imine (1.00 g, 3.39 mmol, 1.0 equiv) and 
tert-butyl 4-methoxybenzylidenecarbamate8 (1.59 g, 6.78 mmol, 2.0 equiv). After 60 hr, the 
reaction mixture was purified by silica gel column chromatography (1/4 Et2O/Hexanes) to yield 
the title product as a white solid (1.56 g, 2.94 mmol, 87% yield). 1H NMR (400 MHz, CDCl3) δ 
7.61 (d, 7.6 Hz, 2H, ArH), 7.40-7.30 (m, 7H, ArH), 7.12 (d, 8.2 Hz, 2H, ArH), 6.80 (d, 8.6 Hz, 
2H, ArH), 6.61 (m, 2H, ArH), 6.35 (d, 8.6 Hz, 1H, ArCHNHBoc), 5.41 (d, 8.4 Hz, CHCO2tBu), 
4.15 (s, 1H, NHBoc), 3.78 (s, 3H, ArOCH3), 1.51 (s, 9H, CO2C(CH3)3), 1.49 (s, 9H, 
CO2C(CH3)3). 13C NMR (100 MHz, CDCl3) δ 172.1, 169.2, 158.7, 155.2, 139.1, 136.2, 133.1, 
130.6, 128.9, 128.5, 128.3, 128.2, 128.1, 127.8, 127.3, 113.6, 81.9, 79.3, 70.3, 56.3, 55.3, 28.5, 
28.0. IR (thin film, cm-1) 3436, 2977, 2933, 1714, 1613, 1486, 1366, 1247, 1152, 1031, 834, 779, 
696, 560. [α]20D = -77.8 (1.0 c, CHCl3). LRMS (FAB+) m/z = 531.18 calcd for C32H38N2O5 
[M+1]+ 531.28. HPLC analysis: Chiralpak AD-H (Hex/IPA = 97.5/2.5, 1.0 mL/min, 254 nm, 23 












General procedure was followed using cyclopropenimine (215 mg, 0.395 
mmol, 0.1 equiv), methyl glycinate benzophenone imine (1.00 g, 3.95 mmol, 1.0 equiv) and tert-
butyl 4-methoxybenzylidenecarbamate8 (1.86 g, 7.90 mmol, 2.0 equiv). After 1.5 hr, the reaction 
mixture was purified by silica gel column chromatography (1/4 Et2O/Hexanes, two columns 
were necessary) to yield the title product as a white solid (1.83 g, 3.75 mmol, 95% yield). 1H 
NMR (300 MHz, CDCl3) δ 7.58 (d, 7.3 Hz, 2H, ArH), 7.36-7.20 (m, 6H, ArH), 7.07 (d, 8.3 Hz, 
2H, ArH), 6.75 (d, 8.3 Hz, 2H, ArH), 6.52 (d, 5.6 Hz, 2H, ArH), 6.30 (d, 8.0 Hz, 1H, 
ArCHNHBoc), 5.43 (d, 7.7 Hz, 1H, CHCO2tBu), 4.26 (s, 1H, NHBoc), 3.71 (s, 3H, CO2CH3), 
3.70 (s, 3H, ArOCH3), 1.45 (s, 9H, CO2C(CH3)3). 13C NMR (75 MHz, CDCl3) δ 172.4, 170.3, 
158.6, 155.1, 138.7, 135.7, 132.5, 130.6, 128.7, 128.5, 128.2, 128.0, 127.6, 127.0, 113.5, 79.2, 
69.6, 56.1, 55.0, 52.1, 28.2. IR (thin film, cm-1) 3431, 2976, 1713, 1613, 1486, 1365, 1247, 1165, 
1029, 699. [α]20D = -108.4 (1.0 c, CHCl3). HPLC analysis: Chiralpak AD-H (Hex/IPA = 93/7, 1.0 
mL/min, 254 nm, 23 °C), 14.6 min (minor + anti), 17.7 min (anti), 19.7 (major), 99:1 dr 
(syn:anti), 97% ee (syn). 
 
 (2S,3R)-tert-Butyl 3-(4-bromophenyl)-3-(tert-butoxycarbonylamino)-2-
(diphenylmethyleneamino)propanoate (30): General procedure was 
followed using cyclopropenimine (185 mg, 0.339 mmol, 0.1 equiv), tert-
butyl glycinate benzophenone imine (1.00 g, 3.39 mmol, 1.0 equiv) and tert-butyl 4-












was purified by silica gel column chromatography (1/9 Et2O/Hexanes) to yield the title product 
as a white solid (1.95 g, 3.37 mmol, 99% yield). 1H NMR (400 MHz, CDCl3) δ 7.58 (d, 6.1 Hz, 
2H, ArH), 7.44-7.30 (m, 8H, ArH), 7.08 (d, 6.4 Hz, 2H, ArH), 6.61 (m, 2H, ArH), 6.36 (d, 6.6 
Hz, 1H, ArCHNHBoc), 5.40 (d, 6.6 Hz, 1H, CHCO2tBu), 4.15 (s, 1H, NHBoc), 1.50 (s, 9H, 
CO2C(CH3)3), 1.49 (s, 9H, CO2C(CH3)3). 13C NMR (100 MHz, CDCl3) δ 172.5, 168.9, 155.2, 
140.1, 138.8, 136.0, 131.3, 130.7, 128.9, 128.7, 128.5, 128.4, 128.1, 127.2, 120.9, 82.2, 79.6, 
69.9, 56.4, 28.5, 28.0. IR (thin film, cm-1) 3431, 2977, 1715, 1628, 1485, 1366, 1284, 1151, 774, 
696, 553. [α]20D = -50.6 (1.0 c, CHCl3). LRMS (FAB+) m/z = 579.03 and 581.03 calcd for 
C31H35BrN2O4 [M+1]+ 579.18 and 581.18. HPLC analysis: Chiralpak AD-H (Hex/IPA = 97.5/2.5, 
1.0 mL/min, 254 nm, 23 °C), 8.3 min (minor), 10.8 min (anti), 12.6 min (anti), 20.5 (major), 97:3 
dr (syn:anti), 86% ee (syn). 
 
(2S,3R)-tert-Butyl 3-(tert-butoxycarbonylamino)-2-
(diphenylmethyleneamino)-3-(4-fluorophenyl)propanoate (31):7 General 
procedure was followed using cyclopropenimine (185 mg, 0.339 mmol, 0.1 
equiv), tert-butyl glycinate benzophenone imine (1.00 g, 3.39 mmol, 1.0 equiv) and tert-butyl 4-
fluorobenzylidenecarbamate8 (1.51 g, 6.78 mmol, 2.0 equiv). After 20 hr, the reaction mixture 
was purified by silica gel column chromatography (1/4 Et2O/Hexanes) to yield the title product 
as a white solid (1.75 g, 3.37 mmol, 99% yield). 1H NMR (400 MHz, CDCl3) δ 7.59 (d, 6.2 Hz, 
2H, ArH), 7.43-7.16 (m, 8H, ArH), 6.95 (t, 6.8 Hz, 2H, ArH), 6.60 (m, 2H, ArH), 6.37 (d, 6.6 
Hz, 1H, ArCHNHBoc), 5.43 (d, 6.6 Hz, 1H, CHCO2tBu), 4.14 (s, 1H, NHBoc), 1.50 (s, 9H, 
CO2C(CH3)3), 1.49 (s, 9H, CO2C(CH3)3). 13C NMR (100 MHz, CDCl3) δ 172.4, 169.0, 163.2, 







114.9, 82.1, 79.5, 70.2, 56.3, 28.5, 28.1. 19F NMR (XXX MHz, CDCl3) δ -115.1 (s, 1F). IR (thin 
film, cm-1) 3435, 2977, 1715, 1629, 1485, 1366, 1219, 1152, 1050, 696. [α]20D = -87.2 (1.0 c, 
CHCl3). LRMS (FAB+) m/z = 519.16 calcd for C31H35FN2O4 [M+1]+ 519.26. HPLC analysis: 
Chiralpak AD-H (Hex/IPA = 97/3, 1.0 mL/min, 254 nm, 23 °C), 7.1 min (minor), 8.0 min (anti), 
9.3 min (anti), 13.6 (major), 99:1 dr (syn:anti), 92% ee (syn). 
 
(2S,3R)-tert-Butyl 3-(tert-butoxycarbonylamino)-2-
(diphenylmethyleneamino)-3-(pyridin-3-yl)propanoate (32a): General 
procedure was followed using cyclopropenimine (185 mg, 0.339 mmol, 0.1 
equiv), tert-butyl glycinate benzophenone imine (1.00 g, 3.39 mmol, 1.0 equiv) and tert-butyl 
pyridin-3-ylmethylenecarbamate8 (1.40 g, 6.78 mmol, 2.0 equiv). After 20 hr, the reaction 
mixture was purified by silica gel column chromatography (4/1 Et2O/Hexanes) to yield the title 
product as a white solid (1.68 g, 3.35 mmol, 99% yield). 1H NMR (400 MHz, CDCl3) δ 8.43 (m, 
2H, ArH), 7.55-7.48 (m, 3H, ArH), 7.37-7.27 (m, 6H, ArH), 7.15 (m, 1H, ArH), 6.58 (d, 6.5 Hz, 
2H, ArH), 6.35 (d, 8.6 Hz, 1H, ArCHNHBoc), 5.43 (d, 8.3 Hz, 1H, CHCO2tBu), 4.13 (s, 1H, 
NHBoc), 1.45 (s, 9H, CO2C(CH3)3), 1.43 (s, 9H, CO2C(CH3)3). 13C NMR (100 MHz, CDCl3) δ 
172.8, 168.6, 155.1, 148.5, 138.6, 136.3, 135.9, 134.4, 130.8, 128.8, 128.5, 128.1, 126.9, 123.1, 
82.3, 79.7, 69.7, 54.9, 28.4, 28.3. IR (thin film, cm-1) 3433, 2977, 2932, 1713, 1626, 1485, 1366, 
1284, 1251, 1151, 1051, 776, 697, 565. [α]20D = -47.8 (1.0 c, CHCl3). HPLC analysis: Chiralpak 
AD-H (Hex/IPA = 90/10, 1.0 mL/min, 254 nm, 23 °C), 6.1 min (minor), 7.2 min (anti), 9.5 min 









(diphenylmethyleneamino)-3-(pyridin-3-yl)propanoate (32b): General 
procedure was followed using cyclopropenimine (215 mg, 0.395 mmol, 0.1 
equiv), methyl glycinate benzophenone imine (1.00 g, 3.95 mmol, 1.0 equiv) and tert-butyl 
pyridin-3-ylmethylenecarbamate8 (1.40 g, 7.90 mmol, 2.0 equiv). The reaction solution was 
diluted to 0.07 M in toluene. After 2.5 hr, the reaction mixture was purified by silica gel column 
chromatography (4/1 Et2O/Hexanes) to yield the title product as a white solid (1.77 g, 3.44 
mmol, 98% yield). 1H NMR (400 MHz, CDCl3) δ 8.50 (m, 2H, ArH), 7.60 (d, 7.4 Hz, 2H, ArH), 
7.50 (d, 7.7 Hz, 1H, ArH), 7.35-7.18 (m, 7H, ArH), 6.56 (d, 5.9 Hz, 2H, ArH), 6.36 (d, 8.2 Hz, 
ArCHNHBoc), 5.50 (d, 8.2 Hz, 1H, CHCO2Me), 4.30 (s, 1H, NHBoc), 3.79 (s, 3H, CO2CH3), 
1.49 (s, 9H, CO2C(CH3)3). 13C NMR (100 MHz, CDCl3) δ 173.2, 169.9, 155.1, 148.5, 148.4, 
138.3, 135.9, 135.4, 134.2, 130.9, 128.7, 128.4, 128.1, 126.7, 123.0, 79.8, 69.0, 54.8, 52.4, 28.2. 
IR (thin film, cm-1) 2978, 1739, 1710, 1484, 1366, 1162, 768, 697. [α]20D = -125.1 (1.0 c, 
CHCl3). LRMS (FAB+) m/z = 460.16 calcd for C27H29N3O4 [M+1]+ 460.22. HPLC analysis: 
Chiralpak AD-H (Hex/IPA = 92/8, 1.0 mL/min, 254 nm, 23 °C), 20.0 min (minor), 21.2 min 
(anti), 23.7 min (major), 29.4 (anti), 96:4 dr (syn:anti), 94% ee (syn). 
 
(2S,3S)-tert-Butyl 3-(tert-butoxycarbonylamino)-2-
(diphenylmethyleneamino)-3-(thiophen-2-yl)propanoate (33):7 General 
procedure was followed using cyclopropenimine (185 mg, 0.339 mmol, 0.1 
equiv), tert-butyl glycinate benzophenone imine (1.00 g, 3.39 mmol, 1.0 equiv) and tert-butyl 
thiophen-2-ylmethylenecarbamate6 (1.43 g, 6.78 mmol, 2.0 equiv). After 24 hr, benzyl ether (161 












(93% 1H NMR yield was determined, see spectrum below). 1H NMR (400 MHz, CDCl3) δ 7.66 
(d, J = 7.1 Hz, 2H, ArH), 7.50-7.40 (m, 6H, ArH), 7.12 (m, 1H, ArH), 6.29 (d, J = 9.2 Hz, 1H, 
ArCHNHBoc), 5.71 (d, J = 9.2 Hz, 1H, CHCO2tBu), 4.22 (s, 1H, NHBoc), 1.46 (s, 18H, 2 x 
CO2C(CH3)3). 13C NMR (100 MHz, CDCl3) δ 172.9, 168.6, 154.9, 144.9, 139.0, 130.6, 129.0, 
128.7, 128.4, 128.0, 127.2, 126.5, 124.5, 124.4, 82.0, 79.4, 70.0, 53.1, 28.4, 27.9. HPLC 
analysis: Chiralpak AD-H (Hex/IPA = 98/2, 1.0 mL/min, 254 nm, 23 °C), 11.7 min (minor), 15.2 
min (anti), 30.2 (major), 97:3 dr (syn:anti), 94% ee (syn). 
 
(2S,3S)-tert-Butyl 3-(tert-butoxycarbonylamino)-2-
(diphenylmethyleneamino)-3-(furan-2-yl)propanoate (34): General 
procedure was followed using cyclopropenimine (185 mg, 0.339 mmol, 0.1 
equiv), tert-butyl glycinate benzophenone imine (1.00 g, 3.39 mmol, 1.0 equiv) and tert-butyl 
furan-2-ylmethylenecarbamate8 (1.32 g, 6.78 mmol, 2.0 equiv). After 20 hr, the reaction mixture 
was purified by silica gel column chromatography (1/4 Et2O/Hexanes) to yield the title product 
as a white solid (1.63 g, 3.32 mmol, 98% yield). 1H NMR (400 MHz, CDCl3) δ 7.57 (d, 7.2 Hz, 
2H, ArH), 7.40-7.20 (m, 7H, ArH), 6.90 (m, 2H, ArH), 6.24 (s, 1H, ArH), 6.13 (m, 1H, ArH), 
6.10 (d, 9.2 Hz, 1H, ArCHNHBoc), 5.50 (d, 9.2 Hz, CHCO2tBu), 4.36 (s, 1H, NHBoc), 1.46 (s, 
18H, 2 x CO2C(CH3)3). 13C NMR (100 MHz, CDCl3) δ 172.6, 168.8, 155.2, 154.0, 141.5, 139.3, 
136.4, 130.6, 129.0, 128.8, 128.4, 128.0, 127.5, 110.4, 106.4, 82.0, 79.5, 67.9, 51.9, 28.5, 28.0. 
IR (thin film, cm-1) 3441, 2978, 2932, 1722, 1622, 1485, 1367, 1284, 1155, 774, 729, 694, 510. 
[α]20D = -71.1 (1.0 c, CHCl3). LRMS (FAB+) m/z = 491.15 calcd for C29H34N2O5 [M+1]+ 491.25. 
HPLC analysis: Chiralpak AD-H (Hex/IPA = 97.5/2.5, 1.0 mL/min, 254 nm, 23 °C), 9.7 min 









(35): General procedure was followed using cyclopropenimine (185 mg, 
0.339 mmol, 0.1 equiv), tert-butyl glycinate benzophenone imine (1.00 g, 3.39 mmol, 1.0 equiv) 
and tert-butyl 4-(trifluoromethyl)benzylidenecarbamate10 (1.85 g, 6.78 mmol, 2.0 equiv). After 
96 hr, the reaction mixture was purified by silica gel column chromatography (1/9 
Et2O/Hexanes) to yield the title product as a white solid (1.68 g, 2.95 mmol, 87% yield). 1H 
NMR (400 MHz, CDCl3) δ 7.60 (d, 7.2 Hz, 2H, ArH), 7.53 (d, 7.2 Hz, 2H, ArH), 7.37-7.30 (m, 
8H, ArH), 6.56 (m, 2H, ArH), 6.46 (d, 8.4 Hz, 1H, ArCHNHBoc), 5.52 (d, 8.4 Hz, CHCO2tBu), 
4.21 (s, 1H, NHBoc), 1.53 (s, 9H, CO2C(CH3)3), 1.51 (s, 9H, CO2C(CH3)3). 13C NMR (100 
MHz, CDCl3) δ 172.7, 168.8, 155.3, 145.2, 138.7, 135.9, 130.8, 128.9, 128.8, 128.7, 128.4, 
128.3, 128.2, 127.1, 125.2, 82.3, 79.8, 69.9, 56.7, 28.5, 28.0. 19F NMR (XXX MHz, CDCl3) δ -
61.4 (s, 3F). IR (thin film, cm-1) 3436, 2979, 2933, 1716, 1621, 1485, 1485, 1367, 1323, 1155, 
1122, 1066, 845, 697. [α]20D = -32.4 (1.0 c, CHCl3). LRMS (FAB+) m/z = 569.14 calcd for 
C32H35F3N2O4 [M+1]+ 569.25. HPLC analysis: Chiralpak AD-H (Hex/IPA = 97/3, 1.0 mL/min, 
254 nm, 23 °C), 6.1 min (minor), 8.2 min (anti), 8.8 min (anti), 14.6 (major), 97:3 dr (syn:anti), 
38% ee (syn). 
 
(2S,3R)-Methyl 3-(tert-butoxycarbonylamino)-2-((E)-4-
chlorobenzylideneamino)-2-methyl-3-phenylpropanoate (36): General 
procedure was followed using cyclopropenimine (97.0 mg, 0.177 mmol, 0.2 
equiv), methyl alanine p-chlorobenzaldimine (200 mg, 0.886 mmol, 1.0 equiv) and tert-butyl 
                                                












benzylidenecarbamate (364 mg, 1.77 mmol, 2.0 equiv). After 34 hr, the reaction mixture was 
purified by silica gel column chromatography (1/4 Et2O/Hexanes) to yield the title product as an 
off-white solid (357 mg, 0.828 mmol, 94% yield). 1H NMR (400 MHz, CDCl3) δ *8.29 (s, 1H, 
HC=N), 8.06 (s, 1H, HC=N), 7.47 (d, J = 8.4 Hz, 2H, ArH), 7.50-7.15 (m, 7H, ArH), 6.20 (d, J 
= 9.0 Hz, 1H, CHNHBoc), *5.89 (d, J = 9.8 Hz, 1H, CHNHBoc), 5.30 (d, J = 9.0 Hz, 1H, 
NHBoc), *5.20 (d, J = 9.8 Hz, 1H, NHBoc), 3.77 (s, 3H, CO2CH3), *3.57 (s, 3H, CO2CH3), 1.40 
(s, 9H, CO2C(CH3)3), *1.38 (s, 9H, CO2C(CH3)3), 1.30 (m, 3H, CH3). 13C NMR (125 MHz, 
CDCl3) δ 173.4, *172.7, *161.6, 161.3, 155.4, *154.9, 139.4, 138.5, 137.3, 137.2, 134.8, 134.4, 
129.7, 129.6, 129.0, 128.9, 128.8, 128.3, 128.0, 127.8, 127.6, 127.5, 79.5, *79.4, *71.6, 70.9, 
60.9, 52.7, 52.0, 28.3, *23.7, 21.3. Note: * denotes chemical shift corresponding to the minor 
diastereomer where discernable. IR (thin film, cm-1) 3428, 2978, 2932, 1735, 1708, 1647, 1486, 
1454, 1365, 1240, 1162, 1112, 1087, 1013, 701, 501. [α]20D = -72.6 (1.0 c, CHCl3).  LRMS 
(FAB+) m/z = 431.11 calcd for C23H27ClN2O4 [M+1]+ 431.17. HPLC analysis: Chiralpak AD-H 
(Hex/IPA = 92/8, 1.0 mL/min, 254 nm, 23 °C), 7.8 min (minor, anti), 7.2 min (minor, syn), 9.5 
min (major, anti), 10.1 (major, syn), 64:36 dr (syn:anti), 63% ee (syn) and 43% ee (anti). 
 
(2S,3R)-tert-Butyl 3-(tert-butoxycarbonylamino)-2-
(diphenylmethyleneamino)-4-methylpentanoate (38): General procedure was 
followed using cyclopropenimine (185 mg, 0.339 mmol, 0.1 equiv), tert-butyl 
glycinate benzophenone imine (1.00 g, 3.39 mmol, 1.0 equiv) and tert-butyl 2-
methylpropylidenecarbamate11 (1.16 g, 6.78 mmol, 2.0 equiv). After 24 hr, another 0.1 equiv. of 
cyclopropenimine 1 (185 mg, 0.339 mmol) was added to the reaction solution. After 72 hr, the 
                                                
11 Probst, N.; Madarász, A.; Valkonen, A.; Pápai, I.; Rissanen, K.; Neuvonen, A.; Pihko, P. M. Angew. 









reaction mixture was purified by silica gel column chromatography (1/9 Et2O/Hexanes) to yield 
the title product as a white solid (1.42 g, 3.04 mmol, 90% yield). 1H NMR (300 MHz, CDCl3) δ 
7.64 (d, 7.0 Hz, 2H, ArH), 7.43-7.14 (m, 8H, ArH), 5.68 (d, 10.0 Hz, 1H, CHCO2tBu), 4.04 (s, 
1H, NHBoc), 3.86 (t, 10.0 Hz, 1H, iPrCHNHBoc), 1.48 (m, 1H, CHMe2), 1.44 (s, 9H, 
CO2C(CH3)3), 1.42 (s, 9H, CO2C(CH3)3), 0.97 (d, 6.7 Hz, 3H, CH3), 0.70 (d, 6.7 Hz, 3H, CH3). 
13C NMR (125 MHz, CDCl3) δ 171.8, 170.5, 155.8, 139.3, 136.7, 130.6, 129.0, 128.6, 128.1, 
127.6, 81.6, 78.7, 66.5, 59.0, 31.6, 28.6, 28.0, 19.6, 19.3. IR (thin film, cm-1) 3429, 2975, 1724, 
1625, 1486, 1449, 1159, 692. [α]20D = -25.3 (1.0 c, CHCl3). LRMS (FAB+) m/z = 467.18 calcd 
for C28H38N2O4 [M+1]+ 467.28. HPLC analysis: Chiralpak AD-H (Hex/IPA = 97.5/2.5, 1.0 
mL/min, 254 nm, 23 °C), 8.1 min (minor), 9.8 min (major), 99:1 dr (syn:anti), 89% ee (syn). 
 
(2S,3R)-Methyl 3-(tert-butoxycarbonylamino)-2-
(diphenylmethyleneamino)-4-methylpentanoate (39): General procedure was 
followed using cyclopropenimine (215 mg, 0.395 mmol, 0.1 equiv), methyl 
glycinate benzophenone imine (1.00 g, 3.95 mmol, 1.0 equiv) and tert-butyl 2-
methylpropylidenecarbamate11 (1.35 g, 7.90 mmol, 2.0 equiv). After 36 hr, the reaction mixture 
was purified by silica gel column chromatography (1/9 Et2O/Hexanes) to yield the title product 
as a white solid (1.46 g, 3.44 mmol, 87% yield). 1H NMR (400 MHz, CDCl3) δ 7.64 (d, 7.3 Hz, 
2H, ArH), 7.43-7.33 (m, 6H, ArH), 7.12 (m, 2H, ArH), 5.65 (d, 10.0 Hz, 1H, CHCO2Me), 4.20 
(s, 1H, NHBoc), 3.93 (t, 10.0 Hz, iPrCHNHBoc), 3.68 (s, 3H, CO2CH3), 1.55 (m, 1H, CHMe2), 
1.45 (s, 9H, CO2C(CH3)3), 0.97 (d, 6.8 Hz, 3H, CH3), 0.72 (d, 6.8 Hz, 3H, CH3). 13C NMR (100 
MHz, CDCl3) δ 172.2, 171.7, 155.7, 138.9, 136.2, 130.6, 128.9, 128.8, 128.5, 128.0, 127.3, 78.8, 








1712, 1626, 1487, 1365, 1166, 772, 695, 566. [α]20D = -28.7 (1.0 c, CHCl3). LRMS (FAB+) m/z 
= 425.17 calcd for C25H32N2O4 [M+1]+ 425.24. HPLC analysis: Chiralpak OD-H (Hex/IPA = 
98.5/1.5, 1.0 mL/min, 254 nm, 23 °C), 9.7 min (minor), 10.4 min (major), 13.5 min (anti), 99:1 
dr (syn:anti), 94% ee (syn). 
 
  (2S,3R)-Methyl 3-(tert-butoxycarbonylamino)-2-
(diphenylmethyleneamino)pentanoate (40): General procedure was followed 
using cyclopropenimine (22.0 mg, 0.040 mmol, 0.1 equiv), methyl glycinate benzophenone 
imine (101 mg, 0.399 mmol, 1.0 equiv), tert-butyl propylidenecarbamate11 (250 mg, 1.59 mmol, 
4.0 equiv) and 4Å molecular sieves (125 mg) in toluene (1.6 mL). After 8 hr, the reaction 
mixture was purified by silica gel column chromatography (1/9 Et2O/Hexanes) to yield the title 
product as a white solid (156 mg, 0.380 mmol, 95% yield). 1H NMR (500 MHz, CDCl3) δ 7.66 
(d, J = 7.3 Hz, 2H, ArH), 7.44 (m, 4H, ArH), 7.33 (t, J = 7.8 Hz, 2H, ArH), 7.11 (m, 2H, ArH), 
5.53 (d, J = 9.8 Hz, 1H, CHCO2Me), 4.15 (m, 1H, EtCHNHBoc), 4.09 (d, J = 2.2 Hz, 1H, 
NHBoc), 3.69 (s, 3H, CO2CH3), 1.44 (s, 9H, CO2C(CH3)3), 1.50-1.45 (m, 2H, 
CH3CH2CHNHBoc), 0.81 (t, J = 7.4 Hz, 3H, CH3CH2CHNHBoc). 13C NMR (125 MHz, CDCl3) 
δ 172.5, 171.5, 155.7, 139.1, 136.3, 130.8, 129.0, 128.7, 128.2, 127.5, 79.1, 67.2, 54.7, 52.2, 
28.4, 26.6, 10.6. IR (thin film, cm-1) 3435, 2971, 2933, 1741, 1713, 1490, 1365, 1161, 778, 697. 
[α]20D = -27.6 (1.0 c, CHCl3). LRMS (APCI+) m/z = 410.86 calcd for C24H30N2O4 [M+1]+ 
411.22. HPLC analysis: for diastereoselectivity: Chiralpak AD-H (Hex/EtOH = 95/5, 0.6 
mL/min, 254 nm, 23 °C), 6.4 min (anti), 6.8 min (syn), 7.6 min (anti) 93:7 dr (syn:anti); for 
enantioselectivity: Chiralpak OD-H (Hex/EtOH = 99/1, 0.6 mL/min, 254 nm, 23 °C), 5.2 min 










(diphenylmethyleneamino)butanoate (41): Methyl glycinate benzophenone 
imine (30.0 mg, 0.117 mmol, 1.0 equiv), cesium carbonate (1.37 g, 4.20 mmol, 12 equiv) and 4Å 
molecular sieves (50 mg) were mixed in a vial containing toluene (2.3 mL). The reaction mixture 
was cooled to 0 °C in an ice bath, at which point tert-butyl 1-(phenylsulfonyl)ethylcarbamate 
(100 mg, 0.350 mmol, 3.0 equiv) and cyclopropenimine (13.0 mg, 0.023 mmol, 0.2 equiv) were 
added. After 12 hr, the reaction was filtered and concentrated in vacuo to a crude oil. The crude 
oil was purified by silica gel column chromatography (2/3 Et2O/Hexanes) to yield the title 
product as a white solid (39.4 mg, 0.099 mmol, 85% yield). 1H NMR (400 MHz, CDCl3) δ 7.68 
(d, J = 6.9 Hz, 2H, ArH), 7.50-7.34 (m, 6H, ArH), 7.10 (m, 2H, ArH), 5.52 (d, J = 9.0 Hz, 1H, 
CHCO2Me), 4.33 (m, 1H, MeCHNHBoc), 4.00 (d, J = 2.5 Hz, 1H, NHBoc), 3.69 (s, 3H, 
CO2CH3), 1.44 (s, 9H, CO2C(CH3)3), 1.08 (d, J = 6.8 Hz, 3H, CHCH3). 13C NMR (125 MHz, 
CDCl3) δ 172.7, 171.3, 155.4, 139.2, 136.3, 130.8, 129.0, 128.9, 128.8, 128.2, 127.6, 79.2, 28.9, 
52.3, 49.0, 28.5, 19.2. IR (thin film, cm-1) 3434, 2976, 1740, 1711, 1626, 1490, 1447, 1366, 
1162, 1056, 779, 698. [α]20D = -4.0 (0.5 c, CHCl3).  LRMS (APCI+) m/z = 396.86 calcd for 
C23H28N2O4 [M+1]+ 397.20. HPLC analysis: Chiralpak AD-H (Hex/IPA = 97.5/2.5, 1.0 mL/min, 
254 nm, 23 °C), 10.4 min (anti), 11.7 min (anti), 12.6 min (minor), 14.3 min (major) 97:3 dr 
(syn:anti), 44% ee (syn). 
 

























General procedure was followed at -25 °C using cyclopropenimine (7.5 mg, 0.013 mmol, 0.1 
equiv), methyl glycinate benzophenone imine (34.0 mg, 0.133 mmol, 1.0 equiv), tert-butyl 3-
(tert-butyldiphenylsilyloxy)propylidenecarbamate11 (220 mg, 0.534 mmol, 4.0 equiv) and 4Å 
molecular sieves (110 mg) in toluene (0.54 mL). After 5 hr, the reaction mixture was purified by 
silica gel column chromatography (1/4 Et2O/Hexanes) to yield the title product as a white solid 
(89.0 mg, 0.133 mmol, 99% yield). 1H NMR (300 MHz, CDCl3) δ 7.61 (m, 6H, ArH), 7.50-7.30 
(m, 12H, ArH), 7.00 (m, 2H, ArH), 5.41 (d, J = 9.8 Hz, 1H, CHCO2Me), 4.35 (broad q, J = 7.5 
Hz, 1H, RCHNHBoc), 4.02 (s, 1H, NHBoc), 3.66 (s, 3H, CO2CH3), 3.65 (m, 2H, SiOCH2CH2), 
1.68 (quintet, J = 6.3 Hz, 2H, SiOCH2CH2CHNHBoc), 1.41 (s, 9H, CO2C(CH3)3), 1.00 (s, 9H, 
SiC(CH3)3). 13C NMR (125 MHz, CDCl3) δ 172.7, 171.4, 155.4, 139.2, 136.3, 135.7, 135.6, 
133.9, 132.5, 130.8, 130.2, 129.7, 129.1, 129.0, 128.8, 128.4, 128.2, 127.9, 127.8, 127.7, 127.6, 
79.1, 68.0, 61.2, 52.2, 50.6, 36.4, 28.5, 27.0, 19.3. IR (thin film, cm-1) 2931, 2858, 1742, 1714, 
1490, 1169, 1108, 739, 699, 504. [α]20D = -8.5 (0.3 c, CHCl3). LRMS (APCI+) m/z = 665.37 
calcd for C40H48N2O5Si [M+1]+ 665.33. HPLC analysis: Chiralpak AD-H (Hex/IPA = 97.5/2.5, 
1.0 mL/min, 254 nm, 23 °C), 5.3 min (minor), 5.8 min (anti), 7.0 min (anti), 8.9 min (major) 
















mmol, 0.1 equiv), methyl glycinate benzophenone imine (32.0 mg, 0.128 mmol, 1.0 equiv), tert-
butyl 4-((tert-butoxycarbonylimino)methyl)piperidine-1-carboxylate (100 mg, 0.320 mmol, 2.5 
equiv) and 4Å molecular sieves (50 mg) in toluene (0.5 mL). After 6 hr, the reaction mixture was 
purified by silica gel column chromatography (1/4 Et2O/Hexanes) to yield the title product as a 
white solid (70.0 mg, 0.124 mmol, 97% yield). 1H NMR (400 MHz, CDCl3) δ 7.65 (d, J = 7.5 
Hz, 2H, ArH), 7.42 (m, 4H, ArH), 7.35 (t, J = 7.6 Hz, 2H, ArH), 7.09 (m, 2H, ArH), 5.62 (d, J = 
9.4 Hz, 1H, CHCO2Me), 4.18 (s, 1H, NHBoc), 4.10 (br s, 2H, CyH), 4.00 (t, J = 9.4 Hz, 1H, 
CHNHBoc), 3.66 (s, 3H, CO2CH3), 2.55 (m, 2H, CyH), 1.77 (m, 1H, CyH), 1.20 (m, 4H, CyH), 
1.43 (s, 9H, CO2C(CH3)3), 1.41 (s, 9H, CO2C(CH3)3). 13C NMR (100 MHz, CDCl3) δ 172.7, 
171.5, 155.8, 154.8, 139.0, 136.2, 131.0, 129.3, 129.0, 128.8, 128.3, 127.4, 79.4, 79.3, 65.3, 57.2, 
52.3, 42.3 (broad), 39.0, 28.5, 28.4. IR (thin film, cm-1) 3421, 2938, 1746, 1715, 1688, 1486, 
1160, 769, 698. [α]20D = -8.9 (0.35 c, CHCl3). LRMS (APCI+) m/z = 565.82 calcd for 
C32H43N3O6 [M+1]+ 566.32. HPLC analysis: Chiralpak OD-H (Hex/EtOH = 99/1, 0.6 mL/min, 
254 nm, 23 °C), 10.9 min (anti), 11.6 min (minor), 13.3 min (major), 15.1 min (anti), 94:6 dr 
(syn:anti), 91% ee (syn). 
 
 (2S,3R)-Methyl 3-(tert-butoxycarbonylamino)-2-
(diphenylmethyleneamino)hept-6-enoate (44): General procedure was 
followed at -25 °C using cyclopropenimine (7.0 mg, 0.012 mmol, 0.1 equiv), methyl glycinate 
benzophenone imine (31.0 mg, 0.122 mmol, 1.0 equiv), tert-butyl pent-4-enylidenecarbamate 
(90 mg, 0.490 mmol, 4.0 equiv) and 4Å molecular sieves (45 mg) in toluene (0.50 mL). After 2 
hr, the reaction mixture was purified by silica gel column chromatography (1/4 Et2O/Hexanes) to 






CDCl3) δ 7.67 (d, J = 7.0 Hz, 2H, ArH), 7.43 (m, 4H, ArH), 7.26 (t, J = 7.3 Hz, 2H, ArH), 7.11 
(m, 2H, ArH), 5.78 (m, 1H, H2C=CHR), 5.54 (d, J = 9.8 Hz, 1H, CHCO2Me), 4.96 (m, 2H, 
H2C=CHR), 4.24 (m, 1H, CHNHBoc), 4.06 (d, J = 2.2 Hz, 1H, NHBoc), 3.68 (s, 3H, CO2CH3), 
2.02 (m, 2H, -CH2-), 1.60-1.45 (m, 2H, -CH2-), 1.45 (s, 9H, CO2C(CH3)3). 13C NMR (125 MHz, 
CDCl3) δ 172.7, 171.4, 155.6, 139.1, 137.9, 136.3, 130.9, 129.1, 128.8, 128.3, 127.6, 115.1, 79.3, 
67.6, 52.8, 52.3, 32.9, 30.3, 28.5. IR (thin film, cm-1) 3433, 3061, 2976, 1740, 1712, 1490, 1446, 
1167, 913, 773, 696. [α]20D = -23.9 (0.45 c, CHCl3). LRMS (APCI+) m/z = 436.86 calcd for 
C26H32N2O4 [M+1]+ 437.24. HPLC analysis: Chiralpak AD-H (Hex/iPrOH = 90/10, 1.0 mL/min, 
254 nm, 23 °C), 5.0 min (minor), 5.2 min (anti), 6.3 min (major), 7.1min (anti), 96:4 dr 
(syn:anti), 91% ee (syn). 
Large-scale Mannich reaction: 
 
Cyclopropenimine (0.674 g, 1.23 mmol, 0.01 equiv), methyl glycinate benzophenone Schiff base 
(31.3 g, 123 mmol, 1.0 equiv) and 4Å molecular sieves (15 g) were mixed in toluene (310 mL, 
0.4 M). tert-Butyl benzylidenecarbamate (38.0 g, 185 mmol, 1.5 equiv) was then added and the 
reaction solution was stirred at room temperature. The reaction was complete after 8 hr, as 
determined by 1H NMR. A small aliquot (0.25 mL) was removed to perform chiral HPLC 
analysis on. HPLC analysis: Chiralpak AD-H (Hex/IPA = 96/4, 1.0 mL/min, 254 nm, 23 °C), 





















phenylpropanoate (46): The remaining reaction mixture was concentrated in 
vacuo, dissolved in THF (985 mL) and added to a 0.5 M citric acid aqueous solution (103 g citric 
acid in 985 mL H2O) in a 5L round bottom flask. The reaction mixture was stirred for 4 hr. The 
approximate 2L of reaction mixture was divided into four fractions to be worked up separately. 
Each fraction of the reaction mixture was washed with Et2O (3 x 300 mL), basified with sat. 
Na2CO3(aq), and extracted with ethyl acetate (3 x 300 mL). The collected ethyl acetate solution 
was concentrated in vacuo to a crude solid that was recrystallized from hexanes to yield the pure 
title product as white crystals (26.7 g, 90.6 mmol, 73% two-step yield). 
Product derivatizations: 
 
Trifluoroacetic acid (12.5 mL) was added to a solution of (2S,3R)-methyl 2-amino-3-(tert-
butoxycarbonylamino)-3-phenylpropanoate (2.50 g, 8.49 mmol) in dichloromethane (200 mL). 
The reaction solution was stirred for 10 hr at room temperature. The reaction was quenched with 
saturated aqueous Na2CO3 (300 mL) and was then extracted with ethyl acetate (3 x 200 mL), 
dried with anhydrous sodium sulfate and concentrated in vacuo to yield crude (2S,3R)-methyl 
2,3-diamino-3-phenylpropanoate as an off-white solid.  
 
(2S,3R)-Methyl 5,6-dioxo-3-phenylpiperazine-2-carboxylate (47): Crude 
(2S,3R)-methyl 2,3-diamino-3-phenylpropanoate (assumed to be 8.49 mmol, 1.0 
equiv) and dimethyl oxalate (1.00 g, 8.49 mmol, 1.0 equiv) were dissolved in dry methanol (85 





i) TFA, CH2Cl2, rt, 10 hr
ii) dimethyloxylate

















refluxing the reaction solution for 2 hr, the reaction solution was concentrated in vacuo to a 
crude brown solid. Washing of the crude solid with a hot mixture of hexanes and 
dichloromethane (1/1, 3 x 30 mL) yielded the pure title product as a white solid (1.53 g, 6.15 
mmol, 72% two-step yield). 1H NMR (400 MHz, (CD3)2SO) δ 9.07 (d, J = 3.6 Hz, 1H, NH), 8.72 
(d, J = 4.1 Hz, 1H, NH), 7.50-7.25 (m, 5H, ArH), 4.97 (d, J = 2.8 Hz, 1H, CHCO2Me), 4.45 (d, J 
= 4.0 Hz, 1H, CHPh), 3.79 (s, 3H, CO2CH3). 13C NMR (100 MHz, (CD3)2SO) δ 170.9, 158.1, 
157.7, 139.2, 128.7, 128.0, 126.1, 58.0, 54.7, 53.1. IR (thin film, cm-1) 3207, 2956, 1744, 1679, 
1437, 1253, 1201, 1177, 1130, 1055, 720, 698, 518. [α]20D = -66.4 (1.0 c, MeOH).  LRMS 
(APCI+) m/z = 248.92 calcd for C12H12N2O4 [M+1]+ 249.08. 
 
 
Benzyl chloroformate (1.90 mL, 13.2 mmol, 1.3 equiv) was added to a stirred solution of 
(2S,3R)-methyl 2-amino-3-(tert-butoxycarbonylamino)-3-phenylpropanoate (3.00 g, 10.2 mmol, 
1.0 equiv) in toluene (10 mL, 1.0 M). Next, 1 M aqueous Na2CO3 (16 mL, 1.5 equiv of Na2CO3) 
was added to the reaction mixture. The reaction mixture became cloudy with an off-white 
precipitate over the course of an hour. The reaction mixture was then extracted with ethyl acetate 
(3 x 50 mL), dried with anhydrous sodium sulfate and concentrated in vacuo to yield a crude 
white solid that was used without further purification.  
 
(2S,3R)-Methyl 3-amino-2-(benzyloxycarbonylamino)-3-phenylpropanoate: 
The crude solid from above was dissolved in dichloromethane (400 mL) and then 
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solution at room temperature for 3 hr, the reaction was quenched with 1 M NaOH (200 mL), 
extracted with ethyl acetate (3 x 200 mL), dried with anhydrous sodium sulfate and concentrated 
in vacuo to give a crude white solid. The crude material was semi-purified by silica gel column 
chromatography (3% MeOH in DCM) to yield the title product as a white solid. This material 
was not completely pure, although the yield was estimated to be 95%; both 1H NMR and 13C 
NMR spectra for this material are provided below for reference. 
 
Benzyl (3S,4R)-2-oxo-4-phenylazetidin-3-ylcarbamate (48): This compound 
was prepared in a similar manner to the previously reported trans diastereomer.12 
The material obtained above containing (2S,3R)-methyl 3-amino-2-(benzyloxycarbonylamino)-
3-phenylpropanoate (estimated to be 9.43 mmol, 1.0 equiv) was dissolved in dichloromethane 
(50 mL, 0.2 M) under an atmosphere of argon and cooled to 0 °C in an ice bath. 
Chlorotrimethylsilane (3.60 mL, 28.3 mmol, 3.0 equiv) and triethylamine (4.00 mL, 28.3 mmol, 
3.0 equiv) were added and the reaction solution was stirred for 1 hr. At this time, tBuMgCl (94 
mL of a 1.0 M solution in THF, 94.0 mmol, 10 equiv) was added slowly and the resulting 
reaction mixture was allowed to warm to room temperature as it stirred for 20 hr. The reaction 
was quenched by adding water (200 mL) and the resulting slurry was filtered through celite. The 
collected filtrate was then extracted with dichloromethane (3 x 100 mL), dried with anhydrous 
sodium sulfate and concentrated in vacuo to a crude oil. The crude material was purified by silica 
gel column chromatography (1/3 EtOAc/Hexanes) to yield the title product as a white solid (440 
mg, 1.49 mmol, 15% three-step yield). 1H NMR (400 MHz, CDCl3) δ 7.40-7.12 (m, 10H, ArH), 
6.30 (s, 1H, lactam NH), 5.40 (dd, J = 5.1 and 9.4 Hz, 1H, CHNHCbz), 5.01 (d, J = 5.1 Hz, Cbz 
                                                





NH), 4.96 (d, J = 2.0 Hz, 2H, CO2CH2Ph), 4.87 (d, J = 9.4 Hz, 1H, CHPh). 13C NMR (100 MHz, 
CDCl3) δ 167.8, 155.4, 136.0, 135.8, 129.0, 128.6, 128.3, 128.0, 126.6, 67.2, 63.2, 57.9. IR (thin 
film, cm-1) 3335, 3218, 3062, 3037, 2961, 1770, 1721, 1693, 1527, 1382, 1251, 1208, 1057, 737, 





imidazole-5-carboxylate (49): Crude (2S,3R)-methyl 2,3-diamino-3-
phenylpropanoate (obtained from same procedure as above, assumed to be 6.79 mmol, 1.0 equiv) 
and triethylamine (4.70 mL, 34.0 mmol, 5 equiv) were dissolved in dichloromethane (68 mL, 0.1 
M). 4-Bromobenzaldehyde (1.23 g, 6.66 mmol, 1.0 equiv) was then added and the reaction 
solution was stirred at room temperature for 1 hr. At this time, the reaction solution was cooled 
to 0 °C in an ice bath and N-bromosuccinimide (1.27 g, 7.13 mmol, 1.1 equiv) was added. The 
reaction solution was allowed to warm to room temperature over 1.5 hr, at which time the 
reaction was quenched with 5% aqueous NaOH (200 mL) and extracted with dichloromethane (3 
x 100 mL), dried with anhydrous sodium sulfate and concentrated in vacuo to a crude yellow 
solid. The crude material was purified by silica gel column chromatography (1/2/17 
NEt3/EtOAc/Hexanes) to yield the title product as a yellow solid (1.75 g, 4.87 mmol, 72% two-
step yield). 1H NMR (400 MHz, CD3OH) δ 7.80 (d, J = 7.9 Hz, 2H, BrArH), 7.62 (d, J = 7.9 Hz, 
2H, BrArH), 7.34-7.30 (m, 5H, ArH), 5.26 (d, J = 6.8 Hz, 1H, CHCO2Me), 4.43 (d, J = 6.8 Hz, 










ii) NBS, 0 °C to rt, 1.5 hr
Br CHO







130.5, 129.9, 129.5, 128.9, 127.4, 126.8, 53.0. IR (thin film, cm-1) 3158, 3030, 2950, 1736, 1608, 
1560, 1494, 1452, 1217, 1123, 1009, 836, 698. [α]20D = +30.0 (1.0 c, CHCl3). LRMS (APCI+) 
m/z = 358.57 and 360.58 calcd for C17H15BrN2O2 [M+1]+ 359.03 and 361.03. 
 
 
Triethylamine (2.10 mL, 15.3 mmol, 3.0 equiv) and 1-hydroxybenzotriazole (1.03 g, 7.64 mmol, 
1.5 equiv) were added to a 0 °C solution of (2S,3R)-methyl 2-amino-3-(tert-
butoxycarbonylamino)-3-phenylpropanoate (1.50 g, 5.10 mmol, 1.0 equiv) and carbobenzyloxy-
L-alanine (1.05 g, 5.10 mmol, 1.0 equiv) in dichloromethane (25 mL, 0.2 M). The reaction 
solution was stirred for 15 min, then N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide 
hydrochloride (1.22 g, 6.37 mmol, 1.25 equiv) was added. After 12 hr, the reaction solution was 
washed with water (1 x 25 mL) and brine (1 x 25 mL), then dried with anhydrous sodium sulfate 
and concentrated in vacuo to yield a white solid. This material was carried forward without any 
further purification.  
Trifluoroacetic acid (5.25 mL) was added to a solution of the crude material obtained 
above (assumed to be 5.10 mmol) in dichloromethane (20.4 mL, 0.25 M). After stirring for 1 hr 
at room temperature, the reaction solution was concentrated in vacuo to yield a white solid. This 



















   EDC, HOBt, NEt3
  CH2Cl2, 0 °C to rt, 12 hr
ii) TFA, CH2Cl2, rt, 1 hr
iii) Boc-Phe-OH 
    EDC, HOBt, NEt3












tetraazaheptadecane-8-carboxylate (50): Triethylamine (2.10 mL, 15.3 mmol, 3.0 equiv) and 
1-hydroxybenzotriazole (1.03 g, 7.64 mmol, 1.5 equiv) were added to a 0 °C solution of the 
crude material obtained above (assumed to be 5.10 mmol, 1.0 equiv) and N-(tert-
butoxycarbonyl)-L-phenylalanine (1.35 g, 5.10 mmol, 1.0 equiv) in dichloromethane (25 mL, 0.2 
M). The reaction solution was stirred for 15 min, then N-(3-dimethylaminopropyl)-N′-
ethylcarbodiimide hydrochloride (1.22 g, 6.37 mmol, 1.25 equiv) was added. After 20 hr, the 
reaction solution was washed with water (1 x 25 mL) and brine (1 x 25 mL), then dried with 
anhydrous sodium sulfate and concentrated in vacuo to yield a white solid. The crude material 
was purified by silica gel column chromatography (2/3 EtOAc/Hexanes) to yield the title product 
as a white solid (2.45 g, 3.79 mmol, 74% three-step yield). 1H NMR (400 MHz, CDCl3) δ 7.40-
7.05 (m, 16H, ArH and NH), 6.99 (s, 1H, NH), 5.57 (s, 1H, NH), 5.38 (s, 1H, NH), 5.31 (t, J = 
6.2 Hz, 1H, CHCO2Me) 5.20-5.00 (dd, J = 9.7 and 63.0 Hz, 2H, CO2CH2Ph), 4.90 (t, J = 6.5 Hz, 
1H, NCHRPh), 4.27 (m, 2H, CHCH2Ph and CHCH3), 3.53 (s, 3H, CO2CH3), 3.05-2.90 (m, 2H, 
CHCH2Ph), 1.35 (br s, 12 H, CHCH3 and CO2C(CH3)3). 13C NMR (125 MHz, CDCl3) δ 173.0, 
172.0, 170.1, 156.4, 155.9, 137.3, 136.7, 136.2, 129.3, 128.9, 128.7, 128.6, 128.4, 128.3, 128.2, 
127.1, 126.9, 80.4, 67.3, 57.0, 56.3, 55.6, 52.5, 50.6, 38.0, 28.4, 18.1. IR (thin film, cm-1) 3303, 
2979, 1737, 1689, 1652, 1526, 1453, 1367, 1239, 1166, 1047, 738, 697, 641. [α]20D = -17.1 (1.0 




Chiral HPLC Traces 
Note: For each entry, the top HPLC trace is a racemic sample that was prepared using standard 
conditions and a cyclopropenimine catalyst lacking a chiral substituent.  
 
































































































































































































































Table 3, entry 2. Two separate conditions were necessary to determine both dr and ee. 
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Chapter 5 
Tris(dialkylamino)cyclopropenium Salts as a New Class of Onium-like Catalysts: Phase 
Transfer Catalysis and Epoxide Opening Catalysis 
 
Introduction 
Group 15 onium compounds, such as ammonium and phosphonium salts, have 
widespread use as components of a number of broadly valuable chemical applications. 1 
Arguably, quaternary ammonium salts are one of the most widely utilized classes of compounds 
throughout the modern world. For example, these salts are used in many household products due 
to their ability to serve as disinfectents, surfactants, herbicides and antimicrobial agents.2 
Additionally, quaternary ammonium salts are used on an industrial scale as catalysts and reagents 
in many different reaction processes.3 Central to the successful employment of these salts has 
been the identification of proper substituents bonded to the ammonium center. Another approach 
to developing novel onium catalysts is the identification of other functional groups that have 
onium-like reactivities. Along these lines, imidazolium4 and guanidinium5 salts have recently 
been under development for onium salt applications. This chapter details the first example of 
utilizing a carbon-centered salt, tris(dialkylamino)cyclopropenium ions, as onium-like catalysts 
in several reaction processes (Figure	  1). 
 
 










•  highly stable
•  readily prepared on scale
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Chapter One reviewed the chemistry of tris(dialkylamino)cyclopropenium (TDAC) ions 
and discussed the synthesis, reactivity and applications of these compounds. Notably, although 
TDAC ions were first synthesized in 1971,6 no reports on their ability to serve as onium-like 
catalysts existed prior to the efforts detailed in this chapter. Surveying their rich literature, we 
were inspired to investigate TDAC catalysis for several reasons. First, TDAC ions are trivially 
synthesized by addition of dialkylamines to pentachlorocyclopropane;7 this would allow for 
straightforward access to a range of structurally unique TDAC ions that could be explored for 
catalysis. Second, Weiss elegantly demonstrated that TDAC cations experience significant 
repulsion between their counteranions, an effect termed “ion-pair strain” that we hoped may lead 
to enhanced catalytic reactivity of TDAC ion pairs.8 Lastly, given the enormous value of 
quaternary ammonium salts, the identification of a fundamentally unique species with like-
properties may have far reaching impacts in the continued development of onium applications. 
With these considerations in mind, we sought to exploit the high stability of TDAC cations for 
phase-transfer applications and also to explore TDAC chloride salts for nucleophilic Lewis base 
catalysis in the context of epoxide opening reactions (Figure	  1).  
 
Phase Transfer Catalysis 
In PTC, the mixing of reactants that are primarily located in separate phases is achieved 
in order to effect reactivity.9 The heterogeneous mixtures can involve liquid-liquid PTC, in 
which aqueous based reagents are effectively mixed with organic molecules in an immiscible 
organic solvent. Additionally, immiscible solid salts can be transported into an organic solvent 
via a solid-liquid PTC process. Liquid-liquid and solid-liquid processes represent the majority of 
PTC applications, although mixing of other phases can occur as well (e.g. gas-liquid PTC). The 
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main advantage of PTC is that participating reactants need not be soluble in the same reaction 
phase; this leads to many practical benefits. First, the use of toxic solvents (e.g. DMSO or DMF), 
which are usually employed to mix highly polar or inorganic salts with organic molecules, can be 
replaced with benign solvent mixtures. In many cases, the use of organic solvents can be entirely 
avoided if the organic reactant and product are both liquids. Importantly, there is an inherent 
compatibility with moisture in many PTC reactions, negating the need for any special 
precautions for anhydrous conditions. Second, by transferring reactants from an aqueous phase to 
an organic phase, PTC gives rise to nucleophilic ion-pairs that are non-hydrated and thus more 
reactive. This allows for shorter reaction times and high catalyst turnover numbers in many 
cases. Finally, PTC reactions that occur under basic conditions (e.g. 50% KOH) exhibit two 
beneficial phenomena: hyperbasicity and the dehydration effect. In base-promoted PTC, the 
deprotonated nucleophile is rapidly transferred from the aqueous-organic solvent interface by a 
phase transfer catalyst; this process drives the acid-base equilibrium allowing inorganic bases to 
promote reactivity in many relatively non-acidic compounds, an effect that has been termed 
“hyperbasicity.” Additionally, the extent of H-bonding present in concentrated aqueous basic 
conditions actually serves to dehydrate the immiscible organic phase. This process, termed the 
“dehydration effect,” explains how PTC can promote reactivity with highly moisture sensitive 
intermediates, such as dichlorocarbene. For these reasons and others, PTC has emerged as a 
major technological force throughout the pharmaceutical, agrochemical, and materials domains. 
Phase transfer catalysts can be divided into two main classes: neutral and ionic systems. 
Neutral phase transfer catalysts function by binding to a metal cation, thus solubilizing the cation 
and allowing the counter anion to enter the organic phases. Examples of these catalysts include 
cryptands and crown ethers; however, they are rarely used industrially due to their size and cost. 
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By far, the most widely used class of phase transfer catalysts are Group 15 onium and onium-like 
salts. These onium-type catalysts include ammonium, phosphonium, imidazolium and 
guanidinium cations; although, without doubt, ammonium-derived phase transfer catalysts are 
the most widely utilized. Many chiral scaffolds have been designed around these functional 
groups that allow for asymmetric ion-pairing catalysis that has now become a reliable approach 
for the production of chiral compounds.10 Given the many practical benefits provided by PTC 
technology and its widespread use throughout the synthetic community, we envisioned a 
fundamentally new catalyst platform would be of value and could provide new design 
opportunities within the PTC realm. A detailed examination of the ionic phase transfer process is 
provided below in order to highlight where these new opportunities may lie.  
A typical liquid-liquid PTC mechanism for the substitution of an alkyl halide with an 
inorganic nucleophile is shown in Figure	   2.11 In the absence of catalyst, the metal salt is 
restricted to the aqueous solution while the electrophilic alkyl halide stays in the organic 
solution; no mixing occurs and thus no reaction is observed. The addition of a cationic phase 
transfer catalyst to this mixture promotes mixing by undergoing anion exchange with the 
nucleophilic anion; the resulting phase transfer catalyst-nucleophile ion-pair is then able to 
migrate into the organic solution, thus enabling electrophile substitution. After substitution 
occurs, the cationic catalyst is able to repeat this function until the reaction is complete. 
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Figure 2. General mechanistic scheme for phase transfer catalyzed substitution reactions. PTC = 
phase transfer catalyst. 
 
 An understanding of the physical principles regulating PTC mechanistic processes 
suggests that structurally novel cations may lead to new catalysts with unique advantages over 
current ammonium- and phosphonium-based catalysts.9 First, the solubility properties of the 
cationic catalyst govern its ability to enter both organic and aqueous phases. The relative 
solubilities for aqueous and organic phases must be balanced so that the catalyst can mix 
reactants efficiently. Furthermore, the size of the cationic catalyst affects the anion-exchange rate 
and controls its maximum possible concentration at the organic-aqueous interface. Therefore, the 
ability to modulate the substituents on a phase transfer catalyst is important for optimization of 
performance in different solvent mixtures (e.g. toluene versus dichloromethane organic 
solutions) and with each specific anionic nucleophile.  
Second, once the key phase transfer catalyst-nucleophile ion-pair enters the organic 
phase, ionic interaction energies regulate the reactivity of the nucleophilic anion. A major 
determinant for this interaction is the ionic radii of the cation and anion; thus cation catalysts 
with larger ionic radii reduce Coulombic interactions and help promote anion nucleophilicity. 
The ionic radius of a specific class of phase transfer catalyst is primarily controlled by the 
atom(s) bearing the ionic charge. For example, most ammonium-based catalysts have similar 
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new catalyst classes that spread ionic charge over a greater volume will reduce Coulombic 
interactions and may lead to increased overall reactivity. 
Perhaps the most important factor governing the success of cationic phase transfer 
catalysts is their overall stability to the specific reaction conditions. This is especially true for 
base-promoted PTC applications, where the use of 50% potassium hydroxide aqueous solutions 
is common. High stability not only leads to higher catalyst turnover numbers but also opens the 
possibility for catalyst recycling opportunities.  
We envisioned that TDAC-based phase transfer catalysts might be able address the 
challenges associated with developing a broadly useful class of phase transfer catalysts. As noted 
throughout this thesis, diverse TDAC ions are trivially prepared and purified on scale from 
inexpensive feedstock chemicals. Furthermore, the symmetrical distribution of ionic charge and 
high stability of TDAC cations is well appreciated throughout the literature.13 With this impetus, 
we detail below the successful development of a new TDAC-based class of phase transfer 
catalysts. 
During the preparation of this thesis, a related report by Dudding detailed the use of N-
cyclopropenium guanidine salt 5 as a phase transfer catalyst for the base-promoted alkylation of 
glycine imine 1a and fluoride substitution of benzyl bromides (Scheme	  1a and b).14 Salt 5 was 
synthesized in three steps from the corresponding urea and no other derivatives were studied. 
Moreover, an in-depth exploration of the generality of this salt was not reported. Our study 
detailed below represents the first application and study of simple TDAC salts for a wide range 
of PTC-based transformations operating via multiple PTC reaction modes. 
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Scheme 1. Dudding’s cyclopropenium guanidine salt 5 as a phase transfer catalyst. 
 
TDAC Phase Transfer Catalysis 
We began our work by selecting a variety of TDAC salts to screen for PTC behavior for 
the alkylation of glycinate imine substrate 1b. The TDAC salts were synthesized in an analogous 
manner as cyclopropenimine catalysts discussed in Chapter 3. For symmetrical TDAC salts, 
excess dialkylamine of low steric hinderance (e.g. dimethylamine) were added to 
pentachlorocyclopropane; for unsymmetrical TDAC salts, excess dialkylamine of high steric 
hinderance (e.g. dicyclohexylamine) were added to pentachlorocyclopropane followed by  
addition of dialkylamine with low steric hinderance. These one-pot protocols led to near-
quantitative formation of the desired TDAC salts with simple washings as the only necessary 
purification operations. Notably, we utilized this straightforward process for the synthesis of 75 
grams (95% yield) of TDAC chloride salt 7 (Scheme 2), which proved to be the optimal TDAC 
ion used in the methodologies described below. 
 
 



























i) HNCy2 (5 eq)
            CH2Cl2, 23 °C, 24 h
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The performance of selected TDAC salts for the benzylation of glycinate imine 1b in 
various solvents is shown in Table 1. We discovered early on that the use of 50% KOH aqueous 
base resulted in optimal yields; importantly, no background reaction was observed using this 
base in the absence of catalyst. To begin, comparison of tris-symmetrical TDAC salts (entries 1–
4) confirm a positive correlation between TDAC liophilicity and catalyst performance. For 
example, the dihexylamino-substituted catalyst outperformed dibutylamino- and dimethylamino-
substituted catalysts, while morphilino-substituted catalyst had very low reactivity. These results 
suggest the ability of the TDAC ion-pair to enter the organic phase governs the overall 
performance of this phase transfer catalyst system. Inspired by the benefits exhibited of the 
bis(dicyclohexylamino)cyclopropenium scaffold in cyclopropenimine catalysis, we next 
explored TDAC derivatives of this type. Notably, TDAC chloride salt 7, with a diethylamino 
head group, performed well (entry 5); however, upon changing its counteranion to iodide in salt 
12, an enhanced reactivity was observed (entry 6). We postulate that this increased reactivity 
results from simultaneous activation of benzyl bromide; this hypothesis is supported by the 
observation of benzyl iodide in the reaction mixture. Iodide salt 12 is obtained from TDAC 
chloride salt by simple ion-exchange using sodium iodide in acetone solvent (see Supporting 
Information). We next examined a variety of solvents in an effort to identify catalyst systems that 
operate under a range of reaction conditions. Thus, catalyst 12 led to moderate isolated yields of 
product 3b in the green solvents ethyl acetate, isopropyl acetate and cyclopentyl methyl ether 
(entries 7–9). We then found that the cyclopropenimine hydrochloride salt 13 had excellent 
reactivity in polar solvents, especially dichloromethane and 2-butanone (entries 10-12). As a 
final note, entries 13-15 show that our new catalyst system performs comparatively and in some 
cases adventitiously over commonly used PTC salts. 
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Table 1. Screen of catalysts for the alkyation of glycinate imine 1b. 
 
a Percent conversion after 24 h, as measured by 1H NMR, average of two runs; *Isolated yields, 
average of two runs; entry 12: 2h reaction time. 
Having identified two optimal catalysts (12 and 13) that operate under a variety of 
reaction conditions, we began to explore the scope of this base-promoted PTC chemistry. Both 
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catalyst 12 in toluene (System A) and catalyst 13 in dichloromethane (System B) were tested for 
reactivity and the optimal results are shown in Table 2. To ensure consistency for these 
heterogeneous reactions, identical stir rates and vial sizes were used throughout and the indicated 
isolated yields represent the average of two trials for each entry. The left side of Table 2 shows 
that aryl ketones (entries 1 and 3), aryl esters (entry 2) and aryl amides (entry 4) serve as 
excellent pronucleophiles for this methodology. Both β-tetralone and 3-methyl-2-oxindole 
underwent double alkylation under the given conditions, while substrates in entries 1 and 2 were 
selectively mono-alkyated. These results demonstrate that the TDAC methodology can promote 
reactivity of substrates within a pKa range between 12-21 in DMSO. The right side of Table 2 
provides a selection of activated alkyl halides (entries 5 and 6) and Michael acceptors (entries 7 
and 8) that functioned as suitable electrophiles for glycine imine 1b. Cumulatively, this 
methodology provides a practical and simple method for promoted reactivity of pronuclophiles 
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Table 2. Substrate screen of TDAC-catalyzed base-promoted PTC reactions.a 
 
a Isolated yields, average of two runs. 
 
Finally, we sought to demonstrate the utility of TDAC ion 12 as a general phase transfer 
catalyst by exploring its use in a rage of other classes of PTC reactions. As shown in Scheme 3, 
catalyst 12 performed excellently for the (a) alkylation of phenol, (b) azide substitution of benzyl 
bromide, (c) oxidation of 1-phenylethanol, and (d) cyclopropanation of styrene. These results 
indicate the broad potential of readily available TDAC salts as phase transfer catalysts for a 
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Scheme 3. General use of TDAC 12 in a range of PTC reaction types. 
 
TDAC Epoxide Opening Catalysis 
We next envisioned that the aforementioned “ion-pair strain” might lead to enhanced 
nucleophilicity of TDAC counteranions and that this could be exploited in the context of 
nucleophilic catalysis. Anion-mediated epoxide opening catalysis was explored for this type of 
catalytic reactivity. We were inspired by the many reports detailing ammonium halides as 
cocatalysts for the Lewis acid-catalyzed carbon dioxide fixation of epoxides.15 We initially 
studied the addition of acid chlorides to epoxides, however, because this homogenous reaction 
was more consistent and reliable for catalyst and condition optimization and comparison.  
To begin, using tris(dimethylamino)cyclopropenium chloride (8) catalyst, we found that a 
0.2 M THF solution containing 2.5 mol% catalyst, phenyl acetyl chloride (23) and 1,2-
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epoxybutane (22) afforded chloroacyloxy adduct 24 in optimal yield and regioselectivity. Using 
these optimized conditions, we next explored the effect of cyclopropenium substitution on the 
observed reaction rates and regioselectivity (Table	  3). We again found that TDAC chloride salt 7 
outperformed other TDAC salts. More notably, the reaction rate, yield and selectivity were 
greater with this TDAC salt than other common onium chloride salts, such as 
tertabutylammonium chloride, tetraphenylphosphonium chloride and imidazolium chloride 14 
(entries 6-8).16  
 
Table 3. Catalyst screen for the chloroacylation of epoxides.a 
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Using catalyst 7, we then developed conditions that allowed for the selective addition of 
phenyl acetyl chloride to a range of terminal epoxides to produce vicinal haloesters (Table 4, 
entries 1-6). We discovered that in certain cases, the addition of pyridine and excess phenyl 
acetyl chloride enhanced yields and regioselectivities (entries 2, 3 and 5).  The mechanistic 
rationale for the superior results in the presence of pyridine is unclear at this time; possibilities 
include its function as a Brønsted and/or Lewis base. Nevertheless, no reactivity was observed in 
the absence of catalyst 7 and good yields and selectivities were achieved for a variety of terminal 
epoxides. Sterically hindered epoxides, such as iso-butylene oxide, performed poorly and led to 
low conversions and regioselectivities (entry 6). Lastly, meso-epoxide cyclohexene oxide proved 
to be a suitable substrate with phenylacetyl chloride and acetyl chloride (entries 7 and 9); 
however, no reactivity was observed with benzoyl chloride (entry 8). 
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Finally, we exploited this epoxide-opening chemistry within the context of carbon 
dioxide fixation to epoxides to deliver cyclic carbonates under 1 atm of CO2. Table 5 shows four 
different epoxides that were simply heated under 1 atm of CO2 in the presence of 2.5 mol% 
TDAC 7; subsequent silica gel chromatography generally yielded cyclic carbonates in good 
yields. These results indicate that TDAC chloride salts function as excellent catalysts for 
regioselective epoxide-opening chemistry and we are currently pursuing other reaction processes 
that capitalize on this previously unknown reactivity.  
 
Table 5. Substrate scope for TDAC-catalyzed epoxide fixation with epoxides.a 
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Catalyst Structure 
The crystalline nature of TDAC 7 allowed us to obtain the molecular structure of this 
catalyst via single-crystal X-ray analysis (Figure 3). As highlighted in Figure 3a, the 
dicyclohexylamino groups torque 17° out of planarity with respect to the cyclopropenium ring; 
this torqueing is nearly identical to that observed in our cyclopropenimine catalyst discussed in 
Chapter 3. The diethylamino head group exhibits a 37° torqueing, suggesting its conformation 
adjusts itself to “fit” into the cyclopropenium scaffold that is flanked by the two 
dicyclohexylamino groups. This effect can be clearly seen in Figure 3b, where the ethyl groups 
are aligned completely perpendicular to the plane of the cyclopropenium ring. Ultimately, the 
bulky dicyclohexylamino groups enforce extreme torqueing of the head group, which places its 
substituents on either face of the cyclopropenium ring. Using this C2-symmetric scaffold as a 
template, we are currently pursuing chiral derivatives via the installation of chiral amino head 
groups for asymmetric phase transfer catalysis.  
 
	  
Figure 3.  Molecular structure of 7 obtained from the Parkin Group (Columbia University).  (a) 
Face view.  (b) Edge view.  The curved arrows and associated degree labels indicate the dihedral 
angle of the cyclopropenium ring and the C-N-C plane of the amino substituents.  The chloride 
counterion has been removed for clarity. 
37°17°
(a) (b)
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Conclusion 
 In conclusion, we have established simple tris(dialkylamino)cyclopropenium salts as 
efficient and general catalysts for phase transfer and epoxide-opening chemistry. This modular 
catalyst platform is readily synthesized on scale with little purification necessary; this was 
demonstrated in a 75-gram preparation of the optimal TDAC catalyst 7. In several cases, it was 
shown that these TDAC catalysts outperformed other notable onium catalyst systems, including 
those derived from ammonium, phosphonium and imidazolium salts. Examination of the 
molecular structure of TDAC 7 revealed an interesting structural phenomenon: enhanced 
torqueing of the diethylamino head group to deliver a C2-symmetric scaffold with each ethyl 
substituent of the head group occupying space on either face of the cyclopropenium ring. We are 
currently working to develop new reaction processes and chiral TDAC variants using the 
chemistry discussed in this chapter. This work represents an important contribution to onium 
chemistry by describing a fundamentally new ionic platform that has excellent catalytic activities 
yet provides intriguing new design opportunities.  
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General information. All reactions were performed open to the atmosphere, unless otherwise 
noted. Methylene chloride, diethyl ether, tetrahydrofuran and toluene were dried using a J.C. 
Meyer solvent purification system. All other solvents and commercial reagents were used as 
provided, unless otherwise noted. Flash column chromatography was performed employing 40-
63 µm silica gel (SiliaFlash P60 from Silicycle). Thin-layer chromatography (TLC) was 
performed on silica gel 60 F254 plates (EMD). Organic solutions were concentrated using a Buchi 
rotary evaporator. 
 1H and 13C NMR spectra were recorded in CDCl3 (except where noted) on Bruker DRX-
300, DRX-400 or DRX-500 spectrometers as noted. Data for 1H NMR are reported as follows: 
chemical shift (δ ppm), multiplicity (s = singlet, br s = broad singlet, d = doublet, t = triplet, q = 
quartet, dd = doublet of doublets, td = triplet of doublets, m = multiplet), coupling constant (Hz), 
integration, and assignment. Data for 13C and 19F NMR are reported in terms of chemical shift. 
Infrared spectra were recorded on a Nicolet Avatar 370DTGS FT-IR. Optical rotations were 
measured using a Jasco DIP-1000 digital polarimeter. High-resolution mass spectra were 
obtained from the Columbia University Mass Spectrometry Facility on a JOEL JMSHX110 HF 
mass spectrometer using FAB+ ionization mode. Low-resolution mass spectrometry (LRMS) 
was performed on a JEOL JMS-LCmate liquid chromatography spectrometer system using 
APCl+ ionization technique.  
Catalyst Synthesis and References 
Catalysts 81, 92, 113 and 134 were prepared according to known procedures. 
                                                
1  Weiss, R.; Schloter, K. Tetrahedron Lett. 1975, 3491. 
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Diethylamino-bis(dicyclohexylamino)cyclopropenium chloride (7). 
Dicyclohexylamine (186 mL, 936 mmol, 6.0 equiv) was added to a stirred 
solution of pentachlorocyclopropane (33.4 g, 156 mmol, 1.0 equiv) in dichoromethane (1.6 L, 
0.1 M) in a 5L round bottom flask. A mild exotherm was observed after approximately 30 
minutes and the reaction was allowed to stir for a further 36 hr at room temperature. 
Dicyclohexylammonium chloride precipitated out of solution during this time. Next, 
diethylamine (32.3 mL, 312 mmol, 2.0 equiv) was added directly to the reaction solution and the 
mixture was stirred for a further 12 hr. At this time, 200 mL of conc. HCl was added to 
precipitate any excess dicyclohexylamine. The mixture was filtered and the filtrate was then 
washed with 1 M HCl (5 x 250 mL) to remove all ammonium salts. The dichloromethane 
solution was then dried with sodium sulfate and concentrated in vacuo to yield the pure title 
cyclopropenium chloride salt as an off-white solid (74.9 g, 149 mmol, 95% yield). 1H NMR (300 
MHz, CDCl3) δ 3.63 (q, J = 6.9 Hz, 4H, NCH2CH3), 3.30-3.40 (m, 4H, NCyH), 1.00-1.95 (m, 
46H, CyH, NCH2CH3); 13C NMR (125 MHz, CDCl3) δ 119.3, 118.8, 61.0, 46.3, 32.5, 25.9, 24.8, 
14.6. IR (thin film, cm-1) 2926, 2859, 1511, 1441, 1375, 1347, 1114, 990, 896, 726. HRMS 
(FAB+) m/z = 468.4326; calcd for C31H54N3+ [M]+ 468.4312. 
 
                                                                                                                                                       
2 Curnow, O. J.; MacFarlane, D. R.; Walst, K. J. Chem. Commun. 2011, 47, 10248. 
3 Yoshida, Z.; Tawara, Y. J. Am. Chem. Soc. 1971, 93, 2573. 























Diethylamino-bis(dicyclohexylamino)cyclopropenium iodide (12). Anion 
exchange was accomplished by mixing an acetone (15 mL) solution of the 
corresponding cyclopropenium chloride (1.53 g, 3.01 mmol, 1.0 equiv) with an acetone (15 mL) 
solution of sodium iodide (0.903 g, 6.03 mmol, 2.0 equiv). The reaction mixture was stirred at 
room temperature for 2 hr as sodium chloride was allowed to precipitate. The reaction mixture 
was then filtered and an additional equivalent of sodium iodide was added to the filtrate. No 
further precipitation was observed over the course of 2 hr. The reaction solution was then 
concentrated in vacuo to a solid mixture of cyclopropenium iodide and sodium iodide. 
Cyclopropenium iodide was extracted in pure form from this solid mixture with dichloromethane 
followed by a water wash to remove trace sodium iodide. The title cyclopropenium salt was 
isolated as a light yellow solid (1.76 g, 2.95 mmol, 98% yield). 1H NMR (300 MHz, CDCl3) δ 
3.61 (q, J = 7.2 Hz, 4H, NCH2CH3), 3.30-3.40 (m, 4H, NCyH), 1.00-1.95 (m, 46H, CyH, 
NCH2CH3); 13C NMR (125 MHz, CDCl3) δ 119.3, 118.9, 60.8, 46.3, 32.4, 25.8, 24.7, 14.6. IR 
(thin film, cm-1) 2929, 2858, 1504, 1439, 1371, 1208, 990, 896. HRMS (FAB+) m/z = 468.4310; 
calcd for C31H54N3+ [M]+ 468.4312. 
 
 
Tris(dihexylamino)cyclopropenium chloride (10). Dihexylamine (4.0 mL, 
17.4 mmol, 6.0 equiv) was added to a solution of tetrachlorocyclopropene 
(0.500 g, 2.80 mmol, 1.0 equiv)  in dichloromethane (28 mL, 0.1 M). The reaction solution was 
heated to 30 °C for 24 hr before direct concentration in vacuo followed by silica gel column 














17% yield). 1H NMR (500 MHz, CDCl3) δ 3.33 (t, J = 7.9 Hz, 12H, NCH2R), 1.63 (m, 12H, 
NCH2CH2R), 1.31 (br s, 36H, NCH2CH2CH2CH2CH2CH3), 0.90 (t, J = 6.3 Hz, 18H, 
NCH2CH2CH2CH2CH2CH3); 13C NMR (125 MHz, CDCl3) δ 116.8, 53.4, 31.7, 29.2, 26.5, 22.7, 
14.1. IR (thin film, cm-1) 2955, 2926, 2857, 1527, 1432, 1375, 1212, 1102, 725. HRMS (FAB+) 
m/z = 589.0001; calcd for C39H78N3+ [M]+ 588.6190. 
 
Phase transfer catalyst screening 
Phase transfer catalyst (0.017 mmol, 0.1 equiv) and tert-butyl glycinate benzophenone imine (50 
mg, 0.167 mmol, 1.0 equiv) were dissolved in solvent (toluene or dichloromethane, 0.85 mL, 0.2 
M) in a 1-dram reaction vial (VWR catalog no. 66011-041). An aqueous 50% KOH solution 
(0.19 mL) was then added to the reaction vial followed by benzyl bromide (0.100 mL, 0.85 
mmol, 5.0 equiv). A 10x3 mm (VWR catalog no. 58948-375) stir bar was added to the vial and 
the reaction mixture was then stirred at 350 rpm at room temperature for 24 hr. Reaction 
progress was monitored by 1H NMR spectroscopy using tert-butyl chemical shifts and 
conversions were determined using a benzyl ether standard. Each reaction was run in duplicate 
and the reported conversions are the average of the two results. Typically, the two results were 
within 5% conversion of each other. In the absence of catalyst, no background reaction is 
observed under these reaction conditions. 
 
Phase transfer catalysis solvent compatibility screen 
Phase transfer catalyst 12 or 13 (0.017 mmol, 0.1 equiv) and tert-butyl glycinate benzophenone 
imine (50 mg, 0.167 mmol, 1.0 equiv) were dissolved in solvent (0.85 mL, 0.2 M) in a 1-dram 
reaction vial (VWR catalog no. 66011-041). An aqueous 50% KOH solution (0.19 mL) was then 
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added to the reaction vial followed by benzyl bromide (0.100 mL, 0.85 mmol, 5.0 equiv). A 10x3 
mm (VWR catalog no. 58948-375) stir bar was added to the vial and the reaction mixture was 
then stirred at 350 rpm at room temperature. Reaction progress was monitored by 1H NMR 
spectroscopy using tert-butyl chemical shifts. Upon complete consumption of tert-butyl 
glycinate benzophenone imine, the reaction mixture was diluted with water (2 mL) and extracted 
with ethyl acetate (3 x 3 mL). The organic extracts were dried with sodium sulfate and 
concentrated in vacuo before purification by silica gel column chromatography (10% ether in 
hexanes eluent). The final product was isolated as a white solid. Each reaction was run in 
duplicate and the reported conversions are the average of the two results. In the absence of 
catalyst, no background reaction was observed except where noted. The results are shown in the 
table below.  
 
Base-promoted phase transfer reactions (Table 2) 
General procedure. Phase transfer catalyst 12 or 13 (0.017 mmol, 0.1 equiv) and 
pronucleophile (0.167 mmol, 1.0 equiv) were dissolved in solvent (toluene or dichloromethane, 
0.85 mL, 0.2 M) in a 1-dram reaction vial (VWR catalog no. 66011-041). An aqueous 50% KOH 
solution (0.19 mL) was then added to the reaction vial followed by the designated electrophile 
(0.85 mmol, 5.0 equiv). A 10x3 mm (VWR catalog no. 58948-375) stir bar was added to the vial 
and the reaction mixture was stirred at 350 rpm at room temperature. Reaction progress was 
monitored by 1H NMR spectroscopy using tert-butyl chemical shifts. Upon complete 
consumption of tert-butyl glycinate benzophenone imine, the reaction mixture was diluted with 
water (2 mL) and extracted with ethyl acetate (3 x 3 mL). The organic extracts were dried with 
sodium sulfate and concentrated in vacuo before purification by silica gel column 
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chromatography using the given eluent. Each reaction was run in duplicate and the reported 
yields are the average of the two results. In the absence of catalyst, no background reaction was 
observed except where noted. See below for substrate-specific details. 
 
 tert-Butyl 2-((diphenylmethylene)amino)-3-phenylpropanoate.5 The general 
procedure was followed using catalyst 13 (9.9 mg, 0.017 mmol, 0.1 equiv), tert-
butyl glycinate benzophenone imine (50 mg, 0.167 mmol, 1.0 equiv) and benzyl bromide (0.100 
mL, 0.85 mmol, 5.0 equiv) in dichloromethane (0.85 mL, 0.2 M). The reaction was complete 
after 20 hr. Purification via silica gel column chromatography (10% ether in hexanes) yielded the 
title product as a white solid. Run 1: 63 mg, 0.163 mmol, 96% yield; Run 2: 64 mg, 0.166 mmol, 
98% yield. 1H NMR (400 MHz, CDCl3) δ 7.58 (d, J = 7.0 Hz, 2H, ArH), 7.30-7.26 (m, 6H, 
ArH), 7.16 (m, 3H, ArH), 7.05 (m, 2H, ArH), 6.61 (d, J = 6.7 Hz, 1H, ArH), 4.10 (dd, J = 4.3 
and 9.1 Hz, 1H, CHCO2tBu), 3.20 (m, 2H, CH2Ph), 1.43 (s, 9H, CO2C(CH3)3). 13C NMR (100 
MHz, CDCl3) δ 170.9, 170.4, 139.7, 138.5, 136.5, 130.2, 130.0, 128.8, 128.3, 128.2, 128.2, 
128.1, 127.8, 126.3, 81.2, 68.1, 39.7, 28.2. 
 
 tert-Butyl 2-((diphenylmethylene)amino)pent-4-enoate.5 The general 
procedure was followed using catalyst 13 (9.9 mg, 0.017 mmol, 0.1 equiv), tert-
butyl glycinate benzophenone imine (50 mg, 0.167 mmol, 1.0 equiv) and allyl bromide (72 µL, 
0.85 mmol, 5.0 equiv) in dichloromethane (0.85 mL, 0.2 M). The reaction was complete after 12 
hr. Purification via silica gel column chromatography (10% ether in hexanes) yielded the title 
product as a clear oil. Run 1: 55 mg, 0.164 mmol, 98% yield; Run 2: 56 mg, 0.167 mmol, 100% 
                                                








yield. 1H NMR (400 MHz, CDCl3) δ 7.64 (dd, J = 1.1 and 8.1 Hz, 2H, ArH), 7.4-7.2 (m, 6H, 
ArH), 7.16 (dd, J = 3.0 and 7.7 Hz, 2H, ArH), 5.71 (m, 1H, C=CH), 5.04 (m, 2H, C=CH2), 4.00 
(dd, J = 5.3 and 7.5 Hz, 1H, CHCO2tBu), 2.63 (m, 2H, CH2CH=CH2), 1.44 (s, 9H, 
CO2C(CH3)3). 13C NMR (100 MHz, CDCl3) δ 171.0, 170.2, 139.9, 136.8, 134.9, 130.3, 128.9, 
128.6, 128.5, 128.1, 117.4, 81.1, 65.9, 38.3, 28.2. 
 
 tert-Butyl 4-cyano-2-((diphenylmethylene)amino)butanoate. 6  The general 
procedure was followed using catalyst 13 (9.9 mg, 0.017 mmol, 0.1 equiv), tert-
butyl glycinate benzophenone imine (50 mg, 0.167 mmol, 1.0 equiv) and acrylonitrile (56 µL, 
0.85 mmol, 5.0 equiv) in dichloromethane (0.85 mL, 0.2 M). The reaction was complete after 1 
hr. Purification via silica gel column chromatography (20% ether in hexanes) yielded the title 
product as a clear oil. Run 1: 53 mg, 0.152 mmol, 91% yield; Run 2: 58 mg, 0.166 mmol, 99% 
yield. 1H NMR (400 MHz, CDCl3) δ 7.47 (dd, J = 1.7 and 5.1 Hz, 2H, ArH), 7.40-7.30 (m, 6H, 
ArH), 7.18 (m, 2H, ArH), 4.05 (dd, J = 4.6 and 7.7 Hz, 1H, CHCO2tBu), 2.45 (m, 2H, -CH2CN), 
2.20 (m, 2H, CH2CHCO2tBu), 1.43 (s, 9H, CO2C(CH3)3). 13C NMR (100 MHz, CDCl3) δ 172.2, 
170.0, 139.2, 136.2, 130.8, 129.0, 128.9, 128.7, 128.2, 127.8, 119.6, 81.9, 63.9, 29.5, 28.1, 13.9.  
 
 tert-Butyl 2-((diphenylmethylene)amino)-5-oxohexanoate. 7  The general 
procedure was followed using catalyst 12 (10.0 mg, 0.017 mmol, 0.1 equiv), 
tert-butyl glycinate benzophenone imine (50 mg, 0.167 mmol, 1.0 equiv) and methyl vinyl 
                                                
6. Zhang, F. Y.; Corey, E. J. Org. Lett. 2000, 2, 1097. 
 
7. Ma, T.; Fu, X.; Kee, W. K.; Zong, L.; Pan, Y.; Huang, K.W.; Tan, C.H. J. Am. Chem. Soc.  









ketone (86 µL, 0.85 mmol, 5.0 equiv) in toluene (0.85 mL, 0.2 M). The reaction was complete 
after 1 hr. Purification via silica gel column chromatography (20% ether in hexanes) yielded the 
title product as a clear oil. Run 1: 54 mg, 0.147 mmol, 88% yield; Run 2: 51 mg, 0.140 mmol, 
84% yield; note: 18% background conversion was observed after 1 hr reaction time. 1H NMR 
(400 MHz, CDCl3) δ 7.64 (dd, J = 1.0 and 8.0 Hz, 2H, ArH), 7.50-7.30 (m, 6H, ArH), 7.15 (m, 
2H, ArH), 3.95 (t, J = 6.0 Hz, 1H, CHCO2tBu), 2.50 (m, 2H, CH2COMe), 2.13 (m, 2H, 
CH2CHCO2tBu), 2.12 (s, 3H, COCH3), 1.43 (s, 9H, CO2C(CH3)3). 13C NMR (100 MHz, CDCl3) 
δ 208.4, 171.1, 170.6, 139.6, 136.6, 130.4, 128.9, 128.7, 128.6, 128.2, 127.9, 81.3, 64.8, 40.0, 
30.0, 28.2, 27.9. 
 
 1,2,3-Triphenylpropan-1-one.8 The general procedure was followed using catalyst 
12 (9.9 mg, 0.017 mmol, 0.1 equiv), 1,2-diphenylethan-1-one (33 mg, 0.167 mmol, 
1.0 equiv) and benzyl bromide (0.100 mL, 0.85 mmol, 5.0 equiv) in toluene (0.85 mL, 0.2 M). 
The reaction was complete after 30 min. Purification via silica gel column chromatography (5% 
ether in hexanes) yielded the title product as a white solid. Run 1: 20 mg, 0.069 mmol, 42% 
yield; Run 2: 22 mg, 0.077 mmol, 46% yield. 1H NMR (400 MHz, CDCl3) δ 7.90 (d, J = 7.2 Hz, 
2H, ArH), 7.45 (t, J = 7.0 Hz, 1H, ArH), 7.35 (t, J = 3.9 Hz, 2H, ArH), 7.25-7.05 (m, 10H, ArH), 
4.80 (t, J = 7.2 Hz, 1H, CHCOPh), 3.56 (dd, J = 7.5 and 13.8 Hz, 1H, CHPh), 3.07 (dd, J = 7.0 
and 13.8 Hz, 1H, CHPh). 13C NMR (100 MHz, CDCl3) δ 199.4, 139.9, 139.2, 136.9, 133.0, 
129.3, 129.0, 128.8, 128.6, 128.4, 128.4, 127.3, 126.2, 56.1, 40.3. 
 
                                                







 5-Oxo-4,5-diphenylpentanenitrile. The general procedure was followed using 
catalyst 12 (10.0 mg, 0.017 mmol, 0.1 equiv), 1,2-diphenylethan-1-one (33 mg, 
0.167 mmol, 1.0 equiv) and acrylonitrile (56 µL, 0.85 mmol, 5.0 equiv) in toluene (0.85 mL, 0.2 
M). The reaction was complete after 15 min. Purification via silica gel column chromatography 
(5% ether in hexanes) yielded the title product as a pale oil. Run 1: 26 mg, 0.104 mmol, 62% 
yield; Run 2: 26 mg, 0.104 mmol, 62% yield. 1H NMR (400 MHz, CDCl3) δ 7.95 (d, J = 7.2 Hz, 
2H, ArH), 7.50 (t, J = 5.4 Hz, 1H, ArH), 7.45-7.20 (m, 7H, ArH), 4.73 (t, J = 7.3 Hz, 1H, 
CHCOPh), 2.44 (m, 2H, CH2CN), 2.25 (m, 2H, CH2CHPh). 13C NMR (100 MHz, CDCl3) δ 
198.3, 137.7, 136.2, 133.4, 129.6, 129.0, 128.8, 128.3, 128.0, 119.4, 52.1, 29.2, 15.3. IR (thin 
film, cm-1) 2925, 2850, 1668, 1596, 1449, 1264, 1199, 988, 754, 694, 593. HRMS (FAB+) m/z = 
250.1228; calcd for C17H15NO [M+1]+ 250.1154. 
 
Phenyl 2,3-diphenylpropanoate. 9  The general procedure was followed using 
catalyst 12 (10.0 mg, 0.017 mmol, 0.1 equiv), phenyl 2-phenylacetate (36 mg, 0.167 
mmol, 1.0 equiv) and benzyl bromide (0.100 mL, 0.85 mmol, 5.0 equiv) in toluene (0.85 mL, 0.2 
M). The reaction was complete after 40 hr. Purification via silica gel column chromatography 
(10% ether in hexanes) yielded the title product as a white solid. Run 1: 50 mg, 0.165 mmol, 
99% yield; Run 2: 50 mg, 0.165 mmol, 99% yield. 1H NMR (400 MHz, CDCl3) δ 7.45-7.15 (m, 
13H, ArH), 6.82 (d, J = 7.7 Hz, 2H, ArH), 4.10 (dd, J = 6.4 and 9.3 Hz, 1H, CHCO2Ph), 3.50 
(dd, J = 9.3 and 13.6 Hz, 1H, CHPh), 3.13 (dd, J = 6.4 and 13.6 Hz, 1H, CHPh). 13C NMR (100 
MHz, CDCl3) δ 172.0, 150.8, 138.9, 138.3, 129.4, 129.2, 128.9, 128.6, 128.1, 127.8, 126.7, 
125.9, 121.5, 53.9, 40.1.  
                                                












 1,1-Dibenzyl-3,4-dihydronaphthalen-2(1H)-one. 10  The general procedure was 
followed using catalyst 12 (10.0 mg, 0.017 mmol, 0.1 equiv), β-tetralone (23 µL, 
0.167 mmol, 1.0 equiv) and benzyl bromide (0.100 mL, 0.85 mmol, 5.0 equiv) in toluene (0.85 
mL, 0.2 M). The reaction was complete after 10 min. Purification via silica gel column 
chromatography (5% ether in hexanes) yielded the title product as a white solid. Run 1: 43 mg, 
0.132 mmol, 79% yield; Run 2: 44 mg, 0.135 mmol, 81% yield. 1H NMR (400 MHz, CDCl3) δ 
7.70 (d, J = 7.8 Hz, 1H, ArH), 7.40 (t, J = 7.5 Hz, 1H, ArH), 7.15 (t, J = 6.6 Hz, 1H, ArH), 7.01 
(m, 6H, ArH), 6.81 (d, J = 7.5 Hz, 1H, ArH), 6.70 (d, J = 6.6 Hz, 4H, ArH), 3.52 (d, J = 12.8 Hz, 
2H, 2 x CHPh), 3.20 (d, J = 12.8 Hz, 2H, 2 x CHPh), 1.91 (t, J = 6.4 Hz, 2H, CH2C=O), 1.74 (t, 
J = 5.4 Hz, 2H, CH2Ar). 13C NMR (100 MHz, CDCl3) δ 214.6, 138.4, 138.4, 137.1, 130.3, 128.0, 
127.9, 127.8, 126.6, 126.5, 126.4, 59.5, 47.8, 40.8, 26.7. 
 
1,3-Dibenzyl-3-methylindolin-2-one.11 The general procedure was followed using 
catalyst 12 (10.0 mg, 0.017 mmol, 0.1 equiv), 3-methyl-2-oxindole (25 mg, 0.167 
mmol, 1.0 equiv) and benzyl bromide (0.100 mL, 0.85 mmol, 5.0 equiv) in toluene (0.85 mL, 0.2 
M). The reaction was complete after 15 min. Purification via silica gel column chromatography 
(15% ether in hexanes) yielded the title product as a white solid. Run 1: 52 mg, 0.159 mmol, 
95% yield; Run 2: 55 mg, 0.167 mmol, 100% yield. 1H NMR (400 MHz, CDCl3) δ 7.26 (m, 1H, 
ArH), 7.20-7.00 (m, 8H, ArH), 6.89 (d, J = 7.1 Hz, 2H, ArH), 6.65 (m, 2H, ArH), 6.40 (dd, J = 
2.2 and 7.4 Hz, 1H, ArH), 5.00 (d, J = 16.0 Hz, 1H, NCHPh), 4.48 (d, J = 16.0 Hz, 1H, NCHPh), 
                                                
10. Miller, B.; Shi, X. J. Org. Chem. 1992, 57, 1677. 
 









3.25 (d, J = 13.0 Hz, 1H, CHPh), 3.12 (d, J = 13.0 Hz, 1H, CHPh), 1.54 (s, 3H, CH3). 13C NMR 
(100 MHz, CDCl3) δ 179.8, 142.5, 136.4, 135.5, 133.2, 130.2, 128.7, 128.0, 127.9, 127.2, 126.8, 
126.6, 123.3, 122.3, 109.3, 50.3, 44.4, 43.5, 24.2. 
 
 1-(tert-Butyl)-2-methoxybenzene.12 The general procedure was followed using 
catalyst 12 (10.0 mg, 0.017 mmol, 0.1 equiv), 2-tert-butylphenol (26 µL, 0.167 
mmol, 1.0 equiv) and methyl iodide (52 µL, 0.85 mmol, 5.0 equiv) in toluene (0.85 mL, 0.2 M). 
The reaction was complete after 1 hr. Purification via silica gel column chromatography (5% 
ether in hexanes) yielded the title product as a clear oil. Run 1: 25 mg, 0.152 mmol, 91% yield; 
Run 2: 26 mg, 0.158 mmol, 95% yield. 1H NMR (400 MHz, CDCl3) δ 7.18 (dd, J = 6.4 and 7.6 
Hz, 1H, ArH), 7.15 (m, 1H, ArH), 6.88 (m, 2H, ArH), 3.83 (s, 3H, OCH3), 1.37 (s, 9H, 
ArC(CH3)3). 13C NMR (100 MHz, CDCl3) δ 158.7, 138.4, 127.1, 126.7, 120.4, 111.7, 55.1, 34.9, 
29.9. 
 
Other phase transfer-catalyzed reactions 
 
Phase transfer catalyst 12 (10.0 mg, 0.017 mmol, 0.1 equiv) and benzyl bromide (20 µL, 0.167 
mmol, 1.0 equiv) were dissolved in isopropyl acetate (0.85 mL, 0.2 M) in a 1-dram reaction vial 
(VWR catalog no. 66011-041). Sodium azide (16.3 mg, 0.251 mmol, 1.5 equiv) was then added 
to the reaction vial. A 10x3 mm (VWR catalog no. 58948-375) stir bar was added to the vial and 
                                                
12. Clayden, J.; Stimson, C. C.; Keenan, M. Chem. Commun. 2006, 1393. 
 












the reaction mixture was stirred at 350 rpm at room temperature. Reaction progress was 
monitored by 1H NMR spectroscopy using methylene chemical shifts. Upon complete 
consumption of benzyl bromide, benzyl ether standard (0.0418 mmol, 0.25 equiv) in an 
isopropyl acetate stock solution was added to the reaction mixture. Reaction yield of benzyl 
azide was then determined by 1H NMR spectroscopy using benzyl ether as the standard 
(integration of methylene protons of benzyl ether verse methylene protons of benzyl azide).13 
The reaction was run in duplicate and the reported yields are the average of the two results. In 
the absence of catalyst, no background reaction was observed. Run 1: 89% yield; Run 2: 100% 
yield. An example 1H NMR spectrum used for this determination is provided below.  
 
 
Phase transfer catalyst 12 (10.0 mg, 0.017 mmol, 0.1 equiv) and 1-phenylethanol (40 µL, 0.334 
mmol, 1.0 equiv) were dissolved in methylene chloride (1.0 mL, 0.3 M) in a 2-dram reaction vial 
(VWR catalog no. 66011-085). Sodium hypochloride solution (bleach, 9% in H2O, 1.1 mL) was 
then added to the reaction vial. A 10x3 mm (VWR catalog no. 58948-375) stir bar was added to 
the vial and the reaction mixture was stirred at 350 rpm at room temperature. Reaction progress 
was monitored by 1H NMR spectroscopy. Upon complete consumption of alcohol, the reaction 
mixture was diluted with water (5 mL) and extracted with dichloromethane (3 x 3 mL). The 
extracted organics were dried with sodium sulfate and concentrated in vacuo to a crude oil. This 
oil was passed through a short silica gel plug with diethyl ether; concentration of this solution 
                                                







CH2Cl2, NaOCl, 23 °C
30 h, 69% yield
OH O
 456 
yielded pure acetophenone as a colorless liquid. The reaction was run in duplicate and the 
reported yield is the average of the two results. In the absence of catalyst, no background 
reaction was observed (>5% conversion). Run 1: 26 mg, 0.216 mmol, 65% yield; Run 2: 29 mg, 
0.241 mmol, 72% yield. 1H NMR (400 MHz, CDCl3) δ 7.95 (m, 2H, ArH), 7.55 (t, J = 7.4 Hz, 
1H, ArH), 7.45 (m, 2H, ArH), 2.61 (s, 3H, CH3). 13C NMR (100 MHz, CDCl3) δ 198.2, 137.2, 
133.2, 128.6, 128.4, 26.7. 
 
 
Phase transfer catalyst 12 (36 mg, 0.060 mmol, 0.1 equiv) and powdered KOH (175 mg) were 
added to a 1-dram reaction vial (VWR catalog no. 66011-041). Next, methylene chloride (0.20 
mL) and styrene (70 µL, 0.60 mmol, 1.0 equiv) were added followed by chloroform (0.30 mL). 
A 10x3 mm (VWR catalog no. 58948-375) stir bar was added to the vial and the reaction mixture 
was stirred at 350 rpm at room temperature. After four hr, another batch of phase transfer 
catalyst X (36 mg, 0.060 mmol, 0.1 equiv) was added and the reaction was stirred overnight. 
After a total reaction time of 16 hr, the reaction was diluted with water (2 mL) and extracted with 
dichloromethane (3 x 2 mL). The extracted organics were concentrated in vacuo and the 
resulting crude oil was purified by silica gel column chromatography (5% ether in hexanes 
eluent) to yield the title product as a colorless oil (100 mg, 0.535 mmol, 89% yield).14 1H NMR 
(400 MHz, CDCl3) δ 7.40-7.20 (m, 5H, ArH), 2.93 (dd, J = 8.5 and 10.6 Hz, 1H, PhCH), 1.98 
                                                
14. Chien, C.-T.; Tsai, C.-C.; Tsai, C.-.; Chang, T.-Y.; Tsai, P.-K.; Wang, Y.-C.; Yan, T.-H. J. 











16 h, 89% yield
 457 
(dd, J = 7.4 and 10.6 Hz, CH), 1.85 (dd, J = 7.4 and 8.5 Hz, 1H, CH). 13C NMR (100 MHz, 
CDCl3) δ 134.7, 128.9, 128.4, 127.7, 60.9, 35.6, 25.8. 
 
Epoxide-opening catalyst screen (Table 3) 
Catalyst (0.05 mmol, 0.025 equiv) and 1,2-epoxybutane (0.17 mL, 1.98 mmol, 1.0 equiv) were 
dissolved in tetrahydrofuran (10 mL, 0.2 M) in a 25 mL round bottom flask. Phenyl acetyl 
chloride (0.260 mL, 1.98 mmol, 1.0 equiv) was then added and the reaction was stirred at room 
temperature. Reaction progress was monitored by 1H NMR spectroscopy. Upon complete 
consumption of 1,2-epoxybutane, a stock solution containing benzyl ether (0.500 mmol, 0.25 
equiv) was added to the reaction mixture. Yields were determined by 1H NMR chemical shifts of 
benzyl ether and epoxide-opened product. Regioselectivity of the epoxide opening was 
determined by 1H NMR integration; see assignment of Table X, entry 1 below for details.  
 
Substrate scope for chloroesterification of epoxides (Table 4) 
 
General procedure. Cyclopropenium catalyst 7 (25.3 mg, 0.05 mmol, 0.025 equiv) and epoxide 
(1.98 mmol, 1.0 equiv) were dissolved in tetrahydrofuran (10 mL, 0.2 M) in a 25 mL round 
bottom flask. Acid chloride (2.00 mmol, 1.0 equiv) was then added and the reaction was stirred 
at room temperature. Reaction progress was monitored by 1H NMR spectroscopy. Upon 
complete consumption of epoxide, the reaction was concentrated in vacuo and the crude oil was 






















 1-Chlorobutan-2-yl 2-phenylacetate and 2-chlorobutyl 2-
phenylacetate. The general procedure was followed using 1,2-epoxybutane (0.170 mL, 1.98 
mmol, 1.0 equiv) and phenyl acetyl chloride (0.31 mL, 2.35 mmol, 1.20 equiv). After 4 hr, the 
reaction was purified using a 2.5% ether in hexanes eluent. The title product was isolated as a 
6.6:1 ratio of regioisomers as a clear oil (0.302 g, 1.33 mmol, 68% yield). 1H NMR (500 MHz, 
CDCl3) δ 7.25-7.35 (m, 5H, ArH), 4.98 (m, 1H, ClCH2CH), 4.25* (d, J = 6.0 Hz, 2H, 
CH3CH2CHClCH2), 3.54-3.63 (m, 2H, ClCH2), 3.60 (s, 2H, ArCH2), 1.65-1.75 (m, 2H, 
CH3CH2R), 1.03* (t, J = 7.3 Hz, 3H, CH3CH2R), 0.87 (t, J = 7.4 Hz, 3H, CH3CH2R); 13C NMR 
(125 MHz, CDCl3) δ 171.0, 133.9, 129.2, 128.5 127.1, 74.4, 67.5*, 60.5*, 45.1, 41.3, 41.1, 
27.7*, 24.5, 10.4*, 9.2. *Denotes minor regioisomer. IR (thin film, cm-1) 3032, 2972, 1734, 
1497, 1455, 1244, 1136, 975, 709, 695. HRMS (FAB+) m/z = 227.0833; calcd for C12H15ClO2 
[M+1]+ 227.0761.  
 
 1,3-Dichloropropan-2-yl 2-phenylacetate. The general procedure was followed 
using epichlorohydrin (0.150 mL, 1.92 mmol, 1.0 equiv) and phenyl acetyl chloride (0.77 mL, 
5.76 mmol, 3.0 equiv). Pyridine (0.160 mL, 1.92 mmol, 1.0 equiv) was also added to the reaction 
solution. After 3 hr, the reaction was purified using a 2.5% ether in hexanes eluent. The title 
product was isolated as a clear oil (0.432 g, 1.75 mmol, 91% yield). 1H NMR (500 MHz, CDCl3) 
δ 7.26-7.35 (m, 5H, ArH), 5.19 (qt, J = 5.2 Hz, 1H, ClCH2CH), 3.70-3.77 (m, 4H, ClCH2), 3.69 
(s, 2H, ArCH2); 13C NMR (125 MHz, CDCl3) δ 170.5, 133.3, 129.3, 128.7, 127.4, 72.1, 42.4, 
41.0. IR (thin film, cm-1) 3032, 2968, 1741, 1497, 1455, 1431, 1241, 1136, 1028, 695. HRMS 











 1-(Allyloxy)-3-chloropropan-2-yl 2-phenylacetate. The general procedure 
was followed using allyl glycidyl ether (0.230 mL, 1.94 mmol, 1.0 equiv) and phenyl acetyl 
chloride (0.77 mL, 5.82 mmol, 3.0 equiv). Pyridine (0.160 mL, 1.94 mmol, 1.0 equiv) was also 
added to the reaction solution. After 2 hr, the reaction was purified using a 2.5% ether in hexanes 
eluent. The title product was isolated as a clear oil (0.388 g, 1.44 mmol, 74% yield). 1H NMR 
(300 MHz, CDCl3) δ 7.26-7.35 (m, 5H, ArH), 5.75-5.90 (m, 1H, CH2CHR), 5.14-5.28 (m, 3H, 
CH2CHCH2OCH2CH), 3.97 (m, 2H, CH2CHCH2), 3.60-3.77 (m, 6H, ArCH2, ClCH2CHRCH2); 
13C NMR (125 MHz, CDCl3) δ 170.9, 170.7, 134.2, 134.1, 133.6, 129.3, 129.2, 129.0, 128.6, 
127.2, 117.5, 117.3, 72.3, 72.1, 70.5*, 68.1, 65.1*, 56.1*, 42.7, 41.2 (* denotes minor isomer). 
IR (thin film, cm-1) 2865, 1738, 1455, 1245, 1135, 1049, 926, 709, 695. HRMS (FAB+) m/z = 
269.0941; calcd for C14H17ClO3 [M+1]+ 269.0866. 
 
 1-Chlorohex-5-en-2-yl 2-phenylacetate. The general procedure was followed 
using 1,2-epoxy-5-hexene (0.220 mL, 1.96 mmol, 1.0 equiv) and phenyl acetyl chloride (0.31 
mL, 2.35 mmol, 1.20 equiv). After 5 hr, the reaction was purified using a 2.5% ether in hexanes 
eluent. The title product was isolated as a clear oil (0.320 g, 1.27 mmol, 65% yield). 1H NMR 
(300 MHz, CDCl3) δ 72.5-7.31 (m, 5H, ArH), 5.67-5.80 (m, 1H, CH2CHR), 4.93-5.10 (m, 3H, 
CH2CHCH2CH2CH), 3.86 (s, 2H, ArCH2), 3.53-3.67 (m, 2H, ClCH2), 2.03 (q, J = 7.1, 2H, 
CH2CHCH2), 1.73-1.81 (m, 2H, CH2CHCH2CH2); 13C NMR (125 MHz, CDCl3) δ 170.9, 170.8, 
137.0, 136.6, 133.8, 129.2, 129.1, 128.5, 127.1, 115.9, 115.5, 72.6, 67.6*, 58.2*, 45.5, 41.3, 41.1, 
33.6*, 30.6, 30.0*, 29.1 (* denotes minor isomer). IR (thin film, cm-1) 2922, 1735,1497, 1455, 








 2-Chloro-1-phenylethyl 2-phenylacetate and 2-chloro-2-
phenylethyl 2-phenylacetate. The general procedure was followed using styrene oxide (0.220 
mL, 1.93 mmol, 1.0 equiv) and phenyl acetyl chloride (0.77 mL, 5.79 mmol, 3.0 equiv). Pyridine 
(0.160 mL, 1.93 mmol, 1.0 equiv) was also added to the reaction solution. After 3 hr, the reaction 
was purified using a 30% ether in hexanes eluent. The title product was isolated as a 1.9:1 ratio 
of regioisomers as a clear oil (0.504 g, 1.83 mmol, 95% yield). 1H NMR (500 MHz, CDCl3) δ 
7.20-7.35 (m, 10H, ArH), 5.97 (dd, J = 8, 4.5 Hz, 1H, ClCH2CH), 5.05* (t, J = 6.3, 1H, ClCH), 
4.43-4.51* (m, 2H, ClCHCH2), 3.68-3.79 (m, 2H, ClCH2), 3.62 (s, 2H, ArCH2); 13C NMR (125 
MHz, CDCl3) δ 169.9, 170.3*, 137.5, 137.0, 133.6*, 129.5, 129.1, 128.8, 128.8, 128.7, 128.6, 
128.6, 128.5, 128.5, 127.4, 127.2, 126.6, 75.4*, 68.0, 59.4*, 46.5, 41.3*, 41.1. *Denotes minor 
regioisomer. IR (thin film, cm-1) 3032, 2959, 1738, 1496, 1454, 1247, 1139, 724, 694. HRMS 
(FAB+) m/z = 275.0833; calcd for C16H15ClO2 [M+1]+ 275.0761. 
 
trans-2-Chlorocyclohexyl 2-phenylacetate. The general procedure was followed 
using cyclohexene oxide (0.20 mL, 1.97 mmol, 1.0 equiv) and phenyl acetyl 
chloride (0.31 mL, 2.35 mmol, 1.20 equiv). After 2 hr, the reaction was purified using a 2.5% 
ether in hexanes eluent. The title product was isolated as a clear oil (0.318 g, 1.26 mmol, 64% 
yield). 1H NMR (300 MHz, CDCl3) δ 7.25-7.60 (m, 5H, ArH), 4.83 (m, 1H, ArCH2COOCH), 
3.81-3.89 (m, 1H, ClCH), 3.65 (s, 2H, ArCH2), 0.88-2.22 (m, 8H, -CH2- x 4); 13C NMR (100 
MHz, CDCl3) δ 170.4, 133.9,129.1, 128.4, 126.9, 76.0, 60.3, 41.3, 34.5, 30.3, 24.2, 23.0. IR (thin 
film, cm-1) 2942, 2864, 1735, 1497, 1453, 1252, 1218, 1150, 1027, 706, 695. HRMS (FAB+) 










trans-2-Chlorocyclohexyl acetate.15 The general procedure was followed using 
cyclohexene oxide (0.20 mL, 1.97 mmol, 1.0 equiv) and acetyl chloride (0.170 
mL, 2.35 mmol, 1.20 equiv). After 24 hr, the reaction was purified using a 2.5% ether in hexanes 
eluent. The title product was isolated as a clear oil (0.173 g, 0.98 mmol, 50% yield). 1H NMR 
(400 MHz, CDCl3) δ 4.80 (m, 1H, CH3COOCH), 3.83, (m, 1H, ClCH), 2.10 (s, 3H, CH3), 1.34-
2.27 (m, 8H, -CH2- x 4); 13C NMR (100 MHz, CDCl3) δ 170.1, 75.9, 60.8, 34.9, 30.8, 24.6, 23.3, 
21.1. 
 
Substrate scope for carbon dioxide fixation with epoxides (Table 5) 
 
General procedure. Cyclopropenium catalyst 7 (0.10 equiv) and epoxide (1.0 mL, 1.0 equiv) 
were added to a 2-dram vial fitted with a septum screw cap. Carbon dioxide was then bubbled 
through the epoxide solution for 15 minutes before the reaction vial was heated to 75 °C under a 
carbon dioxide atmosphere (1 atm balloon). Upon complete consumption of epoxide, determined 
by 1H NMR spectroscopy, the reaction mixture was directly purified by silica gel column 
chromatography to yield pure product. See below for substrate specific details.  
 
 4-Butyl-1,3-dioxolan-2-one. 16  The general procedure was followed using 
cyclopropenium chloride (105 mg, 0.207 mmol, 0.025 equiv) and 1,2-epoxyhexane 
                                                

















(1.0 mL, 8.29 mmol, 1.0 equiv). After 48 hr, the reaction was purified using a 10% ether in 
hexanes eluent. The title product was isolated as a white solid (0.855 g, 5.93 mmol, 72% yield). 
1H NMR (400 MHz, CDCl3) δ 4.72 (dt, J = 2.0 and 5.6 Hz, 1H, CHO), 4.52 (t, J = 8.2 Hz, 
CHO), 4.08 (t, J = 8.0 Hz, 1H, CHO), 1.80 (m, 1H, CHCHO), 1.70 (m, 1H, CHCHO), 1.50-1.30 
(m, 4H, 2 x –CH2-), 0.95 (t, J = 6.7 Hz, 3H, CH3). 13C NMR (100 MHz, CDCl3) δ 155.2, 77.1, 
69.4, 33.4, 26.4, 22.2, 13.7. 
 
 4-Phenyl-1,3-dioxolan-2-one.16 The general procedure was followed using 
cyclopropenium chloride (111 mg, 0.219 mmol, 0.025 equiv) and styrene oxide (1.0 
mL, 8.77 mmol, 1.0 equiv). After 20 hr, the reaction was purified using a 10% ether in hexanes 
eluent. The title product was isolated as a white solid (1.29 g, 7.86 mmol, 90% yield). 1H NMR 
(500 MHz, CDCl3) δ 7.45 (m, 3H, ArH), 7.35 (m, 2H, ArH), 5.65 (t, J = 8.0 Hz, 1H, CHPh), 
4.78 (t, J = 8.4 Hz, 1H, CHO), 4.34 (t, J = 7.9 Hz, 1H, CHO). 13C NMR (125 MHz, CDCl3) δ 
154.9, 136.0, 129.9, 129.4, 126.0, 78.1, 71.3. 
 
 4-((Allyloxy)methyl)-1,3-dioxolan-2-one. 17   The general procedure was 
followed using cyclopropenium chloride (107 mg, 0.211 mmol, 0.025 equiv) and 
allyl glycidyl ether (1.0 mL, 8.43 mmol, 1.0 equiv). After 36 hr, the reaction was 
purified using a 10% ether in hexanes eluent. The title product was isolated as a white solid (1.18 
g, 7.49 mmol, 89% yield). 1H NMR (400 MHz, CDCl3) δ 5.89 (m, 1H, C=CH), 5.32-5.20 (m, 
                                                                                                                                                       
16. Whiteoak, C. J.; Henseler, A. H.; Ayats, C.; Kleij, A. W.; Pericàs, M. A. Green Chem. 2014,  
16, 1552. 
 










2H, C=CH2), 4.81 (m, 1H, CHO), 4.50 (t, J = 8.4 Hz, 1H, OCHCH=CH2), 4.40 (dd, J = 6.1 and 
8.4 Hz, 1H, OCHCH=CH2), 4.05 (m, 2H, CH2O), 3.65 (qd, J = 3.8 and 11.0 Hz, 2H, 
CH2OAllyl). 13C NMR (100 MHz, CDCl3) δ 156.2, 133.8, 118.1, 75.1, 72.7, 68.9, 66.4.  
 
 Hexahydrobenzo[d][1,3]dioxol-2-one.16 The general procedure was followed using 
cyclopropenium chloride (125 mg, 0.247 mmol, 0.025 equiv) and cyclohexene oxide (1.0 
mL, 9.88 mmol, 1.0 equiv). After 7 d, the reaction was purified using a 10% ether in hexanes 
eluent. The title product was isolated as a white solid (388 mg, 2.73 mmol, 28% yield). 1H NMR 
(400 MHz, CDCl3) δ 4.70 (m, 2H, CHO), 1.90-1.10 (m, 8H, CyH). 13C NMR (100 MHz, CDCl3) 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































	   502 
Chapter 6 
Additional Explorations Using Aromatic Ions as Design Elements 
 
Introduction 
This thesis has thus far documented the use of aminocyclopropenium ions as components 
of a new class of chiral Brønsted base catalyst and as onium-like phase transfer and epoxide 
opening catalysts. Other members of the Lambert Group have built upon these results in order to 
further expand these developments and their efforts are summarized in this chapter. Also 
discussed below, in collaboration with the Campos group at Columbia University, we have 
developed a broad research program studying the synthesis, characterization and application of 
polymeric materials that contain aminocyclopropenium ions as a signature empowering feature. 
Lastly, the discovery and study of reversible fulvene formation in the context of a new mode of 
catalysis is described. 
 
Cyclopropenimines 
After the initial developments discussed in Chapter 3, the Lambert group expanded its 
efforts toward continuing the development of 2,3-bis(dialkylamino)cyclopropenimine Brønsted 
base chemistry. We recognized immediately that the straightforward and experimentally trivial 
synthesis of cyclopropenimine bases inherently provides an impetus for widespread application 
of this new class of Brønsted base. Furthermore, the modularity of the cyclopropenimine scaffold 
readily allows for steric and electronic tunability as well as chirality and functional group 
incorporation. Members of the Lambert Group thus set out to explore the potential of 
cyclopropenimine bases in a variety of contexts, including (a) the use of achiral 
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cyclopropenimines for general reaction promotion; (b) cyclopropenimines as components of 
higher analogue superbases; and (c) the continued development of chiral cyclopropenimine 
catalysis. 
 
Achiral cyclopropenimine bases. In many contexts, the use of organic Brønsted bases has 
advantages over the use of inorganic bases such as metal alkoxides, amides and hydrides.1 
Organic Brønsted bases are generally compatible with air and moisture, operate in a range of 
organic solvents and are storable, shelf-stable reagents. Furthermore, unlike inorganic bases, 
organic bases lack a coordinating ion that can often interfere with the desired reaction pathway. 
Indeed, organic Brønsted bases are widely employed for the preparation of complex molecules, 
ranging from natural products to polymeric materials.2 While the advantages of organic Brønsted 
bases are well appreciated, the continued development of new and stronger Brønsted base 
reagents remains a constant challenge. 
Highlighted in Chapter 2, amidines, guanidines, proazaphosphatranes and phosphazenes 
are functional groups that can possess potent basicities (pKBH+ > 22 in MeCN) and are generally 
classified as “superbases.” Among these, the cyclic amidine DBU, acyclic guanidine BTMG, 
cyclic guanidine TBD, and acyclic phosphazene P1-tBu, are among the most commonly 
employed Brønsted base reagents in organic synthesis (Figure	  1).3 Often used as stoichiometric 
reagents, these bases promote eliminations, substitutions, additions and rearrangements of many 
substrate classes (commonly those with pKa <26 in MeCN). Despite their documented success, 
several limitations remain that have prevented organic bases from even greater widespread use. 
For example, simple bicyclic amidines (DBU) and guanidines (TBD) only reach pKBH+ levels 
around 26.0 (MeCN); furthermore, these bicyclic bases are not sterically hindered and 
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addition/substitution of the bases often competes with desired deprotonation reaction pathways.4 
Stronger Brønsted bases, such as proazaphosphatranes and phosphazenes, are expensive reagents 
that require three to five reaction steps for their preparation.5 To address these limitations, 
members of the Lambert Group have been working toward developing simple achiral 2,3-
bis(dialkylamino)cyclopropenimines for use as general Brønsted base reagents (Figure	  1). 
 
 
Figure 1. Cyclopropenimine 1 as a general achiral Brønsted base. 
 
Chapter 3 documented my work toward the general development and understanding of 
2,3-bis(dialkylamino)cyclopropenimine Brønsted base chemistry in the context of asymmetric 
glycinate imine Michael reactions. Armed with this knowledge, graduate student Allison Griffith 
of the Lambert Lab has studied cyclopropenimine 1 as a general Brønsted base in a range of 
reaction contexts. Notably, 1 has been prepared on a 20 gram scale (95% yield) and is a bench-
stable solid that is not prone to decomposition (unlike our chiral cyclopropenimine catalysts, see 
Chapter 3, Catalyst Stability). A few highlights of Allison’s work with this cyclopropenimine are 
provided in Scheme 1. Cyclopropenimine 1 promotes the methylation of phenol (Scheme 1a) and 
catalyzes the addition of diethyl phosphite to cyclohexanone (Scheme 1b), both in excellent 
yields. For comparison, widely used bases, such as BTMG, DBU and NaOH, have little or no 
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Despite the Aldol reaction being one of the most important and widely studied reactions 
in organic chemistry6, few examples of organic Brønsted base-catalyzed reactions of simple 
aldehydes are known.7 The lack of reported reactivity is likely a consequence of the inability of 
most organic Brønsted bases, including DBU and BTMG, to deprotonate and activate simple 
aldehydes. Early in our cyclopropenimine chemistry, we discovered that Aldol additions and 
condensations of propionaldehyde could be promoted by a variety of cyclopropenimine bases. 
With propionaldehyde, Allison has thus shown that catalyst 1 selectively promotes Aldol 
additions in diethyl ether solvent and Aldol condensations in ethanol solvent (Scheme 1c). These 
results highlight the advantages of 1 over commonly used Brønsted base reagents and suggest 
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Higher analogue cyclopropenimine bases. In Chapter 2, the combination of multiple 
superbasic functional groups into higher analogue Brønsted bases was discussed within the 
context of guanidines and phosphazenes. Inspired by this strategy, Lambert Group graduate 
student Eric Nacsa has begun to incorporate the cyclopropenimine functional group into a range 
of higher order Brønsted bases. With the goal of developing some of the strongest known organic 
Brønsted bases while retaining synthetic scalability and modularity, Eric has synthesized the 
cyclopropenimine acid salts shown in Figure	   2. The pKBH+ of these compounds are yet to be 
determined, however it is expected that some of these higher analogue cyclopropenimines will 
possess basicities that rival P2 and P3 phosphazenes.8 It is worth noting that triscyclopropenimine 
10 was synthesized in a straightforward three-step procedure from pentachlorocyclopropane; 
thus, compared to higher analogue phosphazenes, the cyclopropenimine platform may allow for 
large-scale trivial preparation of these very basic compounds. The synthesis of other analogues 
and their application for Brønsted base chemistry is ongoing work in the Lambert Lab. 
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Continued use of chiral cyclopropenimine catalysts. Building on the work detailed in 
Chapters 3 and 4, other members of the Lambert Group have continued to explore the potential 
of chiral cyclopropenimine 17 in asymmetric catalysis. Allison Griffith has demonstrated that 17 
can catalyze the asymmetric Aldol addition of glycinate imine 14 to hydrocinnamaldehyde (15) 
in good yields with moderate levels of selectivity (Scheme	  2a). Graduate student Lea Benkoski 
also used cyclopropenimine 17 as a stoichiometric base for the asymmetric alkylation of 
glycinate imine 14 (Scheme	   2b). Only low levels of selectivity were obtained; efforts toward 
increasing selectivity and rendering this reaction catalytic have thus far been unsuccessful. 
Lastly, the production of quaternary stereocenters in the Michael reaction of alanine and 
phenylglycine imines (20) catalyzed by 17 has shown promising initial results (Scheme	   2c). 
Further efforts, especially through catalyst modification, are ongoing in order to increase 
selectivity levels of these important reactions that produce valuable α-amino acid derivatives.9 In 
Chapter 3, we discovered that the nitrogen atom in glycinate imine substrate 14 was not critical 
for achieving high selectivity in cyclopropenimine-catalyzed reactions. This opened the 
possibility of moving away from this substrate class; thus, graduate student Zara Seibel has 
developed a highly asymmetric Michael reaction between β,γ-unsaturated ester 23 and methyl 
acrylate (Scheme	  2d). 
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Scheme 2. Examples of chiral cyclopropenimine 17-catalyzed reactions. 
 
The conjugate addition of heteroatoms to electron deficient alkenes represents an 
important method for the preparation of N-, O- and S-β-substituted acid derivatives. 10 
Asymmetric variants of these reactions are difficult and are less developed than carbon-based 
Michael additions. In this regard, we have begun to study chiral cyclopropenimines as catalysts 
for asymmetric heteroatom conjugate additions. Graduate student Shane Deighton used 
cyclopropenimine 17 to add benzotriazole (25) to 3-hepten-2-one (26) in moderate yields and 
selectivity (Scheme	  3a). An intramolecular oxa-Michael to assemble the chromane skeleton in 
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series of cyclopropenimine derivatives in attempt to optimize the reaction shown in Scheme	  3, 
although no improvement was observed. More recently, we have continued our collaboration 
with Professor Vetticatt in an effort to understand this oxa-Michael reaction through 
computational modeling. The asymmetric reactions demonstrated in this section clearly 
demonstrate that chiral cyclopropenimines have the potential to find widespread application for 
the synthesis of a range of optically enriched compounds. 
 
 
Scheme 3. Heteroatom conjugate additions catalyzed by 17. 
 
Tris(dialkylamino)cyclopropenium Cationic Polymers and Materials  
Electronically charged materials have emerged as a promising new class of materials with 
potential widespread applications in catalysis12, gas separation13, drug delivery capsules14, fuel 
cell membranes15 and water purification.16 These materials have traditionally been prepared 
through the mixing/swelling of neutral organic polymers with small molecule ionic liquid 
solvents. Once prepared, these mixed materials serve as pseudo-electrolyte polymers; however, 
as the electronically charged species is not covalently bound to the polymer, electrolyte leakage 
from these systems is a common and unavoidable problem.17 Polymerized ionic liquids (PILs) 
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liquids, such as low flammability, chemical and thermal stability and potential widely tunable 
physical properties, while avoiding the possibility of electrolyte leakage from their polymeric 
structure.18 Most commonly, imidazolium-based PILs have been studied, although examples of 
ammonium- and phosphonium-derived PILs exist.19 Unfortunately, a lack of simple tunability 
(steric and electronic) of these functional groups has made the optimization of their structures 
and properties a difficult and cumbersome process. There is thus a high demand and clear 
potential for new classes of stable PILs that are built upon a foundation of robust synthetic 
chemistry. 
Especially with regard to synthetic modularity, but also in terms of performance, the 
inventions described in this thesis thus far have routinely highlighted the benefits of using 
aminocyclopropenium ions as a central design element in a range of applications. We recognized 
early in our work that the high stability of aminocyclopropenium cations coupled with their 
scalable synthesis made them ideal candidates for components of stable cationic polymers. We 
thus began a collaboration with Professor Campos at Columbia University in 2011 to develop a 
general method for the synthesis of cyclopropenium-based cationic polymers. After initial work 
for about six months, students from the Campos Group, including Emma Dell, Jessica Fryer, 
Yivan Jiang and Chris Torsitano, joined in our efforts to arrive at a programmable method for the 
scalable synthesis of aminocyclopropenium-based polymers. After initial development, my 
involvement in this project has primarily been the design and synthesis of cyclopropenium 
monomers. Some highlights of this project are summarized below. 
We first developed tris(dialkylamino)cyclopropenium (TDAC) monomers that featured a 
single handle for polymerization that could lead to linear polymers (Figure	   3). The first 
important structural optimization was the discovery that styrenyl-based TDAC monomers 
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polymerized more reliably than methacryloyl-based TDAC monomers. Second, as a result from 
some of the work detailed in Chapters 3 and 5, we selected dicyclohexylamino, 
diisopropylamino and morpholino as three variable 2,3-dialkylamino groups for the TDAC 
monomers. Notably, the different polarities of these 2,3-dialkylamino groups serve to modulate 
the solubility and segregation/assembly properties of the TDAC polymers. These monomers can 
be synthesized in gram-scale batches and generally only require simple washing for purification. 
 
 
Figure 3. Monomer platform for TDAC-based polymers. 
 
Jessica Fryer and Yivan Jiang then developed efficient methods to polymerize TDAC 
monomers into homopolymers, block copolymers with polystyrene, and random copolymers 
with styrene (Figure	  4).20 For the block copolymers depicted in Figure	  4b, materials with TDAC 
composition between 25-50% (TDAC monomer/styrene) have been prepared. All polymers were 
then fully characterized by determining their molecular mass, percent TDAC incorporation (for 
31 and 32), glass transition temperature, decomposition temperature and solubilities in a range of 
solvents. Additionally, small angle X-ray scattering revealed short ordering in the block 
copolymers of type 31.21 Spencer Brucks, a graduate student in the Campos Group, has shown 
that thin films of these materials self-assemble into a highly ordered morphology via solvent 
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ordering is observed where the matrix consists of the cyclopropenium ion domain. The specific 
properties of the ordering can be controlled by the volume fraction of TDAC in the polymer as 
well as the chosen film processing conditions. Control over the self-assembly of PILs is critical 
for their application as fuel cell membranes. In this regard, the Campos Group has already 
observed that many of the TDAC-based polymers exhibit excellent ion conductivity.21 These and 




Figure 4. Classes of TDAC polymers. 
 
We have additionally prepared TDAC monomers that feature multiple polymerizable 
handles that allow for the production of cross-linked polymers. An example, 
tris(diallylamino)cyclopropenium chloride (33), is shown in Scheme	   4. This ionic liquid 
monomer has been synthesized in over 25-gram scale, and its click-polymerization with a 
polythiol (34) to produce freestanding polymer films has also been achieved on scale. Unlike the 
linear polymers previously discussed, these cross-linked polymers are not soluble in solvents and 
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membranes. Indeed, initial studies have revealed these polymers to be excellent ion conductors.21 
Further study of these cross-linked polymers is ongoing, including their possible employment as 
water purification membranes.  
 
 
Scheme 4. Synthesis of TDAC cross-linked polymers. 
 
Reversible Fulvene Formation22 
Alkylidene cyclopentadienes (fulvenes) have been studied for over a century for their 
interesting physical properties, use as organometallic ligands, and their synthetic utility.23 The 
most distinguishing property of fulvenes is the high polarization of the exocyclic olefin and the 
consequent electropositive character of the 6-position (Figure	  5a). This polarization is attributed 
to the aromatic character of the zwitterionic resonance structure of fulvenes. The polarization of 
the exocyclic olefin resembles that of carbonyls and unsurprisingly fulvenes undergo 
nucleophilic attack at the 6-position.24 In addition, fulvenes can be deprotonated to produce vinyl 
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Figure 5. Properties of fulvenes. 
 
Given this polarization and reactivity, we envisioned that reversible fulvene formation 
could serve as a means for catalytic carbonyl activation (Figure	   6). Fulvene formation is 
commonly achieved by a Knoevengal condensation between a cyclopentadiene and a carbonyl.26 
However, only one example of fulvene cleavage, which required harsh conditions, had been 
reported prior to this work.27 Our lab therefore desired to develop mild conditions and to 
discover cyclopentadienes that would allow reversible fulvene formation with carbonyls. 
 
 
Figure 6. Mechanistic design for cyclopentadiene catalysis. 
 
We envisioned facile fulvene cleavage through the expulsion of a cyclopentadienyl anion 
could be possible with electron deficient cyclopentadienes. My studies began by observing facile 
cleavage of a fulvene by aminolysis to give an imine and a free cyclopentadiene. Treatment of 
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Scheme 5. Initial demonstration of reversible fulvene formation. 
 
After the initial findings, we began a substrate scope investigation of the effects of 
fulvene-imine interchange (Table	   1). The experiments reported were performed by examining 
(a) fulvene formation and (b) fulvene cleavage by 1H NMR and noting both the time required for 
the reaction mixture to reach a steady state as well as the ratio of fulvene to imine at that point. 
In some cases, a fulvene-imine equilibration occurred, while others displayed a more 
complicated fulvene-imine interchange. In Table	  1, several identifiable trends reveal themselves. 
Firstly, the aliphatic amines/imines of n-butylamine and cyclohexylamine promoted equilibration 
faster and had a smaller fulvene:imine ratio than the less nucleophilic aniline. Second, when 
altering the electronic profile of the imine aryl substituent, both electron-withdrawing (entry 4) 
and electron-donating (entry 5) substituents increased reaction time substantially. It was also 
observed that the cinnamaldehyde Schiff base greatly favored fulvene over imine (entry 6), likely 
due to the stability of the highly conjugated 6-vinylfulvene (entries 4-7 were performed by 
labmate Dr. Rockford Coscia). Lastly, we studied the equilibration ability of cyclopentadienes 
38-40.  Cyclopentadiene 38 underwent rapid interchange with aliphatic amines/imines (entries 9 
and 10). Again, aniline promoted interchange slowly (entry 8). We attribute this effect to the 
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cyclopentadiene 35. Cyclopentadiene 39 underwent fulvene-imine interchange, though no 
equilibration was observed with any imine. Cyclopentadiene 40, bearing only one electron-
withdrawing methyl carboxylate, displayed a slow fulvene-imine interchange that greatly 
favored fulvene over imine with aliphatic amines/imines (entries 15 and 16). These results 
suggest that cyclopentadienes/fulvenes bearing a single electron-withdrawing group represent the 
lower boundary of reactivity for facile fulvene equilibration with imines. 
 
Table 1. Substrate scope for reversible fulvene formation with imines. 
 
 
We further demonstrated fulvene-aldehyde interchange under basic aqueous conditions 
between cyclopentadiene 35 and benzaldehyde. Scheme	  6 shows that several THF/aqueous base 
solutions promoted both fulvene formation and fulvene cleavage, while apparently approaching 
equilibrium ratios. These results demonstrate the feasibility of fulvene formation and cleavage on 
aldehydes under mild conditions, which is necessary for cyclopentadiene catalysis.  The primary 
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future goal of this project is to apply reversible fulvene formation as a method to catalytically 
activate carbonyl compounds for a variety of chemical transformations. 
 
 
Scheme 6. Reversible fulvene formation with benzaldehyde in aqueous conditions. 
 
Conclusion 
 The use of aromatic ions as empowering design elements in a wide range of applications 
has been demonstrated throughout this thesis. Inspired by the rich history of aromatic ions in 
organic chemistry, we hypothesized that their simple synthesis, intriguing properties and 
exquisite tunability made aromatic ions ideal candidates for application-focused research. The 
majority of the work described herein utilized the high stability of aminocyclopropenium ions in 
a diverse range of technologies, including Brønsted base chemistry, phase transfer catalysis and 
polyelectrolyte materials. Across these domains the aminocyclopropenium ion derivatives not 
only outperformed many known systems, but it brought with it new design possibilities around 
its cyclopropenium architecture. In a general sense, the work in this thesis only hints at the 
potential these ions have and, as discussed in this chapter, work in this regard is continuing in the 
Lambert Lab. Furthermore, our lab is exploiting other aromatic ions, such as cyclopentadienyl 
anions, to develop similar research programs.  
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THF, 23 °C, 20 h
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Experimental Information 
All reactions were performed using oven-dried glassware under an atmosphere of dry 
argon. Non-aqueous reagents were transferred by syringe under argon. Organic solutions were 
concentrated using a Buchi rotary evaporator. Diethyl ether, tetrahydrofuran, and methylene 
chloride (CH2Cl2) were dried using a J.C. Meyer solvent purification system. Triethylamine 
(Et3N), aniline, cyclohexylamine, and n-butylamine were freshly distilled over CaH2 under 
argon. All other commercial reagents were used as provided. Flash column chromatographywas 
performed employing 32-63 µm silica gel (Dynamic Adsorbents Inc). Thin-layer 
chromatography (TLC) was performed on silica gel 60 F254 plates (EMD).  
1H and 13C NMR were recorded in CDCl3 on Bruker DRX-300, DRX-400, and DRX-500 
spectrometers as noted. Data for 1H NMR are reported as follows: chemical shift (d ppm), 
multiplicity (s = singlet, br s = broad singlet, d = doublet, t = triplet, q = quartet, m = multiplet), 
coupling constant (Hz), integration, and assignment. Data for 13C NMR are reported in terms of 
chemical shift. IR spectra were recorded on a Nicolet Avatar 370 DTGS (Thermo) using NaCl 
salt plates. High-resolution mass spectra were obtained from the Columbia University Mass 
Spectrometry Facility on JOEL JMSHX110 HF mass spectrometer using the indicated ionization 
mode. 
 
Synthesis of cyclopentadienes 
Dimethyl 4,5-diphenylcyclopenta-3,5-diene-1,3-dicarboxylate (35). To 150 mL anhydrous 
ethanol was added dimethyl 2-oxo-4,5-diphenylcyclopenta-3,5-diene-1,3-dicarboxylate1 (5.24g, 
15.0 mmol).  The solution was then cooled to 0 °C and NaBH4 was added portionwise over 10 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1. Moore, J. E.; York, M.; Harrity, J. P. A. Synlett, 2005, 5, 860–862. 
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min with stirring.  The reaction was allowed to continue stirring at this temperature for 15 min 
and was then quenched by addition of 100 mL of water.  The mixture was extracted with EtOAc 
(250 mL).  The organic layer was washed with brine, dried (MgSO4), and concentrated in vacuo. 
The crude alcohol was used in the following step without further purification. 
The crude alcohol was dissolved in THF (200 mL).  Acetic anhydride (2.13 mL, 22.5 
mmol), triethylamine (3.14 mL, 22.5 mmol), and 4-(dimethylamino)pyridine (0.183 g, 1.50 
mmol) were then added and the reaction was stirred at room temperature for 2 hr.  Water (150 
mL) was added and the reaction was extracted with EtOAc (200 mL × 3).  The combined organic 
layers were washed with brine, dried (MgSO4), and concentrated in vacuo.   The crude acetate 
was then used without further purification. 
The crude acetate from the previous step was dissolved in dichloromethane (200 mL) and 
1,8-Diazabicyclo[5.4.0]undec-7-ene (6.72 mL, 45 mmol) was added.  The reaction mixture was 
stirred at room temperature for 2 hr and then quenched by addition of 1M aqueous HCl (100 
mL).  This mixture was extracted with EtOAc (200 mL × 3).  The combined organic extracts 
were washed with brine, dried (Na2SO4), and concentrated in vacuo.  The crude oil was purified 
by flash chromatography (dichloromethane) and recrystallized twice from ether to yield the title 
compound (2.84 g, 8.49 mmol, 57% yield from ketone) as fine colorless crystals.  1H NMR (300 
MHz, CDCl3) δ 7.20 (m, 6H, ArH), 7.00 (m, 4H, ArH), 3.95 (s, 2H, CH2), 3.68 (s, 6H, 
CO2CH3); 13C NMR (75 MHz, CDCl3) 164.2, 156.2, 134.0, 133.8, 129.1, 127.8, 127.3, 51.4, 
43.1; IR (thin film) 1716, 1489, 1434, 1361, 1207, 1102, 1083, 1003, 741, 698 cm-1; HRMS 
(FAB+) m/z = 334.1205 calcd for C21H19O4 [M]+, found 334.1202. 
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Dimethyl 4,5,6,7-tetrahydro-1H-indene-2,3-dicarboxylate (38). To sodium hydride (7 g, 60% 
in mineral oil, 175 mmol) that had been washed with pentanes (40 mL x 3) was added 300 mL 
THF. The resulting suspension was cooled to 0 °C and freshly cracked cyclopentadiene (6.0 mL, 
80.4 mmol) was added via syringe. The reaction flask was warmed to room temperature and 
stirred for 10 minutes before cooling back to 0 °C.  After addition of 1,4-dibromobutane (9.6 
mL, 80.4 mmol), the solution was refluxed overnight. An additional equivalent of sodium 
hydride (3.08 g, 80.4 mmol) was added and the solution was further heated at reflux for 24 hr. 
The reaction mixture was quenched with H2O (250 mL) and extracted with EtOAc (200 mL × 3). 
The organic extracts were washed with brine, dried (Na2SO4), and concentrated in vacuo to give 
10.7 g of pale yellow oil. The crude oil was then used in the following step without further 
purification. 
The crude product from the previous step (10.7 g) was added to 100 mL THF containing 
5 g of activated 4Å mol sieves, and the resulting mixture was stirred at room temperature for 1 
hr.  The dried solution was cannulated into a flask containing an additional 200 mL THF, which 
was then cooled to –78 °C. After addition of n-butyllithium (35.4 mL of 2.5 M solution in 
hexanes, 88.5 mmol), the solution was warmed to room temperature and stirred for 30 min, then 
cooled back to –78 °C and treated with methyl chloroformate (6.8 mL, 88.5 mmol). The reaction 
solution turned purple as it was allowed to stir at room temperature for 36 hr, after which H2O 
(200 mL) was added. The resulting mixture was diluted with Et2O before being extracted with 1 
M NaOH (100 mL x 3). The combined aqueous phase was acidified to pH 1 and extracted with 
EtOAc (150 mL x 3). Concentration in vacuo yielded the title compound as a mixture of olefin 
isomers (600 mg, 2.54 mmol, 3% yield). NMR data is reported as the sodium salt of the title 
compound obtained by treatment with sodium hydride and extraction with water.  1H NMR (300 
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MHz, D2O) δ 6.42 (s, 1H, CpH), 3.70 (s, 3H, CO2CH3), 3.68 (s, 3H, CO2CH3), 2.66 (m, 2H, -
CH2-), 2.45 (m, 2H, -CH2-), 1.64 (m, 4H, 2 x -CH2-); 13C NMR (75 MHz, D2O) δ 169.5, 169.1, 
133.0, 122.9, 119.2, 109.5, 106.9, 50.8, 50.6, 25.5, 24.2, 23.9, 23.7; IR (thin film) 2948, 1739, 
1709, 1552, 1430, 1291, 1261, 1217, 1130 cm-1; HRMS (EI+) m/z = 236.1049 calcd for C13H16O4 
[M]+, found 236.1048. 
 
Dimethyl 3-(1-cyclohexylethyl)cyclopenta-1,3-diene-1,2-dicarboxylate (39). To a mixture of 
sodium (5.31 g, 230.9 mmol) in 200 mL THF at 0 °C was added 30 mL cyclopentadiene (401.8 
mmol). The resulting mixture was stirred at room temperature overnight, after which it was 
cooled to 0 °C, treated with methyl chloroformate (32.98 mL, 428.6 mmol), and then stirred for 2 
hr at room temperature. The reaction mixture was filtered through a celite plug and concentrated 
in vacuo to furnish a brown oil. Addition of Et2O (200 mL) resulted in precipitation of 6.50 g of 
a crude brown solid that contained 1,2-dicarboxymethylcyclopentadienyl anion as its sodium 
salt.  
The crude solid containing this cyclopentadienyl salt (3.00 g) was dissolved in 200 mL 
THF and cooled to –30 °C. Cyclohexanecarboxaldehyde (1.62 mL, 13.4 mmol) and 
cyclohexylamine (1.50 mL, 13.4 mmol) were added and the reaction mixture was allowed to stir 
for 2 hr. Acetic acid (10 mL) was added, and the resulting mixture was stirred for 30 min before 
warming to room temperature and stirring for an additional 15 min. The mixture was diluted with 
H2O (200 mL) and extracted with EtOAc (200 mL x 3). The combined organic extracts were 
washed with brine, dried (Na2SO4), concentrated  in vacuo and purified directly by flash 
chromatography (19:1 hexanes:EtOAc) to yield dimethyl 5-(cyclohexylmethylene)cyclopenta-
1,3-diene-1,2-dicarboxylate (978 mg, 3.5 mmol, 3% yield from cyclopentadiene). 1H NMR (300 
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MHz, DMSO-d6) δ 7.04 (d, J = 10.2 Hz, 1H, Cp=CHCy), 6.88 (d, J = 5.4 Hz, 1H, CpH), 6.66 (d 
of d, J = 1.3 Hz, 5.4 Hz, 1H, CpH), 3.75 (s, 3H, CO2CH3), 3.74 (s, 3H, CO2CH3), 2.85 (m, 1H, 
Cp=CH-CyH), 1.69-1.10 (m, 10H, CyH). 13C NMR (75 MHz, CDCl3) δ 164.9, 164.8, 157.3, 
140.8, 137.9, 129.6, 129.2, 122.3, 51.8, 40.9, 32.5, 25.6, 25.1. 
Methyllithium (8.8 mL, 14.4 mmol) was added via a syringe to a slurry of copper(I) 
iodide (1.337 g, 7.02 mmol) in 100 mL Et2O at –10 °C. The reaction mixture was stirred for 1 hr 
before being cooled to –30 °C. A 5 mL solution of 5-(cyclohexylmethylene)cyclopenta-1,3-
diene-1,2-dicarboxylate (978 mg, 3.5 mmol) in Et2O was added dropwise over 15 minutes, and 
the reaction mixture was immediately quenched with sat. NH4Cl (100 mL), acidified to pH 1 
with 1 M HCl, and extracted with EtOAc (100 mL x 3). The combined organic extracts were 
washed with H2O, brine and dried over Na2SO4. Concentration in vacuo and purification by 
column chromatography (19:1 hexanes:EtOAc) furnished the title compound as a mixture of 
olefin isomers (573 mg, 1.96 mmol, 56% yield).  NMR data is reported as the sodium salt of the 
title compound obtained by treatment with sodium hydride and extraction with 
dimethylsulfoxide. 1H NMR (300 MHz, DMSO) δ 6.16 (d, J = 3.5 Hz, 1H, CpH), 5.37 (d, J = 3.5 
Hz, 1H, CpH), 3.50 (s, 3H, CO2CH3), 3.46 (s, 3H, CO2CH3), 2.95 (quintet, J = 6.9 Hz, 1H, 
CpC(Me)(Cy)H), 1.70-1.50 (m, 5H, CyH), 1.25-0.82 (m, 6H, CyH), 1.01 (d, J = 6.9 Hz, 2H, 
CpC(CH3)CyH);  13C NMR (75 MHz, DMSO) δ 168.3, 166.0, 137.5, 116.6, 110.3, 109.4, 106.7, 
49.2, 49.0, 44.6, 36.6, 31.33, 29.5, 26.5, 26.4, 18.7; IR (thin film) 2926, 2848, 1739, 1709, 1539, 
1435, 1257 cm-1; HRMS (EI+) m/z = 292.1675 calcd for C17H24O4 [M]+, found 292.1661. 
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Methyl 3-tert-butylcyclopenta-1,3-dienecarboxylate (40). A solution of 6,6-dimethylfulvene2 
(22.61 g, 213.0 mmol) in 500 mL Et2O was cooled to 0 °C and slowly treated with methyllithium 
(139.8 mL, 1.6 M in Et2O, 223.0 mmol). The solution was warmed to room temperature and 
stirred for 1 hr. After cooling back to 0 °C, methyl chloroformate (32.91 mL, 425 mmol) was 
added and the solution was stirred for 1 hr. The reaction was then quenched with 500 mL H2O 
and extracted with Et2O (250 mL x 3). The combined organic extracts were washed with brine, 
dried (MgSO4), concentrated in vacuo, and purified by flash chromatography (10:1 
hexanes:Et2O) to yield the title compound as a yellow oil (6.43 g, 35.67 mmol, 19% yield) as a 
mixture of two olefin isomers (3:2 ratio). 1H NMR (300 MHz, CDCl3) δ 7.50 (q, J = 1.7 Hz, 1H, 
CpH, minor), 7.31 (q, J = 2.2 Hz, 1H, CpH, major), 6.23 (m, 1H, CpH, major and minor), 3.80 
(s, 3H, CO2CH3, minor), 3.77 (s, 3H, CO2CH3, major), 3.31 (m, 2H –CH2-, major), 3.28 (t, J = 
1.6 Hz, 2H, –CH2-, minor), 1.20 (s, 9H, C(CH3)3, major), 1.18 (s, 9H, C(CH3)3, minor);  13C 
NMR (75 MHz, CDCl3) δ 167.4, 164.7, 156.9, 143.1, 142.9, 137.6, 134.3, 129.1, 124.0, 51.1, 
51.0, 40.4, 40.0, 33.8, 32.1, 30.6, 29.6; IR (thin film) 2961, 1713, 1530, 1435, 1357, 1239, 1104 
cm-1; HRMS (FAB+) m/z = 180.1150 calcd for C11H16O2 [M]+, found 180.1159. 
 
Synthesis of fulvenes 
Dimethyl 2-benzylidene-4,5-diphenylcyclopenta-3,5-diene-1,3-dicarboxylate (37). Dimethyl 
4,5-diphenylcyclopenta-3,5-diene-1,3-dicarboxylate (50 mg, 0.15 mmol) was dissolved in 1 ml 
THF.  Benzaldehyde (15 µL, 0.15 mmol) and cyclohexylamine (1.7 µL, 0.015 mmol) were added 
and the reaction mixture was stirred overnight at room temperature.  The solvent was removed  
in vacuo and the resulting residue was purified by flash chromatography (4:1 hexanes:EtOAc) to 
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yield the title compound (52 mg, 0.12 mmol, 80% yield) as bright yellow crystals.  1H NMR (300 
MHz, CDCl3) δ 8.50 (s, 1H, Cp=CH-Ar), 7.40-7.50 (m, 5H, ArH), 7.20  (m, 6H, ArH), 7.06 (m, 
4H, ArH), 3.64 (s, 3H, CO2CH3), 3.02 (s, 3H, CO2CH3); 13C NMR (75 MHz, CDCl3) δ 166.3, 
165.2, 150.7, 150.6, 145.1, 139.3, 137.0, 134.4, 133.1, 130.3, 129.6, 129.4, 129.2, 128.3, 127.8, 
127.6, 127.3, 126.7, 124.5, 51.3, 51.1; IR (thin film) 2948, 1721, 1595, 1571, 1434, 1384, 1355, 
1257, 1214, 1193, 1166, 1126, 1075, 1028, 997, 759, 698 cm-1; HRMS (FAB+) m/z = 422.1518 
calcd for C28H23O4 [M]+, found 422.1524. 
 
Dimethyl 2-(4-nitrobenzylidene)-4,5-diphenylcyclopenta-3,5-diene-1,3-dicarboxylate. N-(4-
nitrobenzylidene)aniline (68 mg, 0.30 mmol) was dissolved in THF (3 mL).  Dimethyl 4,5-
diphenylcyclopenta-3,5-diene-1,3-dicarboxylate (100 mg, 0.30 mmol) was then added and the 
resulting mixture was stirred at room temperature for 1 hr.  Solvent was removed  in vacuo and 
the resulting residue was purified by flash chromatography (4:1 hexanes:EtOAc) to yield the title 
compound (83 mg, 0.18 mmol, 60% yield) as a bright orange solid.  1H NMR (300 MHz, CDCl3) 
δ 8.46 (s, 1H, Cp=CH-Ar), 8.29 (d, J = 6.6 Hz, 2H, ArH), 7.63 (d, J = 6.3 Hz, 2H, ArH), 7.24 
(m, 6H, ArH), 7.04 (d, J = 5.1 Hz, 4H, ArH), 3.65 (s, 3H, CO2CH3), 3.09 (s, 3H, CO2CH3); 13C 
NMR (75 MHz, CDCl3) δ 165.8, 164.9, 152.4, 152.1, 147.7, 143.2, 141.5, 140.9, 133.9, 132.6, 
130.7, 129.3, 129.1, 128.3, 128.1, 127.5, 126.1, 124.4, 123.3, 51.4, 51.4; IR (thin film) 1721, 
1592, 1520, 1435, 1383, 1345, 1258, 1215, 1193, 1165, 995, 849, 756, 699 cm-1; HRMS (FAB+) 
m/z = 467.1369 calcd for C28H22NO6 [M]+, found 467.1381. 
 
Dimethyl 2-(4-methoxybenzylidene)-4,5-diphenylcyclopent-3,5-diene-1,3-dicarboxylate. 
Dimethyl 4,5-diphenylcyclopenta-3,5-diene-1,3-dicarboxylate (50 mg, 0.15 mmol) was dissolved 
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in 1 ml THF.  Anisaldehyde (27 µL, 0.23 mmol) and cyclohexylamine (1.7 µL, 0.015 mmol) 
were added and the reaction mixture was allowed to stir overnight at room temperature. Solvent 
was removed in vacuo and the resulting residue was purified by flash chromatography (4:1 
hexanes:EtOAc) to furnish the title compound (40 mg, 0.088 mmol, 59% yield) as bright orange 
crystals.  1H NMR (300 MHz, CDCl3) δ 8.43 (s, 1H, Cp=CH-Ar), 7.49 (d, J = 8.7 Hz, 2H, ArH), 
7.21 (m, 6H, ArH), 7.07 (m, 4H, ArH), 6.97 (d, J = 8.7 Hz, 2H, ArH), 3.87 (s, 3H, CO2CH3), 
3.64 (s, 3H, CO2CH3), 3.16 (s, 3H, ArOCH3); 13C NMR (75 MHz, CDCl3) δ 166.7, 165.5, 161.3 
150.2, 149.7, 145.4, 137.6, 134.8, 133.5, 133.0, 132.8, 129.9, 129.7, 129.3, 129.1, 127.3, 126.5, 
124.7, 114.4, 114.0, 113.7, 51.3; IR (thin film) 1719, 1590, 1509, 1433, 1356, 1306, 1255, 1165, 
1085, 1027 cm-1; HRMS (FAB+) m/z = 452.1624 calcd for C29H25O5 [M]+, found 452.1600. 
 
(E)-Dimethyl 4,5-diphenyl-2-(3-phenylallylidene) cyclopenta-3,5-diene-1,3-dicarboxylate. 
Dimethyl 4,5-diphenylcyclopenta-3,5-diene-1,3-dicarboxylate (50 mg, 0.15 mmol) was dissolved 
in 1 ml THF.  Trans-cinnamaldehyde (21 µL, 0.17 mmol) and cyclohexylamine (1.7 µL, 0.015 
mmol) were added and the reaction was allowed to stir overnight at room temperature. Solvent 
was removed in vacuo and the resulting residue was purified by flash chromatography (4:1 
hexanes:EtOAc) to yield the title compound (44 mg, 0.098 mmol, 65% yield) as bright orange 
crystals.  1H NMR (300 MHz, CDCl3) δ 8.08 (d, J = 12.0 Hz, 1H, Cp=CH-CH=CHPh), 7.68 (dd, 
J = 12.3, 15.0 Hz, 1H, Cp=CH-CH=CHPh), 7.56 (m, 2H, ArH), 7.41 (m, 3H, ArH), 7.23 (m, 7H, 
Cp=CH-CH=CHPh + ArH), 7.05 (m, 4H, ArH), 3.75 (s, 3H, CO2CH3), 3.64 (s, 3H, CO2CH3); 
13C NMR (75 MHz, CDCl3) δ 168.6, 165.6, 149.4, 148.2, 146.4, 144.0, 137.4, 136.4, 135.0, 
134.2, 130.1, 129.5, 129.2, 129.1, 128.1, 127.8, 127.7, 127.6, 127.5, 125.7, 125.4, 124.5, 52.2, 
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51.4; IR (thin film) 1702, 1598, 1578, 1434, 1361, 1263, 1220, 1193, 1163, 1086 cm-1; HRMS 
(FAB+) m/z = 448.1675 calcd for C30H25O4 [M]+, found 448.1693. 
 
Dimethyl 2-(cyclohexylmethylene)-4,5-diphenylcyclopenta-3,5-diene-1,3-dicarboxylate. 
Dimethyl 4,5-diphenylcyclopenta-3,5-diene-1,3-dicarboxylate (50 mg, 0.15 mmol) was dissolved 
in 1 ml THF.  Cyclohexanecarboxaldehyde (27 µL, 0.23 mmol) and cyclohexylamine (3.4 µL, 
0.030 mmol) were added and the reaction mixture was allowed to stir overnight at room 
temperature. Solvent was removed in vacuo and the resulting residue was purified by flash 
chromatography (4:1 hexanes:EtOAc) to yield the title compound (49 mg, 0.11 mmol, 73% 
yield) as bright yellow crystals.  1H NMR (300 MHz, CDCl3) δ 7.32 (d, J = 10.8 Hz, 1H, 
Cp=CH-Cy), 7.16 (m, 6H, ArH), 6.99 (m, 4H, ArH), 3.69 (s, 3H, CO2CH3), 3.57 (s, 3H, 
CO2CH3), 2.63 (m, 1H, Cp=CH-CHR2), 1.82 (m, 5H, CH2), 1.30 (m, 5H, CH2);  13C NMR (75 
MHz, CDCl3) δ 168.5, 165.5, 155.5, 149.4, 147.1, 137.0, 134.8, 133.7, 129.3, 129.2, 127.9, 
127.8, 127.6, 127.5, 126.6, 124.2, 52.2, 51.3, 40.4, 32.7, 25.8, 25.5; IR (thin film) 2929, 2851, 
1724, 1704, 1623, 1434, 1391, 1365, 1258, 1234, 1220, 1194, 1171, 1144, 1128, 994, 699 cm-1; 
HRMS (FAB+) m/z = 428.1988 calcd for C28H29O4 [M]+, found 428.1980. 
 
Dimethyl 1-benzylidene-4,5,6,7-tetrahydro-1H-indene-2,3-dicarboxylate. Dimethyl 4,5,6,7-
tetrahydro-1H-indene-2,3-dicarboxylate (100 mg, 0.42 mmol) was dissolved in 3 mL THF. 
Benzaldehyde (0.13 mL, 1.26 mmol) was added, followed by cyclohexylamine (10 µL, 0.08 
mmol) and the reaction mixture  was allowed to stir for 48 hr at room temperature. Solvent was 
removed in vacuo and the resulting residue was purified by flash chromatography (9:1 
hexanes:EtOAc) to yield the title compound as a red oil (100 mg, 74% yield, 2:1 E:Z). 1H NMR 
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(300 MHz, CDCl3) δ 8.23 (s, 1H, Cp=CH-Ar E isomer), 7.52 (s, 1H, Cp=CH-Ar Z isomer), 7.4-
7.3 (m, 5H, ArH, E/Z isomers), 3.88 (s, 3H, CO2CH3, E isomer), 3.83 (s, 3H, CO2CH3, E 
isomer), 3.79 (s, 3H, CO2CH3, Z isomer), 3.27 (s, 3H, CO2CH3 Z isomer), 2.51 (m, 2H, -CH2- E 
isomer), 2. 42 (m, 4H, 2 x -CH2- Z isomer), 2.05 (m, 2H, -CH2- E isomer), 1.77 (m, 4H, 2 x -
CH2- Z isomer), 1.69 (m, 2H, -CH2- E isomer), 1.49 (m, 2H, -CH2- E isomer). 13C NMR (75 
MHz, CDCl3) δ 166.5 Z, 166.4 E, 164.7 Z, 164.3 E, 143.7, 141.8, 141.4, 141.0, 140.0, 139.3, 
137.0, 136.1, 135.9, 133.6, 133.4, 130.0, 129.4, 129.1, 128.9, 128.1, 128.0, 125.2, 51.9 E, 51.6 
E/Z, 51.3 Z, 26.4 E, 23.8 Z, 23.5 E, 23.0 Z, 22.9 E, 22.3 Z, 22.0 E, 21.7 Z; IR (thin film) 2939, 
2857, 1730, 1713, 1609, 1535, 1435, 1270, 1222, 1122 cm-1; HRMS (EI+) m/z = 324.1362 calcd 
for C20H20O4 [M]+, found 324.1353. The substitution patterns on the fulvenes were confirmed by 
NOESY. 
 
(E)-dimethyl 5-benzylidene-3-(1-cyclohexylethyl) cyclopenta-1,3-diene-1,2-dicarboxylate. 
Dimethyl 3-(1-cyclohexylethyl)cyclopenta-1,3-diene-1,2-dicarboxylate (100 mg, 0.34 mmol) 
was dissolved in 4 mL THF. Benzaldehyde (105 µL, 1.03 mmol) and cyclohexylamine (8 µL, 
0.07 mmol) were added and the reaction mixture was stirred at room temperature overnight. 
Solvent was removed in vacuo and the resulting residue was purified by flash chromatography 
(19:1 hexanes:EtOAc) to yield the title compound as a deep red oil (130 mg, 0.34 mmol, 100% 
yield). 1H NMR (300 MHz, CDCl3) δ 8.22 (s, 1H, Cp=CH-Ar), 7.60-7.56 (m, 2H, ArH), 7.48-
7.40 (m, 3H, ArH), 6.56 (s, 1H, CpH), 3.88 (s, 3H, CO2CH3), 3.83 (s, 3H, CO2CH3), 2.51 (quint, 
J = 6.9 Hz, 1H, CpCH(CH3)(Cy), 1.73-1.67 (m, 5H, CyH), 1.39-0.88 (m, 6H, CyH), 1.15 (d, J = 
7.0 Hz, 3H, CpCH(CH3)(Cy); 13C NMR (75 MHz, CDCl3) δ 167.3, 163.8, 151.5, 144.2, 143.6, 
139.9, 136.5, 131.2, 129.9, 128.7, 124.9, 120.6, 52.0, 51.6, 42.6, 38.3, 31.7, 29.1, 26.6, 26.4, 
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16.6; IR (thin film) 2926, 2848, 1735, 1709, 1613, 1513, 1430, 1287, 1239, 1222, 1057 cm-1; 
HRMS (FAB+) m/z = 380.1988 calcd for C24H28O4 [M]+, found 380.2000. The substitution 
pattern on the fulvene was confirmed by NOESY. 
 
(E)-methyl 5-benzylidene-3-tert-butylcyclopenta-1,3-dienecarboxylate. Methyl 3-tert-
butylcyclopenta-1,3-dienecarboxylate (100 mg, 0.56 mmol) was dissolved in 4 mL THF. 
Benzaldehyde (0.12 mL, 1.20 mmol) and triethylamine (0.80 mL, 0.60 mmol) were added and 
the reaction mixture was stirred at room temperature for 48 hours. Solvent was removed in vacuo 
and the resulting residue was purified by flash chromatography (19:1 hexanes:EtOAc) to yield 
the title compound (130 mg, 0.48 mmol, 86% yield). 1H NMR (300 MHz, CDCl3) δ 8.32 (s, 1H, 
Cp=CHAr), 7.60-7.57 (m, 2H, ArH), 7.50 (d, J = 1.6 Hz, 1H, CpH), 7.44-7.40 (m, 3H, ArH), 
6.57 (d, J = 1.5 Hz, 1H, CpH), 3.84 (s, 3H, CO2CH3), 1.22 (s, 9H, CpC(CH3)3); 13C NMR (75 
MHz, CDCl3) δ 164.4, 157.4, 141.5, 141.3, 140.9, 137.0, 130.8, 129.1, 128.6, 126.1, 118.9, 50.9, 
32.2, 29.6; IR (thin film) 3061, 2952, 2861, 1700, 1613, 1565, 1504, 1343, 1148, 1052 cm-1; 
HRMS (FAB+) m/z = 268.1463 calcd for C18H20O2 [M]+, found 268.1448. The substitution 
pattern on the fulvene was confirmed by NOESY. 
 
Dimethyl 1-(4-nitrobenzylidene)-4,5,6,7-tetrahydro-1H-indene-2,3-dicarboxylate. Dimethyl 
4,5,6,7-tetrahydro-1H-indene-2,3-dicarboxylate (100 mg, 0.42 mmol) was dissolved in 3 mL 
THF. 4-Nitrobenzaldehyde (190 mg, 1.26 mmol) was then added, followed by cyclohexylamine 
(10 µL, 0.08 mmol) and the reaction mixture was allowed to stir for 48 hr at room temperature. 
Solvent was removed in vacuo and the resulting residue was purified by flash chromatography 
(9:1 hexanes:EtOAc) to yield the title compound as a 3:2 E:Z mixture as a red oil (90 mg, 58% 
	   531 
yield). 1H NMR (300 MHz, CDCl3) δ 8.24-8.18 (m, 5H, ArH/Cp=CHAr), 7.51-7.42 (m, 5H, 
ArH/ Cp=CHAr), 3.86 (s, 3H, CO2CH3 E), 3.81 (s, 3H, CO2CH3 E), 3.78 (s, 3H, CO2CH3 Z), 
3.30 (s, 3H, CO2CH3 Z), 2.47 (m, 4H, 2 x -CH2- Z), 2.36 (m, 2H, -CH2- E), 1.90 (m, 2H, -CH2- 
E), 1.75 (m, 4H, 2 x –CH2- Z), 1.65 (m, 2H, -CH2- E), 1.46 (m, 2H, -CH2- E); 13C NMR (75 
MHz, CDCl3) δ 166.2, 165.9, 164.4, 163.7, 147.7, 143.8, 142.9, 142.3, 141.6, 141.3, 139.8, 
138.7, 135.9, 133.8, 133.4, 130.6, 130.0, 128.2, 124.2, 123.3, 123.1, 52.1, 51.9, 51.8, 51.7, 26.4, 
23.7, 23.4, 22.7, 22.2, 21.8, 21.7; IR (thin film) 2948, 2857, 1735, 1709, 1596, 1522, 1435, 1348, 
1265, 1217, 1121 cm-1; HRMS (FAB+) m/z = 369.1212 calcd for C20H19NO6 [M]+, found 
369.1227. 
 
General procedure for fulvene:imine interchange experiments 
Forward. Stock solutions (1-2 mL) of imine (0.30 M), cyclopentadiene (0.30 M) and benzyl 
ether (0.30 M) in CDCl3 were prepared fresh. To an NMR tube, 0.20 mL of each solution was 
added and mixed. The fulvene:imine ratio was monitored by 1H NMR until no change in the 
ratio was observed. See attached NMR spectra. 
Reverse. Stock solutions (1-2 mL) of fulvene (0.30 M), amine (0.30 M) and benzyl ether (0.30 
M) in CDCl3 were prepared fresh. To an NMR tube, 0.20 mL of each solution was added and 
mixed. The fulvene:imine ratio was monitored by 1H NMR and reported at the equilibrium time 
determined for the forward reaction. See attached NMR spectra. 
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